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Abstract 
A global lack of pain and palliative care services means that millions of people each year spend their 
last weeks and days suffering serious, but avoidable physical and psychological pain. More usually 
understood as a national issue, this multiple methods study considers why palliative care should be 
considered an issue for the international development community. 
Use of Global Social Policy as a theoretical lens to view development reveals opportunities for 
palliative care to make gains within the incoming global health priority of achieving Universal Health 
Coverage. It is argued that there is a need to move beyond consideration of palliative care as a moral 
concern towards new ways of ‘framing’ the issue. Presentation of palliative care as being 
economically beneficial is therefore encouraged. By doing so may allow the presentation of palliative 
care as an important element of international development and attract new funding streams. 
A systematic review reveals a lack of ‘international evidence’ for palliative care, particularly in low 
and middle income countries. More encouragingly, opportunities are revealed for existing policies 
and practices to be ‘transferred’ to other similar settings. Yet, an analysis of the national contexts 
from which palliative care has (and has not) developed shows that countries which have not 
developed palliative care are likely to face significant challenges in the delivery of basic healthcare. 
This raises serious questions regarding how such countries can also integrate palliative care into 
their health systems. 
International palliative care experts were consulted to find out how they thought the field can move 
forwards through global advocacy. The far-reaching benefits of palliative care encourage the need 
for palliative care to be constructed in new ways. However ongoing disunity regarding whether 
palliative care is a long term approach or an end of life intervention threatens to undermine how 
activists can construct tractable arguments for palliative care to policymakers. 
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Chapter One  
High Level Overview of the Thesis 
 
Globally, over 60 million people die each year, many of whom do so having spent their last days and 
weeks of life enduring extreme suffering due to a lack of pain treatment and appropriate care.i In a 
context of increasing and ageing global populations, these numbers are set to rise with increased 
strains placed upon health systems threatening their very sustainability.ii In this regard, this thesis 
considers how palliative care can contribute to alleviating these global social problems. 
 
The thesis starts [Chapter Two] by examining claims that there is a global need for palliative care. 
This need is shown to occur due to a lack of availability of pain treatment, as well as medical 
approaches which focus upon aggressive treatment at the expense of delivering appropriate care.iii 
National studies are identified which show that palliative care is an approach which can improve the 
quality of life of people living with serious illness and their families as well as reduce overall costs to 
health systems.iv Yet, in spite of this value proposition and the fact that palliative care services now 
exist in 136 of the world’s 234 countries, there remains a significant gap between supply and 
demand for services.iii Existing narratives of palliative care development have focussed upon 
national-level processes and this chapter shows that there has been little global leadership.  
 
Prioritisation by global health actors is however, shown to hold the potential to significantly 
accelerate palliative care development, through global regulations, resolutions and financing.v In this 
regard, in 2014 the World Health Assembly passed a Resolution calling for national governments to 
integrate palliative care into health systems.vi However, although there are suggestions that access 
to palliative care should be a universal human right, the field remains under-theorised, 
underfinanced and underdeveloped. Chapter Two therefore concludes by presenting the overall 
research question of the study: 
 
Can the global development of palliative care be furthered through increased understanding 
of global policymaking processes and the presentation of palliative care as an international 
development issue? 
 
Chapter Three moves on to apply a Global Social Policy (GSP) perspective to palliative care 
development. Key actors in global health are identified as well as their relative potential to influence 
health policies and practices within nations. Competing narratives are presented for how policies 
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and practices spread internationally.viiviii Additionally, it is suggested that in order to attract global 
financing,  advocacy needs to move beyond conceptualisations of palliative care as a human rights 
issue and use different ‘frames’ with which to influence diverse policymakers. Importantly, it is 
noted that global health policies are often formulated due to considerations of; economic utility, 
available evidence, the severity of problems as well as how straightforward they may be to solve.ix 
 
Chapter Four presents the overall methodological approach and the multiple methods design used 
to allow this research question to be answered. To do so, tenets are drawn from positivism to inform 
a largely interpretivist project. Justification is provided for an iterative research process which saw 
the adoption of diverse methods; systematic review, quantitative analysis using correlations and 
qualitative interviewing of key experts in the field of international palliative care. Detailed 
consideration of each of these methods is presented in subsequent chapters. It is also made clear 
that a GSP perspective will be adopted throughout the study as a theoretical lens through which to 
understand the place of palliative care within broader global health discourses.v 
 
Chapter Five presents a systematic mapping review of international palliative care research. This 
chapter uncovers the extent to which researchers are providing internationally relevant evidence of 
the transferability of palliative care policies and practices. Additionally, whilst research capacity in 
low and middle income countries is low, the extent to which researchers from richer nations are 
supplementing the evidence base for palliative care in other settings is examined. It is shown how 
there is little international economic evidence for palliative care and little interventional research 
which advocates can present to policymakers. Additionally, studies are identified which consider 
‘model services’. That is, instances of good practice which researchers profess may be relevant in 
other resource-similar settings.x  
 
Chapter Six moves on to consider such claims and investigates the structural contexts in which 
palliative care has (and has not) developed to a high level. A broad range of indicators are used, 
drawn from several development domains (disease demographics, health systems, socioeconomics, 
country demographics, politics and economics) to consider their relationship with palliative care 
development. It is shown that nations which are ‘similar,’ in terms of political context, demographics 
and socioeconomic indicators of development, have developed palliative care to similar levels. 
Whilst this raises the possibility that palliative care models may be transferrable to other ‘similar’ 
settings, it is also shown that nations which have not developed services are likely to face serious 
challenges in the provision of welfare services more broadly. It is therefore reiterated, that in order 
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for the 2014 WHA Resolution to be implemented and for palliative care to be considered a priority 
within the new global health priority of achieving Universal Health Coverage, that focussed advocacy 
is required in order to draw the attention of policymakers and global funding agencies to the 
importance of palliative care. 
 
Chapter Seven builds on these findings by eliciting the views of experts in the field of international 
palliative care regarding the adequacy of existing global advocacy efforts and how these efforts may 
be refined in order to progress development. Six thematic categories were generated based upon 
participant responses which reveal both serious barriers and opportunities for the field of palliative 
care to move forwards. These are: 1) Education; changing the culture of medicine; 2) Palliative care 
as an area of global need; 3) Broad benefits of palliative care and the consequences of its absence; 4) 
Prioritisation within health systems and organization of services; 5) Global Policies, Leadership and 
Actors for change; and 6) Framing palliative care. 
 
Within this chapter, a wide range of opportunities are also identified for the further development of 
palliative care. Notably, ‘improving access to pain treatment’ is identified as the most pressing and 
solvable problem. Yet, many of the arguments presented by participants had a ‘time dependency’. 
That is to say, almost all ‘benefits’ of palliative care suggested by participants, were contingent on its 
introduction either as a long term or intervention or as end of life care. This lack of clarity regarding 
just what palliative care is, is identified as the most serious tension within the field.  
 
In Chapter Eight, the thesis concludes by arguing that in spite of clear global need, there are serious 
questions regarding the development model which palliative care has followed. There is an apparent 
ongoing reliance upon individual ‘pioneers’ and organizations, which provide short-term funding, 
leaving palliative care facing an uncertain future. In this regard, key implications of the study are 
presented for; the organization of services, the research community, policy and advocacy. Innovative 
suggestions are made for how the problem of lack of palliative care can be re-defined. Strategic 
advice is also presented for how researchers can equip advocates with policy-relevant evidence to 
appeal to different national and global health policymakers. 
 
Note on the text: to aid the reader, references are presented at the end of each chapter to allow 
easy cross-referencing. 
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Chapter Two 
Understanding the global need for palliative care 
 
Introduction 
 
Each year, worldwide close to 60 million people die from serious illness.i Many of these people 
spend the last few days and weeks of their lives enduring extreme suffering due to a lack of 
appropriate care and pain treatment. ii  As the world’s population increases, the number of people 
who will endure extreme suffering at the end of life will also increase if appropriate interventions 
are not developed to aid these people. Palliative care, a complex intervention comprising of 
“treatment of pain and other problems, physical, psychosocial and spiritual [WHO, 2015]”xviii has 
been suggested as a feasible and appropriate intervention in order to meet the needs of people 
living with serious and life-threatening illnesses.  However, globally palliative services remain 
underdeveloped and the need for palliative care sits alongside many other global health challenges 
with valid claims for policy attention.iii Furthermore, in recent times, global health efforts have 
focussed upon increasing life expectancy through attempts to eradicate illness such as malaria,iv 
rather than on providing appropriate care to people undergoing the universal experience of dying.  
 
This study emerged to answer questions regarding the seriousness of the problem of absence of 
palliative services as well as to consider if palliative care development should be prioritised as a 
global health issue. There is demonstrable global need for palliative care, seen most clearly by the 
overwhelming lack of access to pain-relieving medications for people suffering from conditions 
which are known to cause severe pain.v However, the current rate of global development is 
inadequate for meeting the needs of patients and families for pain and palliative treatments. 
Moreover, existing conceptualisations of how services have developed focus upon community action 
or nation-level leadership and there is an apparent lack of global leadership for palliative care.vi 
 
Global health actors and policies wield significant influence over national health systems 
worldwide.vii However, the broad absence of engagement from global level actors with palliative 
care issues may be considered a significant limiter on development. Moreover, existing explanations 
for the global development of palliative care, fail to take into account forces which operate at global 
level to shape national healthcare policies and practices. That is, current accounts of how palliative 
6 
 
care has developed, do not draw upon theoretical approaches to understanding global policymaking 
processes, nor the place of palliative care within broader global discourses on health. 
 
On this basis, a Global Social Policy (GSP) theoretical stance was adopted throughout the study. GSP 
is a discipline which places a high level of importance upon how global level forces operate to 
influence policies and practices within nations.vii Further detail will be given regarding the theoretical 
underpinnings of GSP in Chapter Three, however, in brief, GSP scholars seek to understanding 
competing explanations for how and why certain policy issues are prioritised over and above other 
valid claims. Increased understanding of such issues may be fruitful in furthering the global 
development of palliative care. 
 
Advocates profess that absence of palliative care is a human rights issue.viii Indeed this study 
emerged from personal experiences witnessing the severity of suffering which people endure due to 
the absence of services as well as the wide-reaching benefits which follow the introduction of 
palliative care. Palliative care is however a relatively new field of healthcare, the professed benefits 
of which are not generally well understoodix and on this basis, a critical standpoint was adopted 
throughout the study: viewing palliative care not from a vested interest but from a position outside 
the field to consider the strength of the evidence-base for palliative care. This also allows an 
unbiased position through which to assess the validity and clarity of the arguments which activists 
deliver to policymakers in order to advance the field through advocacy. 
 
Conceptualising the past and potential future development of this emergent field of healthcare 
raises a series of important and diverse questions. Key questions addressed within the study centre 
around how palliative care has developed internationally thus far, how further rollout of services 
may be accelerated as well as how to overcome the significant barriers which exist to further 
development. Moreover, palliative care is considered as a healthcare issue more broadly, in terms of 
its place and importance alongside other global healthcare challenges. As such, this study adopted 
an iterative methodological approach, which saw different research methods utilised in order to 
answer emerging questions.  
 
Different questions and arguments emerged throughout this thesis. However the first stage was to 
develop an overarching research question for the study. In order to do so, it is first important to 
establish what palliative care is, what its benefits are and what problems are caused by its absence. 
Moreover, given that the first articulation of ‘palliative care’ was made only in the 1960s, it is 
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appropriate to consider what is known about how palliative care as a modern multidisciplinary 
practice has spread internationally.x 
 
What is palliative care? 
 
Palliative care is the term used to describe a multidisciplinary approach to treating and caring for 
people living with serious and life-threatening illnesses and their families/support systems.xviii It is an 
approach to the treatment of people living with serious illnesses which recognises that illness 
impacts upon quality of life across multiple dimensions and can lead to pain and other physical 
symptoms as well as psychosocial and spiritual suffering. Palliative medicine is now recognised as a 
medical specialty or sub-specialty in several countries and may be delivered in all healthcare settings 
as well as in patients’ homes.xi However ‘hospices’ are the clearest example of institutions where 
palliative care is delivered. The first modern hospice was established in the United Kingdom [UK] by 
Cicely Saunders in the 1960s and services now exist in all regions of the world although there are 
significant inequalities and inequities of access both between and within nations.xii 
 
The discipline of palliative care emerged from a recognition that often medical practitioners’ 
approach to treatment is to focus upon curative treatment of illness, without acknowledgment of 
the need to address broader symptoms and suffering. Here, Eric Cassel, an oncologist and seminal 
actor in the early development of palliative care in North America in the 1980’s describes this 
circumstance: 
 
Suffering is experienced by persons, not merely by bodies, and has its source in challenges 
that threaten the intactness of the person as a complex social and psychological entity. 
Suffering can include physical pain but is by no means limited to it. The relief of suffering and 
the cure of disease must be seen as the twin obligation of a medical profession that is truly 
dedicated to the care of the sick. Physicians’ failure to understand the nature of suffering 
can result in medical intervention that (though technically adequate) not only fails to relieve 
suffering but becomes a source of suffering itself [1982. P639.]xiii 
 
In the 1960s the founder of the modern hospice movement, Cicely Saunders, termed suffering of 
this manner ‘total pain’ - a term which continues to be used today.xiv Dating the origins of palliative 
care to this period serves as a reminder that this is a relatively new field of healthcare. 
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Palliative care is deemed to be appropriate for all children and adults living with a serious illness.ii 
Historically, it has been considered as an end of life intervention (i.e. provided to people very close 
to death). However, more recently it has been argued that it should be commenced upon diagnosis 
of a serious illness alongside curative efforts.xv Thus, palliative care may be considered an 
appropriate intervention from the point of diagnosis, up to and beyond bereavement. Another 
historical legacy is that palliative care was once considered appropriate only for cancer patients, 
however, this understanding has been altered and it is said to be a form of care which is appropriate 
for any person living with a serious, life-threatening condition including both infectious and non-
communicable diseases.xvi In addition to holistic care of patients, palliative care acknowledges that 
illness affects not only patients, but also impacts negatively upon the health and wellbeing of their 
families who often act as informal carers. Therefore palliative care treats ‘patients, families and lay 
carers’ as the unit of care.xvii  
 
Despite associations with the end of life, palliative care is a complex intervention comprising 
different elements addressed below, which ‘aims to neither hasten nor postpone death’, and ‘treats 
dying as a normal process’ though may be introduced from diagnosis.xviii The most widely used 
definition of ‘palliative care’ was articulated by the World Health Organization (WHO) as: 
 
An approach that improves the quality of life of patients and their families facing the 
problem associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and treatment of pain 
and other problems, physical, psychosocial and spiritual [WHO, 2002].xviii 
 
The term may be considered problematic, due to conflicting definitions of ‘palliative care’ as well as 
conflicting and complementary additional terms, such as ‘hospice’ and ‘end of life care’, which are 
often inappropriately used interchangeably.xixIn North America for instance, ‘hospice care’ is 
something which is seen as being a distinct form of palliative carexx, whereas in other settings, 
hospices are perceived as institutions which deliver palliative care, often towards the end of life 
rather than from diagnosis.xxi 
 
Palliative care is often delivered by a multi-disciplinary field and may be considered to be a ‘complex 
intervention’ in that it is “made up of many components that act both on their own and in 
conjunction with each other [Nazareth I, 2015]”.xxii This complexity presents challenges to the field 
both in terms of service delivery, with care often delivered in formal (i.e. hospitals) as well as 
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informal (patients’ homes) healthcare contexts.xxiii Additionally, research and evaluation of palliative 
care is complex owing to the wide range of potential outcomes of interest.xxiv  
 
Challenges to service delivery internationally  
 
That palliative care services exist in only 136 of the world’s 234 countries, hints at both a lack of 
awareness of palliative care as well as the significant challenges in terms of delivering the multiple 
elements which comprise ‘palliative care’.ii A clear example of a barrier which exists to the delivery 
of pain treatment is that many national governments continue to prohibit the use of essential pain-
relieving opioid medications through regulations.xxv Often this circumstance arises due to a lack of 
awareness of the benefits to patients of opioids such as morphine, amongst policymakers and 
medical professionals as well as due to fears of misuse and addiction.xxvi However, in spite of 
convincing evidence of the efficacy of opioid medications for the treatment of pain, negative 
attitudes towards them persist.xxvii Fears of misuse are reinforced by the global regulation of opioids 
by the International Narcotics Control Board (INCB), which serves to limit access to opioids by 
treating them as ‘drugs’ rather than enabling their availability as ‘medicines’.xxviii 
 
Further challenges to service delivery exist in terms of a broad lack of palliative care awareness and 
education amongst health care professionals internationally, which means that there is a lack of 
human resources to deliver care.xxix Moreover, formulating and evaluating ‘best practice’ in palliative 
care is challenging due to the diversity of the palliative care patient population and need for services 
to be both context-specific and patient centred. For instance, additional challenges are said to exist 
in providing palliative care to rural populations.xxx Additionally, as palliative care should be culturally 
specific and in line with patient preferences, each patient must be treated holistically on a case by 
case basis.xxxi This raises challenges to health care professionals who cannot assume universal 
preferences and must elicit treatment preferences from patients and their families. For example, 
one aim of palliative care is to facilitate a patient to die in the location of their choice. However, 
whilst patients are often assumed to have a preference to die at home, one study which examined 
preference of place of death amongst Chinese people found a preference to die in a medical 
institution.xxxii 
 
In this regard, the WHO recommends a public health strategy for the implementation for palliative 
care. This strategy emphasises the need for; appropriate policies, adequate drug availability, 
education of health workers and the public and implementation of palliative care at all levels of 
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society.xxxiii This global guidance is useful in terms of agenda setting, however the guidelines are not 
prescriptive and have not been evaluated to determine their relevance in low-income settings. 
Moreover, the high levels of diversity with regards to patient treatment preferences and potential 
treatment outcomes presented by the different elements of palliative care, supports suggestions 
that ‘palliative care’ must be adapted to specific national contexts.xxxiv Furthermore, aspects such the 
current lack of education and availability of medications raise challenges not only to those delivering 
care but to researchers in producing an evidence base for palliative care. There are also specific 
ethical challenges inherent with conducting research with palliative care populations which must be 
addressed in order to produce evidence-based solutions.  
 
The following section, therefore reviews some of the distinct challenges faced by researchers when 
conducting palliative care research.  
 
Obstacles to high quality palliative care research  
 
Challenges to the production of an evidence-base for palliative care begin with the ethical 
complexity of conducting research upon vulnerable people.xxxv Palliative care patients may lack the 
mental capacity to provide informed consent to research studies or indeed may lose capacity during 
any longitudinal study due to the progression of illness.xxxvi Furthermore whilst Randomised 
Controlled Trials (RCTs) are considered the ‘gold standard’ in research, such trials are difficult to 
conduct in palliative care settings, whereby the process of randomisation itself is at odds with the 
aim of palliative care to allow patients choice of their own treatment. xxxvii Such circumstances are 
said to have served to limit the available evidence for the efficacy of palliative care and a lack of 
interventional research. Indeed, it has been suggested that there is reliance upon surveys and 
questionnaires in order to produce evidence for palliative care.xxxviii 
 
Additional challenges to researchers also emerge from the aim of palliative care to meet patient-
goals. As identified above, patient preferences are culturally and context specific.xxxix This raises 
further challenges as understandings of terms like ‘improved quality of life’ may vary between 
different groups.xl Furthermore, whilst there have been efforts to evaluate ‘quality of death’, there is 
of course no opportunity for the experiences of patients to be elicited once they have died and 
outcome measurement is therefore reliant upon learning the experiences  of family members, 
health professionals and loved ones.xli 
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However, there is increasing evidence from around the world to support assertions that palliative 
care improves the quality of life of patients.xlii Additionally, studies have shown that palliative care 
can lead to positive experiences of illness and death for family members which in turn leads to 
improved outcomes following bereavement.xliii Expressed counterfactually, it can be said that 
without palliative care, patients and families would be exposed to unnecessary levels of avoidable 
suffering during illness and post-bereavement. What is more, palliative care is said to be an 
affordable and cost-effective intervention for health care systems. xliv Medications such as morphine 
are relatively cheapxlv and the introduction of palliative care often coincides with the cessation of 
curative treatments which are expensive and often continued long after they may be expected to be 
effective. Significantly, the resources needed in order to deliver palliative care are said to be 
affordable, which supports suggestions that is a feasible mode of care in all resource contexts and 
that its availability should not be constrained for financial reasons in any world setting.xcviii 
 
Global need for palliative care 
 
In spite of demonstrable benefits to patients living with serious illnesses and their families, palliative 
care has been fully integrated into health systems in only 45 of the World’s 234 countries.ii  In 75 
countries, there are no known services at all. This is of concern as in recent times arguments have 
been constructed to suggest that in circumstances where no pain or palliative care services are 
available, the severity of suffering which patients suffer is akin to being physically tortured.xlvi This 
argument has been made by activists to suggest that as palliative care has been shown to reduce 
suffering, that the failure of nations to provide palliative care puts them in breach of human rights 
law, which guarantees citizens to be free from “torture, inhuman or degrading treatment [United 
Nations, 2015]”.xlvii  
 
In 2014, the WHO estimated that globally, 20 million people were living with illnesses which require 
palliative care, based upon an assessment of end of life need.xlviii Within this population, the vast 
majority were adults, 69% of which were over 60 years old which supports suggestions that as 
populations age, palliative care need increases. Children living with serious illness are said to 
represent 6% of the global need for palliative care. These figures are based upon the need for 
palliative care if it is introduced after curative efforts are ceased. Therefore, if people living with a 
diagnosis of a serious illness who would benefit from the introduction of palliative care alongside 
curative efforts, but are not close to the end of life, these numbers increase to over 40 million. In 
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this regard, it is notable that the vast majority of palliative care need is in low and middle income 
countries where there has been limited development of palliative care [Figure 1]. 
 
Figure 1: Distribution by WHO regions of rates of global need for palliative care at the end of life 
 
Source: World Health Organization, 2014xlviii 
 
What the map in Figure 1 does not show, is global need in relation to current service provision. 
China, for example, is known to have the highest gap between need and availability of servicesxlix  
and there are few palliative care services in Francophone countries in Africa.l Additionally, the WHO 
estimates that the need is more than doubled if family members of people who may benefit from 
palliative care are included, pushing estimates of global need towards 100 million people 
annually.xlviii 
 
In addition to this, the world’s population is both growing and ageing, which in real terms means an 
increase in the total number of people who live and die from serious and chronic illnesses who may 
benefit from palliative care.li Furthermore, increased survival periods of children and adults living 
with serious illnesses have led many people to live long lives after being diagnosed. Advocates argue 
that this has led to people living with increased co-morbidities during illness which has further 
increased the need for palliative care.lii Furthermore, global successes in reducing deaths by 
infectious diseases, has seen the burden of long-term non-communicable diseases increase.liii In 
richer nations, where life expectancy is high, the need for palliative care has been further increased 
due to the new public health crisis posed by illnesses such as dementia.liv The burden of dementia 
and other age-related illnesses is also likely to further increase as life expectancies continue to rise in 
low and middle income countries.lv  
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Impact of global ageing 
 
Older people are the demographic with the highest health system usage and there is a growing 
imbalance of people of working age in relation to dependents and a consequent reduction in people 
contributing to health systems funding.lvi Additionally, an almost two-fold increase in the number of 
people dying globally is predicted over the next 40 years, with people expected to experience more 
complex and costly health and social care problems as they approach the end of their lives.lvii  This 
challenges both the capacity and sustainability of ‘health systems’ which within this study are 
understood as: 
 
The combination of resources, organization, financing and management that culminate in 
the delivery of health services to a population [2007].lviii   
 
Many palliative care services exist outside of the formal ‘health system’ and operate independently 
from national health initiatives, with funding from charitable and philanthropic organizations.lix 
Using the above definition allows the inclusion of ‘palliative care’ within discourses of ‘health 
systems strengthening’ and also incorporates public and privately funded systems. Distinctions will 
however be drawn where appropriate when  palliative care services operate outside of any national-
level funding streams or strategies, with ‘integration’ into national health policies a key challenge to 
the field. 
 
As suggested above, modern medical practices often follow technical – and expensive – approaches 
to the treatment of illness, often beyond a stage where curative efforts are likely to be effective.lx As 
such, global ageing has become a key area of health systems development in terms of health 
expenditure, as health systems face increased demand and consequent threats to their 
sustainability.lxi This circumstance benefits neither patients who undergo futile and distressing 
treatments nor health systems which incur high costs unnecessarily.lxii In this regard, palliative care is 
said to become the most effective intervention for improving the quality of life of patients and what 
is more, is said to be a relatively inexpensive intervention, which may reduce costs to healthcare 
systems.lxiii  
 
In spite of such potential benefits, global ageing policies have not prioritised the further rolling out 
of palliative care services. The current response from global organizations such as the United Nations 
(UN) and the WHO to the ‘problem’ of global ageing has centred round the promotion of ‘active and 
14 
 
healthy’ ageing. Policies such as WHO’s Framework for Active Ageing aim to increase wellbeing in 
older people as well as reducing health systems costs through decreased usage.lxiv However, in spite 
of many studies demonstrating a link between illness, death and household povertylxv, little global 
attention has been given to how the negative effects of terminal illness and bereavement may be 
reduced through appropriate intervention. Indeed, with reports that emotional bereavement is a 
luxury which many in the developing world cannot affordlxvi, attention to the financial aspects of 
illness and bereavement appears warranted. 
 
Palliative care in global health discourse 
 
Until recently, palliative care had received little attention within global health policies. However, in 
2014 the palliative care community had cause for optimism that the discipline was receiving greater 
attention when the World Health Assembly (WHA) passed a Resolution which called upon national 
governments to “[strengthen] palliative care as a component of comprehensive care throughout the 
life course”.lxvii The proposition passed unanimously, with all member states of the WHA ratifying the 
Resolution. Significantly, the Resolution placed the obligation to increase palliative care provision 
firmly upon national governments. 
 
It may be suggested, however, that in order for the Resolution to be implemented internationally, 
that support from global actors is likely to be required. Different International Organizations (IOs) 
operate in different ways to impact upon health issues at national level. A detailed overview of the 
roles of different International Organizations (IOs) and other health actors is presented in Chapter 
Three. Here, however it suffices to draw a conceptual difference between ‘normative’ and ‘funding’ 
agencies. Funding agencies such as the World Bank, funded themselves by member countries, have 
the legal and financial power to fund and implement health projects directly.lxviii Therefore, they are 
able to implement their policies and strategies with nations without relying upon national 
governments to finance projects. Alternatively, the role of normative agencies such as the WHO is to 
provide leadership, set norms and standards and provide technical assistance to governments for 
the improvement of health.lxix  
 
The WHA Resolution for palliative care therefore, may be considered an important political 
statement, placing palliative care formally on the global health agenda. However, the absence of 
funding to implement palliative care and meet these ‘standards’ means that the Resolution places 
the financial responsibility for its implementation solely upon national governments. This is 
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significant as many national governments operate within contexts of resource scarcity and many 
health systems worldwide are underfunded, even without additional responsibilities to introduce 
palliative care services.lxx  
 
The current absence of any global funding agency involvement in the implementation of the 
Resolution is therefore of concern as attention and prioritisation by global-funders holds the 
potential for major new sources of finance for governments, particularly of low income countries, to 
implement health projects.lxxi By way of example, Figure 2 shows the increase in Development 
Assistance for Health (DAH) funding for tackling HIV/AIDS following prioritisation of the issue within 
the Millennium Development Goals (MDGs). 
 
Figure 2: Development Assistance For Health (DAH) for HIV/AIDS by channel of assistance, 1990-
2010 
 
Source: Humanosphere, 2013lxxii 
 
This Figure demonstrates that national health financing comes not only from within nation states, 
but that global actors such as the World Bank contribute a high amount of resources.  Additionally, a 
large amount of development financing occurs bilaterally, with richer nations such as the United 
Kingdom (UK) and the United States (US), providing development aid to subsidise health projects 
directly in other nations. 
 
HIV/AIDS was prioritised within the MDGs over and above other health problems in spite of 
representing the highest burden of disease in Sub-Saharan Africa only.lxxiii  This suggests that 
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priorities at global level are not formulated solely upon the scale of health problems. For instance, at 
the inception of the MDGs, non-communicable illnesses such as cancer represented the highest 
global burden of illness, but addressing such conditions was not included as a global health priority. 
Therefore, if policy priorities are not based solely upon need, how then do certain issues come to 
receive more policy attention than other worthy claims?   
 
One explanation for why certain issues become prioritised over and above other valid claims 
suggests that issues receive attention based upon how a problem is ‘framed’. Boas and McNeill 
argue that actors such as powerful states, powerful organizations and even powerful disciplines 
‘frame’ issues: 
 
[Which] serves to limit the power of potentially radical ideas to achieve change…[and] 
makes favoured ideas seem like common sense, and unfavoured ideas as unthinkable 
[2004.p.2]. lxxiv 
 
Many health issues can be ‘framed’ in different ways. For instance, the HIV/AIDS epidemic has been 
presented in many guises, for instance, a national security issue,lxxv a human rights breachlxxvi  and a 
development (economic) limiter.lxxvii Different ‘frames’ are presented by different actors and hold 
the potential to influence and appeal to other actors in line with their own agendas. We see this in 
the differing presentations of the HIV/AIDs crisis as a human rights issue from the WHO (a normative 
agency) and as an economic issue from the World Bank (a financial institution). 
 
In this regard, palliative care is a health issue which has not, as yet, ‘framed’ itself successfully in 
order to receive attention within global health discourses. It follows that there is no specific health 
goal contained within the forthcoming global development priorities, the Sustainable Development 
Goals (SDGs),lxxviii that contains an indicator to measure palliative care development. This suggests, 
that in spite of the WHA Resolution, palliative care continues to develop outside of global health 
priorities.  
 
There are however, opportunities for palliative care to develop further within Goal 3 of the SDGs as 
part of the target to achieve Universal Health Coverage (UHC).lxxix Furthermore, the Worldwide 
Hospice and Palliative Care Alliance (WHPCA) has been recognised as a ‘voluntary partner’ within the 
Goal, charged with implementing the WHA Resolution. However, whilst the WHPCA - like the WHO – 
is able to offer technical assistance to governments, they do not have the resources to fund projects. 
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Additionally, the absence of an indicator for palliative care development within the Goals means that 
any progress will be difficult to measure. Finally, the absence of a palliative care indicator suggests 
that it is not a priority issue and that any funding which is allocated towards meeting the SDGs is 
unlikely to be targeted towards incorporating palliative care as part of UHC.  
 
This study therefore emerged to examine the apparent disconnect between the severity of the 
global need for palliative care and the importance which global policymakers ascribe to the issue. 
The overall aim of this thesis is therefore to consider if, and how palliative care can more 
successfully situate itself as part of broader global health priorities as an international development 
issue. However, before presenting the methods employed in order to address this question, it is first 
important to consider what is known about how palliative care has developed internationally.  If 
global leadership has not (as yet) driven development, how has the practice of palliative care spread 
from its first articulation in the 1960s to exist in all world regions?  
 
What is known about how palliative has care developed internationally?  
 
It is well documented that palliative care (as we now understand it) was pioneered in the UK by 
Dame Cicely Saunders and that it spread to the United States through the work of Saunders as well 
as that of another pioneer, Dr. Elisabeth Kubler-Rosslxxx. More recently, this narrative of ‘pioneer-led 
development’ has been added to by the work of Anne Merriman, who is credited with introducing 
palliative care to Singapore in 1985lxxxi, as well as establishing Hospice Africa in Uganda in 1993. The 
service in Uganda is significant as it is now considered a model of care for the rest of Sub-Saharan 
Africa to followlxxxii. Another study explains the origin of palliative care in Japan as being “brought 
from England”[2010.p.4].lxxxiii  
 
These pioneer-led narratives are reflected in a 2006 study conducted by the International 
Observatory on End of Life Care (IOELC) which represented the first global scoping exercise of global 
palliative care provision.lxxxiv The study was updated in 2011 by the Worldwide Palliative Care 
Alliance (WPCA) however, the 2006 report contained broader analysis of palliative care development 
and will be the focus here.   
 
The study identified 16 factors that they suggest are reasons for what they term the rapid 
international growth of palliative care provision. The methods used to identify these reasons will be 
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critiqued later in the chapter, but firstly, their findings regarding factors which have driven 
development are presented in Table 1. 
 
Table 1: Factors influencing the development of palliative care services 
• The emergence of palliative care champions • Support from volunteers 
• A desire to provide better care for the dying • Good patient and family experiences 
• Freedom from pain being viewed as a human 
right 
• Better access to education and training 
• The growing awareness of new possibilities • Strategic planning and implementation 
• The practical needs of an ageing population • Changes to the laws governing opioids 
• A changing political climate (within the Council 
of Europe, for example) 
• Leadership initiatives are having an effect on 
policymakers 
• Advocacy has become sharply focused • Improved communication systems give easier 
access to information 
• Funding has become available. • Broader support networks are becoming 
established 
Source: Wright M et al. IOELC, 2006.lxxxiv 
 
Aside from ‘freedom from pain being viewed as a human right’, these ‘reasons’ are difficult to 
generalise with international relevance. For example, whilst ‘changes to the laws governing opioids’ 
may have assisted the development of palliative care in certain countries such as the US,lxxxv barriers 
continue to exist in others (e.g. Russialxxxvi) and even differentially within countries (e.g. India).lxxxvii  
The authors make sense of these variables through discussion of two scenarios of palliative care 
development; ‘top down’ and ‘bottom up’ models: 
 
  The ‘bottom up’ model is characterised by an energised group of activists identifying 
local need and deciding to meet it… 
…The ‘top down’ model is where the Ministry of Health becomes involved at an early stage 
and, in collaboration with clinicians, policy-makers, the House of Insurance, and other 
partners, sets in train the strategic and legislative procedures to incorporate palliative care 
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into the national health system of the country [Lynch et al, 2006. P40].ii 
 
Certainly, there are examples to fit this analysis. In India, for instance, the ‘Kerala model’ – now a 
WHO Demonstration project - was a community movement, which led to the adoption of state, then 
national-level palliative care policy development in India.lxxxviii Furthermore, this community-led 
approach is said to offer a potential model for other low-resource settings to follow in terms of 
increasing access to palliative care.lxxxix By way of contrast, a study focussing upon developments in 
Latin America points to; health policy, established plans based on needs assessments and interaction 
with primary care as key determinants of palliative care programs.xc That is, development factors 
which are driven more from national policymakers, or a ‘top down’ approach.  
 
On a global scale, the factors influencing palliative care development presented by the 2006 study 
are difficult to quantify [Table 1]. Although the IOELC report their data collection methods, it is not 
clear which of these explanatory factors of development apply to which countries, nor is it suggested 
that these factors are present in each country in which palliative care has developed. The 2006 study 
did take some tentative steps to engaging with macro-data relating to socioeconomic factors 
reporting data on; Human Development Index (HDI) rankings, Gross Domestic Product (GDP) per 
capita, Crude Death Rates (CDR), and Population in relation to country groupings of palliative care 
development. The data were however, presented only descriptively. Although they claim that a 
“strong correlation between palliative care and human development [p40-1]”, only the percentage 
of countries in each category in relation to their Human Development Level are reported and no 
correlations are demonstrated [Table 2]. 
 
Table 2: Palliative care and Human Development, by group 
Source: Lynch et al, 2006lxxxiv 
 
Criticism of the study’s statistical methods aside, the data does appear to show an association 
between level of palliative care development and level of human development.  A further look at the 
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country classifications in 2011 in relation to Human Development, finds that of the 20 countries who 
had achieved advanced integration into the mainstream health systemxci, 17 of those countries also 
achieved a rating of Very High Human Development in 2011.xcii This apparent association warrants 
greater statistical scrutiny and raises further questions regarding which other structural factors may 
have had an influence over palliative care development. 
 
Additional concerns have, however, been raised regarding the subjectivity of the country group 
classifications themselves and the methods used to determine rankings.xciii Country rankings were 
determined with a mixed-methods approach drawing data from: 
 
Published articles in peer reviewed and professional journals, books and monographs, 
palliative care directories, palliative care and related websites, data provided by the EAPC 
Task Force for the Development of Palliative Care in Europe, IOELC reviews and databases, 
as well as gray literature and conference presentations [2013. p.1096].xciv 
 
In addition to this, where possible, ‘key experts’ within countries were consulted and asked to reflect 
on the level of development in their country. Where this was not possible, rankings were agreed 
between the authors. Both of these methods are problematic due to their subjectivity, risks which 
are acknowledged by the authors. Experts can be a valuable source of data. However, there is an 
inherent risk of information bias when consulting experts, responses risk being over-emphasised to 
reflect the opinion of the expert either to overstate achievements or underestimate failings.xcv  
 
Further, that the authors applied their own country rankings in the absence of key experts based on 
differing available data, raises questions regarding the objectivity of the rankings and their resulting 
comparability. Furthermore, experts who were identified, were asked to reflect upon phrases such 
as “the development of a critical mass of palliative care activism in a wide range of locations [p.4]”xci  
to determine their own ranking, though no guidance is given on how this can (and should) be 
quantified which leaves the rankings open to further critique regarding their subjectivity.  
 
In addition to preliminary efforts to map the global development of palliative care, 2010 saw the 
publication of the first global ‘Quality of Death index’ by the Economic Intelligence Unit (EIU).xcvi  
Forty countries were included in the ranking system, which was based upon ranking weighted 
indicators across four domains; Basic End-of-Life, Healthcare Environment, Availability of End-of-Life 
Care, Cost of End-of-Life Care and Quality of End-of-Life Care. To some extent, the findings echoed 
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those of the WPCA study, with the UK ranked as having the highest quality end of life care, with 
other countries within the top ten concentrated in high-resource settings. 
 
The index was updated in 2015 with 80 countries included in the index and the UK maintaining its 
place at the top of the rankings.xcvii Whilst the top ten is once more dominated by countries from 
high-resource settings, the updated study reported significant progress in the Asia-Pacific region in 
terms of accelerated development of high quality of care. However, in spite of some corroboration 
between rankings between the IOELC and the EIU reports, some discrepancies are a cause for 
concern, which may in part be attributed to the subjectivity of ranking methods and a lack of clarity 
regarding how to measure ‘high quality’ palliative care. For instance, the EIU study in 2010 used a 
10-point scale, on which the United Kingdom achieved first place in the rankings (in line with its 
Group 6 status), however, other countries such as Uganda were classified quite differently between 
the studies. Despite being allocated to the highest available category in the WPCA study, Uganda 
was scored only 2.1/10 by the EIU and occupied 39th place out of 40 in the quality ranking. This 
ranking places Uganda behind Mexico in terms of quality of palliative care provision, a country which 
was categorised by the WPCA as having only ‘isolated palliative care provision’. These discrepancies 
urge caution when using both the WPCA and EIU datasets, however, they remain the only known 
global projects to map development and assess quality of palliative care respectively. 
 
Instances of countries which are said to have developed palliative care services to a high level are 
present in all regions of the world. However, if, as has been suggested, there are different models of 
palliative care appropriate for all resource contextsxcviii, why are high levels of service development 
so concentrated in the developed world? Suggestions that ‘bottom-up’ or community led 
approaches to development as seen in Kerala are replicable in other settings have not been 
accompanied by discussion of the challenges of fostering community engagement in health issues 
through policy.xcix Furthermore, although national governments have been identified as being 
potentially key influences over development, existing narratives do not place palliative care within 
broader global health discourses of development.  
 
This circumstance raises important questions regarding what the role of global actors should be in 
the further development of palliative care. Emphasis upon ‘model services’ which are ‘context 
specific’ is suggestive that few of the challenges that nations face with regards to implementing 
palliative care are ‘shared’. This question of ‘what issues in palliative care are universal?’ is one 
which runs through this entire thesis. Can policies which are formulated at global level translate to 
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person-centred care at the individual level? Additionally, as palliative care development has shown 
to occur largely due to the transfer of ideas and practices between nations, rather than from the 
national implementation of policies made at global level, what is the importance of global level 
actors for the future development of palliative care? The extent to which palliative care research has 
engaged with such issues is, however, unknown and existing narratives of development remain 
largely descriptive, with little application of theoretical perspectives of global policymaking 
processes. 
 
This thesis will demonstrate that strengthening the relationship between national level palliative 
care actors and existing global stakeholders such as the WHO is of extreme importance. This is based 
upon the potential held by global health actors to greatly accelerate the development of health care 
issues. Consider for instance how the Ebola outbreak in West Africa was tackled in 2014. Faced with 
a new health challenge, low income nations such as Sierra Leone, with developmental health care 
systems, did not have the capacity to contain the threat.c It was therefore, the intervention of 
international and global health actors, interceding to assist government responses which led to the 
roll-back of Ebola.  
 
We may understand the obligations placed upon national governments by the WHA palliative care 
Resolution in a similar way. Palliative care has only relatively recently been expressed as an area of 
need. Therefore, it is has been placed on top of existing healthcare challenges in nations where 
health systems are weak and life expectancies are low. Moreover, in such circumstances palliative 
care services are generally not present and the approach to care is not well understood. Richer 
countries also face challenges in further developing palliative care, where need continues to increase 
and the focus shifts from providing a basic level of care to improving quality of care, for instance in 
the Netherlands.ci 
 
It is therefore clear that new approaches and new resources are required in order to advance 
palliative care development. Engagement by the palliative care community with new global 
institutions – most particularly funding and regulatory agencies – is vital in order to facilitate the 
global development of palliative care. Yet, as will be shown, an apparent reliance upon framing 
palliative care as an international human rights issue may not be a strategy which is likely to engage 
with global funding agencies. This thesis therefore seeks to answer the following research question: 
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Can the global development of palliative care be furthered through increased understanding 
of global policymaking processes and the presentation of palliative care as an international 
development issue?  
 
Answering this question, may help palliative care capture the attention of a wide range of new 
stakeholders and attract new sources of funding. Moreover, increased understanding of the 
importance of palliative and its wide reaching benefits may ensure that it is included as a 
fundamental aspect of the new global health priority of achieving Universal Health Coverage. 
 
Conclusion 
 
It has been shown in this chapter that there is a demonstrable global need for palliative care. 
Millions of people each year continue to endure high levels of suffering caused by serious illness 
without receiving appropriate pain treatment and care during illness and at the end of life. Palliative 
care has been shown to be effective in vastly improving the quality of life of people living with 
serious illness and their families.  Although the concept of palliative care was only developed in the 
1960s, services now exist in 136 of the world’s 234 countries. However, worldwide there remains a 
significant gap between demand and supply of palliative care services. Moreover, as the world 
population both increases and ages, it has been shown that the need for palliative care will increase 
further. Yet, serious challenges exist to the further development of palliative care services and 
essential medicines for palliative care such as morphine continue to be prohibitively regulated at 
both national and global levels.  
 
Existing narratives of palliative care development focus upon processes which occur within nations 
and have been shown to lack theoretical insight with regards to global policymaking processes. Such 
characterisations have rarely located development within the broader landscape of global health 
governance which in part reflects the historical disengagement between global level and palliative 
care actors. However, new global attention for palliative care in the form of a 2014 WHA Resolution 
calling upon governments to integrate palliative care into health systems has raised hopes for an 
acceleration of palliative care development based upon globally-set norms and standards.  
The Resolution may be considered an important political statement in recognition and promotion of 
palliative care. Seen more broadly however, it also places new healthcare responsibilities on 
governments and already financially-strained health systems. Whilst health systems in all world 
contexts face serious budget pressures, the Resolution does not contain any financial backing in 
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order to implement its terms. Moreover, awareness of palliative care worldwide remains low and 
serious action is required to ensure that the Resolution is implemented and does not remain an 
aspirational statement. 
 
This thesis considers the opportunities presented by increased understanding of and engagement 
with global health policymaking processes to consider palliative care an international development 
issue. Significant funding opportunities are potentially available from important global health actors 
such as the World Bank. However, to date, palliative care does not yet appear to have ‘framed’ itself 
as an issue of developmental importance to global funding agencies.  
 
Before moving on to set out the methodological approach [Chapter Four], it is important to examine 
how a Global Social Policy approach identified in this chapter can enrich understanding of palliative 
care development to date within the global governance landscape. By doing so, key challenges and 
opportunities for the further development of the field are identified. Further sub-research questions 
are also generated in terms of how and why palliative care as a neglected healthcare issue may be 
able to achieve policy prioritisation. 
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Chapter Three 
Towards a Global Social Policy Understanding of International Palliative Care 
Development 
 
Introduction 
 
In response to current research  and development narratives which have often viewed palliative care 
as an national issue in isolation from other global healthcare priorities (as identified in Chapter Two), 
this chapter seeks to situate palliative care within the context of processes of international and 
global healthcare development. As such, it looks beyond existing palliative care literature, towards a 
theoretical understanding of global policymaking processes offered by the Global Social Policy (GSP) 
school of thought.  
 
GSP seeks to understand how policies are formed and why certain policy issues are prioritised over 
and above other equally valid claims. Moreover, GSP scholars acknowledge that there has been a 
shift from social policy formulation taking place almost purely at national level towards a system 
where a high degree of influence over national social policies is exercised by global level actors.i That 
is, that there has been a globalisation of economic, social and political issues – with the health sector 
a key element of this. 
 
It is therefore appropriate to begin this chapter, by considering how this shift to global-level 
policymaking has occurred and been influenced by forces of globalisation, as well as to identify the 
key actors operating at global level to influence healthcare policy. The following section therefore 
reviews how globalisation has presented new challenges in terms of health policy as well as 
impacting upon the autonomy of nation-states to determine policy. Following this, key actors in 
global health are identified with discussion regarding their relative power to influence and 
implement policies within nations of all world settings. Where appropriate key challenges and 
opportunities for the further development of the field of palliative care within a globalised world, 
are considered. 
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Globalisation and health  
 
Global Social Policy scholars suggest that the global level has seen a wide range of state, non-state 
and private actors emerge to operate within what has been termed a “contested terrain of global 
governance [2007.p.15]”.ii It has been argued that this globalisation of governance has impacted 
upon the capacity of states to act in the interests of their citizens. In terms of healthcare, Richard 
Dodgson et al [2002] suggest that processes of globalisation have impacted upon the power of 
national governments to act autonomously in the interests of the health of their populations in four 
key ways.iii 
 
Firstly, it is argued that globalisation has increased trans-border health risks.  For instance, the 
potential for the spread of infectious diseases between nations is increased due to higher levels of 
international travel and migration.iv Additionally, air-borne diseases such as malaria pay no respect 
for international borders and provide international threat. To understand palliative care in these 
terms is, however, challenging and scholars do not appear to have engaged with and understood 
palliative care in a globalised world. Due to high symptom burdens, seriously ill palliative patients 
are often forced to be sedentary.v Moreover, whilst people carrying transmittable illnesses can and 
do cross borders, such occurrences are not conceptualised as a communicable threat based upon 
their palliative care needs.  Furthermore, no examples of research studies are known to have 
identified palliative patients crossing borders as part of ‘medical tourism’ in order to access palliative 
care. Instead, more notable have been instances of people travelling internationally in order to 
receive an assisted death, a phenomenon seen predominantly between countries which both have 
palliative care services. For instance, people travelling from the United Kingdom (UK) where assisted 
dying is illegal, to Switzerland where it is permitted.vi 
 
Secondly, as referred to above, the emergence of non-state actors at global level has served to limit 
the relative influence which national governments are able to exert in response to globalising forces 
which affect basic determinants of health.ii In this regard, the distinct roles of state and non-state 
actors have become blurry in terms of activities such as agenda setting, resource mobilisation and 
allocation and dispute settlement.vii One consequence of this has been that through trade laws, the 
interests of powerful private sector actors have been protected, which limits the potential for 
nation-states to implement policies which impact upon private profits. A recent example from 
Uruguay illustrates this, where Phillip Morris, the transnational tobacco company, successfully sued 
the government for its restrictive smoking laws introduced to promote public health.viii  
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It may be suggested that private entities such as pharmaceutical companies, have vested-interest in 
a biomedical model which promotes expensive curative treatments over relatively cheap medicines 
for palliative care.ix This circumstance therefore represents a barrier to palliative care, which 
promotes a cognitive shift away from overly-medicalised approaches to the treatment of illness.x 
However, whilst palliative medicines are often inexpensive, the need for them is prevalent and set to 
increase.xi On this basis, it is of concern that the palliative care community does not yet appear to be 
engaging with the pharmaceutical industry as a potential partner. Profits margins may be smaller for 
palliative medicines when compared with other treatments, however demand dictates that the 
pharmaceutical industry will have an interest in supply.xii Moreover, the pharmaceutical industry is a 
present reality and in this regard, the potential for the private entities to lobby alongside palliative 
care activists for the de-regulation of opioid medications warrants attention which it does not yet 
appear to have received. 
 
Thirdly, forces of globalisation have been shown to be associated with the sustenance and widening 
of socioeconomic, political and environmental problems.xiii  For instance, neoliberal policies have 
been shown to widen the income gap both within and between nations.xiv From the 1980s, policies 
of structural adjustment saw loans being made to nation-states to fund healthcare, with 
conditionalities that healthcare services would be privatised in order to secure funds.xv Once more, 
such policies served to limit the capacity of states to act in their own interests, with additional 
concerns regarding the potential of private systems to increase inequality in terms of access to 
healthcare services.xvi With palliative care services currently concentrated in high income countries, 
this circumstance raises concerns that should global funds be accessed by low and middle-income 
countries for palliative care, that they may be obliged to use such funding to develop private services. 
Therefore, access to such services may become predicated on capacity to pay for care, a situation 
which would run counter to public health recommendations for palliative care development.xvii 
 
Finally, globalisation has contributed to a reduction of the political and practical capacity of 
governments to respond to global health challenges in several key ways; for instance again in terms 
of the availability of essential medicines. In 1995, under the administration of the World Trade 
Organization (WTO), the Trade-Related Aspects of Intellectual Property Rights (TRIPS) became 
international law and allowed pharmaceutical companies to patent pharmaceutical processes and 
products for 20 years.xviii Identified above was a potential role for pharmaceutical companies to 
promote palliative care interests through de-regulation of opioid medications. However, such trade 
laws urge a note of caution when regarding the pharmaceutical industry as a potential ally for 
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palliative care. That is, de-regulation would place no obligation upon companies to provide cheap 
medicines and indeed more expensive medicines such as patented fentanyl patches are more 
profitable.xix Therefore, there is a risk that companies may only make profitable medicines available, 
which would further accentuate socioeconomic inequalities of access to healthcare identified above. 
 
Such issues will be returned to in a subsequent section of this chapter which focusses upon the 
influence of Transnational Corporations (TNCs). However, in order to understand the complex 
relationships and interactions between important global actors as well as national governments, it is 
appropriate to first consider who the key actors in global health are, their primary mandates, as well 
as their relative power to influence policies in national settings. On this basis, the following section 
presents a brief overview of how globalisation has seen new actors in global healthcare policymaking 
making emerge.  
 
A brief history of global health governance 
 
The shift of healthcare governance from operating solely at the national level, which saw new global 
actors emerge to influence health care policy internationally, is not a purely modern phenomenon. 
However, the twentieth century saw processes of globalisation accelerate exponentially.ii 
International Organizations (IOs) emerged, funded by member states, but operating outside of 
national jurisdictionsxx In Chapter Two, a conceptual difference was drawn between different IOs. 
Normative agencies, such as the World Health Organization (WHO), whose primary role may be 
considered ‘agenda setting’ and funding agencies, for example the World Bank, which have the 
resources required to directly implement policies and practices within nations in line with their own 
development mandates. Here follows, a brief discussion which provides further detail regarding the 
roles and influence of these different global actors in terms of how they wield influence over 
national health policies and practices. 
 
Normative agencies 
 
Normative agencies such as the United Nations (UN) in 1945 and the WHO in 1948 emerged in order 
to address new and pre-existing global challenges relating to social issues including: human rights 
economic development, education and health.ii Within such organizations, member-states formulate 
global guidance and issue policies through global resolutions, conventions and regulations in 
response to perceived areas of global need. Such policies are agreed at the global level by member 
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countries from all resource contexts, meaning that all nations aspire to the same standards in spite 
of different levels of resource availability. Nation-states must also formally ratify resolutions and 
conventions in order to be bound by their terms. However, although ratification does leave 
countries subject to international law, enforcement mechanisms at global level are underdeveloped, 
and few individuals or organizations are ever criminally prosecuting for violating the terms of their 
international agreements. For example, the United Nations Convention on the Rights of the Child 
(UNCRC) issued in 1989 has been ratified by 196 countries, however prosecutions for violating the 
terms of the agreement are rare, despite many cases of known violations of this treaty.xxi In this 
sense, such policy types may be considered ‘aspirational’.xxii 
 
A notable exception, however, of a convention which does have a formal enforcement mechanism is 
the 1961 Single Convention on Narcotic Drugs which continues to be implemented by the 
International Narcotics Control Board (INCB).xxiii This is significant for palliative care, as the INCB is 
the international regulator for opioid medications such as morphine. In this regard, due to the high 
prevalence of governments which continue to restrict their use, the INCB has faced severe criticism 
for restricting morphine as a ‘narcotic drug’, rather than enabling access as an ‘essential 
medicine’.xxiv 
 
However, more usually, conventions and resolutions including the WHA Palliative Care Resolution 
are not formally enforced.xxv Indeed, whilst normative institutions such as the WHO and other UN 
agencies have important leadership roles to play in terms of setting global norms and standards, 
they are not able to implement policies directly within nations and rely upon their policy 
recommendations to be adopted voluntarily by nation states. xxvi This is of concern as identified in 
Chapter Two, as developmental healthcare systems desperately require new sources of financing for 
palliative care if they are to implement the Resolution. In this regard, attention now turns to global 
funding agencies, institutions which do hold the financial power necessary to implement policies and 
practices of their own design within nations.  
 
Global funding agencies 
 
The 1980s saw the emergence of International Financial Institutions (IFIs) such as the World Bank 
and the International Monetary Fund (IMF) as powerful actors in global health policy.ii Like the UN, 
both institutions are also funded by member-states. However, in contrast such organizations to 
normative agencies which focus as health as a human right, the IFIs largely consider good health as a 
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mechanism for the delivery of their primary objectives of poverty alleviation and economic 
growth.xxvii The following quote from Jim Yong Kim, the current president of the Bank is illustrative: 
  
To promote inclusive growth, the World Bank Group works to facilitate the diffusion of 
knowledge and support countries in investing in the productivity and skills of their people 
[2014].xxviii 
 
This speech, delivered in 2014 to articulate the Bank’s ongoing strategy for international 
development is notable as it adopts a ‘human capital’ approach to the furthering of health and 
includes no mention of human rights. Moreover, it is consistent with what has been the historic 
approach of the Bank to international development, that the lives of everyone are improved through 
overall economic growth.xxix Therefore, primarily global funding agencies disburse funds and 
implement programs within low and middle income countries. However, this emphasis upon 
economic interest, rather than human rights would appear to limit the opportunities for palliative 
care to engage with such organizations, as current advocacy efforts focus upon the presentation of 
access to palliative care as a human right.xxx 
 
A further distinction between the IFIs and normative agencies is that they are able to implement 
their policies directly. A common mechanism of doing so has been through conditional loans.xxxi The 
approach of the Bank towards health development has centred around policies which aim to restrict 
public spending on welfare services and enable the involvement of the private sector in service 
delivery. This approach which was most prominent in the 1980s and 1990s but which continues 
today became known as one of structural adjustment.xxxii Under this model, countries are granted 
conditional loans to implement health projects, which are dependent upon the reduction of state 
involvement in healthcare delivery and the opening up  of health systems to private providers and 
consequently, global markets.ii Once more, this appears to place such funding agencies in opposition 
to palliative care statements, which articulate a public health strategy for the development of 
palliative care.xxxiii 
 
Although policies of structural adjustment have been severely criticised, as mechanisms of increased 
debt for low income countries as well as promoting societal inequality through decreased access to 
health and education services, they remain a key tool of the IMF and the World Bank.xxxiv For 
instance, Greece amidst financial collapse received loans from the IMF on the condition that 
austerity measures were implemented including drastic cuts to public health expenditure.xxxv The 
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measures are said to be decreasing access to essential medicines as well as increasing inequality of 
access to healthcare as private services emerge to meet demand, but on a pay-for-use basis. This 
demonstrates the ongoing neoliberal agenda of the IMF and that the global trend of privatisation of 
healthcare systems based upon global-level influence continues. However, the extent to which the 
increasing prevalence of privately delivered health services and the implications of this for palliative 
care is not well understood. It is therefore notable that within current narratives of development, 
such issues are not considered and palliative care development is often presented as being driven 
either by charitable and faith-based funding as well as publically funded models.xxxvi  
 
In this regard, palliative care appears to have benefited to some extent from the rise of other 
another source of non-state health financing, global philanthropy.xxxvii Global philanthropy 
organizations disburse funding towards social issues and partners of their own designation, often 
through grants. Whilst palliative care does not appear to have received financing from other global 
funding streams, the Open Society Institute (OSI) funded the Project on Death in America which 
aimed to improve access to palliative care and promote compassionate care of the dying in the 
United States.xxxviii Additionally, OSI funded projects in Central and Eastern Europe, Asia and Africa 
through the International Palliative Care Initiative (IPCI).xxxix However, philanthropic funding is often 
short-term and OSI is unlikely to be able to promote the further global development of palliative 
care in isolation.xl 
 
What then is the overall relevance for palliative care in understanding this global healthcare 
landscape? As presented, the primary role of normative organizations such as the WHO is to set 
standards, provide leadership and raise awareness of health issues. This was seen through the 
ratification of the palliative care resolution by the WHA. However, this global commitment remains a 
notional one and cash-strapped governments retain the responsibility for meeting their stated 
obligations.  Yet, whilst IOs like the World Bank and the Global Fund distribute a vast amount of 
funding they have paid little attention to palliative care. Moreover it appears that any financing for 
palliative care from such institutions would only come, if it was presented as an issue in terms of the 
broader development strategies and policy priorities of global funders.  
 
In this regard, a vast amount of funding was shown to be have been diverted towards tackling 
HIV/AIDS following its inclusion as one of the MDGs in Chapter Two. Where then does palliative care 
fit within global health priorities? To answer this question, attention now turns to past and current 
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global healthcare priorities in order to examine whether these have (or could) facilitate, or indeed 
limit, the further development of palliative care. 
 
Global health priorities: Millennium Development Goals 2000-2015 
 
Between 2000 and 2015, the global health priorities focussed upon the agreement of eight 
Millennium Development Goals (MDGs). xli Although all goals may be considered relevant to health, 
three in particular were targeted at improving global health; reduced child mortality, improved 
maternal health and combatting HIV/AIDS, malaria and other (infectious) diseases. Significantly, 
none of these targets had mention of palliative care. Moreover, the focus upon infectious diseases 
moved attention away from non-communicable illnesses, which cause the highest proportion of 
need for palliative care.xlii  
 
The establishment of the goals saw new commitment from national governments to providing 0.7% 
of annual national Gross Domestic Product (GDP) for international development.xliii Accordingly, a 
vast amount of financial resources were committed to attaining the MDGs by 2015 and the global 
health governance system was re-designed.ii New organizations emerged to disburse the vast 
amount of funds raised from donor countries, such as the Global Fund to Fight Aids, Tuberculosis 
and Malaria.xliv Also funded by member-states, the Global Fund differs from other IOs here inasmuch 
as funds are allocated in response to nationally devised plans, an approach which is said to be more 
aligned with national level needs and priorities.  In this regard, conditionalities of funding placed 
upon countries relate not to how money should be spent, but upon the achievement of performance 
based targets.xlv 
 
Although there has been significant progress in tackling infectious illnesses like HIV/AIDSxlvi, vertical 
financing for disease specific strategies had broader, negative consequences for national health 
systems. It has been argued that progress towards tackling such diseases through targeted 
interventions came at the expense of more holistic health systems strengthening which may have 
better incorporated palliative care.xlvii Furthermore, it is suggested that stronger health systems are 
more responsive to new healthcare challenges in that they “have the capacity not only to deliver 
interventions efficiently but also to sustain high levels of coverage, especially of the poorest and 
most vulnerable [2006.p87]”.xlviii In this regard, it is notable that existing narratives of palliative care 
development have not reported upon any benefits for palliative care based upon the outgoing MDGs 
and the vast amounts of financing which accompanied them.  
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Global Health Priorities: Sustainable Development Goals 2015-2030 
 
In 2015 the new globally defined priorities were agreed - the Sustainable Development Goals (SDGs) 
- which will shape global policymaking until 2030.xlix Of the 17 Goals, the most relevant to health is 
Goal 3 to ‘Ensure healthy lives and promote well-being for all at all ages’ which includes a target to: 
 
Achieve universal health coverage, including financial risk protection, access to quality 
essential health-care services and access to safe, effective, quality and affordable essential 
medicines and vaccines for all.xlix 
 
Achieving Universal Health Coverage (UHC) is a goal within which palliative care interests may more 
readily be advanced than through the disease-specific, targeted interventions which characterised 
the MDGs. Furthermore, the Worldwide Hospice and Palliative Care Alliance (WHPCA), has been 
included as a technical advisor in order to integrate palliative care into countries’ health systems in 
accordance with the WHA resolution.l 
 
However, it must be noted that there is no financial resources made available from either the UN or 
the WHPCA in order to fund the integration of palliative care. Additionally, the broadness of UHC as 
a goal necessarily means that decisions must be made regarding which areas of healthcare should be 
prioritised. The World Bank professes that development funding will need to increase from billions 
to trillions in order to meet the SDGs. Additionally, the World Bank favours a ‘results-based financing’ 
approach and in this regard, it is of concern that the Goals do not include an indicator for palliative 
care development.li This is of particular concern to the palliative care community, due to the 
challenges of providing an evidence-base for palliative care identified in Chapter Two due to the 
complex array of potential inputs and outputs of palliative care as a complex intervention.lii 
Furthermore, it is not known the extent to which palliative care researchers are providing evidence 
in international context in terms of effectiveness and cost-effectiveness of interventions, a question 
which will be considered in Chapter Five.  
 
IOs are likely to allocate funding for the attainment of the SDGs in line with their own organizational 
mandates. For instance, as suggested above, the World Bank is likely to fund projects health projects 
from a perspective of furthering human capital as opposed to human rights. However, IOs can be 
influenced in order to draw attention to neglected issues of international relevance. Accordingly, 
one characterisation of the broader aim of international to development is in terms of providing 
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‘global public goods’.ii In this sense, whilst the policies of nation-states are implicitly focussed upon 
improving conditions within countries, global level actors may be considered to hold responsibility 
for issues which are shared between nations. What then are ‘public goods’ and could meeting the 
global need for palliative care provision be understood in such terms?  
 
Global Public Goods 
 
Public goods are described as “goods that benefit all but which are not particularly in the interests of 
any one person to make and sell or any one consumer to buy [2007.p.121].”ii Street signs serve as a 
national-level example, as anyone can benefit from them and one person’s usage does not diminish 
the benefit to others. Most commonly such goods are publicly funded as they benefit all and there is 
unlikely to be benefits for private companies. 
 
At the global level, public goods are similarly non-rivalrous and non-excludable, but hold 
international benefit, for instance the eradication of infectious diseases, which cross borders and 
therefore represent an international threat.ii It follows, that to tackle such issues, international 
cooperation is required and it is suggested that sovereign states have become embedded within 
broader transnational forces in order to address such threats.liii   In this regard, the argument that 
transnational action centres around the provision of ‘global public goods’ appears to carry some 
weight. Especially when we consider the importance given to infectious diseases in the MDGs that 
prioritised the eradication of infectious disease such as HIV/AIDs and Tuberculosis which are not 
constrained by national borders and may therefore be considered ‘shared threats’. However, it is too 
simplistic to consider that altruism is the sole determinant of global policies. Indeed, the notion of 
‘global goods’ does not explain how other health issues, less easily defined as ‘global goods’liv  - such 
as reduction in child mortality have become global priorities. 
 
In this regard it is difficult to conceptualise provision of palliative care as a global public good, as 
suffering which occurs due to illness is felt largely at the individual level and does not represent a 
trans-border threat. Furthermore, use of palliative medications reduces their supply and it cannot be 
said that the benefits of pain treatment are ‘non-divisible’, as one persons’ use of medicines, 
reduces the overall supply. Whether this scenario should concern the palliative care community is 
unclear, because as demonstrated using the child mortality example, global attention has been 
shown to not only focus upon the provision of public goods as its mandate. It does however appear 
to preclude a ‘re-framing’ of palliative care as a global public good in order to attract the attention of 
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policymakers. Therefore, the palliative care community must consider different ways in which 
palliative care can be presented as an issue of global need which is worthy of policy prioritisation. 
 
What then, are the competing narratives for how and why policy is formulated at global level? In 
order to answer this question, it is important to consider two divergent understandings of both the 
role played by global level actors based upon insights from both World Society Studies and Global 
Social Policy (GSP). These two schools of thought are detailed below, however, to provide some 
context, a key difference in understanding centres around the questions of whether social policy 
issues should be considered in terms of their similarity or of their difference.  
 
World Society theorists for instance emphasise the similarity of national social policies and 
institutions. lv That is, if we look at each country of the world, we will see schools, hospitals and other 
institutions which can be described as ‘world professional standards’. Alternatively, GSP theorists 
emphasise the differences between countries, for instance disparities in resources or why some 
countries have publicly funded health systems and others have privately funded systems.ii 
  
On this basis, here follows a discussion of two schools of thought which represent each side of this 
competing and complementary debate, beginning with World Society Studies. 
  
World Society Studies 
 
The starting point of analysis for World Society Theorists is to suppose that there is a pre-existing 
global society which transcends borders and transmits values, practices and institutions to nation-
states through global cultural and associational processes.lvi Scholars such as John Meyer [1997], 
argue that nation states organize themselves around universalistic models and understandings of 
concepts, shared by global actors, such as citizenship, human rights and education. A key insight 
regarding the suggestion of social policy issues: 
 
Rest[s] on claims to universal world applicability; for example, economic models of 
development and fiscal policy and medical models of the human body and health care 
delivery are presumed to be applicable everywhere, not just in some locales or regions 
[p.148].lvii 
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This analysis rests on the assumption that cross border associations act to spread policies and 
practices in line with these ‘universalistic models’. Through this natural diffusion of ‘agreed social 
norms and practices’ nation states become organized around a set of shared principles and 
institutions.lviii  
 
In terms of palliative care, to follow this line of argument to its logical conclusion would be to 
suggest that there exists such ‘universalistic models’ of provision which require no adaptation to 
context and again raises questions regarding which elements of palliative care are ‘universal’. In line 
with ‘medical models of the human body’, it may be said that people worldwide experience pain 
similarly based upon ‘universal physiology’.lix However whilst there is some explanatory value in 
attempting to understand the world through universal truths and consensuses, this analysis feels 
glossy. There are many approaches to the delivery of palliative care – and even the universality of 
‘pain’ is contested, with suggestions that cultural beliefs impact on individuals’ experience of pain. lx 
Nor does ‘universality’ account for the diversity of institutions and settings in which palliative care is 
delivered in spite of the existence of ‘hospices’ in all world regions.lxi 
 
By characterizing fields such as healthcare as global institutions, World Society scholars are largely 
dismissive of the role of policy in the formulation and delivery of health and instead appear to 
characterize the emergence of organizations to deliver health services as inevitable. Indeed, Meyer 
points to the similarity of healthcare organizations between nations which, he argues “makes sense 
only of common world forces at work [2009.p.180]”.lxii This analysis is consistent with the concept of 
‘policy diffusion’, whereby, when confronted with a challenge, policymakers observe the policy 
responses in other contexts and then respond similarly. That is, that “when confronted with a 
problem, decision makers simplify the task of finding a solution by choosing an alternative that has 
proven successful elsewhere [2008.p.841]”lxiii, through processes of policy learning.  
 
This understanding of policy development identifies ‘geographical clusters’ of similar policies and 
practices which emerge from a policy genus that have apparent universal applicability. In this regard, 
there is some evidence that palliative care practices have converged in this manner, with the WPCA 
global mapping study identifying an apparent geographical cluster of palliative care development, 
emanating from Uganda [Figure 3]. Full detail of the constituency of country groups is presented in 
Appendix 3. It therefore serves here to note the concentration of ‘green countries’ in Sub-Saharan 
Africa, which have higher palliative care development and that orange, yellow and red indicate lower 
levels. 
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Figure 3: Levels of palliative care development in Africa 
 
Source: WPCA, 2011xxxvi 
 
However, what World Society Theory appears to not explain convincingly is how these institutions 
such as palliative care services come in to being or account for the differences between them. 
Furthermore, by characterising policy diffusion as a ‘natural process’ is to diminish the active roles 
played by ‘transfer agents’ such as Ann Merriman who is credited with introducing palliative care to 
Africa in 1990.lxiv Nor does a geographic analysis explain the high level of development of palliative 
care in a country such as Australia, which is geographically isolated from other countries that have 
successfully integrated palliative care into the health system.lxi New perspectives have therefore 
suggested that policy diffusion occurs more between nations which are ‘similar,’ for instance in 
terms of socioeconomic indicators, rather than based only upon geographic proximity.lxv However, 
the extent to which palliative care has developed ‘similarly’ in ‘similar’ nations, is not known, a 
question which is returned to in Chapter Six.  
 
In spite of the clear global diversity in policies and practices as well as the wide range of resources 
available to global organizations to influence social policies, Meyer is however dismissive of the 
power of global actors. He writes: 
 
The structures of the world polity are mostly...not actors. They produce talk – scientific talk, 
legal talk, nonbinding legislation, normative talk, talk about social problems, suggestions, 
advice, consulting talk, and so on – not binding authoritative action [1999.p.127].lviii 
 
This apparent generalisation does hold elements of truth. For instance, this analysis could serve as a 
critique of normative global agencies such as the WHO. As previously discussed, the WHO issues 
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standards, guidance and other recommendations they suggest that national governments and health 
practitioners should follow. For instance, the WHO Cancer Pain Ladderlxvi, evidence-based clinical 
guidelines on how pain should be treated or the recommendations within the WHA Resolution that 
palliative care should be part of the continuum of care. What they do not do, is fund the 
implementation of their policies nor wield binding influence over how nation-states should deliver 
healthcare.lxvii 
 
However, the WHO exists alongside a complex array of actors in global health, many of which do 
have both the finance and the power to influence national health policies directly as has been 
demonstrated. Moreover, the direct transfer of policies of privatisation through conditional loans is 
too direct to be dismissed as a ‘global force at work’. 
 
The apparent failure of World Society Studies to account for the difference in policies and practices 
around the world, alongside their inappropriate dismissal of the ability of global actors to exert 
direct influence over national governments warrants attention. Additionally, it is not convincing to 
dismiss the influence of global-level policies on the policies and practices of nation-states. Both the 
MDGs and the SDGs did not simply ‘emerge’ but were formulated through processes of contestation 
and reconciliation of competing agendas. Moreover the vast amount of resources which are made 
available for meeting global goals following this prioritisation cannot be separated from the policies 
which led to their allocation. Thus, it is important to understand how policy is formulated at global 
level and how and why certain issues become prioritised at the expense of other valid claims. In this 
regard, a GSP understanding of policy development offers insight beyond the passive explanations 
offered by World Society Scholars to understand policy formulation within a “contested terrain of 
emerging global governance [Deacon, 2007. P.15].”ii We turn to this now. 
 
Global Social Policy 
 
Global Social Policy (GSP) scholars refutes the extent of ‘universalism’ emanating to nations from the 
global level proposed by World Society Studies and dismiss the suggestion that global organizations 
are ‘non-actors’. Instead, GSP scholars view the global level as a place where a wide range of actors 
contest appropriate social policy approaches in line with their own agendas.ii Moreover, they 
suggest that the role of the global governance system should be to further extend processes of 
global redistribution, global social regulation and global social rights.ii 
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By emphasising both the power and the agency with which global institutions are able to act, GSP 
scholars suggest that global organizations do not act purely in the interest of nation-states, but 
“develop their own ideas and pursue their own agendas [2004.p.2].”lxviii  Additionally, GSP does not 
perceive the transfer of global norms, standards and institutions as occurring through passive, 
inevitable processes and instead, suggest that this occurs due to dynamic processes, emphasising 
the agency with which actors are able to act. On this basis, in order to make sense of how policies 
and practices are transferred both between nations and from the global level to nation-states, we 
turn to the theoretical framework of ‘policy transfer’. lxix 
 
The policy transfer theory proposed by Dolowitz and Marshlxx  builds upon earlier work regarding 
policy learning, with both of these theories emerging from the premise that: 
 
Every country has problems, and each think that its problems are unique…However, 
problems that are unique to one country…are abnormal…confronted with a common 
problem, policy makers in cities, regional governments and nations can learn from how their 
counterparts elsewhere responded [1991.p.3].lxxi 
 
This position suggests that when faced with a common problem, it is rational to look at how others 
have responded to the same problem and to learn lessons – both positive and negative – from how 
the problem was addressed elsewhere. When these lessons directly, or indirectly, lead to the 
introduction of similar policies in alternative settings, Dolowitz and Marsh term this ‘policy transfer’. 
In their words: 
 
Policy transfer, emulation and lesson drawing all refer to a process in which knowledge 
about policies, administrative arrangements, institutions etc. in one time and/or place is 
used in the development of policies, administrative arrangements and institutions in another 
time and/or place [1996.p.344].lxx 
 
Policies and practices can therefore be transferred between all levels of the global governance 
architecture, with appropriate adaptations to context. For instance, between global organizations to 
nations (e.g. adoption of the WHA Resolution), from state to national level (e.g. India’s palliative care 
policy is based upon that of Kerala statelxxii) or between nations (e.g. Switzerland has now 
implemented its first community-led palliative care model based upon the Keralan modellxxiii). Such 
transfers are carried out across a spectrum, from voluntary transfer, to coercive transfers.lxx 
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Voluntary transfers occur when policymakers in one context identify a problem, or area of need and 
seek to identify how others in different contexts have dealt with a similar problem and then adopt 
similar policy – with appropriate adaptations for context. It has been suggested, however, that 
instances of purely voluntary transfer are rare and that this conceptualisation ignores issues of 
power within the policymaking contextlxxiv and further raises concerns regarding the future adoption 
of opt-in policies such as the WHA Palliative Care Resolution. Additionally, whilst policymakers in 
settings where palliative care has not developed may look at other, similar countries, which have 
developed services, they would not be obliged to adopt similar or indeed any policies. Instead, any 
such implementation would rely upon policymakers both perceiving that lack of palliative is a 
problem and indeed having the political will to divert resources towards providing services. 
 
At the other end of the spectrum coercive transfers take place either directly, for instance through 
conditional loans, or indirectly, due to factors such as interdependence and the formulation of 
international law which places obligations upon nations to respond with policies to abide by their 
terms.lxxv However, it is important to reiterate, that many ‘international laws’, whilst technically 
‘binding’, such as the International Covenant on Human Rights are often not enforced.lxxvi 
 
Conceptualising policy learning and policy transfer within this spectrum, hints that the potential for 
national governments to formulate policy purely voluntarily may be limited. Instead, a great deal of 
policy is formed within a system of formal and informal commitments, complex power relations and 
competing agendas at an increasingly important global level which is said to be accelerating 
processes of policy transfer.lxxvii  
 
Within a context of competing discourses of competing health issues at global level, for instance  a 
health systems approach to combatting illness Vs disease-specific interventionslxxviii, what then 
dictates how global policies are determined? Whilst recognising the influential role that IOs hold at 
global level, GSP also acknowledges the presence and influence of a much wider range of actors 
including, as previously acknowledged, knowledge networks International Non-Governmental 
Organizations (INGOs), and Transnational Corporations (TNCs) conflict and contest over policy at 
global level. A brief discussion of the active and potential influence that each of these groups may 
wield follows within a context of how certain issues become prioritised over others at global level 
and for the further development of palliative care. 
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The Importance of Knowledge Networks 
 
The transfer of knowledge, information and expertise is characterised in many different fashions. 
Diane Stone describes ‘global knowledge networks’ as “professional associations, academic research 
groups and scientific communities that organise around a special subject matter or issue 
[2002.p.2].lxxxi Similarly, Peter Haas uses the term ‘epistemic community’ to characterise “a network 
of professionals with recognised expertise and competence in a particular domain and an 
authoritative claim to policy-relevant knowledge within that domain or issue-area [1992.p.3]”.lxxix  
This discussion will adopt Jeremy Shiffman’s understanding of a global health network as: 
 
Cross-national webs of individuals and organizations linked by a common concern about a 
particular global health problem [2013].lxxx 
 
Such networks are characterised by a broad range of institutions and actors, united in a common 
cause, which can include: development agencies, foundations, think tanks, universities, consultancy 
firms as well as individual experts and academics.lxxxi Shiffman argues that such networks are of 
interest as: 
 
Many global health analysts present evidence that material factors such as mortality and 
morbidity burden and the availability of cost-effective interventions may not explain the 
variance in the levels of attention health issues receive [2009.p.608].lxxxii 
 
This analysis calls to mind the discrepancy in global attention between infectious and non-
communicable diseases at the global level, whereby communicable diseases have been prioritised – 
in spite of them representing a lower burden of global disease than Non-Communicable Diseases 
(NCDs). That is, that there must be another explanation for how issues become prioritised if policies 
are not solely formulated by targeting issues with the highest level of need. To understand the role 
of global networks within global policymaking processes of prioritisation, it is important to 
understand both how and why such networks emerge and how effective they can be in achieving 
their aims.lxxx  
 
Networks may emerge in response to global legislation, for instance, in Argentina, it is suggested 
that the government’s ratification of the Convention on the Rights of the Child opened the discursive 
space for rights-based advocates in the country to emerge.lxxxiii In this regard, there are perhaps 
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opportunities for palliative care activists in the Americas to further organise and make policy gains in 
response to the designation of palliative care for older people as a human right by the General 
Assembly of the Organization of American States in 2015.lxxxiv Here, however, the focus is upon how 
networks form in response to the apparent absence, or marginalisation, of issues at global level by 
actors who perceive them to be important areas of need.  
 
Such networks form when actors, such as think tank experts, university academics and NGO 
researchers whom share similar values, causal assumptions and problem perceptions coalesce 
around issues perceived to be neglected.lxxxi Networks are formalised through regularised 
communication, the formulation of rules and resource divisions within the network. Over time, they 
may become institutionalised through the formation of advisory boards and through recognition by 
state and multilateral organizations in the formulation and implementation of policies. The 
formation of the European Association for Palliative Care (EAPC) Research Network serves as an 
example in terms of palliative care.lxxxv  
 
It is suggested that the effectiveness of such networks is intrinsically linked to factors which led to 
their original formation as well as the features of the networks themselves, their policy 
environments and the characteristics of the issues they address. lxxxvi More specifically, Shiffman 
argues that robust networks are more likely to achieve their aims based upon the particular 
characteristics of the issues that they address. That is, in terms of severity of the problem in hand 
the tractability of the problem (how straightforward it may be to solve) and the nature of the 
affected population (such as children as a ‘vulnerable group’ who have not ‘caused’ the problem 
they suffer). 
 
Viewed with this lens we gain further insight into the prioritisation of infectious diseases over NCDs. 
During epidemics, new populations may be infected across borders and infectious diseases may be 
visibly seen to be causing death high in numbers indiscriminately and are therefore easily perceived 
as ‘severe’ problems. Additionally, such problems may be perceived as ‘solvable’ due to the 
existence of vaccinations or known methods of disease control such as quarantining infected 
caseslxxxvii. By way of contrast, NCDs are often long term illnesses with a complex array of causes, and 
limited approaches to ‘cures.’ Moreover NCDs are predominantly found amongst older people, often 
considered a ‘marginalised population’ and whom may be considered to have caused their own 
illness through lifestyle choices.lxxxviii  
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This analysis presents a serious challenge for activists to present palliative care as a viable ‘solution’ 
to the global need of palliative care patients. Emergent palliative care knowledge networks, must 
therefore aim to ensure that the types of evidence for palliative care are able to clearly express why 
palliative care is needed, why it will help address the problem and how it can be implemented. Such 
evidence not only allows palliative care to be presented as a ‘solvable’ problem, but would also be 
in-keeping with the approach of funding agencies which use results-based approaches to 
financing.lxxxix  
 
A further factor to consider in terms of considering why certain issues become prioritised relates to 
the extent of opposition to the introduction of any one policy. For instance, it may be argued that 
the prioritisation of infectious diseases is practical as there are fewer actors who may have 
competing interests when formulating policies to address them.xc To explain and expand upon this 
point, we turn to a discussion of the role and influence that Trans-national Corporations (TNCs) are 
able to exert on policies relating to global health. 
 
Trans-National Corporations and global health 
 
Alongside neoliberal policies introduced by the international financial organizations, which 
promoted the privatisation of public services, globalisation has seen powerful business lobbies 
increase their power on the global stage as Trans-National Corporations (TNCs).ii The threats that 
TNCs pose to global public health are diverse. However, to narrow the discussion, here, the focus 
will be upon two different business interests that may be able to exert direct influence over policies 
aimed at improving public health, the tobacco and pharmaceutical industries. 
 
In this regard, it is suggested that globalisation has increased both the power of corporations over 
governments.xci For instance, TNCs are able to shift capital and production and this threat of ‘capital 
flight’ encourages states to create favourable tax conditions for TNCs for fear of them moving 
elsewhere – at the expense of raising revenue for social welfare.xcii Indeed it has been argued further 
that the fundamental global business view of public provision of welfare services is that: 
 
State provision is justified only if it contributes directly to economic growth or at least 
doesn’t undermine it, and is affordable only if it exists in an environment populated by 
profitable successful firms [Deacon. p.209. 2010].ii 
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This approach is consistent with that of the IFIs, but where TNCs impact upon global health more 
directly, is through trade agreements. Free trade agreement such as the Trans-Pacific Partnership 
Agreement in 2015 threaten to enable TNCs to limit the power of governments to implement 
policies aimed at improving the public health of their citizens as well limiting access to medical 
services and treatments through increased user fees.xciii Such trade agreements may therefore be 
seen as additional challenges for universal access to medicines adding to the potential for the 
pharmaceutical industry to make only expensive, patented palliative medicines available. What is 
more, such occurrences are in keeping with the rights of pharmaceutical companies to patent 
medicines for 20 year periods, enshrined in the Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPS).xciv   
 
In this regard, it is important to emphasise that such trade agreements oblige nations to abide by 
them by law, once agreed, nations do not ‘opt-in’. The interests of private companies may therefore 
become entrenched, at the apparent expense of public health. This is important for the palliative 
care community as it seeks a reduction in expensive treatments once they may be deemed to be 
‘futile’.xcv However, this existing approach to medicines is highly profitable for private companies 
who have a vested interest in the continuation of high usage of expensive treatments.  
 
Yet, in spite of the apparent power and influence which transnational companies are able wield of 
global health policies, the extent to which palliative care community has engaged with this reality is 
not known. TNCs are therefore powerful actors at the global level, even if their presence appears to 
be more as limiters, rather than innovators in improving global health. It follows, that although TNCs 
do not explicitly set global health goals, they do have influence over what they are not. In this regard, 
it may be considered important to consider the potential role which they can play in either 
enhancing or limiting palliative care palliative care development. 
 
However, if TNCs represent business interests, what role does civil society have to play in global 
health policymaking? To consider this question, here follows a short discussion regarding the final 
group of actors that will be focussed upon in this chapter: International Non-Governmental 
Organizations (INGOs). 
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International Non-Governmental Organizations (INGOs) 
 
The final group of actors for discussion here, are said to act as a buffer against the apparent 
democratic deficit in global policymaking circles: International Non-Governmental Organizations 
(INGOs)xcvi. These transnational civil society bodies represent a diverse range of interests, on behalf 
of which they lobby for greater global attention as well delivering interventions and conducting 
research. INGOs have few formal powers within global policymaking circles, however they are able 
to exert influence at global level through ‘agenda setting’.xcvii INGOs such as Oxfam and Amnesty 
International are credited with a wide range of accomplishments, including putting climate change 
on the global agendaxcvii and forwarding the case for human rights.xcviii  
 
INGOs are non-profit institutions and are able to operate either independently, or as recognised 
partners of International Organizations (IOs) such as the United Nations (UN). They are said to act as 
representatives of civil-society at global level and were described in 1995 by Kofi Anna, the former 
Secretary General of the UN as: 
 
An essential part of the legitimacy without which no international activity can be meaningful 
[1995].xcix 
 
Such organizations promoting palliative care are certainly emerging, both at the regional and global 
levels. For example, the European Association for Palliative Care (EAPC) is acknowledged by the 
Council of Europec whilst the International Association of Hospice and Palliative Care (IAHPC) is in 
formal relations with the WHO.ci In this regard, palliative care INGOs may have a significant role to 
play in holding governments accountable to the apparent commitments they have made to 
providing palliative care through the signing of the 2014 WHA Palliative Care Resolution.  
 
The legitimacy of INGOs themselves is, however, often contested and this characterisation of INGOs 
acting as ‘guardians of public morals’ is questioned, with critics pointing to a lack of democratic 
process within and between organizations.cii That is, that as non-elected bodies, they do not 
necessarily hold any legitimate claim to represent civil society and are not necessarily held 
accountable for their actions. Further, there is an inherent tension between the two roles that 
INGOs play, in terms of advocacy and service provision. As service providers, INGOs actively enter 
the governance system of global development, instead of acting as critique of this system. INGOs 
may win contracts from IOs to deliver services at national level. However by doing so, their 
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imperatives towards agitating for social change and social justice may be compromised as they 
grapple with the tensions of securing lucrative organizational contracts and the associated 
limitations that such grants place up on the ability of INGOs to act independently.ciii  
 
These may be considered significant issues which palliative care INGOs must grapple with. In terms 
of service provision however, INGOs such as the EAPC, provide technical assistance, but do not 
themselves implement services, which may reduce any potential conflict of interest. A more serious 
challenge therefore relates to the representativeness of palliative care INGOs of the wishes of civil 
society. In this regard, it was identified in Chapter Two, that global need for palliative care is often 
presented technocratically, with experts saying that there is a need for palliative care. It is therefore 
essential, that the research community generates evidence that patients want palliative care and 
that it is acceptable to them. Whilst there are rational arguments, that pain medication is an 
appropriate response to pain, as global policymaking becomes ever more evidence-basedciv, it is 
important to be able to back claims that there is a need for palliative care with robust evidence. 
However, the extent to which the international palliative care community is generating such 
evidence is unknown, a question which is addressed in the Chapter Five. 
 
The existence of a robust evidence base would allow INGOs to use differing and nuanced ‘frames’ 
with which palliative care could be presented to appeal to different actors. However, though 
palliative care INGOs hold the potential to influence global policymakers they sit alongside a wide 
range of other health policy claims. How then are certain health lobbies able to influence 
policymakers over and above other valid claims? In this regard, the final section of this chapter looks 
beyond the field of palliative care, in order to examine how other health lobbies have successfully 
attracted policy interest, to determine what the field of palliative care may be able to learn from 
other fields in order to accelerate development. 
 
Addressing global social problems through advocacy 
 
As demonstrated in this chapter, global health policies cannot be characterised simply as responses 
to areas of global need or as the provision of global public goods. Policy prioritisation has been 
described more in terms of how different actors exercise their relative power and resources to 
determine policy priorities.  
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In this regard, advocacy can play a key role in determining which health issues become considered 
‘global issues’ or ‘global problems’. Throughout this thesis, advocacy is understood as: 
 
A range of activities aimed at persuading decision makers to design, adopt, and change 
policies and practices to secure direct and lasting benefits for the people we work with 
[Bryer and Magrath.1999.p.170]  
 
It is suggested that the potential for advocacy efforts to achieve change centres around two key 
characteristics of campaigns; credibility and salience.lxxxii By credibility is meant, how ‘honestly’ social 
problems are represented whilst salience refers to the relevance of issues to key stakeholders 
including public opinion. This links to the key tenets of a successful advocacy campaign as suggested 
by Ann Pettifor, the architect of the Jubliee 2000 campaign, which saw approximately $100 billion of 
debt written off for developing nations.cv 
 
Pettifor argues that the cornerstone of a successful advocacy campaign rests on several key factors. 
Firstly, understanding the context within which the campaign will operate in terms of the political, 
economic and social terrain is key, issues which this chapter has considered and which are returned 
to in Chapter 6. Within this, activists must consider who potential allies may be as well as actors who 
may oppose the issue being promoted as identified above in terms of palliative care and TNCs.  
Secondly, Pettifor emphasises the need for: 1) a clear articulation of the problem in hand; 2) clearly 
defined goals and the need for clear ‘asks’ of an advocacy campaign; 3) pre-determined rebuttals of 
opposing arguments; and 4) use of appropriate ‘frames’ of the issue to the differing key actors that 
the campaign aims to influence.cv  Yet, in spite of this complexity, Shiffman argues that: 
 
Almost all [health advocacy communities] take the same two rhetorical steps: first making a 
“problem” claim surrounding severity and neglect of their issue, and then a “solution” claim 
surrounding the problem’s tractability and the benefits that would accrue from addressing it 
[p609.2009].lxxxii  
 
This analysis raises significant challenges for palliative care advocates. As was identified in Chapter 
Two, the global need for palliative care is not well understood by global policymakers. Moreover, 
palliative care patients are likely to have complex symptom burdens which require multi-faceted 
solutions and indeed palliative care is considered a ‘complex intervention’.cvi The many elements of 
palliative care including pain management, emotional support etc. make their presentation as a 
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tractable solution to patient suffering challenging. Moreover, the varied ways in which palliative care 
can be delivered again raises questions regarding the ‘universality’ of different elements of palliative 
care and would appear to limit the potential to clearly define a ‘problem’ and ‘solution’. 
Furthermore, the broad similarity between all advocacy campaigns which sit alongside palliative care, 
through the presentation of ideational issues, raises questions regarding how certain issues attract 
the attention of policymakers at the expense of others?  
 
Amidst competing claims, social constructionists argue that issues are not prioritised based on their 
actual importance, but based upon how important the issue is portrayed.cvii  Within this context, the 
importance of INGOs is increased due to the necessity for strong institutions to underpin successful 
advocacy campaigns. Understanding institutions as “rules, norms, and strategies adopted by 
individuals operating within or across organizations [p.37.2007]”cviii, INGOs are an organizational 
embodiment of advocacy. The power of such organizations lies in their ability not only to mobilise 
people and resources around a particular issue, but to maintain and negotiate how issues are 
‘framed’ in response to changing contexts and challenges. For instance, Advocacy International is 
currently working upon a campaign which aims to re-frame maternal mortality, from an emphasis 
upon mortality, to a focus on effective solutions. The MamaYe campaign emphasises survival rather 
than mortality and is engaging local communities with stories of successful treatment and a 
campaign to ‘give blood to save a Mama’.cix It may be suggested, that such campaigns helped ensure 
that maternal mortality, was not superseded by new health ‘trends’ and was included as a specific 
indicator of the SDGs. 
 
However, whilst re-conceptualising problems is one way of attracting attention, GSP scholars focus 
upon the relative power of established frames in terms of their likelihood of influencing 
policymakers. Accepting that there may be alternatives, Labonte and Gagnon focus upon six policy 
frames and rank their potential to influence health policy: 1) national security; 2) international 
development; 3) global public goods; 4) trade; 5) human rights; and 4) ethical/moral reasoning.cx The 
authors argue that each frame holds the potential to influence policymakers to differing degrees, 
with health issues presented as ‘national security’ threats the most likely to attract attention. The 
‘national security argument’ was one which attracted great attention for HIV/AIDs and the same 
argument has been used to mobilise resources more recently, for the Ebola outbreak in West 
Africa.cxiSecurity is followed by development and provision of global public goods as the most 
pervasive frames, significantly, when these frames are presented as economic issues or as means, or 
limiters, to economic growth. 
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Frames promoting trade as a means to improve health by way of market integration and economic 
growth are ranked fourth in this categorisation, whilst normative arguments for health as a human 
rights issue or moral/ethical problem rank as the frames least likely to influence national-level 
policymakers. It is suggested, that for ethical or moralistic frames to achieve influence, there must 
be some legal underpinning to claims of advocates, for instance through international conventions. 
However, the authors pessimistically conclude: 
 
Neither moral nor legal argument, in the absence of enforcement mechanisms, is necessarily  
compelling as an economic or political rationale [2010].cx  
 
Yet, apparently contrarily, they also argue: 
 
Economically, both the global public goods and development frames have some health 
utility in foreign policy debates, but only if they are located beneath a penumbra of ethical 
reasoning and legal obligation [2010].cx 
 
This analysis provides lessons for the palliative care community and supports the idea that advocates 
must present their issue within a variety of frames to consider what may resonate with a diverse 
range of actors at all levels of governance. Palliative care has, however, never been theorised in such 
terms and there appears to be a continuing reliance upon presenting global need for palliative care 
statistically as well as human rights arguments for its implementation. Moreover, it is not known, the 
extent to which researchers are producing evidence which is internationally relevant to equip 
knowledge networks and INGOs with evidence-based arguments upon which to frame palliative care 
need as a problem and provision as the solution.  
 
Discussion 
 
The application of theoretical understandings of global policymaking processes to understand 
palliative care as a global health issue, raises significant opportunities and challenges for the further 
development of the field. In terms of challenges, it has been shown that global policies are not 
formulated solely in response to level of need. Additionally, the provision of palliative care does not 
appear to be an issue which can be presented as a ‘public good’ as it is a problem which is 
experienced by patients and families and does not present a wider threat to communities or other 
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nations. Moreover, it appears that the global level organizations which are engaging with palliative 
care issues, such as the WHO, lack the power to implement their own policies within nations directly. 
 
However, other global-level actors including funding agencies, knowledge networks, transnational 
companies and INGOs have emerged as potential powerful actors for change. Yet, whilst funding 
agencies have the power and resources in order to directly implement palliative care policies and 
practices within nations it does not appear that the palliative care is yet producing nuanced, 
evidence-based arguments in order to engage with them. Moreover, creative ‘frames’ for palliative 
care are unlikely to gain traction without firm evidence, a notion backed by the suggestion that 
moral and ethical arguments, are the least likely to influence policymakers. This is an uncomfortable 
truth, however it is one which the palliative care community must engage with.  
 
That funding agencies operate ‘results-based financing’ and that advocacy efforts gain the greatest 
traction when defining both problems and solutions clearly, represents key challenges to the field of 
palliative care. Moreover, whilst there is evidence from countries such as the United Kingdom, of the 
effectiveness of palliative care it has not been established whether such evidence has broader 
implications.cxii Additionally, whilst there are countries where no palliative care services exist to be 
evaluated, it is important to establish whether palliative care researchers are producing evidence 
which has international relevance. Dynamic forces have been identified which have shown that 
practices and policies have developed based upon geographical proximity, however, it is not known 
the extent to which such processes have relevance for nations in other geographic locations. 
 
To address this gap, Chapter Five presents a Systematic Mapping of Review of International Palliative 
Care Research in order to establish whether palliative care researchers are overcoming barriers to 
high quality research identified in Chapter Two, to produce the types and strength of evidence with 
which advocates are able to creatively ‘frame’ palliative care to global policymakers. Before doing so 
however, the following chapter presents the overall methodological strategy of the thesis. A 
multiple-methods approach is justified, explaining how a methodologically iterative approach 
allowed original research questions to emerge during processes of ongoing reflection and revelation. 
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Chapter Four 
Methodology 
 
Introduction 
 
In Chapter Two a brief history of international palliative care was given to show that existing 
narratives of development have been conceptualised only simplistically and without sophisticated 
consideration of theoretical understandings of policy spread and development. As a potential 
remedy, the previous chapter offered a Global Social Policy (GSP) perspective as a critical lens 
through which to consider how palliative care may be able to achieve policy prioritisation. It was 
argued, that in order for palliative care development to be accelerated, that new approaches were 
needed including new ways of ‘framing’ palliative care based upon evidence-based arguments.  
  
The intention of this short chapter is to set out the overall methodological approach of this study in 
order to answer the research question:  
 
Can the global development of palliative care be furthered through increased understanding 
of global policymaking processes and the presentation of palliative care as an international 
development issue? 
 
As will be explained below, in order to answer this question, the research was divided into three 
distinct phases, each of which had distinct sub-research questions and required the use of distinct 
methods. Overall, a largely qualitative approach was adopted, but multiple methods were employed 
in order to answer several additional more focussed sub-research questions which were generated 
iteratively during the course of the research. On this basis, this chapter presents a brief overview of 
the methods employed by the study, with more detail and discussion of their utility presented in 
subsequent chapters. It proceeds to consider the broad research paradigm adopted in order to 
justify both the iterative study design as well as the employment of a multiple methods research 
strategy. The chapter concludes with consideration of ethical risks faced by the project, which, due 
to the lack of any medical intervention, vulnerable populations and full consideration of ethical 
issues throughout the project from design to delivery, may be considered low. 
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Overview of methods  
 
Three different research methods were adopted during the project, to answer the overarching 
research question as well as additional questions which emerged during the project in line with the 
inductive approach used throughout the study.i On this basis, the project was conducted in three 
distinct phases: 
 
1. A systematic mapping review of international palliative care research 
2. Quantitative analysis using correlations between structural indicators of country 
development and level of palliative care development 
3. Semi-structured, qualitative interviews of key experts within the field of international 
palliative care 
 
Due to this diversity, the specific methods including the sub-research questions, study design, data 
collection, data analysis etc. are presented separately within subsequent, free-standing, but linked 
chapters for each element of the study. The focus in this chapter is therefore to consider the overall 
research paradigm adopted by the study as well as to justify the use of multiple methods as a 
rational way of answering different sub-research questions.ii As each method was utilised to answer 
specific, but linked questions, no formal process of triangulation was used.xxiv However, in various 
ways, findings from each element of the study interact to either support or challenge each other. 
Therefore, ways in which the findings from each part of the study coalesce in order to answer the 
overall research question are considered. 
 
This multiple methods study was guided by an iterative approach to research design, whereby the 
methods employed were guided by emergent areas and questions of interest.iii This approach 
reflects the wide ranging scope of the study and was deemed appropriate to both answer specific 
questions (systematic review, correlations) as well as to answer broad questions (elite interviewing) 
regarding international palliative care advocacy, questions which were developed based upon 
emergent findings. Therefore, the multiple-methods approach was adopted not to duplicate and 
validate findingsiv (although instances where this occurs are noted through the study), but to 
produce complementary findings and increase understanding of the complex field of international 
palliative care development. On this basis, theory development was driven through inductive 
process, which allowed theory to emerge from the data, rather than through examination of existing 
theories through hypothesis testing.v 
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Although there is a long tradition of the employment of multiple methods in order to answer 
complex questions, their use is not universally accepted.vi It is therefore appropriate to provide 
justification for the methodological approach employed by this study and to consider the overall 
robustness of the approach and understand just what it is appropriate to infer from findings arising 
from the use of multiple methods. The following section therefore reviews the research paradigm 
used by the study as well as some of the debates regarding the utility of the methodological 
approach adopted. 
 
Research paradigm and approach 
 
All research is undertaken within a selected research paradigm, which serves to dictate the types of 
questions which may be considered ‘answerable’ and consequently the methods which can be used. 
‘Research paradigm’ is a broad term, which is said to encompass specific elements including: 
ontology and epistemology.vii Ontology is a term which questions the nature of reality, in terms of 
whether researchers study objective reality as something which is pre-existing, waiting to be 
discovered, or if it is something which is constructed through processes of interaction.viii  
Epistemology relates to theoretical understanding of the nature of knowledge and investigates the 
origin, nature and limits of human knowledge.ix  
 
Consequently, different epistemological positions allow researchers to answer different questions, 
based upon understandings of reality and therefore different methods are adopted in order to 
answer differing questions. In practice, different understandings of epistemology, lead to differing 
claims from researchers regarding the validity of knowledge which emerges from research findings. 
A key distinction between two epistemological positions may be drawn by understanding two 
schools of thought on polarised sides of the divide: positivism and interpretivism.  
 
Positivists believe that reality exists independently from researchers and therefore, that ‘knowledge’ 
is something which is pre-existing which can be proven to be certain through the production of 
replicable results. For instance, in medical research, ‘knowledge’ may be generated through the use 
of experimental studies and quantitative research methods, to answer questions such as: is drug X 
effective in curing disease Y? v On the other side of the debate, interpretivists perceive of knowledge 
as something which is intentionally constituted through lived experience. Interpretivists do not seek 
to prove social phenomena, but aim to make defensible knowledge claims, through the use of 
qualitative research methods.x 
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The research questions formulated within this study do not allow definitive answers to be generated 
using a positivist approach. Interpretive research is often criticised by positivists due to the non-
replicability of research findings.x This study, however, rejects such criticism and operates mainly 
from an interpretivist standpoint that seeks to understand social phenomena emerging from data 
collected during qualitative interviews.xi It follows that semi-structured interviews were conducted, 
in order to ascribe meaning to participant responses and increase understanding, rather than to 
generate objective ‘facts’.vi  
 
However, through examination of statistical indicators of country development as well as the use of 
level of palliative care development as an ordinal outcome measurexii, the study also draws upon an 
epistemological position which combines principles of both interpretivism and positivism – rejecting 
the idea that the two positions are incompatible. In doing so, it accepts the possibility that more 
than one truth may exist regarding phenomena. This position is informed by the argument that: 
 
Interpretive analysis can provide crucial information to inform positivist causal theories that 
might otherwise have been missed [2013.p.161]xiii  
 
This situation can be seen most clearly, through informal discussion in Chapter Six of palliative care 
development, which draws upon statistical indicators of the structural contexts within which 
palliative care services have (or have not) developed. Emergent findings were then critiqued and 
corroborated using the views of key experts in international palliative care research regarding 
factors which have driven development. 
 
However, it is important to acknowledge, that the study draws upon a positivist approach through 
the use of correlations between structural indicators with level of palliative care development, for 
their explanatory value only. That is, correlations were used to describe the contexts in which 
palliative care has developed, not to develop any causal assumptions. On this basis, regression 
analysis was not conducted as the chapter does not seek to suggest that any one indicator causally 
effects level of palliative care development, only that they are associated.xiv  
 
It is common in mixed method studies, to employ triangulation, in order to cross-check findings and 
answer a single research question.xxiv This study, however, does not do so as different methods were 
used iteratively in order to answer emerging questions from data. That is that diverse methods were 
employed to answer different questions, rather than to validate a single answer to a single question. 
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It follows, that the study is presented as using ‘multiple methods’ rather than ‘mixed methods’. A 
mixed-methods approach often asks confirmatory as well as explanatory questions concurrently in 
order to corroborate results obtained using qualitative and quantitative methods to answer the 
same question.xv ‘Multiple methods’ is a more appropriate conceptualisation of this study, however, 
as it describes the use of distinct research methods within an overall project, which incorporates 
more than one study. Additionally, each different study design exists in relative isolation, whilst also 
contributing towards answering the overall research question.xvi 
 
The study therefore operates mainly from an interpretivist standpoint and seeks to understand 
social phenomena emerging from data collected during qualitative interviews.xvii Such methods are 
relatively new in health care research, which more commonly aims to produce replicable results for 
instance in terms of proving whether a certain drug therapy is effective.vi In this regard, the study 
draws upon purposive and snowball sampling of key experts and imparts inductive reasoning in 
order to increase the validity of broader findings. Nevertheless, it must be acknowledged, that using 
such an approach means that findings cannot be disaggregated from the role of the researcher in 
producing them.xviii Additionally, generation of data through interviews relies on interaction between 
a researcher and study participants and therefore the social world which is present to be understood, 
is bounded within the confines of the knowledge and experiences of both the researcher and the 
research subjects.xix  
 
Risk of researcher bias 
 
One methodological risk which ran throughout the study was that of ‘researcher bias’. That is, due to 
the active presence of the researcher in the research process, there was a risk that results may be 
influenced due to the active process of their generation.xx This active role played by the researcher 
holds the potential for individual bias to be introduced into a project at all stages as the following 
quote explains: 
 
A researcher's background and position will affect what they choose to investigate, the angle 
of investigation, the methods judged most adequate for this purpose, the findings 
considered most appropriate, and the framing and communication of conclusions [2001. 
P.485].xxi 
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Within this study, the role of the researcher became ever more active during processes such as 
coding, through which meaning was ascribed to study participants’ words as well as during analysis, 
where decisions were taken regarding which elements of participants’ responses were important to 
the research question. Indeed, due to the large amount of data generated through interviews, it was 
incumbent upon the researcher to bring coherence and structure to the data.xxii  This circumstance 
arose also, when conducting the systematic mapping review [Chapter Five], where judgement calls 
were necessary to determine whether papers met the inclusion criteria as well as to which thematic 
category they should be assigned. Thus, without appropriate safeguarding, the risk of researcher 
bias was present throughout the study. 
 
In order to meet this methodological challenge, reflexivity was exercised by the author at all stages 
of the project. Reflexivity may be defined as “an attitude of attending systematically to the context 
of knowledge construction, especially to the effect of the researcher, at every step of the research 
process [Wood.2015]”.xxiii In this regard, the internal reliability of processes such as coding was 
tested through the involvement of a second/third researcher in such processes.xxiv That is, that some 
transcripts were double coded and decisions regarding inclusion/exclusion of research papers within 
the systematic review were reached by two researchers independently making such decisions, then 
cross-checking and with final decisions reached through consensus. However, in instances where 
there was divergence of opinion, final decisions were made by the author. More detail regarding 
such efforts is provided within distinct methods sections of subsequent chapters, however, such 
issues are important to acknowledge here, to underline that a robust methodological approach was 
adopted throughout the study, in order to increase the overall validity of research findings.  
 
Theoretical underpinning and ethical approach 
 
In terms of theoretical approach, this thesis draws upon Global Social Policy (GSP) explanations of 
global policymaking processes. However, it is important to acknowledge, that whilst theoretical 
literature is drawn upon to increase the validity of findings, that this study does not seek to 
empirically test any GSP assumptions. Instead, theoretical literature is drawn upon to increase 
understanding of global palliative care development, based upon pre-existing theoretical 
understanding of processes of policymaking and prioritisation. Accordingly, where appropriate, 
findings which support GSP perspectives are noted. Additionally, where phenomena appear to occur 
for which a GSP theoretical perspective does not increase understanding, GSP is critiqued 
appropriately. On this basis, the study should appeal to both palliative care and GSP audiences. 
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Finally, although this project may be considered ‘low risk’ in terms of ethical issues arising, this study 
began from an understanding that in qualitative research, the validity of research findings is reduced 
if research has not been conducted to high ethical standards.xxv In line with the overall 
methodological structure of the study, any relevant ethical considerations specific to each chapter 
are considered alongside more detailed discussion of the research methods for each. However, here 
it is appropriate to note, that in terms of research procedure, the study was conducted in line with 
principles of Good Clinical Practice and the Declaration of Helsinki.xxvi The study received full ethical 
approval from the University of Sheffield, School of Health and Related Research (ScHARR) Research 
Ethics Board on the 27th April 2015 [Appendix 1]. 
 
Conclusions 
 
This chapter has described and reflected upon the overall methodological strategy of the study. The 
use of a multiple methods approach has been justified as a rational method of answering different 
questions. It has also been shown why a largely qualitative, interpretive approach was selected in 
order to answer the overarching research question of the study, for which no objective ‘correct’ 
answer is possible. Instead, through rigorous research process and appropriate safeguarding, the 
findings in response to separate questions will be synthesised in order to provide a methodologically 
justifiable knowledge claim. 
 
In Chapter Three, key insights from the field of GSP were presented in terms of how global health 
policies are formulated and why certain issues receive policy prioritisation over and above other 
worthy claims. It was argued that palliative care development may be accelerated through the 
presentation of evidence-based ‘frames’ to global policymakers who have the power and resources 
to fund service development. However, the extent to which researchers are equipping advocates 
with evidence which is internationally relevant is not known. On this basis, the next chapter presents 
a Systematic Mapping Review of International Palliative Care Research to identify whether 
researchers are providing evidence to advocates which is likely to influence global policymakers. 
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Chapter Five 
A Systematic Mapping Review of International Palliative Care Research 
 
Introduction 
 
As identified in Chapter Two, globally speaking, the need for palliative care continues to greatly 
outstrip supply. In spite of this, recognition from global level actors has been limited, with palliative 
care receiving attention mainly from normative and civil-society organizations and little or no 
engagement from funding agencies. This circumstance is of concern to the global development of 
palliative care, as normative institutions do not hold the power to implement policies and projects 
services and instead rely on the production of guidance and their primary roles are to set standards 
and provide leadership.i In this regard, it has been argued that engagement is needed from a wider 
range of global actors with the resources in order to fund palliative care development within low-
income contexts. However, in order to engage with powerful global health care actors it is necessary 
to make evidence-based claims to attract the attention of global policymakers.xii  
 
Drawing upon Global Social Policy theory (GSP), it has been identified in Chapter Three how policies 
and practices can be transferable between nations. Additionally, it has been shown that policy 
claims gain greater traction, when social problems are presented as ‘solvable’ and the message is 
delivered by a wide range of actors, through international research networks and International Non-
Governmental Organizations (INGOs). Furthermore, it is known that in order for health issues to 
attract the attention of policymakers, an evidence-base is required.ii  Evidence of effectiveness and 
cost-effectiveness of interventions can equip advocates with the tools required in order to influence 
policy-decisions and resource allocation. Additionally, backed by evidence, advocates are able to 
engage with the less tangible issues of policy prioritisation such as how health problems should be 
‘framed’ to resonate with global policymakers. 
 
However, the extent to which researchers are facilitating such processes by producing research 
which has international relevance, is unknown. It is this from context that this chapter emerged. 
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Rationale for the review 
 
Older people are the demographic with the highest health system usage and there is a growing 
imbalance of people of working age in relation to dependents and a consequent reduction in people 
contributing to health systems funding.iii Additionally, an almost two-fold increase in the number of 
people dying globally is predicted over the next 40 years, with people expected to experience more 
complex and costly health and social care problems as they approach the end of their lives.iv  This 
challenges both the capacity and sustainability of health systems.  Further roll out of palliative care 
services internationally has until recently received little global-level attention is spite of ‘global 
ageing’ emerging as a key area for international development.v 
 
The primary aim of palliative interventions is to improve the quality of life of patients facing life-
limiting illnesses and their families.vi However, it is also suggested that increased access to palliative 
services through a public health approach holds the potential for broader benefits including reduced 
overall health expenditure through reduced usage of primary and critical carexl and reduced out-of-
pocket expenditure for households.vii Additionally, national-studies have demonstrated that 
palliative care can reduce unnecessary and expensive hospital admissions.viii 
 
Conceptualising palliative care in economic terms as well an urgent health need, would allow its 
consideration as an international development issue which aims to increase levels of both human 
and economic development.ix Moreover, as referred to in Chapter Three, many of the key global 
health actors, such as the World Bank, prioritise development models through economic 
mechanisms, which suggests that evidence supporting economic arguments for palliative care may 
be an effective way of engaging with new financiers.  
 
However, in spite of many studies demonstrating a link between illness, death and household 
poverty in both lowx, and high-income settingscvi little global attention has been given to how such 
negative effects of terminal illness and bereavement may be reduced through appropriate 
intervention. Indeed, with reports that emotional bereavement is a luxury which many in lower-
income countries cannot afford,xi attention to the financial aspects of illness and bereavement is 
warranted. Additionally, presenting palliative care in this manner may be considered an innovative 
‘frame’ with which to engage policymakers as part of broader development efforts towards poverty 
reduction.ix 
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It is known that in order for health issues to attract the attention of policymakers, an evidence-base 
is required.xii In this regard, palliative care as a research field has grown alongside global 
development of services with output increasing yearly.xiii In 2002, a systematic review of empirical 
palliative care research was conducted which located around 400 papers – around 90% of which had 
been conducted post-1990. By 2011, a paper entitled ‘World-wide literature survey on geriatric 
palliative medicine’, identified 404 papers -  323 of them primary research studies - within only the 
five year period between 2007-2011.xiv  Although the two studies did not compare like-for-like 
outcomes, this nevertheless indicates an exponential rise in palliative care research activity. 
 
However, there are ongoing concerns regarding the evidence-base that palliative care researchers 
are providing to policymakers.xv  For example, there are issues relating to the difficulties of 
measuring outcomes in palliative care such as; quality of care, quality of death and bereavement 
resolutions. In addition, research capacity is low, particularly in low-income regions like Sub-Saharan 
Africa, where there are concerns that researchers lack the resources to inform the delivery of 
appropriate care.xvi In this regard, Figure 4 presents the results of a review of geriatric palliative care 
and shows that poorer regions are contributing little to the evidence base. 
 
Figure 4. Global Geriatric Research Publications, 2006-2011 by Continent 
 Source: Curiale, V. 2011.xiv 
Additionally, there are various barriers to the production of high-quality research, such as, ethical 
issues associated with conducting research on vulnerable populations.xv 
 
As research capacity in low and middle-income countries is low, it is important for researchers in 
other settings, to produce evidence which has international relevance.xvii For instance, given 
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suggestions that palliative care services such as that in Kerala may be transferrable to other settings, 
the extent to which evidence supports such claims, is unknown.xviii In recognition of the need for 
internationally relevant evidence, initiatives such as the European Palliative Care Research 
Collaborative [EPCRC] have emerged to facilitate the implementation of European evidence based 
guidelines in palliative care.xix However, with an urgent need for research collaboration between low 
and high-resource countriesxx, the extent to which western researchers in palliative care are 
supplementing research evidence in other settings is unknown. Moreover, no study has yet, to date, 
sought to understand and categorise the landscape of international palliative care research to 
determine whether research capacity in under-researched regions is being supplemented by 
international researchers.  
 
Given these gaps in our understanding, the aim of this study was to conduct a systematic mapping 
review to identify all published literature on international palliative care research. ‘International 
research’ was defined as involving two or more countries due to the potential of comparative 
research to increase common understanding.xxi In the same regard, studies focussed on the ‘global’ 
level were included as well as papers from a single country if they specifically and primarily focussed 
on the international transferability of their findings. This approach was adopted to achieve the aim 
of producing a thematic map of international research themes and issues. Additionally, the extent to 
which attention is focussed upon low-income countries where little palliative care research is known 
to be conducted by national researchers is considered. Finally, this chapter analysis asks whether the 
evidence-base being produced by international researchers facilitates consideration of palliative care 
as a public health issue and/or a concern for the broader international development community. 
This review is the first of its kind to examine the quantity and scope of international palliative care 
research. 
 
This systematic mapping review therefore aimed to answer the following specific questions: 
 
1. What is the typology of academic literature focussing on palliative care in a global context? 
2. What are the research strengths of the field and where is evidence lacking? 
3. Where and when has research been produced? 
4. Which countries and world regions is research focussing upon? 
5. Is the research field growing? 
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To answer these questions, a study selection strategy was developed in order to identify relevant 
information and is presented below. 
 
Methods 
 
A systematic mapping review is an established literature review method that is employed in order to 
map out and categorize existing literature from which to commission primary research by identifying 
gaps in the research literature’. xxii This method is appropriate for reviews which anticipate large 
numbers of included studies.  This review method was selected as opposed to other methods which 
combine heterogeneous literature, such as narrative review, due to ongoing association between 
narrative reviews and a lack of systematic approach.xxiii 
 
Search strategy for Identification of Studies 
 
In line with the aim of the review to produce a picture of the full academic field of global palliative 
care research, the search strategy was designed to be as sensitive and systematic as possible.xxiv By 
doing so, it was recognised a consequence of this was that many of the returned outputs would not 
be relevant to the study. However, a more specific search strategy was likely to have missed many 
outputs relevant to the review and thus an inclusive approach was taken.  
 
To ensure that an appropriate search strategy was developed, a scoping exercise of keyword terms 
was undertaken. Search terms were developed through consultation with an expert in palliative care 
research (CG) and an expert in global social policy research (AK). Terms were initially developed 
iteratively based upon existing knowledge of the field which were then checked for synonyms using 
a thesaurus.  
 
There was some disagreement as to whether certain terms should be included – for example, 
‘universal’ when searched with ‘palliative’. Here, the interdisciplinary team worked well. CG, as the 
palliative care lead, argued that ‘universal palliative care tends to be used a synonym for generalist 
palliative care rather than international palliative care’. Conversely, AK stated that ‘the term is used 
in the global social policy literature, particularly diffusion/world society theory’. After discussion, it 
was decided that the term should be included, as searching for ‘universal AND palliative’, would 
produce outputs relevant to universal health coverage and the exclusion criteria would remove the 
‘generalist palliative care’ literature – unless it had an international perspective. 
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After the consultation process, search terms were decided upon for a scoping exercise and are 
presented in Table 3. The scoping exercise was conducted by searching ‘topic’ with all of the key 
words and search terms in Web of Knowledge with the root term, ‘global’. In general, the exercise 
produced manageable results, for example, what was anticipated to be one of the major searches, 
“global AND palliative” returned 708 outputs. Problems did emerge, however, from two of the 
suggested key words – ‘death’ and ‘dying’. When searched with ‘global’, the two terms produced 
‘approximately’ 29,775 and 10,813 outputs respectively. This figure it was agreed was, practically, 
too high to apply the inclusion/exclusion to. 
 
Table 3: Provisional search strategy for scoping exercise 
 
Root terms (having searched 
and included synonyms) 
Key words to be searched with 
Root terms (having searched 
and included synonyms) 
Search terms (to be searched 
with and without hyphenation 
as appropriate) 
Global Palliative "Opioid availability" 
International Palliation "supportive care" 
Europe Palliat "Terminal illness" 
Africa Hospice "Terminally ill" 
Asian Death “Terminal disease” 
North America Dying "end-of-life-care" 
South America Bereavement “Terminal care” 
Transnational   
World   
Worldwide   
Developing World   
Universal   
Supranational   
Multinational   
 
A further scoping exercise was undertaken. The inclusion/exclusion criteria were applied to the first 
100 returned results for the searches “global AND dying” and “global AND death” to assess how 
many of the returned outputs would be relevant to the study and not picked up by any of the other 
search terms. The search for ‘global AND death’ produced only one output which would be included 
in the study, but as the output would have been found by 'global AND palliative', it was decided that 
‘death’ could be removed from the search strategy. 
 
The search for ‘global AND dying’ produced four outputs which would be included in the study – only 
three of which would have been located by the existing search strategy. As a result, the term ‘end-
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of-life-care’ was refined to ‘end-of-life’ to ensure that the output entitled ‘Researching the end-of-
life in old age: cultural, ethical and methodological issues’xxv would have been identified, although 
this specific paper was not eventually included.  
 
Although the amended search strategy would have found all four included outputs from this search, 
it was decided that further refinement of the search strategy was necessary, as excluding ‘global 
AND dying’ when 4/100 outputs were relevant was deemed unacceptable. As a result, it was 
deemed that the terms ‘global AND dying AND care’ and global AND “care of the dying” should be 
investigated. The returned results were as follows: 
 
global AND dying AND care = 637 returned outputs. 
global AND “care of the dying” = 3 returned outputs. 
 
With the higher results returned by ‘global AND dying AND care’, the inclusion/exclusion criteria 
were again applied to the first 100 returned outputs. Three papers were identified in this manner, 
but all had been found by alternative searches and it was agreed that the term should not be added 
as it had yielded nothing new from a high amount of returned outputs (637). It was decided that 
‘global AND “care of the dying”’ should be added to the search strategy as it had yielded relevant 
outputs (3) from low returned search results (also 3). Other minor changes made after the scoping 
review were that ‘Asian’ was changed to ‘Asia’, and ‘Developing Countries’ was also added. In 
addition, terms where the ‘root’ of a word would find the longer term (for example, palliat* and 
palliative/palliation) the longer terms were also removed to simplify the search process. 
 
The scoping review was performed and the results verified and discussed with a palliative care 
expert (CG). This scoping exercise led to the following changes being made to the search strategy. 
 
Removed; 
Death, dying, ‘end- of-life-care’, Asian, worldwide, ‘developing world’, palliative, palliation 
 
Added 
‘care of the dying’, ‘end-of-life’, asia  
 
Following this scoping exercise of keyword search terms, the search strategy using MeSH headings 
and keywords was formulated [Table 4] and agreed with an Information Specialist, experts in the 
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fields of palliative care and international health policy research.  Five bibliographic databases 
(CINAHL, ASSIA, Web of Knowledge, Cochrane Library and Psychinfo) were searched using the 
developed search strategy. Searches were conducted between the 4th and 9th of July 2013, no start 
date filter was applied. Hand searching of reference lists and experts in the field were also consulted 
to identify additional relevant texts. 
 
Table 4: Summary of search strategy for systematic review 
 
1. Global OR International OR Europe OR Africa OR Asia OR North America OR South  
America OR Transnational OR World OR Universal OR Supranational OR  
Multinational OR “Developing Countries” 
 
AND 
 
2. Palliat OR Hospice OR “Opioid availability” OR “Supportive Care” OR “Terminal  
illness” OR “Terminally ill” OR “Terminal disease” OR “End-of-life” OR “Terminal  
Care” OR “Care of the dying” OR bereavement 
 
 
The electronic search strategy yielded 14058 outputs which were imported into Endnote along with 
one additional paper identified through discussion with experts in the field (n=14059). Duplicates 
(n=1894), books and book chapters (n=499), patents (n=22) and theses (n=31) were removed. The 
remaining outputs (n=11613) were then exported to Microsoft Excel for the inclusion/exclusion 
criteria to be applied. In order to meet the aims of the review, a list of inclusion/exclusion criteria 
was devised [Table 5]. 
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Table 5: Inclusion / Exclusion Criteria 
Included 
To be included, outputs had to be: 
 ‘International research’ defined as research focussing upon two or more countries, the 
global level, or where national research explicitly expresses international relevance of 
findings 
 Empirical research published in full with methods reported 
 Relevant to palliative care, palliative medicine or end-of-life-care 
 Available in full text form 
 Available in English  
 Published in a peer-reviewed journal 
Excluded 
Outputs were excluded if they were: 
 Outputs where search terms are used out of context 
 Conference proceedings 
 Book chapters/book reviews 
 Non-empirical papers (methods not reported) e.g. non-systematic reviews 
 Editorials/Commentaries/Opinion Pieces/Letters/Theses/News articles/Policy 
statements/Grey literature 
 
Applying the Inclusion/Exclusion Criteria 
 
Once the searches have been performed, the inclusion/exclusion criteria were applied to the 
returned results. A total of 11613 articles were initially reviewed using title/abstract, of which 11123 
articles did not meet the inclusion criteria [Figure 5]. Full text articles were then retrieved for the 
remaining 490 papers and the inclusion/exclusion were applied by JC. Most of these papers were 
retrievable through the University Library or were available online through open access. Additional 
papers were retrieved by attending the British Library sites at both Boston Spa and London. 
Following this, a second independent screening of all included titles/abstracts was undertaken by CG 
and consensus agreed by discussion in cases of disagreement. Where there was any confusion 
regarding the relevance of the output, the full paper was consulted once more and the final decision 
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made by the author. During this process, regular discussions were held wherever decisions had to be 
made regarding the eligibility of studies. Each meeting was minuted and during the discussions, 
several broad decisions were reached regarding the following issues. 
 
Papers relating to euthanasia/assisted dying  
 
It was decided that such papers would be excluded, as although there are conflicting viewpoints, 
there are several statements from palliative care organizations which specifically state that assisted 
dying and euthanasia are not part of palliative care.xxvi The exception to this rule was that any 
relevant papers commenting on the subject from a palliative care standpoint would be included. 
 
Non-Empirical papers 
 
Many published articles (n=306) relevant to palliative care in international context were identified by 
the search strategy which did not meet the inclusion criteria as they did not report using research 
methods e.g. discussion pieces, editorials, letters etc. Typically, such articles offered evidence-
backed arguments, but did not contribute new material to the evidence-base. Articles excluded from 
the review within this category were retained to inform analysis of both the review and the broader 
project. 
 
What is ‘international’? 
 
The inclusion criteria provide a clear explanation of how ‘international’ research was defined [Table 
5].However, an issue which arose whilst applying the Inclusion/Exclusion criteria, was how to deal 
with outputs relating to settings with differing understandings of sovereignty. For instance, England, 
Scotland, Wales and Northern Ireland may be understood as individual nations, or as the United 
Kingdom (UK). Likewise, Hong Kong may be treated as a sovereign nation or as part of China. A 
consistent approach was used for understanding nations by adopting the UN country classification 
system. On this basis, one article which compared hospice practices in England and Walesxxvii, the UK 
was treated as a national study and excluded, although it is acknowledged that there has been 
devolvement of healthcare in this circumstance from the UK government.xxviii 
 
Data extraction originally intended to extract data which specified each country involved in the 
research, however, this information was commonly not reported e.g. studies referred to participants 
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from ‘several European countries’, rather than reporting each country by name.  Therefore, data was 
extracted by region rather than by country. Country-level information was extracted if it was noted, 
to enrich analysis and discussion.  
 
Regions were characterised along continental lines, with the ‘non-continental’ Caribbean grouped 
with South America. Papers which solely focussed upon the global level rather than a particular 
region were described as ‘global’. The term ‘global’ is used where worldwide relevance is suggested, 
whereas ‘international’ is used to refer to more than one country.  
 
Quality appraisal 
 
Due to the scale of the review, as well as the diverse study designs which were included, no formal 
quality appraisal was undertaken. Instead, decisions regarding the quality of research were made by 
reviewing study designs as per the hierarchy of evidence.lxxviii This approach was used with caution, 
recognising that different study designs are appropriate for answering different questions and that 
randomised controlled trials, the ‘gold standard’ in research, are not feasible in all scenarios. This is 
especially true in in palliative care research, where ethical issues surrounding randomisation and the 
inclusion of vulnerable groups in research limit the occasions where such trials are appropriate.xxix 
Nevertheless, as global health policymaking continues to become more evidence-based, it was 
deemed appropriate to consider the type and strength of study designs being used in international 
palliative care research.ii 
 
The full process of study identification is presented in the flow diagram [Figure 5]. 
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Figure 5: Identification of relevant studies 
 
 
Data extraction 
 
A total of 184 studies met the study inclusion criteria. Each included study is referred to as an output. 
Data were extracted from all outputs using a data extraction form, which was piloted to ensure that 
all relevant data were captured. The outcomes extracted are reported in Table 6. Additionally, due 
to the large amount of studies included, aggregated outcomes are presented and the full reference 
list of included studies can be found in Appendix 2. 
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Table 6: Outcomes Extracted from Included Studies 
 
1. 1. Year of publication 
2. 2. Journal of publication 
3. 3. Region(s) of output focus 
4. 4. Region of First Author of output 
5. 5. Study design. Eg; cross-sectional, randomised controlled trial etc 
6. 6. Thematic focus of output 
 
It is accepted that using First Author to indicate Lead author is something of a crude measure of 
determining leadership on a project and thus attributing research to a region. Different academic 
disciplines have different conventions relating to authorship. In Sociology, for example, the highest 
prestige is given to the First Authorxxx, whereas, in Biomedical Science, the senior author, or 
research-group leader is commonly listed last.xxxi It was agreed that this was nevertheless a useful 
indicator of where research emanates from and would be extracted. 
 
Before proceeding to give an overview of the data analysis and synthesis processes, it is first 
appropriate to acknowledge, that all decisions taken with regards to study identification involve the 
active role of the researcher. Therefore, the following section considers the risk of bias within the 
review. 
 
Risk of bias 
 
It was recognised (and regrettable) that non-English language papers were excluded from the review. 
The resources available to the author did not permit the use of translational services. It is accepted 
therefore that this may introduce some geographic and language bias to the study. However, no 
non-English articles were identified and excluded, so this risk of bias was deemed minimal. 
Nevertheless, future researchers are urged to search in a wide variety of languages in any future 
update to this review. 
 
Additionally, there is a small amount of bias away from clinical aspects of palliative care in favour of 
palliative care more as a policy issue. For instance, clinical trials which have relevance for palliative 
care and are likely to have benefits for many patients may not have been identified due to using the 
blanket term ‘opioid’ to identify issues relating to essential medicines. Specific medicines used in 
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palliative medicine were not searched for individually.  This approach is line with the aims of the 
study to consider international palliative care research, rather than studies which may have 
international relevance. There is no implication that clinical outcomes from drug treatments are 
likely to differ amongst similar patient groups, however the international relevance of studies would 
have had to be made explicit in either title or abstract for the study to have been identified by the 
search strategy. On this basis, it must be acknowledged, that in spite of a rigorous search strategy, 
some relevant papers may not have been included in the review. 
 
All decision-making processes took place collaboratively to ensure a reflexive approach to research 
data however, ultimately the author made all final decisions. Processes of dual-coding and eligibility 
assessment were used in order to increase the validity and reliability of findings, however again, in 
cases of any disagreement, final decisions were made by the author. Such processes increase the 
likelihood of replicability of the study, however, this was not the overall aim of this qualitative 
review and all findings should be approached with consideration of the overall methods used to 
develop them.xxxii 
 
Data analysis  
 
Data analysis was conducted using a descriptive thematic method for data synthesisxxxiii. This method 
was chosen as it facilitated the aim of the review: to systematically produce an overview of 
international palliative care research based on the thematic focus of included papers.  
The development of thematic categories was undertaken using a two-phased approach. Firstly, a 
‘descriptive coding’ method was used to identify the primary focus of outputs based upon abstracts 
and full texts.xxxiv Secondly, mind-maps were used in order to examine relationships between 
emergent codes which resulted in the development of overarching themes which were then checked 
by a study supervisor (CG). Themes therefore emerged from the coded outputs themselves and it 
follows, that many outputs were potentially relevant to more than one theme. When such issues 
occurred, they were resolved by discussion amongst the study team and outputs were allocated to 
themes with an emphasis upon the primary research objectives of each study as opposed to being 
guided by the title of the work.  
 
Papers were analysed descriptively and allocated into emergent thematic categories by reviewing 
abstracts and full texts. Themes were applied, based upon the primary focus of the output and then 
checked by a study supervisor (CG). The process was then repeated, refining the thematic categories 
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and then verified once more before being finalised. Findings were then summarised descriptively 
according to the themes identified during extraction. 
 
Results 
 
Total outputs by year of publication 
 
The earliest research paper identified on palliative care in an international context was published in 
1986 (n=1) [Figure 6]. Between 1986 and 1990, only one more paper was published, indicating that 
the development of international palliative care research remained slow during that period.  
 
The following ten years up until 2000 showed increased outputs in the field of international 
palliative care with 16 papers published across this decade. Since then, there has been an 
exponential rise in international research activity in the field, with 151 relevant papers published 
between 2001 and 2012.  
 
Figure 6: Total outputs (n=184) by year of publication  
 
 
The increase in research output from 2006 follows the publication of at least 2 WHO policy papers in 
2004 calling for palliative care to be an international public health policy.xxxvxxxvi  Additionally, the 
Journal of Pain and Symptom Management (JPSM) published a special issue on international 
palliative care in 2007, many papers from this issue are included in the review which helps explain 
the spike in output of that year. 
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From the end of 2012 up until July 2013* when the searches were conducted, 15 relevant papers 
had been published. 
 
Journal of Publication 
 
The 184 included outputs were published in 75 different peer reviewed journals. Of these, only 3 
journals have published 10 or more outputs [Table 7], with the Journal of Pain and Symptom 
Management and Palliative Medicine publishing the greatest proportion of articles  (n=39 (21%) and 
n=24 (13%) respectively). Other outputs were located in a wide range of journals varying from BMC 
Public Health (n=3) and Social Science in Medicine (n=2), to the Journal of Aids and Behaviour (n=1). 
The range of journals represented a wide range of disciplines, including medicine, nursing, social 
work and others.  
 
Table 7: Top 6 Journals which have published included international palliative care research 
articles 
 
Journal title Total 
Journal of Pain and Symptom Management  39 
Palliative Medicine 24 
Journal of Palliative Medicine 10 
Journal of Palliative Care 7 
BMC Palliative Care 5 
International Journal of Palliative Nursing 5 
 
Nevertheless, there is only what can be considered a ‘critical mass’ of interest in palliative care in an 
international context (as reflected by included publications) in three journals – The Journal of Pain 
and Symptom Management (n=39), Palliative Medicine (n=24) and the Journal of Palliative Medicine 
(n=10). The ‘top-six’ journals which have published relevant outputs are shown in Table 7. It 
demonstrates drop-off in publication output from the two most prevalently publishing journals to 
the rest of the journals identified. 
 
Location of First Author 
 
The location of the first author was extracted by noting the country in which the lead authors’ 
institution was located [Figure 7]. There was an uneven distribution in the geographical location of 
first authors who have published palliative care research in an international context.  
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Figure 7: Location of first author based on home institution 
 
 
Using the country of the first authors’ organization as an indicator reveals that 55% of international 
research originated from Europe, 23% from North America, followed by Asia, with 12%. The lowest 
levels of international research activity were found in Australasia (5%), South America and the 
Caribbean (3%) and Africa with only 2% of first authors based in this region.  
 
Region of research focus 
 
The focus of the research by region was extracted by noting the regions in which the actual research 
took place and/or the study was concentrated, as opposed to the location of the first author. In 
terms of the region of research focus, Europe was the most researched region with 32% of 
international research focussed there [Figure 8]. Following this, there is a relatively even spread 
between regions. The Global level was the second most researched areas with 15% of international 
focussed on region, followed by Asia (13%) and North America (13%), Africa (11%) and  Australasia 
(10%) well represented. South America and the Caribbean receives the least research focus (7%) 
however, the region is more prominent than suggested by the location of first authors.  
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Figure 8: Focus of included outputs by region (n=7) 
 
 
 
The disparities between region of first author and research suggest that research focussed on these 
regions is not actually being led by those who are based in or from these regions. For example, a 
study where the first (and contact) author is based in the United States explores palliative care for 
persons with HIV/AIDS in Africa.xxxvii Additionally, one UK study moves beyond contributing to the 
evidence-base in a developing setting (Uganda) and aims to increase the research capacity of local 
researchers.xxxviii 
 
Moreover therefore, these results suggest that there is greater research funding and capacity in 
developed regions (such as Europe and North America) which enables researchers to conduct 
research in an international context.  
 
Thematic overview 
 
Through descriptive analysis of included outputs, a total of 10 thematic groups emerged. The 
configuration each is presented in Table 8 and is followed by a synthesised analysis of each category 
with examples of studies included in each theme reported. 
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Table 8: Overview of thematic categories (n=10) 
 
Theme 
 
Description 
 
Death and dying Outputs focussing upon issues relating to death and dying – including  
assisted dying – from a palliative care perspective. 
 
Education Outputs focussed upon palliative care teaching, training, education  
and curricula. 
 
Ethics Outputs examining ethical issues relevant to palliative care, such as;  
decision-making, research practice and attitudes.  
 
Evaluation Outputs conducted performing evaluations of palliative care interventions; 
including service models, models of clinical practice, pharmaceutical 
interventions, clinical tools, patient outcome measurement tools etc. 
 
Law Outputs reporting legal issues and legislation in palliative care, either 
specific to palliative care or generic legislation that is relevant to aspects of 
palliative care. 
 
Methodological Outputs reporting on issues relating to methodology in palliative care 
research, including methodological challenges and opportunities in  
palliative care research. 
 
Policy Outputs reporting policy-level issues relevant to; standards, opioid  
availability, human rights, consensus building and international   
organization guidance etc. 
 
Services and 
Settings 
Outputs reporting different palliative care services around the world in  
terms of models and foci of care (eg home care / disease specific  
care) as well as settings (eg rural areas). Typically included outputs focussed 
upon the identification of services and did not conduct full evaluation. 
 
Stakeholders Outputs reporting on issues specific to different stakeholders in  
palliative care eg. physicians, nurses, patients, families etc. Commonly, 
included outputs focussed upon the ‘attitudes’ of these groups to specific 
issues. 
 
Symptom 
Management 
Outputs reporting on symptoms of palliative care patients (eg. Cancer  
pain), symptom prevalence and management. 
 
 
Of the 184 empirical research papers included in the review, Evaluation (n=53, 29%) was the 
dominant theme [Figure 9]. Stakeholders was the second most prevalent theme (n=38) with 21 % of 
the research focus. The third most researched theme, with 15% of the research focus, Services and 
Settings (n=28). Also with 15% of the research focus, was Policy (n=27). Relatively low engagement 
with issues relating to death and dying (n=13, 7%) are revealed by the review. There is also a low 
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level of research focussed upon efforts to improve Education within palliative care (n=12, 7%) and 
Symptom Management represents only 4% of international research output (n=7). Finally, there is 
low engagement from international researchers with ethical (n=3, 2%) and methodological (n=2, 1%) 
issues relating to palliative care and only 1 paper focussed on legal issues in international context. 
 
Figure 9: Thematic focus (n=10) of included outputs (n=184) 
 
 
 
Whilst the scale of the review made it unfeasible to describe each study included within the review, 
the following sections provide an overview of the research focus within each thematic category. The 
full reference list of included studies is provided in Appendix 2. Each theme is here presented in 
order of total papers allocated to the category, from highest to lowest. 
 
Evaluation (n=53) 
 
Many studies within this theme focussed upon tool-validation. For example, one study evaluated the 
palliative care assessment tool - the Sheffield Profile for Assessment and Referral for Care 
(SPARC).xxxix This tool was developed in one context (United Kingdom) and was then evaluated in 
another (Poland). Also common, were evaluations of different models of care.xl Such studies tended 
to focus upon one specific model of care and then make extrapolations of how a similar approach 
may work in other contexts and regions.xli One study with broader relevance to the overall PhD 
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evaluated a morphine public health programme for cancer and AIDS pain relief in Sub-Saharan 
Africa’xlii,  
 
Stakeholders (n=38) 
 
Stakeholders was the second most prevalent theme (n=38) with 21 % of the research focus. Within 
this theme, many studies used questionnaires to elicit the attitudes, practices and experiences 
relevant to end of life care from different groups such as; physicians,xliii nurses,xliv patients,xlv and the 
general public.xlvi All such studies were conducted in circumstances where there was access to 
palliative care and none engaged with stakeholder groups in terms of considering consequences of 
lack of access to palliative care. 
 
Services and Settings (n=28) 
 
Studies within this theme focus primarily upon efforts to map the existence of availability of 
palliative services internationally.xlvii Additionally, specific elements of palliative care are reviewed 
including; deep sedationxlviii GP home visitsxlix and bereavement support.l 
 
Also present within the theme was one study which considered access and equity of access in 
HIV/AIDSli, disease-specific palliative care as well as another which considered the particular 
challenges of providing care to rural populations.lii  
 
Policy (n=27) 
 
Many studies within this theme focussed upon issues such as access to essential medicines,liii 
consensus-building,liv barriers to the development of palliative carelv as well as articulations of 
clinical standards in palliative care.lvi One study demonstrated the lack of recognition from the 
broader medical establishment in Europe regarding palliative care as a medical specialtylvii, whilst 
another considers regulatory barriers which exist in Europe which serve to limit access to pain 
medications.lviii 
 
Interestingly, no included study considered palliative care in terms of broader health care priorities 
such as the Millennium Development Goals. Nor did the review identify any study considering the 
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international relevance of palliative care models within universal health coverage health systems 
such as Costa Rica and Australia.lix  
 
Death and Dying (n=13) 
 
This theme included significant focus upon cultural beliefs regarding death and the end of lifelx, often 
presented comparatively between different nations.lxi Another specifically focussed upon the idea of 
death being a cultural taboo.lxii Other studies engaged with similarly intangible concepts, such as 
‘meaning’ in terms of the transition towards end of life care.lxiii No included article considered 
palliative or end of life care in terms of its relationship (or non-relationship) with assisted dying or 
euthanasia. 
 
Education (n=12) 
 
This theme revealed instances of collaborative international educational efforts including the use of 
teleconferencing as a mechanism for educational deliverylxiv as well as a report on the 
implementation of an international education program in Tanzania.lxv Although a relatively low 
number of studies were identified within the theme, almost all focussed upon the transferral of 
educational initiatives from one circumstance to another, including a participatory knowledge 
exchange, whereby the focus of the study was an educational partnership between Canada and 
Chile.lxvi 
 
Symptom Management (n=7) 
 
Limited research attention was identified in terms of international research of symptom 
management. However, of the included studies, the most prominent symptom considered was types 
of pain, specifically cancer painlxvii and breakthrough painlxviii Other symptoms considered were 
fatiguelxix as well as other physical and psychological symptoms.lxx 
Additionally, one study focussed upon trends of opioid consumption between nations to 
demonstrate the ongoing inequality of access to pain relief between nations.lxxi 
 
 
 
 
93 
 
Ethics (n=3) 
 
Few studies engaged with ethical issues relating to palliative care in international context. Those 
which did, considered ethics in terms of their cultural specificitylxxii, issues which emerge following 
the diagnosis of a terminal illnesslxxiii and consideration of what ethics committees should require in 
order to grant access to death certificates for a study which aimed to compare medical decisions at 
the end of life between nations.lxxiv 
 
No study identified took a broader view of ethical issues in terms of whether there is an 
international ethical prerogative to increase access to palliative care. 
 
Methodological (n=2) 
 
Of only two studies which engaged with methodological issues in international context, one 
considered study design in terms of implementing an end of life care pathwaylxxv and the other 
offered a methodological framework for conducting economic analyses in end of life care.lxxvi 
 
Legal (n=1) 
 
The one study within this category analysed the respective laws of five countries in terms of how 
they enable, or limit, access to opioid medications with regards to international guidance from the 
World Health Organization (WHO) and the International Narcotics Control Board (INCB).lxxvii The 
inclusion of Texas as a state serves as a reminder that legal barriers can vary even within a single 
nation. However,  surprisingly, no studies were identified which critique legal issues in terms of the 
suggestion that access to pain and palliative treatments should be considered a human right. 
This broad analysis has revealed several issues in terms of areas of research weakness and strength 
of international palliative care research. However, before proceeding to analyse further, issues 
which have emerged from the review, the following section presents a short overview of the types of 
research which have been conducted as well as their relative strength in terms of each study designs’ 
position on the hierarchy of evidence. 
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Study design and quality of evidence 
 
In terms of research methods, of the 184 empirical articles included, 88 (50%) were produced using 
quantitative methods, 37 (21%), qualitative methods and 31 (18%) were mixed-methods papers, and 
20 (11%) were systematic reviews. 
 
Looking more closely at the study design of primary approaches and the quality of evidence being 
produced, this review reveals that the growing evidence-base for palliative care in an international 
context consists largely of study designs which are low on the hierarchy of evidencelxxviii. The most 
prevalent study design was cross-sectional studies with 92 outputs using this method, of which 22 
had a retrospective direction. Systematic reviews (n=23) were the second most prominent study 
design, followed by Cohort studies (n=8). Just two randomised controlled trials (RCTs) were 
identifiedlxxixlxxx and only one economic evaluation.lxxxi 
 
Whilst it has been recognised that the hierarchy of evidence is a relatively crude measure of quality 
appraisal, the high prevalence of descriptive, rather than interventional, studies remains a concern. 
There is also an absence of longitudinal studies, suggesting an absence of research on how relevant 
outcomes change over time. 
 
Discussion 
 
This review reveals that the field of international palliative care research is a relatively new but 
growing field, with some international research activity in all regions of the world.   
 
Research is however, predominantly focused in Europe and North America. This echoes findings 
from a 2004 study which found a low level of geriatric palliative care research emanating from low 
and middle-income countries and suggested an association between the level of palliative 
development within a region and its research output.c This is perhaps unsurprising and reflects 
broader trends in academic research in developed regions where greater funding and institutional 
capacity exists that facilitates greater research output.lxxxii  More pertinently, publications focussing 
upon the global level indicate that there is growing engagement with palliative care as a global issue. 
Findings suggest that, to some extent, researchers from high-income regions, such as Europe and 
North America, are undertaking research in low and middle-income regions of the world, such as 
Africa.  
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However, some opportunities do appear to being missed by researchers regarding the production of 
evidence which may assist policymakers seeking to implement the terms of the WHA Resolution and 
ensure palliative care is included as part of the new global priorities to achieve Universal Health 
Coverage (UHC). The conclusion therefore considers some of the key issues arising from the review 
as well as potential strategies for researchers to progress palliative care as an important global 
health issue. 
 
International research; networks and challenges 
 
There are signs that international palliative care research networks are emerging, with researchers 
from different countries working collaboratively, through research projects such as the EURELD 
Consortium commissioned by the European Union.lxxxiii This is significant due to the potential held by 
international research networks to exert influence within policymaking processes identified in 
Chapter Three.lxxxiv For instance, EURELD conducted a study of physicians' attitudes towards end-of-
life decisions comparatively between seven countries.lxxxv Such studies serve to identify the 
acceptability of different policies and practices across countries as well as helping to forge consensus 
with regards to ‘best practice’ in palliative care.lxxxvi International research projects such as EURELD 
deliver synthesised findings directly to policymakers increasing the likelihood of policy influence and 
may encourage a movement towards the development of internationally recognised standards in 
palliative care and assist with identifying issues of ‘universal’ interest in palliative care.  
 
The internationalisation of research does, however, potentially raise new issues for researchers in 
palliative care and particularly for those from richer countries who are conducting studies in poorer 
regions. Challenges are multi-faceted and include a range of ethical issues such as: ensuring the 
relevance of research to local populations,lxxxvii conducting research to international ethical 
standardslxxxviii regardless of national regulations and involving local people and researchers to 
ensure that research is participatory, with informed consent.lxxxix There are also broader questions 
regarding the legitimacy of researchers from richer nations conducting research in lower-income 
settings, given the uneven power relations that inevitably exist in such research contexts xc and the 
risks of imposing western norms in differing cultural contexts.xci Such issues can be considered 
additional to barriers which exist to palliative care research at national-level such as the (extreme) 
view that palliative care patients should not be asked to participate in research at allxcii and the legal 
and ethical difficulties regarding whether a surrogate can or should provide consent for subjects who 
lack decision-making capacity.xciii 
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The low level of experimental studies identified by this review suggests that national-level barriers 
which limit opportunities for palliative care research are being mirrored at the international level. 
For example, the low prevalence of patient-centred research suggests that ethical challenges 
relating to consenting dying people into research are not being met.   
 
In light of the low quality of evidence identified by this review, it is of concern that only one paper 
emerged which engages with methodological issues. There is an apparent absence of research which 
engages with how barriers to conducting ethically sound research can be overcome in order to 
improve the quality of the evidence base. Nor are there any examples of methodological learning 
from other research disciplines which focus upon vulnerable populations that may face similar 
challenges to the production of evidence. 
 
Palliative care is a discipline which has historically faced problems conducting study designs like RCTs 
due to the ethical complications inherent when randomising patients. Whilst the absence of 
palliative care services in many countries of the world is of great concern, this circumstance may 
offer opportunities for researchers to cast light on the true scale of human suffering caused by lack 
of access to palliative services. For instance, comparative evaluative research may be justifiable, 
examining differences in patient, family, and health systems outcomes, between nations or regions 
where there are palliative services and those where there are none. This may be conducted with no 
study intervention and could be conducted alongside capacity-building efforts to empower 
researchers in settings where little or no research is currently taking place. The absence of services is 
a grave omission from such countries’ health systems. However, pragmatic evaluative research of 
this manner may help draw attention to the very real suffering which occurs in such settings and also 
provides an opportunity to evaluate the effectiveness and cost-effectiveness of palliative care.  
 
Researchers may also consider looking beyond the field, at other disciplines which have faced similar 
barriers to high quality research. The Global Network for Women’s and Children’s Health Research 
CNWCHR, for instance, has successfully overcome ethical and regulatory challenges to conduct trials 
involving pre-term babies and produce a robust evidence base. xciv Currently it seems that the 
international approach adopted by palliative care researchers extends only within the field and not 
more broadly to examine how other disciplines have been able to overcome the barriers to ethically 
conducted international research on vulnerable groups. 
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Global Ageing and International Development 
 
No outputs were published in journals which focus specifically on international issues relating to 
development or ageing more broadly, which suggests that research is conducted within the field and 
that palliative care has not yet attracted the attention of the broader global health research 
community. Additionally, no studies engage with the major health financiers, such as the World Bank, 
as existing or potential future funders of palliative care. This suggests that international palliative 
care continues to operate outside of broader discourses of international development, global ageing 
and global health. This is of major concern, as in a global policy context where above all, poverty 
reduction is prioritised, it seems palliative care researchers are missing opportunities to make a case 
for a how a holistic intervention pre and post bereavement may be able to reduce avoidable 
suffering whilst contributing to broader development priorities.  
 
In this regard, the lack of interventional research and evidence of the economic viability of palliative 
care services is of further concern. Global funding agencies such as the World Bank characterise 
global health in economic terms and are influenced by economic evidence in making their funding 
decisions.xcv Moreover, such agencies will disburse funding towards the achievement of UHC using 
‘results-based financing.’xcvi  In this regard, ongoing problems regarding how to define the inputs and 
outcomes of palliative care services to determine both their feasibility and effectiveness, makes it 
likely that palliative care will not benefit from funding allocated in this manner. Lastly, development 
appears to have accelerated in countries such as Costa Rica and Australia which have incorporated 
palliative care as part of universal health coverage.lix It therefore seems a major omission, that no 
studies were identified which evaluated such models with consideration of their transferability to 
other settings. In order to appeal to key global funding agencies, future research needs to resonate 
more directly with international development discourses. For instance, it may seek to explore the 
links between illness and poverty and how palliative care may be an appropriate intervention at the 
end of life to help mitigate negative financial aspects of death relating to household poverty.  
 
National level research has demonstrated how palliative care can help reduce costs to families and 
health systems of treating patients at the end of life.xcvii The argument that palliative care is both an 
appropriate form of care as well as being the cheapest is convincing. Moreover, presented in this 
manner, a strong argument can be made for palliative care to a broader international development 
audience. Once more, researchers may profit from looking outside the field, to see how health 
lobbies like the HIV/AIDS movement gained global attention, by presenting HIV/AIDS as both a 
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humanitarian crisis and a limiter of economic growth through reduction of human capital due to 
AIDs-related deaths.xcviii  
 
Public Health 
 
A total of 11 studies were identified which explicitly took a public health perspective. Three of these 
studies evaluate existing services and provide evidence in support of a public health approach to 
palliative care delivery. Other studies focus largely upon access to essential medicines and on ‘place 
of death’ as an outcome. However, no studies provide comparative evidence of effectiveness or 
cost-effectiveness of palliative care for health systems, households or individuals. Global ageing 
policies continue to further the argument for ‘healthy ageing’xcix, however, this negates the truism, 
that no matter how healthily populations age, death can only ever be postponed and health systems 
must be robust enough to meet this challenge. Therefore, the absence of research which places 
palliative care within the context of broader health systems strengthening is a concern. 
 
Indeed, although the review searches were conducted in 2013 – prior to agreement of the 
Sustainable Development Goals (SDGs) – no study identified, considers palliative care as part of 
Universal Health Coverage (UHC). This may help explain why there is no specific mention of palliative 
care within the SDGs on the basis that there is not an evidence base to demonstrate the feasibility of 
palliative care within UHC. For instance, countries such as Australia and Costa Rica have universal 
health coverage with palliative care a part of this.lix Such examples warrant research attention in 
terms of identifying how this has been achieved, any resultant benefits and indeed theoretical 
discussion about how such models may be appropriate in other settings. 
 
There is also a substantial shortage of interventional research and evaluation of palliative care 
delivery within the broader context of health systems in terms of, feasibility, effectiveness and cost-
effectiveness. This finding broadly mirrors the findings of a review of worldwide survey geriatric 
palliative medicine which also identified a shortage of experimental studies.c The low prevalence of 
RCTs suggests that questions remain regarding the appropriateness of this methodology in palliative 
care researchci in spite of increasing evidence that cluster randomisation can be an effective design 
for research in end of life situations.cii   
 
Little evidence was identified to suggest that international palliative care researchers are reaching 
out to other disciplines and schools of thought, to consider how palliative care issues such as how 
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palliative care could be advanced by engagement with the right to die or anti-right to die 
movements. Both of which promote the necessity of high quality palliative care before such 
measures should be considered. Nor is there any international evidence to support claims that 
palliative care is part of the whole continuum of care, from prevention and through bereavement. 
What evidence is there that palliative care can contribute to preventing illness as well as mitigating 
its negative effects.  
 
Finally, looked at through the lens of international research, claims from researchers that there is a 
global need for palliative care, are not backed up by studies demonstrating that further roll-out of 
services is what populations want. Additionally, whilst some research activity was identified as 
occurring in Hong Kong, no studies were identified which consider the whole of China. This is a 
considerable omission considering not only that China holds almost 20% of the world’s populationciii, 
but that the country is known to have the highest gap between need and supply of palliative care 
services.civ 
 
Overall these findings suggest that international palliative care research is contributing little in terms 
of the presentation of palliative care within broader discourses on health. The implications of this, as 
well as questions which have emerged from this review to inform the broader PhD study are 
considered below.  
 
Conclusion 
 
This review has revealed that international palliative care researchers are not maximising 
opportunities for further development by failing to produce evidence which is likely to engage with 
new global funding agencies. Given the opportunities to present palliative care as an important 
element of universal health coverage within the SDGs, it is of concern that no studies were identified 
which examined national models of UHC to determine their wider applicability. Additionally, the lack 
of research demonstrating the economic viability and feasibility is of serious concern, particularly 
when we consider the importance to which funding agencies are ascribing to ‘results-based 
financing’. National level studies have shown how serious illness can plunge families into poverty in 
low-income countriescv and as richer countries such as the United States.cvi In this regard, it appears 
that palliative care researchers are continuing to miss opportunities, to consider the role which 
palliative care may be able to play in reducing such financial burden within the context of broader 
global health debates. 
100 
 
In Chapter Three, it was identified how processes of policy diffusion sometimes occur geographically 
and it was suggested that such narratives overlook the key role played by palliative care champions 
in spreading palliative care practices. However, it was also suggested, that characterising the spread 
of policy based upon geographic proximity alone is not a convincing explanation for the spread of 
palliative care. Instead, it was argued that more usually it is ‘similar’ countries which adopt ‘similar’ 
policies.cvii In this regard, existing narratives of development have considered such issues 
simplistically, attributing ‘similarity’ to financial factors such as Gross Development Product (GDP) 
only.xlvii Furthermore, studies included within this review present models of palliative care in 
different settings and profess their applicability to other similar settings for the same financial 
reasons.cviii 
 
However, if palliative care is to be included as part of UHC, it must do so within the context of other 
development challenges facing nations. In this regard, it is too simplistic to characterise nations 
based upon level of income only and the broader national circumstances in which palliative care has 
(and has not) developed is not known. On this basis, the following chapter aims to enrich 
understanding of how palliative care practices have spread through an examination of the structural 
circumstances in which they have done so. Moreover, answering the question of whether ‘similar’ 
countries have developed palliative care ‘similarly’ will allow increased understanding of the 
transferability of ‘model services’ to other settings. 
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Chapter Six  
From Which National Development Contexts have Palliative Care Services 
Emerged? 
 
Introduction 
 
In Chapter Two, existing narratives of palliative care development were considered with a focus on 
the related International Observatory on End of Life Care (IOELC) and Worldwide Palliative Care 
Alliance (WPCA) studies as the only global maps of palliative care services.iii The linked studies 
offered several explanatory factors for the international spread of palliative care including ‘increases 
in awareness and desire to improve care for the dying’. Furthermore, in Chapter Three it was 
identified how it appears that palliative care has developed to some extent in geographical clusters, 
for instance in Sub-Saharan Africa [Figure 3]. 
 
Geographic clustering of policies and practices is consistent with World Society Studies theory 
regarding policy diffusion. World Society Scholars suggest that practices such as palliative care 
spread naturally, as nations become organized around shared principles and institutions, with such 
processes happening most prominently in regions of geographic proximity.iii  However, this analysis 
was critiqued as being too passive and did not recognise the significant dynamic actions undertaken 
by ‘transfer agents’ such as Anne Merriman, who introduced palliative care into Uganda. Moreover, 
‘natural diffusion’ does not account for differences in practices between nations, nor how 
geographically isolated countries such as Australia have developed palliative care to a high level.ii  
 
On this basis, it was suggested that Global Social Policy (GSP) analysis of policy convergence 
occurring due to dynamic processes of lesson learning and policy transfer was more convincing.iv 
That is, policymakers facing ‘similar’ policy challenges look to other contexts in order to determine 
how other similar nations have formulated policy responses and consequently adopt similar policies. 
Such processes are said to occur most prominently between countries which are ‘similar’.v In this 
regard, Chapter Five identified several studies which described ‘model services’ in varied income 
resource-contexts, with study authors making claims that such models may be transferrable to other 
‘similar’ settings.vi  
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However, in such studies, what wasn’t described was what it means for countries to be considered 
‘similar’. Indeed similarity was characterised economically only, though the complexity of terms such 
as ‘low-resource setting’ was not addressed. Furthermore, the WPCA study offers little to increase 
understanding in this regard.  Few statistical indicators relating to countries’ level of development 
were included, and were not adequately problematized or theorised in terms of potential 
relationships with palliative care development. For instance, Human Development is reported in 
relation to palliative care development, however, specific elements of this composite indicator are 
not considered, nor why they may be relevant to palliative care. Furthermore, a focus purely upon 
financial context belies other challenges to the delivery of healthcare in diverse settings, for example 
ensuring access to services for rural populations.vii 
 
On this basis, this chapter presents a descriptive analysis of the national contexts from which 
palliative care services have (and have not) developed. International Organizations (IOs) collate a 
wide range of country indicators relating to international development. Using such indicators, it is 
possible to present a detailed analysis of the contexts within which policymakers operate, in terms 
of key development opportunities and challenges.  
 
Rationale for the study: The international spread of palliative care services and practices; policy 
learning, diffusion and transfer 
 
The WPCA’s global map of palliative care demonstrates that palliative care services can now be 
found in all world regions [Figure 10]. Additionally, it shows that the highest concentrations of 
development are to be found in high-income settings. This raises questions regarding  why, when 
studies identified in the review suggest that palliative care roll-out is feasible in all resource-contexts, 
have services developed so patchily? 
 
Existing narratives of development have emphasised the key role played by ‘champions’ as well as 
the significant role played by international pioneers. As identified in Chapter Two, Cicely Saunders is 
credited with the establishment of the modern hospice movement.viii Other notable early pioneers 
include Elisabeth Kubler-Ross who introduced palliative care to the United Statesix and Ann-
Merriman who did likewise in both Singapore and Uganda.x Considering such personalities in terms 
of the policy learning literature, is to suggest that processes of international palliative care 
development and transferral of social norms has been driven by ‘transfer agents’, rather than 
broader global influences or policies.xi  
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Additionally, active educational initiatives and processes of lesson-learning emanating from ‘model 
services’ such as Hospice Uganda may be considered too dynamic to be termed ‘natural processes of 
diffusion’.xii Indeed, Hospice Uganda was established in order to serve as a ‘model for Sub-Saharan 
Africa’, therefore encouraging active processes of international lesson-learning may be considered 
as a part of its mandate.xcv  
 
Figure 10: Global Map of Palliative Care Development 
 
 
Source: WPCA, 2011i 
 
Chapter Two showed how palliative care has developed in spite of a lack of global leadership. 
Therefore attention must be given to processes of policy learning and transfer between nations as 
opposed to the relationship between nations and global organizations to understand palliative care 
development to date. For instance, we may understand the concentration in richer nations in terms 
of ‘similar’ countries adopting similar policies.xiii That is that policymakers within such nations face 
similar challenges and thus look to other settings in order to consider potential policy responses.  
 
Whilst geographical proximity at a practical level, makes the international transferral of ideas and 
convergence of practices through transfer agents and other processes of lesson learning more 
straightforward, notions that proximity imply similarity are contested.xiv That is, geographic 
proximity does not necessarily mean that nations are similar in any domain, be it geographically, 
politically or in terms health system organization. On this basis, this chapter considers the structural 
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similarities and differences regarding the structural contexts within which palliative care services 
have (and have not) developed. For instance, it may be suggested that the celebrated model of 
community provision of palliative care in Kerala, India has developed in spite of the broader Indian 
context, where access to services remains extremely low.xlvii How then did such a model develop? 
Additionally, it is well known that Kerala has unexpectedly high social development indicators in 
relation to other Indian states, could it be that it was because of such contextual factors that such a 
service was able to emerge in spite of resource restrictions? 
 
Whilst causal relationships between such factors are difficult to determine, this chapter considers 
such questions. Additionally, the suggestion that it is activities at national, rather than global level 
which have driven development, are placed under further scrutiny. Findings from the WPCA study 
included both testable and non-testable suggestions by using global indicators. For instance, the 
suggestions that development has been driven by ‘the practical needs of ageing populations’ may be 
considered by interrogating demographic indicators relevant to populations and ageing. However, 
factors such as ‘increased awareness of palliative care’ are less questionable using development 
indicators.ii 
 
Without downplaying the achievements of palliative care champions such as Merriman, it is 
important to remember that services – and policies – are not formed within a vacuum. Alongside 
motivated individuals, what other factors have driven palliative care development? The current state 
of knowledge has not placed palliative care within broader structural processes of health care 
development. Moreover, researchers have not yet fully engaged with macro level data – collected by 
International Organizations such as the World Health Organization (WHO) and the World Bank – 
which may be relevant to the development of the field.  
 
This study aimed to rectify these gaps in the knowledge base by examining the broader structural 
contexts in which palliative care has (and has not) developed to a high level.  
 
Aims and objectives 
 
The aim of this chapter is to consider the structural contexts of nations based upon indicators of 
their development in relation to the extent to which they have integrated palliative care into their 
health care systems. A broad range of developmental indicators will be used in this regard to answer 
the following aim: 
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Aim: To determine in which national developmental contexts palliative care services have (and have 
not) emerged 
 
In addition to meeting this broad aim, this study aimed to meet several further objectives: 
 
1. To test policy learning assumptions regarding whether policies and practices are more likely 
to ‘diffuse’ geographically, or based on contextual similarity between nations. 
 
2. To explore claims that palliative care is a feasible intervention in all world settings 
 
3. To determine whether palliative care has developed to similar levels in countries which are 
‘similar’ in terms of disease demographics, socioeconomics, and country demographics (eg 
has palliative care developed most significantly in countries which have predominantly 
urban or rural populations?) 
 
Methods 
 
Study design 
 
In order to answer these questions and meet the objectives of the chapter, a quantitative design was 
used to explore potential relationships between predictor variables and level of palliative care 
development. Spearman’s Correlation test was used to determine any observed linear relationships 
between structural variables and level of palliative care development which were unlikely to be due 
to chance. The outcome variable (level of palliative care development) was the WPCA country 
classifications from 2011, selected as the only usable data which determines rankings for all world 
countries.ii Predictor variables were selected iteratively using a theoretical approach drawing from 
several macro-datasets including the World Bank Development Indicators,lxvii the Economist 
Intelligence Unit (EIU)xv and Transparency International.xc  
 
It is recognised that direct cause and effect influence over development would have been difficult to 
identify, however the methods used do not seek to establish causal relationships between variables. 
Instead the study provides descriptive examination of the structural contexts within which services 
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have developed to add to understanding of the circumstances in which palliative care services and 
practices have developed.  
In order to identify variables of potential interest, a theoretical approach to understanding palliative 
care and healthcare development was adopted and will be outlined in terms of variable selection. 
However, before considering which variables may have been of interest, it was important initially, to 
identify what data are available in the public domain in order to meet the aims and objectives of the 
study. The first step was to identify the outcome variable and consider the validity of this indicator 
itself.  
 
Outcome Variable: level of palliative care development 
 
As identified in Chapter Two, in recent times researchers have attempted to map both the global 
development of palliative care as well as to assess the quality of its provision. In 2010 the Economist 
Intelligence Unit, ranked the ‘quality of death’ of 40 countries, an exercise repeated and extended in 
2015 to include 80 countries.xv However this study is limited by its inclusion of less than half of the 
world’s countries or areas, and only the Worldwide Palliative Care Alliance (WPCA) study has 
mapped global levels of development, the results of which are the focus of this section.ii  
 
The WPCA study reports the level of development in the ‘234 countries or areas’ as defined by the 
United Nations (UN) on a six-point scale. The overall typology of country groups is presented in Table 
9 and the full characteristics of each group are presented in Appendix 3.  A discussion follows here 
regarding the validity of the WPCA’s conclusions as well as the methodological approach used to 
formulate them. 
 
In Chapter Two it was identified how these country groupings are somewhat subjective and that the 
methodological approach used to determine them had limitations. For instance, there was reliance 
upon ‘key experts’ within nations to determine their own countries’ ranking, which is associated 
with a risk of information bias.xvi Further questions were raised regarding the validity of some of the 
rankings including Uganda’s due to conflicting assessments found by the Economist Intelligence 
Unit’s study examining quality of care, which gave the country a low ranking.xvii Indeed, the EIU 
ranked Uganda, a country the WPCA considers to have achieved full integration of palliative care 
into its health system, below Mexico, a country which the WPCA characterises as having only 
‘isolated palliative care provision’ only.  
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Table 9: Typology of country groups 
 
Country 
group 
Recoded 
category 
Characteristics of group 
Group 1 1 No known hospice-palliative care activity 
Group 2 2 Capacity building activity 
Group 3a 3 Isolated palliative care provision 
Group 3b 4 Generalised palliative care provision 
Group 4a 5 Countries where hospice-palliative care services are at a stage of 
preliminary integration into mainstream service provision 
Group 4b 6 Countries where hospice-palliative care services are at a stage of advanced 
integration into mainstream service provision 
 
These discrepancies urge caution whilst using the WPCA country group classifications. However, in 
spite of the methodological limitations of the WPCA study, their results remain the only global index 
of level of palliative care service development and as such their categorisations were used as the 
dependent variable. It is also important to note, that in spite of the methodological limitations 
identified, the WPCA rankings has been widely adopted and cited by organizations including the 
WHO.xxiii 
 
Levels of international development by country category: descriptive statistics 
 
As described in the previous section, WPCA country rankings were determined in 2011 by drawing 
upon a wide range of data and then categorised into groups. As the typology used by the WPCA 
included two-point categories (e.g. 4a and 4b), therefore, country groups were recoded into 
continuous ordinal data on a six-point scale [Table 9]. The distribution of countries within each 
recoded category is shown in Figure 11.  
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Figure 11: Distribution of countries by level of palliative care development 
 
 
 
An uneven spread of palliative care development is revealed and it is of concern that ‘no known 
activity’ is the most prevalent group.  
 
It is important to acknowledge that ordering the variables as an ordinal scale presented a problem 
for analysis. Some models assume a metric in which it is the same ‘distance’ between adjacent 
groups which is unlikely to be the case.xviii For example, to move from Group 1 (no provision) to 
Group 2 (capacity building) is likely to be more straightforward, than moving from Group 3b 
(generalised provision) to Group 4 (preliminary integration into mainstream service provision). 
Therefore the conclusions which were drawn from this ordinal scale were largely narrative and did 
not seek any predictive value. In addition it was deemed appropriate to use the ordered scale 
without applying any weightings to the country categories.   
 
Theoretical approach to variable selection 
 
In order to give some focus to the identification of potentially relevant variables, a theoretical 
approach was undertaken to identifying variables of interest.xix Based upon guidance identified in 
Chapter Two from the WHO that a public health approach should be taken to palliative care 
developmentxx, the first domain considered for potential relevance focusses upon measureable 
aspects of such an approach. The WHO recommendations suggest that a public health approach to 
palliative care, should work within the ‘culture, disease demographics, socioeconomics and health 
care system of a country.’ Therefore, the distinct aspects of a public health approach are here 
considered separately, followed by other domains of theoretical interest.  
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Disease Demographics 
 
One of the key arguments that advocates use for a greater roll-out of palliative care services, is that 
there is a global need for palliative care.xxi Chapter Five revealed an overall absence of a patient-
voice in terms of what their ‘needs’ may be at the end of life. We are therefore, left with 
technocratic arguments that there is a normative need for palliative care based upon disease 
prevalence.xxii  
 
Therefore, figures for what the level of need for palliative care is, are based on calculated estimates 
of global disease prevalence rather than public demand for services. The illnesses the WHO 
considers may benefit from palliative care listed for both children and adults are as follows: 
 
Adults: Alzheimer’s and other dementias, cancer, cardiovascular diseases (excluding sudden deaths), 
cirrhosis of the liver, chronic obstructive pulmonary diseases, diabetes, HIV/AIDS, kidney failure, 
multiple sclerosis, Parkinson’s disease, rheumatoid arthritis, drug-resistant tuberculosis (TB). 
 
Children: cancer, cardiovascular diseases, cirrhosis of the liver, congenital anomalies (excluding 
heart abnormalities), blood and immune disorders, HIV/AIDS, meningitis, kidney diseases, 
neurological disorders and neonatal conditions [p.10].xxiii 
 
More generally, it is often stated that palliative care is appropriate for both non-communicable 
(NCDs) and communicable diseases (CDs).xxiv  
 
The Bank and the WHO collected total deaths by country in only 2000 and 2012. Whilst both of these 
dates fall outside of the five-year period specified, the information was deemed too relevant to 
disregard and as such, an exception was made to the date range to include the 2000 figures on total 
deaths by CDs and NCDs.  
 
Although there is now recognition that palliative care is beneficial for sufferers of NCDs and 
infectious illnesses,xxv it is only since 2002 that this has been recognised within the WHO 
definition.xxvi Therefore one line of enquiry within this study was to examine whether the vast 
amount of financing from the Millennium Development Goal (MDG) era towards infectious diseases 
has furthered palliative care development.xxvii Therefore, deaths from communicable and non-
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communicable diseases (as a percentage of total deaths) were included as independent variables for 
analysis. 
 
Socioeconomics indicators 
 
Socioeconomic factors are some of the key predictors of health, at global, national and individual 
levels.xxviii Whilst advocates maintain that palliative care is feasible and deliverable in all resource 
contexts, a glance at the global distribution of palliative care services is enough to show that services 
are concentrated in richer nations [Figure 10].xxix Yet, notable examples of celebrated services do 
exist in poorer regions, such as the Neighbourhood Network of Palliative Care (NNPC), in Kerala, 
India, a community-led service which is considered replicable model for the rest of India and the 
developing world.xxx Kerala is, however, vaunted for more reasons than palliative care development 
having achieved many social indicators more akin to a more highly developed country than the rest 
of India.xxxi High life expectancy and literacy rates form the context from which the NNPC has 
emerged, suggestive of a link between social indicators and palliative care development.  
 
Health systems 
 
Calls for a public health approach to be taken to palliative care development, sit alongside the 2014 
WHA Palliative Care Resolution calling for palliative care should to be fully integrated into health 
systems.xxxii  Yet, in Chapter Two, it was identified that many palliative care services operate outside 
of formal healthcare systems. xxxiii On this basis, a broad conceptualisation of the term ‘health system’ 
was adopted to incorporate informal services and understand a health system as:  
 
The combination of resources, organization, financing and management that culminate in 
the delivery of health services to a population [1991].xxxiv  
 
This definition acknowledges that ‘many factors outside the health system influence people’s health, 
such as poverty, education, infrastructure, and the broader social and political environment’.xxxv 
Understanding health systems in these terms therefore requires a much broader conceptualisation 
of factors which may influence health system performance. One such explanation, describes health 
systems as ‘complex adaptive systems’, where nonlinear relationships between different factors 
interact over multiple scales, which often produce unexpected outcomes.xxxvi Using this definition, 
roads, for example, may be part of this ‘system’, as without them, access to healthcare is likely to be 
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compromisedxxxvii. Their presence, however, may also contribute to new health problems such as 
respiratory illness due to increased cars and pollution, as well as increased traffic accidents. 
Questions also arise regarding whether there have been different levels of development between 
publicly funded or private health care systems. 
 
Viewing palliative care as part of complex health systems provided justification for a broad approach 
when considering how palliative care services may have developed and led to a widening of 
approach beyond a focus purely upon a public health approach to development.  For instance, 
political context and country demographics are circumstances within which all health policy 
decisions are made.  
 
The following section therefore considers other domains which are known to have influence over 
public health more generally: political context, country demographics and economic factors.  
 
Political context 
 
An apparent absence from the recommended public health approach to palliative care is 
consideration of the influence of political factors over healthcare development.xxxviii  Political 
ideology and policies form the context within which health systems function and develop. Informed 
by a study which used political ideology as part of an analytical public health framework, inferences 
may be made regarding government commitment to healthcare based upon levels of spending 
relative to countries’ wealth.xxxviii Additionally, there have been links drawn between strength of 
democracy and health outcomes – regardless of a country’s wealth, level of inequality or the size of 
its public sector.xxxix More generally, it is suggested that countries which have fewer inequalities are 
likely to have better health outcomes.xl As such, health systems and services cannot be separated 
from the ‘political context’ in which they operate. ‘Political context’ was therefore added as a 
theoretical domain from which to include variables. 
 
Country demographics 
 
Each nation of the world faces different challenges to delivering healthcare based upon the 
demographic make-up of the country. In epidemiological terms, ‘demography’ is defined as: 
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The study of populations, especially with reference to size and density, fertility, mortality, 
growth, age, distribution, migration, vital statistics and the interaction of these with social 
and economic conditions.xli 
 
Such factors occupy much discussion within discourses on palliative care. Specifically in terms of : 
ageing populationsxlii, mortality ratesxliii and the challenges of delivering services in rural areas.xliv 
Such factors are added to the related socioeconomic indicators discussed above and variables were 
drawn from this domain [Table 12].  
 
Economic indicators 
 
The final domain which was included in the analysis is concerned with countries’ economic context. 
Gross National Income (GNI) is considered a key component of a countries’ human development.xlv 
Further, a nations’ wealth is a strongly associated with health outcomes of its people.xlvi Additionally, 
richer nations provide financial assistance to poorer nations to fund healthcare through Official 
Development Assistance (ODA), though it is not known the extent to which this has had an impact 
upon palliative care development. Whilst advocates argue that palliative care delivery is feasible in 
all resource contextsxlvii, the extent to which nations’ wealth or levels of ODA received have had an 
influence over levels of palliative care service development is not well understood.  
 
The theoretical underpinning of this study therefore, emanated from the domains of socioeconomics, 
disease demographics, health care systems, politics, demographics and economics.  
Although this conceptualisation of theoretical factors relevant to health is inclusive, it is not 
exhaustive. Indeed, for reasons of feasibility, it was necessary to be selective, with the types of 
variables included in the study. The following section outlines therefore, other theoretical domains 
which were considered for inclusion in the study, but excluded as unfeasible. 
 
Variable domains considered and excluded 
 
Cultural factors 
 
This study recognised that cultural appropriateness is an essential element of effective palliative care 
delivery.xlviii However, due to the high diversity within any ecological data relating to culture, it was 
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decided that cultural indicators were unlikely to be a useful explanatory indicator to use within the 
model. This decision was guided by understanding culture as: 
 
A set of shared and enduring meaning, values and beliefs that characterize national, ethnic, 
or other groups and orient their behaviour [1991].xlix 
 
Attempting to apply such a definition to a whole nation, would have been extremely problematic. 
That is, in the globalised world we live in, where processes of migration have seen diverse 
populations living in countries across the world, it is difficult to ascribe a single set of cultural beliefs 
– and therefore indicators – to a single nation. l Therefore, when ‘public health approach’ 
recommendations that palliative care should be rooted in the ‘culture’ of a nation, it must be 
acknowledged that there will be competing definitions and understandings of what a ‘national 
culture’ means, particularly in relation to beliefs and practices relating to death and dying.li For 
instance, in Australia, studies showing which suggest a patient-preference for a home deathlii, do not 
adequately incorporate a desire from aboriginal people to die in their traditional lands, which may 
not be their current ‘home’ as the term is more generally understood.liii 
 
Accordingly, attempting to formulate culturally-appropriate policies even within countries is 
challenging. Extrapolating this challenge to the formulation of global level policies is even more so. 
Therefore, whilst it is acknowledged that delivery of palliative care must be culturally sensitive, no 
indicators of ‘culture’ were included as independent variables.liv 
 
Religion 
 
The history of palliative care is not complete without consideration of the role of religion in its 
development.lv Considered the first modern Hospice, St Christopher’s itself, carries it with it implicit 
associations with Christianity. The incorporation of spiritual care by Cicely Saunders into her 
conception of ‘total pain’ also recognised the importance of religion in peoples’ lives and particularly 
at the end of life.lvi That religion continues to play a role in the development of palliative care 
services is not in dispute. Certainly faith-based organizations continue to promote and establish 
palliative services.lvii 
 
However, without diminishing the historical and ongoing contribution of religious groups to 
promoting palliative care, here, religious indicators were not included in the analysis.  In part, this is 
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as global policymaking organizations such as the UN profess to develop policies using a secular 
approach.lviii Furthermore religious diversity around the world makes it difficult to determine what 
‘religion’ a country is. A clear example, for instance is India, which is commonly considered a Hindu 
country, but in reality is highly diverse, for instance, there are approximately 172 million Muslims in 
India, a number which would rank as the eighth most populace country in the world.lix Therefore, 
due to this heterogeneity it was deemed inappropriate to ascribe a single religion to any one country. 
Additionally it is known that Christian missionary groups from Europe have played an active role in 
introducing palliative care into other settings (eg Africa), national indicators of religion would not 
adequately represent such processes.lx Therefore, indicators of religion were not included in this 
analysis, although the study recognised the importance of including spiritual care within palliative 
services to people of all denominations as well as to people of no faith.   
 
Identifying independent predictor variables 
 
The next stage of the study was to identify development indicators of potential interest as the 
independent variables. Several International Organizations (IOs) collate international development 
indicators including the World Bank and the UN. Therefore, before identifying potential variables of 
interest, it was first appropriate to consider data which is available to ensure that the study was 
feasible, before focussing upon potential variables of interest. 
 
Available data sources 
 
International Organizations – such as the WHO and the World Bank – collect macro data on 
development indicators, available in the public domain.  A major challenge of this study was to 
isolate the variables for inclusion in the project which may have relevance to palliative care 
development and broader health care systems. On this basis, consideration of potential variables to 
be included began from an acceptance of the Bank’s conceptualisation of health which 
acknowledges that:  
 
Many factors outside the health system influence people’s health, such as poverty, 
education, infrastructure, and the broader social and political environment [2007].lxi 
 
This definition is useful as it acknowledges the varied ways in which context influences health. For 
instance there are known associations between poverty and higher rates of both infectious and non-
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communicable illnesses.lxii Accordingly, understanding ‘health’ in this manner, necessitated 
consideration of a wide range of variables which may have provided the context within which 
palliative care services have developed.  
 
Due to the broad range of development indicators collected by the World Bank (n=1327), it was 
decided that the World Bank’s databank would be the starting point for variable selection. Although 
the WHO and the Bank share data sources, the selection of the Bank’s data reflects its self-applied 
status as the ‘Knowledge Bank’ with the resources to collate a huge amount of development 
indicators comparatively.lxiii Moreover, the Bank’s data has been widely used by researchers in order 
to analyse levels of development of nations comparatively, for instance in domains such as social 
welfare.lxiv In any event, there is much crossover between the data. Both organizations use the same 
data for ‘total deaths by cause’ for instance.   
 
The headings listed by the World Bank of their development indicators offer some insight into the 
broad range of data available (Table 10). 
 
Table 10: Development data categories collected by the World Bank 
 
Agriculture & Rural 
Development 
Economic Policy & External 
Debt 
Environment 
Health Poverty Science & Technology 
Aid Effectiveness Education Financial Sector 
Infrastructure Private Sector Social Development 
Climate Change Energy & Mining Gender 
Labor & Social Protection Public Sector Urban Development 
Source: World Bank Data, 2013lxiii 
 
Broadly speaking, the World Bank collect ‘each’ year from national governments and other 
international agencieslxv, though there is a high amount of missing data. The reasons for missing data 
are varied and include; sporadic data collection by countries, lack of data reporting due to conflicts 
or lack of statistical capacity and simply because as national borders are redrawn, new countries 
122 
 
emerge whilst others cease to exist.lxvi In addition, as much of the data collected is collated from the 
statistical systems of member countries, data quality is heterogeneous and reliant upon the 
performance of national systems.lxvii Data is available from 1960 onwards.  
 
Other data sources 
 
Whilst the range of data collected by the World Bank is comprehensive, it is not exhaustive and to 
capture the full range of potentially relevant macro-level data, other sources were identified 
informed by both palliative care and GSP literature. The International Narcotics Control Board (INCB), 
for example, collects country-level data on opioid consumption per capita which is collated by the 
Pain and Policy Studies Group and is likely to be relevant to palliative care.lxviii Additionally, civil-
society institutions produce and collate global level data of potential theoretical interest. For 
instance, Transparency International measures levels of corruption within countrieslxix, whilst the 
Economist Intelligence Unit, ranks the international strength of democracy by country which serve as 
an indicators of political context.lxxxvi  
 
Data cleaning and selection 
 
Having considered developmental domains of theoretical interest to the study, the next phase of the 
study was to isolate variables of potential interest using an inductive approach within selected 
theoretical domains. This involved the development of hypothetical reasons, rooted in palliative care 
literature, why individual variables may be relevant to palliative care development. On this basis, the 
following section describes how variables were selected drawing upon the theoretical domains 
selected for analysis based upon the availability of data. 
 
The first stage of data cleaning was to ascribe a palliative care score to all countries for which there 
is World Bank data. Therefore the full spreadsheet of development indicators was downloaded, with 
the appropriate palliative care score entered to matched countries.  
 
Of the 234 countries and territories assigned a palliative care rating by the WPCA, only 207 had a 
matching country classification with the World Bank [WB] due to ongoing territorial disputes and 
different conceptualisations of sovereignty. For example, the WB groups the channel islands, 
whereas, the UN lists Guernsey, Jersey etc separately. On this basis, 27 ‘countries and territories’ 
were removed from the sample and are reported in Appendix 5. All countries and territories 
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removed had a palliative care development rating of between 1 and 3. In reducing the country 
sample from 234 to 207, the broad story told by the distribution is changed only slightly [Table 11]. 
Group 3 (Isolated provision) becomes the mode instead of Group 1 (no known activity) 
 
Table 11: Total countries in each country group before and after removal of unmatched countries. 
 
Country 
Group 
Frequency 
(n=234) 
% of countries 
in group 
Total removed 
from each 
classification group 
Frequency 
(n=207) 
% of countries in 
classification 
group 
1 75 32 17 58 28 
2 23 10 4 19 9 
3 74 32 6 68 33 
4 17 7 0 17 8 
5 25 11 0 25 12 
6 20 9 0 20 10 
 
After this ‘matching’ process between UN and World Bank country classifications, the final country 
sample for analysis was 207. The full list of countries included within the analysis as well as their 
palliative care ranking and study number is presented in Appendix 6. The greatest challenge for data 
cleaning, was to address the problem of missing data. It was decided that data would only be 
included for the five year period up to and including 2011, the year that the outcome variable data 
was collected. This five year period was selected through discussion with palliative care (CG) and 
statistical expert (MC) as reasonable time-free from which to make reasonable associations between 
palliative care development and broader developmental context.  However due to the sporadic 
nature of data collection, some exceptions were made to this approach. For example, in line with the 
theoretical importance of disease demographics and health systems, data from 2000 was included 
as this was the only available date collected prior to 2011.  
 
Limitations of the data 
 
As with all studies of this nature, the conclusions which can be drawn from the results of the analysis, 
must be tempered with caution, due to the limitations of the data used to form them. Having 
critiqued the reliability of the WPCA country groupings, in this section, the complications of 
analysing national level data comparatively are presented when different mechanisms have been 
used in order to compile the datasets. 
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In essence, this study aimed to compare the structural contexts of countries, to isolate variables 
which may have led to (or been led by) palliative care development. Thus, it was important to 
consider methodological issues relating to international comparative research as well as what can be 
learned from comparative research.  
 
International comparative research can be conducted to determine, analyse and explain similarities 
and differences across societies.lxx An immediate observation regarding the comparability on the 
dependent variable, would be that although there are only 6 country categories, sharing a category 
with another country, does not make the palliative care systems in those countries the same. Instead, 
they have achieved a shared ranking. Problems regarding the validity of these rankings were 
discussed above, however accepting the scores as the best available data, countries within each 
category can be deemed comparable.  
 
A key insight that can be offered by comparative research is to develop ‘robust generalizations’ – a 
necessary component of developing effective global policies.lxxi Yet, this study did not intend to 
isolate a ‘golden variable’, one which provides a ‘pathway’ for how palliative care development 
should be enabled. Instead, it aimed more modestly, to describe the national contexts within which 
palliative care has, and has not, developed.  
 
The major challenge to this study of using international data comparatively was the comparability of 
the data itself. As recognised, the World Bank relies on country-collected data which raises a whole 
range of issues for the researcher. These issues include, but are not limited to homogeneity of data 
samples, completeness of data, both within countries and as reported to the World Bank and 
competing definitionslxxii 
 
In this sense, all of the variables included in the analysis had flaws. However, the use of one outcome 
variable derived from a single study, allows us to consider countries within each country grouping as 
‘comparable cases’.lxxiii Thus, the use of an ordinal scale allows us to consider what other 
characteristics are shared between countries within each country grouping.  
 
With regards to the independent variables, it was deemed impractical to consider the risks of biases 
within each variable between all countries. Therefore, the risk of bias across countries was 
considered equal and in spite of the limitations of the data, this study followed other researchers in 
using such data on the premise that it is the ‘best available’.lxxiv 
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After gaining understanding of the wide range of variables available, the next phase of the study was 
to refine potential variables of interest using a theoretical approach. On this basis, the following 
section describes the process that potentially relevant structural indicators were identified, through 
consideration of theoretical understandings of palliative and health care development. 
 
Variable selection 
 
Having considered the available data and appropriate theoretical domains from which variables of 
interests may be drawn, a scoping exercise was undertaken of World Bank data in order to consider 
the hypothetical relevance of variables using an inductive approach, drawing from the data 
categories presented in Table 10. This involved reviewing available data and considering indicators in 
terms of whether a theoretical argument could be constructed for their inclusion as an indicator of 
palliative care development. In this manner, it was straightforward to include indicators such as 
percentage of total deaths due to communicable diseases [Table 12] in order to consider questions 
such as ‘has palliative care benefitted from high levels of global funding for infectious diseases’?’ 
Similarly, it was clear that many variables collected by the Bank had no theoretical relevance to 
palliative care, for instance ‘Methane emissions (kt of CO2 equivalent).’lxxv 
 
Once a full review was undertaken, this process was reviewed by a palliative care expert (CG). In 
cases of disagreements regarding the inclusion of variables, such instances were resolved through 
discussion and based upon the strength of a theoretical argument for the inclusion of any given 
variable. Final decisions were made by the author. In this manner, additional variables such as 
‘strength of democracy’ were added to the sample based upon the theoretical approach to variable 
selection described. In this instance a strong known link between strong democracies and good 
health of populations.xxxix  
 
A full list of the 28 final agreed predictor variables can be found in Table 12 along with the 
theoretical domain from which they were selected. A full description and detail of each variable as 
well as a theoretical reason for the inclusion of each is presented in Appendix 4.  
 
Data for potentially relevant indicators was imported into SPSS and the most recent indicators within 
the five-year period 2007-2011 were consolidated. In many circumstances, data was not available 
for each indicator to match the full sample of countries. When this occurred, missing data were 
126 
 
removed from the analysis and the total countries included in each correlation are reported in 
Appendix 4. This process was documented, listing the years of data included for each country as the 
total number of countries for which there was data for any given indicator.  
 
Table 12: Included independent variables (n=28) by theoretical domain 
 
Predictor variable 
Theoretical 
domain 
Cause of death, by non-communicable diseases (NCDs) (% 
of total) 
Disease 
demographics 
Cause of death, by communicable diseases (% of total) 
Life expectancy at birth, total (years) 
Socioeconomic 
Age dependency ratio (% of working-age population) 
Literacy rate, adult total (% of people ages 15 and above) 
Out-of-pocket health expenditure (% of total expenditure 
on health) Death rate, crude (per 1,000 people) 
Prevalence of undernourishment (% of population) 
GINI index 
International tourism, number of arrivals 
Internet users (per 100 people) 
Consumption of morphine equivalent in mg per capita  
Health systems 
Hospital beds (per 1,000 people) 
Health system ranking 
Health expenditure, public (% of GDP) 
Political context 
Health expenditure, private (% of GDP) 
Corruption index 
Public spending on education, total (% of GDP) 
Strength of democracy 
Population ages 65 and above (% of total) 
Country 
demographics 
Mortality rate, infant (per 1,000 live births) 
Urban population (% of total) 
Birth rate, crude (per 1,000 people) 
Mortality rate, adult, male (per 1,000 male adults) 
Mortality rate, adult, female (per 1,000 female adults) 
Population growth (annual %) 
GNI per capita (constant 2005 US$) Economic 
indicators Net ODA received per capita (current US$) 
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Relationships between predictor variables and level of palliative care development 
 
Following the inductive approach to variable selection described, using Spearman’s Correlation test, 
several variables (n=28) were tested for their relationship with the outcome variable [Table 12]. 
Spearman’s correlation test was selected due to its known appropriateness for examining ordinal 
outcomes. The significance level was set at 5%, therefore any p < 0.05 was considered statistically 
significant. This was not adjusted for multiple comparisons, because the p-value was regarded only 
as a guide. Most variables from the Bank were numerical data and were determined to be ‘scale’ 
data in SPSS, as they are ordered categories with a meaningful metric.lxxvi Life expectancy at birth is 
an example of a ‘scale’ variable. Also selected for analysis, were ordinal variables, such as Corruption, 
which was limited to scores between 0 and 10. Boxplots were also plotted to demonstrate where 
there were outliers, that is, points which are 1.5 times the interquartile range above the upper and 
below the lower quartile. The analysis of the strength of relationships between variables used the 
rule of thumb presented in Table 13. 
 
Table 13: Interpretation of correlation coefficient 
 
Value of correlation coefficient (r) Strength of association 
1 Perfect 
0.9 < r < 1 Very Strong 
0.5 < r ≤ 0.9 Strong 
0.3 < r ≤ 0.5 Moderate 
0 < r ≤ 0.3 Weak 
0 Zero 
Source: Cohen L, 1992lxxvii 
 
When considering any potential relationships between the variables, it was not assumed that 
significant association meant causation between the dependent and independent variables. That is, 
it is not suggested that any specific independent variable has had a direct influence over 
development. Instead, independent variables are used to add richness to understandings of the 
contexts within which palliative care services have developed. Further, no assumptions were made 
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regarding the nature of any relationships.lxxviii That is, it is not inferred that independent variables 
have causality with the dependent variable, or vice versa. An illustrative example would be with 
regards to morphine equivalent consumption levels. Without additional information, it is not 
possible to infer whether higher levels of consumption have driven palliative care development, or 
whether, higher development has driven higher consumption. Furthermore, it was due to such 
uncertainty that regression analysis was not completed, in that it would be too simplistic to suggest 
that an increase in any single variable would have a clear effect upon level of palliative care 
development. Additionally, as the aim of the study was not to produce a predictive model of 
variables which predict levels of palliative care development, a wide range of variables were able to 
be included to enrich narrative analysis. Moreover, practical issues relating to the availability of data, 
would have reduced the size of the potential country sample in terms of palliative care development 
which was not in line with the aims of the study 
 
Results 
 
Informed by the theoretical domains identified above, a total of 28 variables were included in the 
analysis drawing upon development data from the World Bank area and other data sources [Table 
14]. To reiterate, hypothetical reasons were determined for the inclusion of each variable and are 
presented in Appendix 4. For instance, it may be suggested that given the historical association 
between palliative care and cancer, that countries with a higher proportion of NCDs may be more 
likely to have developed palliative care. 
 
Using all available data, Spearman correlations were calculated, the results of which are presented 
below along with the domain from which variables were selected [Table 14]. 
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Table 14: Relationships between independent variables and level of palliative care development  
 
Domain Independent variables Correlation 
coefficient 
P-value 
Disease 
demographics 
Cause of death, by non-communicable diseases (% 
of total) 
0.529 <0.001 
Cause of death, by communicable diseases (%of 
total) 
-0.481 <0.001 
Socioeconomics Life expectancy at birth, total (years) 0.445 <0.001 
Age dependency ratio (% of working-age 
population) 
-0.324 <0.001 
Literacy rate, adult total (% of people ages 15 and 
above) 
0.272 0.001 
Out-of-pocket health expenditure (% of total 
expenditure on health) 
-0.158 0.031 
Death rate, crude (per 1,000 people) 0.152 0.032 
Prevalence of undernourishment (% of population) -0.049 0.591 
GINI index -0.259 0.001 
International tourism, number of arrivals 0.684 <0.001 
Internet users (per 100 people) 0.471 <0.001 
Health systems Consumption of morphine equivalent in mg per 
capita 
0.587 <0.001 
Hospital beds (per 1,000 people) 0.301 <0.001 
Health system ranking -0.418 <0.001 
Political Health expenditure, public (% of GDP) 0.362 <0.001 
Health expenditure, private (% of GDP) 0.129 0.078 
Corruption index 0.570 <0.001 
Public spending on education, total (% of GDP) 0.182 >0.025 
Strength of democracy 0.618 <0.001 
Demographic Population ages 65 and above (% of total) 0.524 <0.001 
Mortality rate, infant (per 1,000 live births) -0.499 <0.001 
Urban population (% of total) 0.320 <0.001 
Birth rate, crude (per 1,000 people) -0.447 <0.001 
Mortality rate, adult, male (per 1,000 male adults) -0.346 <0.001 
Mortality rate, adult, female (per 1,000 female 
adults) 
-0.448 <0.001 
Population growth (annual %) -0.218 <0.002 
Economic GNI per capita (constant 2005 US$) 0.595 <0.001 
Net ODA received per capita (current US$) -0.376 <0.001 
 
Of the 28 variables entered, only 2 did not have a significant relationship with palliative care 
development. Here relationships between the independent variables and level of palliative care 
development are presented. A short discussion follows the presentation of each theoretical domain. 
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Disease Demographics 
Cause of death, by non-communicable diseases (% of total) 
 
There is a strong positive relationship between the two variables (r=0.529). This suggests that 
palliative care has developed most strongly in countries where NCDs are the primary causes of death. 
Further, it is shown that where less than 20% of deaths are from NCDs, it is likely that, those 
countries have no palliative care provision [Figure 12]. The relationship between the variables is 
however, not linear, with a greater percentage of deaths by NCDS in Group 4 countries than in 
Group 5, though we do find the highest number of deaths from NCDs in Group 6 countries.  
 
Figure 12: Boxplot examining the relationship between cause of death by NCD and palliative care 
development (r=0.529, p=<0.001) 
 
In Group 6, the outlier 194 is Uganda (194), where less than 20% of people die from NCDs, but which 
has achieved the highest level of palliative care development. In Group 4, Swaziland (176) and Papua 
New Guinea (46) have achieved generalised provision of services in a context of high levels of death 
from infectious diseases. 
 
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of 
total) 
 
A moderate negative relationship exists between the variables (r=-0.481) which supports the finding 
that palliative care services have predominantly emerged to meet the needs of NCD patients. 
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Figure 13: Boxplot examining the relationship between cause of death by communicable disease 
and palliative care development (r=-0.481, p=<0.001) 
 
In terms of outliers, in Group 5 (Zimbabwe (207) and Malawi(115)) and 6 (Uganda (194)) the indicate 
that these countries are exceptional to the broader trends and have developed palliative care to a 
high level in response to communicable diseases [Figure 13]. Overall, however in countries where 
most deaths are caused by communicable disease, palliative care services are less likely to have 
developed.  
 
Disease demographics and palliative care development 
 
Palliative care services appear to have developed most in countries where NCDs represent the 
highest burden of disease. This finding supports narratives regarding the historical association 
between palliative care and NCDs, predominantly cancer. NCDs are the cause of most deaths 
throughout the world, with 68% of cases attributed in 2012. In Group 6 countries, the median 
percentage of deaths by NCDs is 88% compared with 27% in Group 1 Countries.  
 
In this regard, globally speaking, it seems that developmental efforts aimed at tackling infectious 
illnesses have not incorporated palliative care alongside such efforts. An ongoing association 
between infectious diseases and povertylxxix is also suggestive that services have developed 
predominantly to meet the needs of richer populations. 
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Socioeconomic factors 
Life expectancy at birth, total (years) 
 
There is a moderate positive relationship between the two variables (r=0.445). This suggests that 
palliative care has developed most strongly in countries where people live longer. Viewing the 
boxplot [Figure 14], however, it is shown that in all but one country groupings there are countries 
with life expectancy of over 80 suggesting that increased life expectancy has not been a major driver 
of service development.  
Figure 14: Boxplot examining the relationship between life expectancy and palliative care 
development (r=0.445, p=<0.001) 
 
However, in Group 6 countries, the quartile range is highly concentrated around life expectancy of 
80, with only two outliers (Uganda (194), Romania (154)). This supports the suggestion that palliative 
care has developed in countries where a high proportion of the population is likely to live into old 
age. Outside of Group 6, increased life expectancy seems to be less of a determinant of countries’ 
palliative care development.  
 
Age dependency ratio (% of working-age population) 
 
Age dependency ratio is a measure of the working age population in relation to people under 15 and 
over 64. The correlation coefficient (r=-0.324) suggests a moderate negative relationship between 
the variables. The higher the ratio of dependents to working age people in a country is associated 
with lower levels of palliative care development [Figure 15].  
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Figure 15: Boxplot examining the relationship between age dependency ratio and palliative care 
development (r=-0.324, p=<0.001) 
 
Whilst the boxplot is indicative of a high level of uncertainty regarding the relationship, the 
moderate negative association challenges the notion that palliative care has developed to meet the 
needs of ageing populations internationally. More likely perhaps, however is that it is the lower age 
bracket (people aged 0-15) is influencing this relationship. Instead it could therefore be suggested 
that palliative care has not developed where there is a broadly young, rather than ageing population.  
 
Literacy rate, adult total (% of people ages 15 and above) 
 
There is a weak, positive relationship between literacy rates and level of palliative care development 
(r=0.272) 
 
Figure 16: Boxplot examining the relationship between literacy rates and palliative care 
development (r=0.272, p=0.001) 
 
The weakness of this relationship is perhaps attributable to the overall high levels of literacy in the 
sample, making differences more difficult to detect [Figure 16].  
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Out-of-pocket health expenditure (% of total expenditure on health) 
 
A weak negative association is shown by the correlation coefficient between pocket health 
expenditure and palliative care development (r=-0.158). This suggest that in countries where more 
people pay for healthcare at the point of use, that palliative care services are less likely to have 
developed. 
 
Figure 17: Boxplot examining the relationship between out-of-pocket expenditure on health and 
palliative care development (r=-0.158, p=0.031) 
 
The boxplot however suggests no one overarching narrative of the relationship between the 
variables [Figure 17]. However it is noticeable that in Group 6 where the median out of pocket is 
expenditure is lowest, the highest level of development is found. Uganda (194) and Singapore (165) 
are the only two outliers within the sample, where out of pocket expenditure is unexpectedly high in 
relation to level of development. The slight negative relationship between the two variables 
suggests that where people have to pay for healthcare treatment, that the trend is not towards 
expenditure on palliative services. 
 
Death rate, crude (per 1000 people) 
 
A weak positive relationship is revealed between crude death rates and palliative care development 
(r=0.152). This casts doubt on the suggestion that palliative services have emerged to meet the 
needs of the dying. 
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Figure 18: Boxplot examining the relationship between crude death rates and palliative care 
development (r=0.152, p=0.032) 
 
The boxplot demonstrates however, that there is no clear narrative to be made around the variables 
[Figure 18]. The highest median death rate is found in Group 4 countries and the median is higher in 
Group 6 countries than in Group 1. The result is suggestive of individual development experiences in 
different countries and does not support the idea that services have developed in response to 
prevalence of need. 
 
Prevalence of undernourishment (% of population) 
 
There is a very weak negative relationship between levels of undernourishment and palliative care 
development (r=-0.049).  
 
Figure 19: Boxplot examining the relationship between prevalence of undernourishment and 
palliative care development (r=-0.049, p=0.591) 
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This relationship is neither linear, nor significant and the association is so weak that the variable may 
be disregarded as not relevant to the outcome variable [Figure 19]. Additionally, the World Bank 
does not currently collate data for undernourishment for countries such as the UK and the United 
States, which is why Group 6 appears to have higher than expected prevalence. 
 
GINI Index 
 
The GINI coefficient is a measure of income inequality within a nation [Appendix 4]. A weak, 
negative relationship with palliative care is demonstrated by the Spearman correlation coefficient 
(r=-0.259). This is suggestive that in countries with higher levels of income inequality, that palliative 
care is less likely to have developed. 
 
Figure 20: Boxplot examining the relationship between level of income inequality within nations 
and palliative care development (r=-0.259, p=0.001) 
 
However, the weakness of the relationship – as well as the inconclusive evidence of a trend – means 
that firm conclusions regarding the association between these two variables are not possible [Figure 
19]. There is the smallest suggestion that lower inequality within a country is linked to greater 
palliative care development, however, this conclusion should be treated with caution.  
 
International tourism, number of arrivals 
 
There is a strong relationship between the two variables (r=0.684) suggesting that the more tourists 
that visit a country, the higher the level of palliative care development.  
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Figure 21: Boxplot examining the relationship between total annual international tourism arrivals 
and palliative care development (r=0.684, p=<0.001) 
 
The high amount of outliers demonstrated by the boxplot however, suggest that this indicator 
should be understood with caution. However, as the boxplot shows [Figure 21], there is a clear trend 
towards countries with high levels of tourism having higher levels of palliative care development. 
This supports the suggestion that international tourism can lead to social policy responses in low-
income settings.lxxx In this regard, it is also notable that there are very low levels of tourism in Group 
1 and 2 countries alongside an absence of palliative care development. 
 
Internet users (per 100 people) 
 
The moderate positive relationship between the two variables (r=0.471) appears to justify the 
inclusion of internet use as a variable. High internet use is associated with higher levels of palliative 
care development. 
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Figure 22: Boxplot examining the relationship between levels of internet use and palliative care 
development r=0.471, p=<0.001) 
 
Once more Uganda (194) appears as an outlier along with Romania both of which have achieved 
high levels of service development in spite of relatively low internet use within the country [Figure 
22]. Yet, this trend does not preclude that there may be high internet use amongst the palliative care 
community, which is not demonstrable through population level data.  
 
Socioeconomic indicators and palliative care development  
 
Most socioeconomic indicators included in the analysis relate to palliative care in expected patterns. 
For instance, in countries where life expectancy is higher, palliative care services have developed to 
a higher level. This finding supports the WPCA analysis that palliative care services have developed in 
order to meet the needs of ageing populations. Additionally, that higher adult literacy rates and 
greater internet use are also features of countries with higher levels of service development, 
supports ‘access to education’ and ‘improved communication systems’ as factors which have 
influenced service development. Indeed tourism, the strongest relationship identified in this analysis 
(0.684) may also form part of the process of ‘broader support networks’ becoming established. 
 
However, the ratio of dependents to working age people has a negative relationship with palliative 
care development. The greater the ratio between workers and dependents, the less likely that 
palliative care has developed. This finding challenged the hypothetical reasoning for including the 
variable and disputes the finding that palliative care has developed to meet the needs of ageing 
populations. However, there is a moderate positive relationship between population ages 65 and 
above (% of total) and level of palliative care development (r=0.524). This means that the association 
between higher levels of dependents to working age people and its negative association with 
palliative care development may be explained by dependents consisting of predominantly younger 
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rather than older people. Furthermore, it is known that in many low-income countries that there is a 
high caregiving burden upon young carers. lxxxi  It is not known however, the extent to which younger 
people caring for older dependents is attributable to societal norms or is due to practical realities in 
circumstances where there is no palliative care.  
 
Additionally, poor socioeconomic outcomes were associated with lower levels of palliative care 
development in terms of low internet use and therefore decreased opportunities for lesson-learning. 
Furthermore, in countries where there is higher economic inequality between national populations, 
services are less likely to have developed. These indicators suggest additional developmental 
challenges within these countries which perhaps forms part of the explanation as to why palliative 
care services have not developed. However, it should also be noted that in countries such as the 
United States, income inequality is very high therefore caution should be used when associating 
income inequality with a countries’ level of palliative care development.lxxxii However, it should also 
be noted that wealth is reported as a positive determinant of access to palliative care.lxxxiii 
 
Health Systems 
Consumption of Morphine Equivalent (ME) in mg per capita 
 
There is a strong positive relationship between ME consumption and level of palliative care 
development (r=0.587) which suggests that global ME consumption is concentrated in countries 
which have higher levels of palliative care availability.  
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Figure 23: Boxplot examining the relationship between Morphine Equivalent consumption and 
palliative care development (r=0.587, p=<0.001) 
 
Although the relationship is only moderate, the boxplot demonstrates that ME consumption is highly 
concentrated in Group 5 and 6 countries [Figure 23]. However, morphine consumption remains very 
low in some countries within Groups 5 and 6. For instance there is a real difference in consumption 
between two Group 6 countries: in Uganda (194), consumption is 0.75mg per capita, in relation to 
Canada (35) where it is 657.27mg per capita. More generally, the boxplot shows a broad lack of ME 
consumption within country groupings 1-4, in which most countries of the world are located. 
 
Hospital beds (per 1,000 people) 
 
There is a weak positive association between hospital beds (per 1,000 people) and level of palliative 
care development (r=0.301). This suggests that in countries in which there are more hospital beds 
available per person, that some of these may be being used for palliative care purposes. 
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Figure 24: Boxplot examining the relationship between hospital bed per 1000 people and palliative 
care development (r=0.301, p=<0.001) 
 
An extreme outlier in Group 1 is Monaco, which raises doubt regarding the territory’s palliative care 
rating [Figure 24]. It is difficult to conceive that a place with the highest ratio of people:hospital beds 
has no palliative care services at all. More generally, there is an uneven positive trend here, though 
the range of hospital beds per person appears similar across all groups. Group 6 has the highest 
median score of beds per 1000 people.  
 
Health system ranking 
 
This is a measure of health system strength in terms of; improvement in health, responsiveness and 
distribution of services.lxxxiv France (65) has the top rated health system and a low health system 
score is indicative of a strong health system.  
 
There is a moderate negative relationship between health system strength and level of palliative 
care development (r=-0.418). This indicates that stronger health systems are more likely to have 
developed palliative care services. 
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Figure 25: Boxplot examining the relationship between health system ranking and palliative care 
development (r=-0.418, p=<0.001) 
 
The boxplot shows a clear trend, with weaker health systems associated with lower palliative care 
development [Figure 25]. Group 6 comprises most of the top-ranked country health systems. Two 
outliers in Group 6 (Romania (154), Uganda (194)), show relatively weak health systems, which have 
been able to achieve high levels of development in spite of this circumstance. Yet, there is high 
diversity within the sample and there are countries across all Groups which have highly ranked 
health systems.  
 
Health systems and palliative care development 
 
Although the WHO’s ranking of health systems occurred in 2000, there is evidence that palliative 
care has developed most effectively as an element of stronger health systems 
 
In Group 6, Romania (154) and Uganda (194) were outliers in terms of health system strength. This 
supports pioneer-driven narratives of development, whereby services have developed to a high level 
in spite, or outside of the formal health care system. Indeed, Casa Sperentai in Romania, now 
considered a ‘model service’ began as one UK nurse and a single Romanian nurselxxxv, whilst Dr Anne 
Merriman played a key role in the introduction of palliative care in Uganda.xcv 
 
Linked to this, in countries where there are a greater proportion of hospital beds relative to the 
population, development was likely to be higher. However hospital beds (per 1,000 people) does 
appear to be a less clear indicator of level of palliative care development. Across Groups 1, 3 and 4 
there are countries with a high proportion of beds relative to the population. In these countries, it 
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may be suggested, that little prioritisation has been given to palliative care in spite of available 
inpatient facilities. 
 
As may be anticipated, consumption of Morphine Equivalent (ME) drugs was associated with higher 
levels of palliative care development. Consumption of ME drugs has been included within the 
context of health systems, however, government legislation is necessary in order for the drugs to be 
available at all. Further, education regarding how to use these drugs is also a necessary component 
of ensuring access this form of pain relief. What is most notable from international consumption 
levels of ME drugs, is the degree to which consumption is concentrated in Group 5 and 6 countries 
and suggests that where ME equivalents are being prescribed and consumed, that they are being 
used for palliative purposes. 
 
Political Context 
Health expenditure, public (% of GDP) 
 
This variable is a measure of both government expenditure on health, as well as the political 
commitment to healthcare that this embodies. A moderate positive relationship is displayed by the 
correlation coefficient between the variables (r=0.362). This finding supports the hypothesis that 
palliative care is better able to flourish and develop in countries where there is strong political 
backing and financing for provision for healthcare.  
 
Figure 26: Boxplot examining the relationship between public health expenditure and palliative 
care development (r=0.362, p=<0.001) 
 
The spread of outliers between the country groups serves as a reminder that there is no natural 
process from government funding, to palliative care service development. The broadly positive trend 
144 
 
displayed by the boxplot, is however, supportive of the idea that government commitment to 
publicly funded healthcare provision has served as a fertile context for palliative care services to 
have emerged [Figure 26]. 
 
Health expenditure, private (% of GDP) 
 
This variable is a measure of out-of-pocket spending, private insurance, charitable donations and 
direct service payments by private corporations. There is a weak positive (non-significant) 
relationship between private health expenditure and palliative care development (r=0.129). 
 
Figure 27: Boxplot examining the relationship between private health expenditure and palliative 
care development (r=0.129, p=0.078)
 
There is, however, no obvious linear trend to the data, suggesting that the indicator has little (if any) 
general influence over service development [Figure 27]. It is noticeable however that Uganda (194) 
is shown to have relatively high private expenditure compared with other countries and is a 
potential line of enquiry for how services have developed in the country.  
 
Corruption 
 
A low Corruption score indicates high levels of perceived corruption. The strong positive relationship 
(r=0.570) between the two variables shows that lower levels of corruption are associated with 
higher levels of service development [Figure 28]. 
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Figure 28: Boxplot examining the relationship between levels of corruption and palliative care 
development (r=0.570, p=<0.001) 
 
The boxplot does however reveal many outliers. Focussing upon Group 6 (high development) it is 
shown that palliative care has developed to the highest country group in spite of high levels of 
corruption in three countries (Italy (92), Romania (154) and Uganda (194)). 
 
Public spending on education, total (% of GDP) 
 
There is a weak positive relationship between public spending on education and level of palliative 
care development (r=0.182). This finding tentatively supports the rationale for including the 
indicator, that high government welfare expenditure would be associated with higher levels of 
palliative care development. 
 
Figure 29: Boxplot examining the relationship between levels of public spending on education and 
palliative care development (r=0.182, p=>0.025) 
 
In spite of the positive association, however, the interquartile range of Group 1 countries extends 
higher than that of Group 6 countries [Figure 29]. Moreover, the median spend of Group 5 Countries 
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is higher than that of Group 6 countries. Whilst there is no suggestion that decreased expenditure is 
associated with palliative care development, conclusions suggesting the opposite of this should be 
treated with caution.  
 
Strength of Democracy 
 
This indicator is a composite score, produced by the Economist Intelligence Unit (EIU), which gives 
an overall strength of democracy score based on the following elements: electoral process and 
pluralism, functioning of government, political participation, political culture, and civil liberties.lxxxvi 
For this ordinal variable, a score of 10 indicates ‘perfect democracy’, whilst a score of zero, no 
democracy at all.  
 
There is a strong relationship between strength of democracy and level of palliative care 
development (r=0.618), which represents the highest correlation coefficient included in the sample. 
 
Figure 30: Boxplot examining the relationship between strength of democracy and palliative care 
development (r=0.618, p=<0.001) 
 
There is a clear upward trend relating the strength of countries’ democracy with its level of service 
development [Figure 30]. In Group 1, Cabo Verde (32) is an outlier, with a relatively strong 
democracy (7.92), but no known palliative care service at all. 
 
Political context and palliative care development  
 
As may be expected, there is a positive association between public spending on health (% of GDP) 
and palliative care development, though the relationship is moderate (r=0.362). Countries in Group 6 
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have the highest median public spending on health of 7.69 as a percentage of GDP. This suggests 
that greater government commitment to health funding may have acted as a facilitator to palliative 
care development as part of public health approaches.  
 
There was, however, evidence that governments in Group 1 were committing high proportions of 
available resources to healthcare, but that these resources were not allocated towards palliative 
care. Moreover, percentage indicators must be viewed within a context of total GNI, whereby a high 
percentage of limited resources may still represent relatively low levels of financial resources being 
committed to health.  Questions may also be raised by the outliers in Group 1 (n=4), Tuvalu (193), 
Marshall Islands (120), Micronesia (124) and Kiribati (98)) – where extremely high percentages of 
GNI were allocated to healthcare. Such countries receive aid from the United States and there is 
evidence that unusually high proportions of government resources have been allocated towards the 
private delivery of healthcare which has not benefitted palliative care.lxxxvii In Group 3, Cuba (48) and 
Lesotho (106), have higher than anticipated spending for the group, but have developed only limited 
capacity for palliative care. 
 
Weaker evidence indicates that higher private spending on health (% of GDP) supports palliative care 
development. A high amount of outliers across groups suggests that there is little association 
between level of private healthcare spending and palliative care. Of interest, however, Uganda (194) 
has relatively high private health expenditure and the relationship between private health 
expenditure and palliative care in the country may offer one explanation for its high levels of 
development. Additionally, the inclusion of charitable funding within ‘private funding’ is consistent 
with a known situation, where much palliative care funding in Uganda comes from charitable 
funders such as the Elton John Foundation.lxxxviii It is no surprise that the United States (198) with its 
private health system and high levels of palliative care development also appears as an outlier. 
 
Overall, taking public and private expenditure together, there is a clear indication that greater 
spending on health care, through government and private streams has some relationship with 
palliative care development. There is limited evidence, however, that government commitment to 
spending on education is having the same effect. 
 
The strength of democracy and levels of corruption within countries had two of the strongest 
associations with palliative care identified by the analysis. These findings, support theoretical 
notions that higher corruption leads to poorer health outcomes and that stronger democracies 
148 
 
improve health.lxxxix Corruption within governments and at the health-sector level, may lead to 
decreased access to health services and the misallocation of resources.xc Low public awareness and 
expectation for palliative services may also leave the sector particularly vulnerable to 
misappropriation of funds. Conversely, the finding that stronger levels of democracy are associated 
with higher palliative care development supports the idea that stronger political institutions 
facilitate improved outcomes in terms of universal health policy issuesxci, including palliative care. 
 
Overall, the findings suggest that political factors may have been able to positively influence the 
international development of palliative care. This analysis does, however, run both ways. Where 
indicators of corruption are high and those for democracy and spending on health low, palliative 
services have developed only to a limited extent or not at all.  
 
Demographic context 
Population ages 65 and above (% of total) 
 
There is a strong positive relationship between the two variables (r=0.524). The greater the 
percentage of people in a country who are over 65 is associated with a higher level of palliative care 
development [Figure 31]. This supports the hypothesis that palliative care has developed to meet 
the needs of ageing populations. 
 
Figure 31: Boxplot examining the relationship between the percentage of population aged 65 and 
above and palliative care development (r=0.524, p=<0.001) 
 
However the boxplot reveals that there are many countries that have high percentages of their 
population over 65 which have not apparently developed to meet ‘the practical needs of an ageing 
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population’. Uganda is an outlier (194), with a low percentage of its population over 65 and a high 
palliative care development score.  
 
Mortality rate, infant (per 1,000 live births) 
 
There is a moderate negative relationship between the variables (r=-0.499) suggesting that infant 
mortality rates are higher in countries where palliative care is least developed [Figure 32]. 
 
Figure 32: Boxplot examining the relationship between infant mortality rates and palliative care 
development (r=0.499, p=<0.001) 
 
Yet, the high amount of outliers shown in the boxplot, suggest that caution should be exercised 
before making generalisations about the relationship. Palliative care seems to have developed to a 
level in certain contexts in spite of high mortality rates, however only two Group 6 countries have 
higher than expected infant mortality rates, Uganda (194), once more, and Romania (154). Overall, 
the moderate relationship between the variables suggests that countries which have not developed 
palliative care to a high standard face serious challenges regarding the delivery of other aspects of 
healthcare. 
 
Urban population (% of total) 
 
A moderate positive association (r=0.320) links a higher percentage of total population living in 
urban areas with higher palliative care development [Figure 33].  
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Figure 33: Boxplot examining the relationship between urban populations and palliative care 
development (r=0.320, p=<0.001) 
 
This finding adds support to the suggestion that palliative care services have developed mainly to 
meet the need of urban populations and that there are additional challenges in providing services in 
rural areas.xcii There are some settings, however, with high proportions of urban populations which 
have either not developed palliative care (Monaco (135)) or done so to a very limited extent (Qatar 
(153)). Once more it is difficult to intuitively understand in Monaco there would be no end of life 
care services at all, whereas Qatar may serve as an example of a country which has not given 
palliative care any policy attention. 
  
In Group 6, the solitary outlier is once again Uganda (194), suggesting that either the country has 
managed to overcome the challenges of providing services to rural populations or that questions 
must be asked regarding the allocation of the highest level of service development.  
 
Birth rate, crude (per 1,000 people) 
 
There is a moderate, negative relationship between crude birth rates and palliative care 
development (r=-0.447) which suggests that in nations where infant mortality rates are higher, that 
palliative care is less developed. 
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Figure 34: Boxplot examining the relationship between birth rates and palliative care development 
(r=0.447, p=<0.001) 
 
In Group 1 there is a wide range of birth rates, whilst in Group 6, birth rates are characterised by 
being low [Figure 34]. This finding is in support of the hypothesis that whilst high levels of resources 
are required to tackle issues regarding birth rates, that need for palliative care has not as yet, been 
addressed. In Group 6, Uganda (194) is again an outlier, whilst in Group 5, Malawi (115), Tanzania 
(183) and Zambia (206), have achieved a level of integration of palliative care into their health 
systems in spite of high birth rates. This suggests that caution should be exercised when considering 
the relationship between the two variables. 
 
Mortality rate, adult, male (per 1,000 male adults) 
 
A moderate negative relationship is revealed between male mortality and palliative care 
development (r=-0.346) which suggests that male mortality is higher in countries where palliative 
care is least developed. 
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Figure 35: Boxplot examining the relationship between male mortality rates and palliative care 
development (r=0.346, p=<0.001) 
 
This finding is suggestive that in countries where there is a higher proportion of deaths amongst a 
population in a given year and the need for palliative care great, that people are unlikely to receive 
palliative care. The low quartile range in Group 6 indicates that lower mortality rates allow better 
planning and organization of end of life services [Figure 35]. That said, there is a broad range of 
mortality rates within Group 5 countries.  
 
Mortality rate, female, male (per 1,000 female adults) 
 
There is a moderate negative relationship between female mortality rates and palliative care 
development (r=-0.448), though stronger relationship than that of male mortality rates (r=-0.346). 
 
Figure 36: Boxplot examining the relationship between female mortality rates and palliative care 
development (r=-0.448, p=<0.001) 
 
Again, lower mortality rates are concentrated in Group 6 countries – with the exception of two 
outliers (Romania (154) and Uganda (194)) [Figure 36]. Overall, the indicator suggests that the higher 
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the risk of dying – and particularly for women - the lower the level of palliative care services that will 
be available if indeed they are present at all. 
 
Population growth (annual %) 
 
There is a weak negative relationship between increasing populations and level of palliative care 
development (r=-0.218) which gives a slight indication that palliative care services are less likely to 
have developed in nations with an increasing population  
 
Figure 37: Boxplot examining the relationship between population growth and palliative care 
development (r=-0.218, p=<0.002) 
 
The boxplot indicates, however, that conclusions should be drawn regarding this relationship with 
caution as there appears to be no clear trend to the relationship [Figure 37].  
 
Demographic context and palliative care development 
 
The WPCA study reports that palliative care services have developed to meet the needs of ageing 
populations. This argument is supported, as countries which have a higher percentage of people 
over 65 in the population, tend to have achieved higher levels of palliative care development. 
Using this indicator does, however, overlook the fact that many people die under the age of 65 who 
may benefit from palliative care.  
 
In countries where people are more likely to die within a given year, based on mortality rates, 
palliative services are less likely to have developed. In countries where birth rates continue to 
outnumber death rates (increasing populations), services are also less likely to have developed. 
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Evidence also emerges that there is inequity within countries regarding access to services. Countries 
with a higher percentage of their population living in urban areas are more likely to have developed 
palliative care, which suggests that people living in urban areas are more likely to have access to 
services. This finding mirrors those of a study within the systematic review which describes 
additional challenges regarding providing services to rural populations.xcii 
 
Economic Context 
GNI per capita (constant 2005 US$) 
 
A strong positive relationship exists between GNI per capita and level of palliative care development 
(r=0.595) which suggests that richer nations are more likely to have developed services than poorer 
countries. A positive upwards trend is displayed by the boxplot before a leap in GNI amongst Group 
6 countries [Figure 38]. 
 
Figure 38: Boxplot examining the relationship between GNI per capita and palliative care 
development (r=0.595, p=<0.001) 
 
There is evidence that some countries with high GNI have made little progress in developing 
palliative care. Equatorial Guinea (58) is an outlier amongst Group 1 countries, whilst the Bahamas in 
Group 2(14) has only capacity building initiatives despite a per capita GNI of >$20,000 per capita. Of 
note also, three Group 6 countries (Poland (150), Romania (154), Uganda (194)) have achieved the 
highest level of service development in spite of a GNI per capita far below what may have been 
expected. This supports the suggestion that a nations’ wealth is not the sole determinant of 
palliative care development.  
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Net Overseas Development Assistance (ODA) received per capita (current US$) 
 
A moderate, negative relationship is revealed by the correlation coefficient (r=-0.376). Net receivers 
of ODA are concentrated amongst Group 1 and 2 countries [Figure 39]. In Group 5, Serbia (162) - a 
relatively new independent nation following military conflict - appears as an outlier.  
 
Figure 39: Boxplot examining the relationship between ODA per capita and palliative care 
development (r=-0.376, p=<0.001) 
 
The relationship supports the idea that net donors of aid have also been able to better develop 
palliative care services. It also suggests that development aid is not being (or has not yet been) used 
to support the development of palliative care. 
 
Economic context and palliative care development  
 
Using Gross National Income (GNI) per capita as a measure of a country’s wealth, there is clear 
evidence that richer countries are more likely to have developed palliative care services than poorer 
countries. In line with this, it makes rational sense, that wealthier countries are net donors of Official 
Development Assistance (ODA) whilst poorer countries receive this money. There is not, however, 
any evidence that net receivers of ODA have used these financial flows to forward palliative care 
development when viewed globally. Countries which receive ODA are less likely to have developed 
palliative care services, which supports the broader finding that palliative care has not yet engaged 
successfully with global funding agencies.  
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Discussion 
 
The findings of this Chapter both support and challenge the notion of transferability of palliative care 
policies and practices. It has been shown that countries such as the United Kingdom (197) and 
Australia (11) which have successfully integrated palliative care into their health systems have 
similarities beyond simply indicators of wealth and high life expectancies. Conversely, in lower-
resource settings it has been shown that failure to develop palliative care services is one 
developmental challenge which sits alongside many others.  
 
Transferability of services 
 
Understanding palliative care development in terms of broader development context and similarities, 
moves the discussion on from explaining policy diffusion in terms of ‘geographic clustering’, where 
policy convergence is explained in terms of a natural spread of good ideas and practices.iii The 
general convergence of geographic clusters towards integration into health systems seen most 
clearly in Europe and North America, is thus better understood in terms of the contextual similarities 
between the countries.xciii That is, it appears that structural similarity of nations rather than 
geographic proximity is the clearest explanation of palliative care practices have converged between 
countries. This analysis also helps us to explain why other ‘similar’ countries in terms of these 
contextual factors have developed palliative services similarly in spite of geographic distance. 
Australia’s presence in Group 6 may be explained in this manner as a literal ‘island of development’ 
in a continent characterised by low provision of palliative care [Figure 10]. Furthermore, there is 
evidence that palliative care has developed to the highest level in countries with strong democracies. 
 
Additionally, ‘broader support networks’ in the form of the WHO and bilateral donations from Italy 
to strengthen home based care have contributed to Uganda’s apparent success in rolling out 
services.xciv However, given the questions which were raised with regards to the validity of Uganda’s 
ranking as a Group 6 country, based upon its relatively low score within the EIU Quality of Death 
index, some questions are raised.xvii Owing to Uganda’s consistent presence as an outlier within 
correlations, it may be asked whether the country has achieved success in spite of broader 
contextual factors, or whether it’s rating as a Group 6 country is appropriate.   
 
Contextual similarly does not solely drive policy convergence. Indeed there are other dynamic 
processes at work in Sub-Saharan Africa which have led to a cluster of Group 5 and 6 countries in the 
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region [Figure 3]. Hospice Uganda was established, following the inauguration of Africa’s first 
Hospice in Zimbabwe in 1990, with the mission statement of becoming “a ‘model’ hospice which 
would be affordable and culturally acceptable to Africa and could be adapted to the different 
circumstances”.xcv Characterising hospice in Uganda as a model for Sub-Saharan Africa, contains the 
implicit suggestion, that countries in the region have similarities, or shared characteristics which may 
make similar policies both feasible and amenable. Supported by Hospice Africa, an Organization 
established to promote the spread of the practice of palliative care through educational efforts, 
there is already suggestive evidence of policy diffusion emanating from Uganda. That Hospice 
Uganda itself was only founded in 1994, adds a more optimistic outlook on the development of 
palliative care in Sub-Saharan Africa which appears to be occurring with some dynamism.  
 
Based upon the findings of the chapter, it may be fruitful for national policymakers seeking to 
implement the terms of the WHA palliative care resolution to look not just at neighbouring countries, 
but at other countries of similar developmental level in order to learn lessons regarding how 
palliative care can be implemented. For instance, due to its success, the ‘Kerala Model’ has received 
attention from policymakers from countries as diverse as Thailand, Ireland and the Seychelles.xcvi Of 
course there may be lessons to be learned from what has been achieved in Kerala, for instance the 
benefits of community-engagement in provision of services. However, policymakers seeking to 
transfer the model must consider a broad range of contextual factors. For instance, beyond 
considerations of social indicators, Kerala is the third most densely populated state in Indiaxcvii, has 
this made it easier to foster community participation? 
 
Moreover, as part of volunteer-training in Kerala, potential volunteers are asked to understand 
concepts such as the basics of cancer care, effective communication, complete assignments and 
projects, tasks which appear reliant upon a good level of education.xcviii Additionally, from a history 
of political socialism, democracy is said to ‘work better’ in Kerala, which is consistent with the finding 
that palliative care develops most strongly within robust democratic systems.xcix In this regard, other 
Indian states may be regarded as dissimilar to Kerala in many respects in spite of geographical 
proximity. Further analysis is needed in order to determine which other regions or countries may be 
considered ‘similar’ to Kerala. In this regard, it is perhaps telling that no other state in India has as 
yet adopted the ‘Kerala model.’ However, there are currently efforts to implement the Keralan 
model in West Bengal - another state in India.c It will be interesting to discover whether this policy 
transfer is successful, though unfortunately there is no evidence currently in the public domain to 
make judgement. 
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Need for model services 
 
The findings of this chapter further commend the achievements of ‘model services’ which have 
developed in contexts of low development indicators. Significantly model services appear to have 
driven processes of policy convergence more easily in geographic regions of contextual similarity. 
For instance, in Sub-Saharan Africa, palliative care appears to have spread rapidly between similar 
countries, in spite of relatively low socioeconomic and health indicators. In this regard, we may 
attribute much of the success in rolling out palliative care to the qualitative factors such as 
‘increased awareness of policymakers’ identified by the WPCA study.ii Certainly the work of Anne 
Merriman, Hospice Uganda’s founder can be described as that of a ‘palliative care champion’. 
Additionally, ‘focussed advocacy’ has been offered as a reason for the early adoption of palliative 
care by Uganda’s Ministry of Health, which has facilitated access to opioids and seen palliative care 
incorporated into the National Health Policy Plan.  
 
Of concern for the continent, however, is that the ‘cluster of higher development around Uganda 
does not yet seem to have made an impact in the rest of Africa. This may be explained due to the 
disproportionately high level of global attention focussed upon Sub-Saharan Africa during the MDG 
era which has seen high levels of finance and technical assistance targeted upon the region.ci There 
are also clear contextual dissimilarities between Northern and Southern Africa, in terms of race, 
climate and language.cii It was not feasible to investigate such factors within this study, but they may 
form some explanation for why ‘lessons’ emanating from Uganda are less receptively learned in 
Northern countries. In this regard, it may be said that new ‘model services’ are needed which are 
appropriate for distinct regions such as Northern Africa. 
 
Elsewhere, in other regions of low provision – such as Latin America and the Caribbean - attention 
should be given to identifying and facilitating ‘model services as well as potential contextual 
similarities between countries. In 2002, seven ‘demonstration projects’ in 7 countries (Argentina, 
Barbados, Chile, Colombia, Ecuador, Panama, Venezuela) were awarded funding by the Pan 
American Health Organization (PAHO) to expand palliative care services.ciii From this grouping, Chile 
has achieved Group 5 status (preliminary integration into the health system) along with Puerto Rico 
and Costa Rica, a country which incorporates palliative care as part of universal health coverage.civ 
Additionally, the Chilean government has mandated that health centers are required by law to 
require high quality care, with palliative care a part of this.cv 
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Focussed attention should be given to how these policies and ‘model services’ have achieved success, 
and the structural contexts in which they have developed.  Concerns must, therefore, be raised, 
regarding the levels of international research activity focussed upon the region, with only 23 studies 
identified in Chapter Five which focus upon Latin America and the Caribbean. This suggests, that 
researchers are not yet fully utilising the potential of research and evaluation, to facilitate processes 
of ‘lesson learning’ and policy diffusion in the region.  
 
Low palliative care development consistent with nations facing broader development challenges 
 
This chapter has revealed the scale of the challenge facing governments who have ratified the WHA 
Resolution but have not yet developed palliative care. In spite of the achievements of model services, 
which suggest that palliative care is feasible in all world contexts, the frequency with which 
examples such as Kerala and Uganda are used underlines their rarity. In this regard, focussing upon 
positive examples undermines the challenges which exist for the further development of palliative 
care. In countries which haven’t developed palliative care, based upon the findings of this chapter, 
life expectancies and government spending on health are likely to be low. The greater narrative 
therefore is that palliative care is one among many other developmental challenges faced by nations. 
Moreover, whilst awareness of palliative care amongst public and policymakers remains lowcvi, there 
is little to suggest that its development will be prioritised over and above other prevalent areas of 
social need.  
 
Although there is evidence that palliative care is something which is introduced as other 
development indicators increase, the scale of other issues which require attention in such nations 
suggests that if palliative care development is to be accelerated in such circumstances, that new 
approaches are needed. 
 
Conclusion 
 
This chapter has demonstrated that there are strong links between level of palliative care 
development and other structural indicators of development. It has been shown, that palliative care 
has developed most fruitfully in nations which have strong development indicators relating to six 
structural domains; health systems, socioeconomics,  disease-demographics, population 
demographics, politics and economics. Alongside the qualitative factors identified by the WPCA 
study, it seems that there is some natural development of palliative care services along with other 
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indicators of country development. That is, that palliative care seems to come along with broader 
development improvements within a country. However, such processes do appear to become 
accelerated when ‘model services’ are able to act as policy genera and promoters of education.  
 
There is evidence to suggest that palliative care has developed similarly, in similar national contexts. 
Socioeconomically similar countries in Western Europe, North America (as well as Australia) have all 
achieved the ‘highest’ levels of palliative care development, from contexts of other strong 
development indicators. Additionally, examples from Sub-Saharan Africa show that some countries 
have been able to develop palliative services in spite of national contexts of low development and 
there is an apparent regional cluster emerging around Uganda. 
 
However, in spite of this global development which has seen palliative care develop in all regions of 
the world, it is important not to underestimate the challenges which still remain in all settings. 
Whilst the WPCA rankings are useful in order to survey the international picture, even in settings 
which have achieved integration of palliative into the broader health system, such as the United 
Kingdom, services are not yet available to everybody who would benefit and there are further 
questions relating to quality of care.cvii Elsewhere, services remain either patchy or non-existent 
within developmental health systems which struggle to provide even a basic standard of healthcare 
services. In this regard palliative care activists must acknowledge that that the adoption of a public 
health approach to palliative care development, which incorporates calls for a reallocation of 
existing resources, means that such resources would have to be taken from other areas of social 
need. 
 
Whilst the ongoing spread of palliative care practices appear to have a developmental momentum, 
without further intervention, millions of people will continue to suffer due to lack of access to high 
quality pain and palliative services. Although facing different challenges, what unites all world 
regions in terms of palliative care, is that they would all benefit from greater attention from 
policymakers and investment in services. In this regard, in order to accelerate palliative care 
development beyond that which appears to occur alongside other processes of countries’ 
development, it is clear that more must be done in order to attract greater engagement from such 
stakeholders at all levels of governance. 
 
In Chapter Three theoretical understandings of policymaking processes were offered in terms of how 
certain health issues have become prioritised over and above other worth claims through strategic 
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and targeted advocacy. Accordingly, the following chapter presents a thematic analysis of the views 
of key experts in the field of international palliative regarding current advocacy efforts and how 
global advocacy for palliative care may become more refined.  
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Chapter Seven  
Can palliative care development be furthered through global advocacy? 
 
Introduction 
 
In the previous chapter [Chapter Six], it was shown how palliative care development has been highly 
consistent with the broader development level of nations. This is significant for two reasons. Firstly, 
the scale of the broader development challenge faced by many nations, which have not yet 
developed palliative care to a high level in terms of low life expectancies, poor maternal mortality 
rates and so on, is large. Secondly, the achievements of ‘model services’ such as Hospice Uganda are 
underlined, in that they appear to have emerged in spite of this broader context of relatively low 
levels of development. In this regard, two key reasons for the establishment of the Palliative Care 
Association of Uganda and the Association of Palliative Care in Africa have been identified as 
financial support from international charitable organizations as well as targeted advocacy of the 
national government by Hospice Uganda.i  
 
In many senses, this scenario reflects the broader development challenges to palliative care. That is, 
the need to raise the awareness of policymakers as well as attract new sources of finance to fund 
the development of services. In this regard, in Chapter Three it was suggested that palliative care has 
not yet received attention from global health actors who have the resources and influence to 
accelerate the development of palliative care. One suggested reason for this lack of engagement of 
global actors was that activists had not yet ‘framed’ palliative care in ways likely to attract the 
attention of global funding agencies.  
 
Yet, Chapter Six showed that palliative care development appears to have some natural momentum 
and that the pace of this is highly consistent with other developmental progress within nations. This 
raises the question: how the current pace of palliative care development may be accelerated 
through global advocacy efforts? It is to this topic that this chapter now turns.  
 
Rationale for the study  
 
As global attention moves towards the incoming Sustainable Development Goals (SDGs), there is a 
real opportunity for palliative care to make gains as part of moves towards the attainment of 
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Universal Health Coverage (UHC).ii However, the absence of an indicator to measure progress 
towards the implementation of the 2014 World Health Assembly (WHA) Resolution for palliative 
care is of concern. Furthermore, that palliative care sits alongside more measurable SDGs for 
instance reduced maternal mortalityiii, suggests that it will not receive prioritisation in comparison to 
other such issues. In this regard, ongoing low awareness of palliative care amongst global health 
actorsiv and the absence of an indicator with which to measure progress risks a scenario where 
palliative care may not be identified as an important element of UHC – in spite of the WHA 
Resolution. 
 
It was established in Chapter Three that global policymakers do not necessarily prioritise issues 
based solely upon need, but also upon how social problems are ‘framed’. Until now, palliative care 
has most commonly been framed as a human rights issue, through proclamations such as the Prague 
Charter, which called for governments to acknowledge palliative care as a human right.v However, it 
has been noted that not all frames hold the same likelihood of influencing policymakers.vi Moreover, 
it has been identified that human rights frames may not be useful in terms of engaging global health 
funders such as the World Bank, who conceptualise health economically, as an issue of human 
capital.vii In this regard, this current chapter considers the views of experts regarding how the 
argument that palliative care is a human right is constructed as well as questions regarding its 
potential to achieve policy gains. Moreover, in recognition that social issues can be framed in 
multiple ways, alternative ways of ‘framing’ palliative care are considered in terms of their relative 
potential to influence policymakers.vi 
 
Yet, how issues are framed is not the sole determinant of whether certain issues receive 
prioritisation. Aspects of a successful advocacy strategy are commonly said to hinge around two key 
rhetorical steps: firstly, establishment of a ‘problem’ as severe and neglected, as well as to present a 
‘solution’ regarding the tractability of the problem and the benefits which would accrue from 
addressing it.lxv  
 
In this regard, this chapter raises concerns regarding the clarity with which palliative care is 
presenting these rhetorical steps. Chapter Two identified how the need for palliative care is often 
presented using disease statistics, an approach which is undermined to some extent due to low 
levels of understanding of what palliative care is as well as competing understandings of its meaning. 
Additionally, given the relatively low grade of studies identified in Chapter Five with which advocates 
are able to present the ‘solvability’ of the problem of lack of palliative care, it is appropriate to 
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consider expert views regarding why a lack of palliative care is a problem, how palliative care 
addresses the problem and what the benefits are of increased access to it. 
 
This chapter emerged to answer such questions. Sixteen key international palliative care experts 
were recruited with a view to consider how global palliative care advocacy efforts may be refined in 
order to engage with new global actors, attract new sources of funding and ensure that palliative 
care makes gains within the global health priority of achieving UHC.  Thus contributing towards 
answering the overall research question of this thesis:  
 
Can the global development of palliative care be furthered through increased understanding 
of global policymaking processes and the presentation of palliative care as an international 
development issue? 
 
The study aimed to meet the following aim and objectives: 
 
Key aim 
 
 To explore the views and perspectives of international palliative care experts regarding 
existing and future advocacy strategies 
 
Objectives 
 
 Refine how the problem of lack of palliative care is defined  
 To consider what the ‘key asks’ of the palliative care community are  
 Identify key targets for advocacy and consider how palliative care should be ‘framed’ to 
appeal to different actors at global level  
 To identify key challenges to the further development of the field 
 Consider the relationships between existing and potential ‘allies’ for the palliative care 
lobby 
 To examine existing international advocacy strategy for palliative care in relation to 
World Health Organization guidance on the key tenets of a successful advocacy strategy  
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Approach and methods 
 
Design 
 
Explorative qualitative interviews with key experts were conducted as an appropriate strategy to 
improve understanding of how the problem of lack of palliative care services is structured.viii This 
approach is in line with the objectives of the study to consider how arguments for increased 
palliative care availability internationally can become more refined. Moreover, it is consistent with 
the broadly interpretivist standpoint undertaken during the study and the objective of the chapter to 
increase understanding, rather than generate any objective ‘facts’.ix 
 
Study population sample and consent procedure 
 
Semi-structured, in-depth interviews were conducted with a sample of 16 key experts with diverse 
backgrounds. Experts in the field of international palliative care were recruited for their ‘epistemic 
expertise’, meaning their capacity to provide strong justifications for a range of propositions within 
the subject.x As the study has a global focus, the sample participants were recruited from all regions 
of the world including: low-, middle- and high-income countries. As palliative care is a 
multidisciplinary field, participants were included from varied areas of specialty, but they were 
united by being leaders within the field and consisted of people holding influential positions within 
the field.xi . Although all participants had an international presence, their ‘region’ was based upon 
their country of origin. However, the focus of their work and their previous experiences emerged 
during interview and was noted. Participants were not directly asked for their ethnicity, nor for their 
nationality, in order to reduce the extent of identifiable information collected and thus to assist with 
maintaining their anonymity.xii 
 
Additionally, in order to balance technocratic opinions against the views of the public, one public-
patient representative who had experience in palliative care research was included in the sample. 
This inclusion is in line with guidance that healthcare research “needs patient input at every level if it 
is to succeed [2015]”.xiii 
 
Purposive sampling was initially used in order to ensure that participants would have high levels of 
understanding and insight into the research questions.xiv This approach was also used to ensure that 
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there was representation of all habitable world regions within the study. Prior to the 
commencement of recruitment, it was considered that 10-15 participants would be included within 
the sample. This figure was determined as it was deemed to be both feasible in terms of recruitment 
and also, given the nature of the study population of key experts, sufficient to provide a rich dataset 
reflecting differing views and experiences.xv Nevertheless, the sample size of 10-15 remained under 
constant review.  
 
Using a purposive approach, key experts in international palliative care were identified based upon 
talks attended at international conferences as well as accumulated knowledge of the field. Potential 
participants were approached via e-mail inviting them to participate in the study. For instance, the 
first participant recruited to the study in this manner was approached as they were known to be a 
senior pharmacist working to increase access to palliative care essential medicines within an 
international Organization. A Participant Information Sheet (PIS) [Appendix 7] was attached, which 
described the project and the nature of their potential involvement. A copy of the Consent Form 
[Appendix 8] was also sent which showed exactly what they were being asked to consent to. In some 
instances, the Interview Guide was also provided Table 16. Potential participants were encouraged 
to ask any questions they may prior to their involvement in the study in line with Good Clinical 
Practice (GCP).xvii 
 
Originally, the intention was to take Informed Consent either electronically or in writing. However, 
following feedback from the Research Ethics Committee (REC) it was decided that this may create an 
unnecessary barrier to study recruitment due to practical complications taking written consent 
electronically.xvi On this basis and as potential participants were not considered to be part of a 
‘vulnerable population’, audio-recorded oral consent was considered to represent full Informed 
Consent.xvii Nevertheless, all points of the Consent Form were read aloud to study participants and 
consent taken prior to the commencement of interviews. 
 
As potential participants were professional people and the study is low risk, there was no formal 
‘cooling off’ period, an approach approved by the REC. Therefore, if participants read the PIS and 
were happy to participate, then consent was taken immediately and an interview arranged or 
commenced. Potential participants were left to consider their potential participation for as long as 
they needed and the date and time of interviews was designated by participants. Moreover, it was 
made clear to participants that they were free to end their interview and withdraw from the study at 
any time.xviii  
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Having identified several participants and conducted one interview, in order to supplement 
recruitment a ‘snowball approach’ to sampling was adopted.xix This involved asking study 
participants both in the PIS and during interview, to recommend other suitable potential participants 
anonymously. Most prominently, this process took place at the European Association for Palliative 
Care (EAPC) Conference in Copenhagen in 2015. Several interviews (n=7) were conducted at the 
Conference where the study generated a good deal of interest. Participants recruited in this manner 
were also provided with the PIS and Consent Form before informed consent was taken orally prior to 
the commencement of interviews.   
 
It is acknowledged that the adoption of a ‘snowball’ approach to sampling carried with it risks of 
‘community bias’, whereby, experts would recommend further participants in their sphere of 
interest only.xix However, as to some extent, it was the relatively small international palliative care 
community which recruitment aimed to identify, this approach was deemed justifiable. Moreover, as 
a purposive approach was also maintained, diversity within the sample was achieved. 
 
For instance, using this approach, Africa emerged as a region of specific interest, due to the diverse 
range of ethnicities and socioeconomics within the region. Two interviews with participants from 
Africa, both of whom heralded from a richer nation and were not ethnically ‘African’. Therefore, it 
was deemed appropriate to include an additional participant from a different socioeconomic setting 
within Africa (Kenya) who brought a different perspective to the study. 
 
The interview-process was never intended to be a consensus-building exercise and instead was 
explorative, aiming to explore how key issues and problems are structuredviii  in relation to how the 
field of palliative care should move forwards. On this basis, after sixteen interviews had been 
completed, it was decided that based upon the richness of the data which had already emerged 
alongside considerations of feasibility that recruitment should close. A brief overview of the 
characteristics of the study population is presented in Table 15 along with the length of each 
interview. Although detail is kept to a minimum in order to protect participants’ anonymity, it should 
be made clear that the sample included significant actors in international palliative care. Such 
involvement may be summarised as working with and between a diverse range of International 
Organizations, International Associations of palliative care as well as actors working across a diverse 
range of countries internationally. 
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Table 15: Characteristics of study population (n=16) 
 
ID Area 
represented 
Primary training Illustrative international role(s) and expertise Interview 
length 
01 Europe Pharmacist  Senior Pharmacist for International Organization  00:52:33 
02 N. America Activist  Advocacy Officer for International Palliative Care 
Association 
 00:30:37 
03 N. America Physician  Consultancy  for International Palliative Care 
Associations 
 00:28:50 
04 Asia Physician  President of National Association of Palliative Care 
 International palliative care education coordinator 
 00:31:05 
05 Asia Physician  Medical Director of National Hospice 
 Consultancy  for International Palliative Care 
Associations 
 00:44:40 
06 Africa Paediatric Nurse  Chief Executive of an International Children’s Palliative 
Care Association  
 00:29:50 
07 Africa Physician   CEO of national Hospice Palliative Care Association  
 Chair of International Palliative Care Association 
 Technical advisor to International Organization 
 Director of global palliative care media outlet 
 00:42:46 
08 Europe Project 
Manager 
 Project Manager of philanthropy organization funding 
European palliative care leadership training 
 00:26:33 
09 S. America Physician  Executive Director of International Hospice Association  00:46:28 
10 Europe Private 
Physician 
 EAPC Task Force Member of Regional Palliative Care 
Association  
 International Researcher 
 Pharmaceutical Consultancy 
 00:58:15 
11 Europe Patient-Public 
Representative 
(PPI) 
 Experienced PPI Representative   00:37:35 
12 N. America Human Rights 
Activist 
 Associate Director of Health and Human Rights 
Organization 
  
13 N. America Physician  Board Member International Palliative Care 
Association 
 00:54:29 
14 Australasia Physician, 
Lawyer 
 International Human Rights Law 
 International palliative care capacity building 
consultant 
 01:12:23 
15 S. America Physician  President of Regional Palliative Care Association  Written 
response 
16 Africa Activist  Co-founder of Regional Palliative Care Association  
 Implementation and evaluation of palliative care 
services across Africa 
 Lobbyist and Advocacy Officer for International 
Philanthropy organization 
 01:07:02 
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It should be acknowledged, that due to the global focus of the project, it was not feasible to use a 
sample which could be said to ‘representative’ of all global expert views on palliative care. 
Additionally, it is not reasonable to suggest that any given participant could speak for all issues of 
relevance to a specific region. Thus, it is not appropriate to say that ‘data saturation’ was achieved 
although this was never an aim of the study. However, recruitment was ended when it became clear 
that significant issues began to continually recur.xx For instance, no new perspectives were emerging 
with regards to the suggestion that access to palliative care should be considered a human right. 
Instead, different viewpoints which had already emerged during interviews were being either 
interpreted slightly differently or reinforced. Practical realities also dictated that additional 
recruitment would risk the feasibility of the delivery of the project.xx Moreover, within the relatively 
small field of international palliative care, availability of suitable professionals was a present issue. 
However, it should be noted that the inclusion of 16 key experts goes over and above guidance 
which suggests that it is “sometimes difficult to think of more than ten interviews [Saumer and Given. 
2013.p.25.]”.xx 
 
Interview procedure 
 
All interviews (n=16) were conducted by JC between 04/05/2015 and 10/07/2015. Eight out of 
sixteen interviews were conducted face-to-face, seven of which at the EAPC Congress in Copenhagen 
and one in Sheffield. Seven interviews were conducted via skype. All interviews were recorded using 
a ‘Zoom H1 Handy Recorder’. Recordings of all interviews came out clearly and did not present 
difficulties for the transcriber (JC). Due to language difficulties, one participant responded to the 
questions in writing with follow up questions by the author sent and responded to via e-mail. 
Semi-structured interviews were conducted using a pre-developed Interview Guide [Table 16]. The 
Guide was piloted with an international palliative care researcher (LB) who was not part of the final 
sample.  
 
This useful exercise did not change the substance of questions but led to them being expressed in a 
more meaningful way.xxi After refinement, this guide formed the basis for all interviews [Table 16]. 
As  the interview process progressed, questions became increasingly ‘off-script’ in order to both gain 
data on key areas of interest which had not been covered in other interviews as well as in response 
to emerging areas of interest. Thus, to some extent, the responses of earlier participants who 
ascribed diverse meanings to the same question, informed further questions for later interviewees. 
This approach was justified, as neither the questions nor analysis required quantifiable data.xi 
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Moreover, the intention of qualitative interviews was largely to facilitate rich conversation, rather 
than gain stock responses to rigid questions.xxii 
 
Table 16: Interview guide provided to participants 
1. Could you please describe briefly how your work relates to palliative care in an international context? 
 
2. It is often said that there is a global need for palliative care. What do you think is meant by this? 
 
3. Are there examples from around the world where palliative care is working well and what are the benefits 
(and for whom)? 
 
4. Who are the key organizations/individuals/partners involved with palliative care advocacy at global level who 
are best positioned to influence decision-makers? 
 
5. How is the current argument promoting palliative care being made at global level? 
 
6. How does palliative care fit in with current global health priorities? Do current policies help or restrict further 
development of palliative care? 
 
7. What do you think should be the overall objective for global palliative care advocacy? 
 
8. What do you think should be the key message which palliative care advocates should deliver to decision-
makers?  
 
9. What, in the short term, what would be three realistic changes that you would like to see at global level that 
advocates should focus on? 
 
10. Who are the key decision-makers/global organizations that palliative care advocacy should seek to influence? 
 
11. Who are potential key partners for the palliative care lobby that do not work in palliative care currently? 
 
12. Different arguments for palliative care may resonate with different global actors. Can an argument be made 
for palliative care within the following domains? 
  
 International Development (as an economic issue) 
 As a Human Rights Issue 
 As an issue for the private health care actors 
 As an ethical or moral imperative 
 
13. What are potential barriers/arguments against the further roll-out of palliative care?  
 
Case notes and observations were recorded both during the interviews as well as immediately after, 
to identify emerging areas of interest, additional questions for future participants and to assist with 
analysis in line with good interviewing practice.xxiii  
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Data Management 
 
Interviews were stored on an encrypted laptop and transcribed within one week of the interview 
date. Each participant was assigned a unique Study ID in to retain their anonymity on transcripts. 
Identifiable data including e-mail correspondence and a sheet which links each participant’s name 
and their Study ID were stored on an encrypted device separate to that which non-identifiable study 
data was stored. During transcription, any names of individuals which were given during interview, 
were replaced by ‘XX’ within transcripts. Names of organizations given during transcription were 
recorded due to their relevance the study. However, no participant job titles which may have made 
individuals identifiable through their association with organizations were reported.  
 
Transcripts (n=16) were imported into 'NVivo 10 - Qualitative Data Analysis Software’ for analysis.‎  
 
Thematic analysis 
 
Thematic analysis took place within five distinct stages: 
1. Sensitisation to the data 
2. Free coding 
3. Theme development 
4. Review of themes 
5. Iterative approach to writing 
 
Step one: sensitisation to the data 
 
As all interviews were conducted by the author, a good understanding of the content of interviews 
was present from the outset of data analysis. Additionally, following each interview, reflections upon 
the content of the interview were written.xxiv Emergent ideas based upon participants responses 
during the interviews were also noted and written up following completion of interviews.xxv 
All sixteen interviews were transcribed by the author which allowed new areas of interest to emerge 
from the process and transcription. Case notes were recorded and used both to inform questions for 
future interviews as well as to record preliminary thoughts on potential areas of interest for 
analysis.xxiv All interview recordings were clear and there were few problems in producing an 
accurate representation of the interview. In the few instances where there was a break in the 
recording, this was noted within the transcripts and the duration of the break, indicated.  
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Transcription was performed ‘non-verbatim’ in that all words spoken participants were recorded, 
but utterances such as ‘ummm, ahh’ were not noted. This approach was used as the aim of the 
research was to consider the content of participant responses, rather than to ascribe any potential 
meaning to how words were spoken.xxvi The validity of transcripts, was assessed by the by re-
listening to the recordings and checking the text for accuracy.xxvii Further sensitisation was 
conducted by re-reading and annotating the completed transcripts to identify broad topics of 
interest for further analysis.xv  
 
Step two: Free coding 
 
The development of thematic categories was undertaken using a two-phased approach to generate 
a thematic framework on which further analysis was based. In stage one, initial codes were applied 
to all transcripts. A ‘descriptive-coding’ method was used to identify topics of interest within the 
data.xxviii  
 
This approach, involving continuous re-reading of the transcripts and noting passages of interest, 
may be termed a ‘pawing process’ in which numerous codes were applied to passages of interest.xxix 
Latent codes were applied with a view to understanding meaning within the transcripts, rather than 
simply reporting upon content.xxx Using this approach, a total of 286 unique codes were applied. 
Descriptive statistics of the prevalence of codes within transcripts were noted to identify common 
areas of interest, though thematic development was based more upon what was considered 
important, rather than what was prevalent.xxxi Furthermore, this approach ensured that novel views 
were fairly represented.  
 
To increase the validity of this coding approach, transcripts were coded by an additional palliative 
care professional (CG) to determine whether the coding approach used by the first author was both 
consistent and accurate.xxxii This exercise demonstrated high levels of agreement in terms of the key 
issues being identified by the coding process. Common issues identified by both authors included; 
drug availability, human rights discourses, as well as the challenges and dangers relating to the 
transfer of policies and practices between contexts. 
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Step Three: Development of a thematic framework 
 
In line with the overall theoretical approach of the thesis, initial themes were developed based upon 
a Global Social Policy (GSP) understanding of global policymaking processes. Theme development 
was conducted by engaging both with codes identified as well as by returning to the original 
transcripts and field notes.xxiii  
 
Coded transcripts were consulted and relationships between codes and issues identified. Mind maps 
were used in order to draw out complexities and overlaps between such relationships.xxxiii For 
instance, several participants raised issues related to educational curricula and palliative care. It was 
not of interest to the study to engage with details of such curricula, in terms of ‘what drugs are 
recommended for the treatment of breakthrough pain’? Instead, what was of interest, were issues 
such as: in which contexts and settings would such curricula meet the educational needs of 
practitioners? Where have such curricula been used? And if such materials are transferred between 
nations, whether it was appropriate to do so and what modifications were made in order for 
curricula to be locally relevant? Additionally, themes were not determined by questions asked to 
participants and instead emerged from participant responses and their theoretical relevance.  
 
It follows that many codes were relevant to more than one potentially emergent theme. For 
example issues relating to teaching curricula may relate to several distinct codes: 
 
 Education – as curricula are a common way of setting educational standards 
 Lack of Awareness – curricula as a response to a perceived lack of awareness of palliative care 
issues and treatments amongst students and medical practitioners 
 Appropriateness – are curricula appropriate in all international settings, are the necessary 
resources available for the curricula to be applied in practice? 
 Transferability – what are educational needs which are common between nations, and what 
elements of curricula require adaptation when transferring them between settings?  
 
Thus, themes and sub-themes were preliminarily developed by viewing issues of interest to the 
participants through a GSP theoretical lens in order to answer the research questions using a 
deductive approach.xxxiv Several issues underpinned all emergent themes and to avoid undue 
repetition, these are only made explicit where necessary. For instance, in line with the overall aim of 
the chapter to consider how the global advocacy strategy can become more refined, almost all 
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emergent issues may be considered relevant to advocacy which consequently is not presented as a 
theme.  
 
Additionally many relevant issues – for instance lack of access to essential medicines – may be 
present at local, national, international or global level, with resultant consequences for policy 
development and advocacy. Where such circumstances applied, differing approaches to address a 
single issue are presented for each level. Illustrative examples for how such an issue may be present 
at each of these levels are presented below. 
 
Table 17: Barriers to access to essential medicines at different levels of governance 
 
Level of Governance Illustrative example of barrier to access to essential medicines. 
Local Lack of trained practitioners to prescribe and administer medicines. 
National National regulations prohibit access. 
International Lack of profitability of opioids to pharmaceutical companies, limits their 
willingness to supply. 
Global Access to opioid analgesics prohibitively regulated as a narcotic substance 
rather than enabled as an essential medicine. 
 
In-keeping with the aim of completing a thematic analysis, themes were not developed based upon 
level of governance, however, the consequences of dealing with a ‘single’ issue at different levels 
and how the different levels interact are discussed. 
 
Step Four: Finalising the thematic framework 
 
Within any qualitative analysis, it is not possible to report on every issue of interest within the data 
collected. Thus, themes were structured by examining relationships between codes and in terms of 
being of most interest to the research questions.xxxv 
 
A preliminary framework was developed before being reviewed by a palliative care expert (CG). 
Following discussions, thematic categories were refined and sub-themes reduced by consolidating 
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them within broader thematic categories. No explicit limit was placed upon how many themes were 
identified, nor how many sub-themes were appropriate within these broader categories. It was, 
however, acknowledged that it was neither feasible nor useful to attempt to report on a high 
number of sub-themes. Through discussion and by returning to the transcripts, some sub-themes 
were removed by incorporating them within broader thematic categories as examples. Additionally, 
through the processes of defining each main theme, some sub-themes naturally served as examples 
of relevant issues within such categories. In this manner, both themes and sub-themes were refined 
during an ongoing process in which original transcripts were re-consulted, to ensure that themes 
moved beyond narrative description into more meaningful analysis.xxxvi Finally, during writing, some 
thematic categories were amended in order to structure logical arguments in line with the act of 
writing itself being an important element of analysis.xxxvii 
 
Limitations 
 
Although every effort was made to use robust qualitative methods, certain limitations must be 
noted of this element of the study. Risks associated with researcher bias were noted in Chapter Four 
and will not be repeated here. It serves to add that, during interviews, every effort was made to ask 
open questions in order to obtain authentic responses as opposed to asking ‘leading’ questions.xxxviii 
Moreover, as has been described, reflexivity was employed during the coding process, which was an 
ongoing process, involving self-reflection and discussion to ensure that the thematic framework 
developed reflected participants’ views.xxxix 
 
Given that the study has a global focus, an increased sample size would have further enriched the 
data.  Specifically, it would have been interesting and appropriate to include participants from 
‘distinct’ regions within continental boundaries. For instance, approximately 60% of the world’s 
population lives in Asia and cannot be assumed to be a homogenous population.xl Therefore, it 
cannot be said that voices from India and Malaysia ‘represent’ the continent. It would therefore 
have been interesting to include a participant from the Middle East and particularly China. However, 
although representatives from all continental world regions were included within the sample, the 
study does not claim global representativeness. Instead, the study aims to enrich understanding of 
palliative care in global context by drawing upon the epistemic expertise of key palliative care 
experts.x  
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In this regard, it is important to acknowledge the issue of positionality during interviews and within 
the study sample. As described in Chapter Four, the researcher undertook ongoing reflexivity 
throughout the research process in order to maintain an objective position, examining palliative care 
as an ‘outsider’ and strengthen the validity of findings.xli However, it should be noted that all study 
participants were ‘insiders’ and advocates for palliative care, which means that any dissenting views 
opposing the further development of palliative care may not have been reported.xlii Findings must 
therefore be understood in this regard and the inclusion of a broader range of stakeholders such as 
policymakers and dissenters represents an avenue for future research. Therefore, whilst the 
methods utilised have been justified in detail, the results should be read as an interpretation of 
social reality, as opposed to a presentation of objective ‘facts’.xliii  
 
 
Results 
Thematic categories (n=6) 
 
From the wide-reaching data, 6 thematic categories emerged during analysis. In the following 
section, each of these themes is defined, before the analysis proceeds in greater detail and in 
response to the research questions. 
 
1. Education; Changing the Culture of Medicine 
 
This theme emerged as issues relating to education underpinned much of the data collected and 
related to both how palliative care has developed internationally, as well as how it may do so further. 
It examines the view that policymakers and medical practitioners lack the knowledge and skills 
required to provide palliative care, as well as a response to a lack of awareness of palliative care 
amongst the public, medical professionals and policymakers. Existing efforts to provide palliative 
care education are appraised, both nationally and internationally. Additionally, the theme reflects 
views that increased palliative care education can lead to increased palliative care practice as well as 
a cultural shift in medical practice. Palliative care education is discussed as a response to the broad 
perception that the medical practice, with a heavy emphasis on doctors as opposed to other health 
professionals, has become over-technical. Participants shared that view that the ‘culture of medicine’ 
focusses upon treating patients’ illness at the expense of not caring for patients as individuals with 
needs beyond curative treatment. 
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Overall, the theme reflects the predominant view amongst participants, that there is a global lack of 
understanding regarding what palliative care offers which may be addressed through increased 
education at all levels of governance and healthcare. Finally, the theme examines processes of 
‘international lesson learning’, in terms of how positive and negative ideas and practices are 
transferred from one national context to another. 
 
2. Palliative Care as an Area of Global Need 
 
This theme explores the consequences which result from the global lack of palliative care services 
and lack of access to pain relieving medicines. It presents how palliative care experts understand and 
conceptualise this need, which is an important element of refining how arguments for greater roll-
out of services can be made through advocacy. Different forms of need and their causes are 
identified within and between countries, relating to inequalities and inequities of access. Pitted 
against this global need, barriers to the field’s development at national, international and global 
level are examined. Such barriers are explored as well as participants’ views on how they may be 
overcome. Moreover, the theme looks at global forces which may be acting either to promote or 
restrict the further development of the field. 
 
3. Broad Benefits of Palliative Care and the Consequences of its Absence 
 
It is well known that palliative care treats patients and families/carers as the unit of care. However, 
this theme emerged to reflect the diverse range of ‘benefits’ which participants suggested that 
palliative care can offer. ‘Benefits’ which may occur at individual, community and societal levels are 
reported. Incorporating discussions regarding ongoing stigma to both illness and death, the theme 
includes discussion with regards to how palliative care can help to improve such attitudes and, by 
doing so, create more resilient societies. Additionally, benefits are discussed for healthcare systems 
with regards to the feasibility of integrating palliative care as well as how palliative care can 
contribute to the sustainability of healthcare systems. Finally, the counterfactuals to the suggested 
broad benefits are presented, in terms of the consequences of not providing palliative care for all 
stakeholders. Importantly, almost all of the suggested benefits are shown to have a ‘time 
dependency’, in that they are reliant upon the introduction either early in the course of illness or as 
an end of life intervention. 
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4. Prioritisation Within Health Systems and Organization of Services 
 
This theme emerged to reflect discussions surrounding the idea of prioritisation between different 
elements of palliative care as an intervention, national health system organization and global health 
policymaking. The theme places palliative care within broader global areas of health need in order to 
understand where palliative care lies in relation to other health priorities within developmental 
healthcare systems. Within the global context of competing claims for limited resources, the theme 
explores the economic viability of further rolling out palliative care services. Additionally, whilst the 
study has identified a clear preference for a public health approach to development, this theme 
examines the role of the varied actors within the private sector (private health systems, health 
insurers, pharmaceutical companies etc) as either enablers or barriers to further development of 
palliative care practices. Finally, the theme considers the merits of a reallocation/redistribution of 
health resources as a strategy for increasing resources for palliative care and from where such 
resources may come from.  
 
5. Global Policies, Leadership and Actors for change 
 
This broad theme emerged to reflect the range of actors who have the (potential) power to 
influence palliative care development. The different actors who operate for change in palliative care 
policy practice and development are identified. Furthermore, divergent views held amongst 
participants regarding the potential for global level policies to effect change are reported as well as 
the role which ‘leaders’ can play, at global and national levels. Questions are also raised with regards 
to the sustainability of pioneer-led models of palliative care. Additionally, this theme reflects the 
need for the palliative care lobby to make alliances with other global health groups and institutions 
in order to achieve wide-reaching and sustainable change. 
 
Also within this theme, current global-level policies including the WHA palliative care Resolution and 
the potential role for civil society actors to hold governments accountable to their obligations are 
discussed.  Moreover, the very appropriateness of global level policies to diverse regions of the 
world is considered including questions regarding which issues in palliative care are ‘universal’. On 
this basis, the merits of adopting regional, rather than global, approaches to advocacy are discussed. 
This reflects the emerging issue, that although there are shared challenges for all world regions, a 
regional approach to policy development and palliative care leadership may be a more effective way 
 184 
 
to promote palliative care. Regional palliative care organizations in all world regions are considered 
in terms of what unites each of these organizations and the differing challenges that they face. 
 
6. Framing Palliative Care 
 
How the argument for palliative care is made by international advocates is a central question of the 
study. As such, this theme emerged due to the varied ‘frames’ with which activists are using to 
advocate for palliative care, as well as new innovative ways in which they may be able to do so. The 
theme examines which arguments may be effective in influencing different global health actors and 
raises questions about the appropriateness of using certain arguments in all settings. Questions of 
how different arguments interact with each other are raised, such as the compatibility of different 
human rights claims (i.e. right to autonomy, right to palliative care and right to die).  The relative 
strength of each argument is problematized in terms of their likelihood to effect the change that 
they seek. Additionally, the merits of adopting regional, rather than global, approaches to advocacy 
are considered. This reflects the emerging issue that, although there are shared challenges for all 
world regions, it is rational for different regions to approach them in culturally relevant ways. 
 
Theme One: Education: Changing the Culture of Medicine 
 
 “Without… awareness, that could be from the public or from professionals, the development of 
palliative care cannot work very well.” Physician, Europe (P10) 
 
Education as a broad concept, either implicitly or explicitly, underpinned almost all discussions with 
participants. A general lack of awareness amongst the public, professionals and policymakers of 
palliative care and pain treatment was suggested throughout interviews. Additionally, there were 
strong views that such stakeholders have negative attitudes towards illness and death, perceiving 
them as unnatural processes which can be halted. Such attitudes appear to filter in to global 
discourses on health, which uses militaristic language when speaking about illness, suggesting that it 
is something which must be fought. Discourses such as ‘war on cancer’ are consistent with how 
current medical practice operates, which it was suggested is too focussed upon treating specific 
illness with curative intent, at the expense of caring for patients. That is, that the medical profession 
has become enmeshed with narratives which see death as a ‘failure of medicine’, and not part of the 
life course. What united all of these issues between participants was the strong suggestion that the 
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negative consequences of each of them may be addressed through greater palliative care education. 
Additionally, although the theme generally challenged existing practices of doctors, innovative 
suggestions emerged regarding how nurses may be empowered to deliver pain medication in order 
to increase access – particularly in rural areas.  
 
However, a further issue of interest which emerged during discussions, related to what palliative 
care actually is. Divergent understandings, most specifically regarding the timing of when palliative 
care becomes relevant, were common. Additionally, it emerged that ongoing issues regarding the 
use of diverse terms – such as palliative care and end of life care – continue and threaten to 
undermine the clarity of the message with which the palliative care community hopes to increase 
‘education’.  
 
 
Competing definitions and understandings of palliative care 
 
Reflecting known problems regarding how to define palliative care, it was apparent during the 
interview process that when referring to ‘palliative care’, participants used the term based upon 
conflicting understanding of its meaning.xliv The major discrepancy in understanding arose regarding 
the timing of when palliative care should be introduced. One participant who had experience of 
working in both Africa and North America, commented upon this, raising concerns about how such 
divergent understandings impact upon the clarity of the message being given to global policymakers: 
 
“I think in Africa, unlike the West, palliative care is seen as applicable from the point of 
diagnosis… we [Africa] are looking at palliative care beyond end of life care. If you look at the 
west, they are looking at palliative care as end of life care, as really linked with end of life 
care, so there is a conflict there for us to resolve as a global community, what are we talking 
about?” Activist, Africa (P16) 
 
It was not clear whether this was an issue of understanding or of palliative care in practice, however, 
it did become evident from ‘Western’ participants, that palliative care was something which was 
generally introduced as an intervention much closer to the end of life than from ‘diagnosis’.  
 
Such responses from participants at times appeared to reflect their own views and at others are 
suggestive of the circumstances within which they work. However, whether fuelled by an association 
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with palliative care as an intervention towards the end of life, or practical reasons such as late 
referral, certainly, there was a high prevalence of references to the deteriorated condition of 
patients presenting for palliative care in western settings. In Australasia, for example, one 
participant commented: 
 
“People can be suffering a long period before palliative care gets involved, symptoms can be 
unremitting, conversations have not occurred about death and dying and I think it does 
require a much more whole of medicine approach.” Physician, Australasia (P14) 
 
This quote is also supportive of a broadly held view amongst participants, that medical professionals 
lack awareness of what palliative care is, what it hopes to achieve and how it should delivered, in 
short, a lack of education. Such issues are addressed further in subsequent sections.  
 
It is, however, important to emphasise that there was a broad consensus regarding what the goals of 
palliative care are. Interestingly, although palliative care research often uses outcome measures 
relating to ‘quality of death’, it was improvement of quality of life which occupied most of the 
discussion in terms of what palliative should aim to achieve, centring around a shared goal of 
meeting the treatment goals of patients and families. In support of this suggestion, this quote from 
North America is illustrative: 
 
“The main benefits are that people get more appropriate care, you know, they get care that’s 
more tailored to the goals they have for care, and if you take the time to help patients and 
their families work out what their goals for care are, then you usually make better decisions, 
than if you’re just going, one thing after another, treatment wise.” Physician, North America 
(P03) 
 
Additionally, it is important to note, that the only patient voice within the study was supportive of 
such a conceptualisation of palliative care: 
 
“As I understand it, palliative care offers an improvement in quality of life, which means, that 
whoever is caring for someone who is having palliative care, their quality of life will improve 
as well.” PPI Representative, Europe (P11) 
 
Aside from divergence on the appropriate timing of palliative interventions, there was implicit unity 
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amongst participants regarding the principles of palliative care with which activists should seek to 
educate stakeholder groups. However, to some extent this unity of understanding is undermined 
due to conflicting terms used within palliative care. Indeed, in the global sense, the clarity of the 
message with which palliative care seeks to educate people faces problems quite literally ‘not 
speaking the same language’. 
 
Importance of terminology 
 
There was broad consensus amongst participants that the WHO definition of palliative was both 
appropriate and meaningful. However, there was acknowledgement of the confusion caused by the 
use of conflicting terms within the field which are sometimes used as synonyms for palliative care 
and at others, to describe something quite different. As most participants expressed doubt as to 
how well palliative care is generally understood, the use of consistent terminology emerged as an 
important issue: 
 
“People didn’t really understand when I said ‘palliative care’, ‘what are you talking about?’ 
Just like everyone understands what Oncology means, what paediatrics means, what 
geriatrics means, we have nothing for palliative care. We have got palliative care, hospice 
care, supportive care, end of life care. That crucial terminology carries so much meaning”. 
Physician, Asia (P05) 
 
In this regard, there was some suggestion that the WHO definition is somewhat technocratic, which 
may limit its usefulness for engaging with lay audiences. One physician from Asia, for example, 
quipped:  
 
“It’s very simple, if you look at how you define palliative care, I mean the WHO, you know, I 
mean the latest definition is about 10-12 years old, talks all kind of stuff about impeccable 
assessment, blah blah blah, but according to me, it’s basically, good medicine, sorting out 
issues of the person, not the patient, I’d like to call it the person” Physician, Asia (P04) 
 
Evidently the point was made in a somewhat blasé fashion, however it does raise the issue of 
whether the WHO definition is meaningful to non-clinical audiences. However, the more prevalent 
issue identified during the interview process, related to terms competing with palliative care, with a 
consequent reduction in clarity of meaning, especially within non-English speaking settings:  
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“I accept the World Health definition, and it says palliative care…but where does that leave 
this term ‘hospice’? …Until the World Health had the palliative care definition, hospice 
existed for twenty thirty years before that, and although generally we say palliative care and 
hospice are synonyms, in reality, they are now not seen as the same…. Changing from 
hospice, to palliative care, to supportive care, we actually have no words for any of those 
things, so what do we call our services?”” Physician, Asia (P05) 
 
With public understanding of what palliative care so low around the worldxlv, use of overlapping 
terms such as ‘palliative care’ and ‘end of life care’ raises questions regarding the key message of 
‘palliative care’ as to whether the term should have a predominant focus upon quality of life, or 
quality of end of life care.  
It is important to acknowledge, however, that amongst participants, distinctions between quality of 
life and quality of end of life represented more of a difference in emphasis than principle. A clear 
commitment towards facilitating positive experiences for patients and families at the end of life was 
evident amongst all participants. However, when considering how to improve the understanding of 
public and professionals, there was no identifiable abandonment of the will to improve attitudes to 
illness and death by leaving them out of the conversation. Instead, it was suggested that by 
focussing upon palliative care as ‘quality of life’ rather than ‘end of life’ that improvements in 
experiences at the end of life may be made naturally and not by confronting the issue directly. One 
palliative care physician reports on how this has occurred within his own national advocacy 
campaign: 
 
“In many countries, discussion on death is such a taboo issue, and hence, in my own country, 
we have eliminated virtually all, consciously eliminated all talk on terminal care, and dying, in 
the sense that, we need to look at suffering and improve quality of life, and let the issue of 
death worry about itself.” Physician, Asia (P05) 
 
In summary, in spite of broadly shared principles regarding what ‘palliative care’ is and when it 
should be introduced, it remained a contested term amongst participants. Some of this confusion 
may stem from the fact that the WHO definition has changed, in the sense that it is only fairly 
recently that palliative care was recommended from diagnosis rather than closer to the end of life. 
Nevertheless, it is of concern for the clarity of message which advocates can hope to deliver to new 
stakeholders, that confusion remains regarding the meaning of the term itself. Indeed with this lack 
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of clarity emanating from key experts in palliative care, it is perhaps understandable that within the 
broader culture of medical practice, awareness of palliative care appears to remain low.  
 
Palliative care within current medical practice 
 
There was a high degree of consensus amongst participants that there is a lack of awareness of 
palliative care amongst medical professionals. Although the study did not include any medical 
professionals from outside the field of palliative care, participants seemed to share a negative 
perception of the medical profession in terms of how doctors, as opposed to other health 
professionals, treat patients during serious illness and towards the end of life. Participants tended to 
perceive medics as being focussed upon a technical approach to curing illness, at the expense of 
treating patients as people and caring for them as such. The following quote sums up quite 
succinctly this broad perception as well as how such a situation may have occurred: 
 
“So many advances in medical practice, clinical practice, and high-tech, methods of dealing 
with disease, has meant that people are living a whole lot longer, but our medical schools 
focus on cure, with very few actually look at the softer skills that require, that are care and 
the actual impact that happens when, when a person has got a life-threatening illness.” 
Physician, Africa (P07) 
 
This perception of the ‘treatment culture’ of medicine was not isolated to any one world region. 
Indeed, participants from all regions strongly suggested that often a medicalised approach continues 
beyond a timeframe in which curative efforts could hold the possibility of being effective. Referring 
to the dying-phase, one participant suggested: 
 
 “People who are dying at the moment, they are treated in a very technical way. They keep 
irradiating people with cancer, people with other diseases, they try to heal the disease, but 
not or often, doctors and healthcare more generally, ignores the symptoms and to relieve the 
suffering that comes with it.” Pharmacist, Europe (P01) 
 
Two major reasons were suggested by participants for this cure-focused scenario:  1) lack of 
awareness of palliative care and 2) structural pressures upon doctors to maintain curative efforts 
even when they are unlikely to be effective. It is therefore important to consider the broader context 
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within which medical practitioners work and how patients, hospitals and society more generally, 
expect doctors to approach illness.  
 
Death as failure 
 
Whilst participants broadly shared the view that physicians are often culpable of providing 
inappropriate care during the terminal phase of illnesses, it is important to emphasise that this was 
not intended to be criticism of individual practitioners. Instead, there was criticism of the wider 
structural context in which practitioners were situated. There was acknowledgement, for example, 
that practitioners work within an ideational context, in which militaristic language can sometimes be 
used when speaking of illness: 
 
“Unfortunately… the medical students are taught, it’s almost like it’s a battle that they need 
to win. In fact, the other day there was an article I read, where somebody was lamenting, 
‘why do we use words which are related to war?...’He lost the battle to cancer’…’we will use 
all of the ammunition in our hands’, you know.” Physician, Asia (P04) 
 
Such language filters in to attitudes and practices of medical professionals, and indeed public 
attitudes more generally. It follows that fears and negative attitudes towards illness are reinforced, 
leading to perceptions that the death of a patient is treated not as part of the natural process of life, 
but as a failure of medicine:  
 
“Medicine and physician was wrong in the last years and has abandoned the patient when 
the patient cannot be cured when the patient cannot be the object of the success for the 
physician” Physician, Europe (P10) 
 
Such situations see aggressive curative treatments maintained beyond the point where they are 
likely to be effective. In line with this, a broad lack of awareness amongst practitioners as to when 
and why palliative care should be introduced was an issue voiced strongly by many within the study.  
An oft-used example by participants was the appropriateness of chemotherapy for advanced cancer, 
as opposed to palliative care. Whilst this reflects an implicit division between curative efforts and 
palliative care, it remains illustrative of the preference within medical practice to maintain 
aggressive treatments at the expense of palliation. Yet, as was also identified within Chapter Five, 
little is known regarding patient preferences in such circumstances. Referring to patient preference 
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with regards to ongoing chemotherapy or palliative care towards the end of life, one participant 
promoted both increased communication between physicians and patients and also lamented the 
lack of research on patient preference: 
 
“If the patient knows that he is at the end of life, he doesn’t prefer chemotherapy, but the 
question is, who is dealing with the truth with the patient, who is asking the patient ‘what do 
you want?’ Physician, Europe (P10) 
 
An apparent consequence of failing to determine patient treatment preference and a lack of 
recognition of palliative care as an appropriate intervention is that medical practitioners do not 
present palliative treatments to their patients as an option. Thus, within hierarchical relationships of 
power, coupled with a lack of awareness amongst the public and professionals, curative treatments 
were perceived to be presented to patients as the ‘only option’ without consideration of the 
benefits that a palliative approach may hold. In such circumstances, patients may forgo their 
autonomy in relation to defining their own health pathway on the basis that people cannot request 
something which they do not know about. However, the extent to which patient populations are 
willing to endure high amounts of suffering with a vain chance of cure is unknown. 
 
One consequence of over treatment is an increased burden of suffering upon the patient due to 
ongoing futile treatments.xlvi Indeed, such circumstances certainly appear to add weight suggestions 
that physicians do not always have the requisite skills in order to reduce overall symptom burden 
whilst they maintain focus upon curing that illness. One physician from North America reflected 
upon his experience of the condition of patients presenting for palliative care in his institution: 
 
“People come to us, and oftentimes, they look like a train wreck, I mean, they look like 
they’re going to die soon, and as we get them sorted you, get their symptoms controlled, get 
them, you know, get their bowels working correctly… wash them up… and they start to feel 
good” Physician, North America (P03) 
 
Why then, do physicians continue with curative efforts beyond a stage of illness where they are 
likely to be successful? At this point, it is appropriate to switch the focus away from the awareness 
of physicians, towards what they may be expected to know, based upon their medical education. 
 
Doctor training and curricula 
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A prevalent issue which emerged during discussions related to the relative absence of palliative care 
and symptom management training within undergraduate medical training curricula. This issue may 
be considered an important one due to the strength of feeling apparent amongst participants 
regarding this situation: 
 
“How we can accelerate the development of palliative care?... several answers are possible, 
but I only have one answer for you today.. The answer is, train physicians in the school of 
medicine, that’s your answer” Physician, Europe (P10) 
 
Several participants reported that appropriate curricula exist, but a lack of integration into broader 
medical curricula as well as a degree of tokenism towards important skills such as pain management 
is the problem. For example, speaking about one European country and the attention which is paid 
to pain management within medical training, one participant reported: 
 
“Even if it’s included in the curriculum its often just for a few hours, not enough to learn how 
to treat pain…in Hungary there was someone who went over this for various medical 
specialties and it was always between three and twelve hours… and they also looked at 
veterinarians and they get between 34 and 40 hours.” Pharmacist, Europe (P01) 
 
This is a troubling comparison and a convincing example of a broad lack of awareness of the 
importance of such skills within medical practice. Indeed, given the emphasis placed upon education 
as part of the WHO’s public health strategy for palliative care developmentxlvii, it is of great concern 
that one participant reported on a study of medical schools in Western Europe and found: 
 
“There were universities where they did not have any pain treatment in the curriculum” 
Pharmacist, Europe (P01) 
 
Through such conversations, it emerged that lack of education amongst physicians continues to 
serve as a major barrier in terms of patient access to pain treatment. Often, opioid availability is 
defined as a problem relating to how medicines are regulated. However, even within countries 
which do not prohibit access to medicines such as morphine, there were real concerns that medical 
professionals did not have the requisite knowledge and skills to prescribe them appropriately and 
that suitable guidance was not available: 
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“[The] problem is that there is a lot of doctors [that] don’t learn how to titrate patients, or 
dose the analgesics, and also if you go to textbooks, often it’s wrong or incomplete. For 
instance, there’s hardly any textbooks saying that for unsupervised patients, you should 
never increase the opioids more than 50% in 24 hours. The starting dosages are often too 
high for unsupervised patients and there’s not any textbooks saying to stop in a way that you 
avoid the withdrawal syndrome”. Pharmacist, Europe (P01) 
 
Furthermore, in terms of guidance available to a global audience, there were additional concerns 
regarding the relevance of current pain management guidelines. As one participant commented: 
 
“The problem with not having guidelines is of course, at the moment, the only book you have 
is ‘cancer pain relief’ which is the 1987 guidelines, and when you’re advocating for pain relief, 
for palliative care and saying it’s also for HIV/AIDS patients. So, you need, as WHO, to have 
guidelines that are broad, and cover everything and as long as you don’t have that, then 
many people apply the three-step ladder for all types of pain and I think that scientifically it’s 
correct, but legally, these WHO guidelines are only looking at cancer pain”. Pharmacist, 
Europe (P01) 
 
Yet, amidst such concerns, many positive stories arose of educational efforts. However, positive 
examples often served to highlight how variable educational initiatives are, both internationally and 
within countries. Reflecting upon the extent which palliative care education provided to 
undergraduates has improved and lengthened within their institution in Australia, from a single day 
session, one participant reported: 
 
“…Now we have a full week with the students, so we immerse them, we go on ward rounds, 
we talk, I speak to them about the care of the dying, which is the only lecture they will get in 
their undergraduate degree on that topic, and then also just the sense of our perspective in 
terms of communication, symptom management and all of that, and they, universally they 
find it revelatory” Physician, Australasia (P14) 
 
However, even in Australia, which was cited by one participant as having “well, integrated palliative 
care strategy in its health agenda, health budget and health education [Physician, South America 
(P09)”, the Australasian participant conceded that provision of palliative care education to 
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undergraduate students was ‘not universal’ within medical schools. Although the apparent 
acceptability of the training to the medical students was positive, due to the importance that many 
participants within the sample placed upon the integration of palliative care education into medical 
curricula, the patchiness in educational provision is a concern.  
 
Despite this, examples emerged from diverse contexts where integration of palliative care into the 
medical curriculum is occurring. For instance, in Uganda, it was reported that education is “the 
model for sustainability” [Activist, Africa (P16)]. Furthermore, integration was considered to be 
something which may not only further the development of palliative care, but which may serve as a 
driver for change against the technocratic culture of medicine:  
 
“If we don’t normalise palliative care in the health [education] of the future physicians, we 
cannot try to change the way to do medicine 10 years later, first, we have to teach physicians 
in the school of medicine” Physician, Europe (P10) 
 
Although the importance of integration was emphasised by participants, there was some 
acknowledgement that this required national strategies for palliative care development. Yet, in spite 
of the acknowledged importance of integration into medical curricula, this was not the dominant 
reason expressed amongst participants with regards to how palliative care has spread internationally.  
 
International lesson-learning 
 
Many participants within the study reported that they had been trained in palliative care in a context 
other than that in which they originated from. For example, one representative from Asia trained in 
the United Kingdom, whilst a South American participant trained in the United States. Additionally, 
participants discussed international educational initiatives, whereby institutions in different nations 
cooperated to offer accredited palliative care courses. Central to such discussions was the distinction 
between elements of palliative care practice which are ‘universal’ or appropriate in all national 
contexts, and elements which require adaption within different settings. A clear example of such 
distinctions arose regarding pain management. One participant, who reported on their experiences 
in conducting palliative care ‘sensitisation’ courses in a wide variety of settings explained: 
 
 195 
 
“If I’m doing pain management for example, the pharmacology is the same, the approach to 
assessment is the same, teaching that, what’s different is, ‘what drugs do they have?’” 
Physician, North America (P13) 
 
What this describes, is that individuals in any setting respond to pain treatment in a universal way, 
however, educating medical professionals on how to prescribe and administer opioids is only 
appropriate if medicines are available to practitioners. Pain medicine serves as a relatively 
straightforward example regarding the appropriateness and transferability of key skills and practices 
due to the universality of physiology. More complex issues arose relating to transferability of more 
cultural aspects of palliative care: 
 
“If you’re doing communicating bad news, negotiating goals of care… principles are the same, 
what you have to do is to find out, ‘what are the ethics, that guide clinical care, as well as 
laws that exist in a country?’ and you need to adapt all of that to that setting.” Physician, 
North America (P13) 
 
This quote echoes a response reported above, whereby it is suggested that there is a need for 
palliative care guidelines to contain both universal principles, along with the flexibility for them to be 
adapted to local context.  
 
Through discussions of the example of pain management education, the potential for damaging (as 
well as beneficial) lessons to be taught when educators work in other settings was revealed. Such 
issues arose in two distinct ways. One participant reported upon their perception that in the Asian 
setting, when palliative care doctors came from Western settings, that there was a tendency for 
Asian doctors to accept their opinions with undue reverence:  
 
“There’s a perception for example, in some low-resource countries, that an expert in England 
or North America or somewhere, would be seen as a more, as a more acceptable, 
knowledgeable person than someone from their own country. ‘The Foreign Expert’” Physician, 
Asia (P05) 
 
Of greater concern, however, was the suggestion that Western clinicians visit low-resource settings 
under the guise of lesson-sharing, but with the additional motive of promoting specific 
pharmaceutical products for their own benefit: 
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“Someone from UK comes over [to] Malaysia as a palliative care person and says “this is 
what we use in England, I like this product, it’s wonderful’… I think that’s where you have the 
ethical and moral imperative. Does that, is that right for a person in UK to come over to a 
low-resource country and tell them what to use, especially under the guise of a 
pharmaceutical product. They’re invited, they’re often paid [by the pharmaceutical 
companies] it’s a sales pitch!” Physician, Asia (P05) 
 
Indeed, whilst it was evident that many positive changes have occurred due to processes of 
international lesson-learning, such narratives were often couched with words of caution. Another 
participant reflected upon the dangers associated with the ‘unintended consequences of medical 
missionaries’ and offered suggestions of how the negative effects of short-term programs can be 
mitigated: 
“You can’t go just once, you have to have a strategic plan … I want to know what the people 
are doing in follow-up from the courses I’ve run, if people who are coming to my larger 
programs, I want administrative commitment that these people are going to be hired. 
There’s only so far I can go, I can’t demand that people have morphine, unless they want the 
course in the country, in which case I can say, ‘well I need to have morphine in order to run 
the course, I won’t run the course without morphine’, because it’s stupid to go into a course 
and teach things, go into a country and teach things, which people can’t practice next week. 
It’s actually stupid.” Physician, North America (P13) 
 
Whilst the ethical tensions associated with processes of international lesson-learning warrant 
consideration, overemphasis on such dangers risks undermining the many positive examples of 
international educational processes which have led to major progress in palliative care development. 
Many services in low-resource settings were described as having their genus from local researchers 
travelling to other contexts to learn about palliative care. For instance, one physician from South 
America described how their experience of palliative care in North America led to the establishment 
of the first hospice in their home country: 
 
“I went to school…in the US and then I went back to [country] after doing my undergraduate 
degree … I did clinical psychology and neuro-psychology and that’s how I ended up working 
in the pain field, but then I went back to [country] and I realised that what I had seen in my 
training, was not available because of several issues, one of them was, no access and no 
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availability of medications and the second one and very important one was the lack of 
education” Physician, South America (P09) 
 
Additionally, although challenges were reported associated with resource context, the participant 
also described a more symbiotic experience of lesson learning, through discussions of how transferal 
of ideas between settings can have positive benefits for both sides. One beneficial lesson for low-
resource settings was the relationship between medical professionals and patients: 
 
“You also have the issue of patient autonomy which in the rich countries is I think more 
defined and better respected, or at least more respected in developed countries, in 
developing countries this whole issue of patient autonomy and patients as part of the 
decision-making process, at least when I was there, it’s almost non-existent and you have a 
very vertical model of…the physician making decisions and then the nurse implementing the 
decisions and the patient accepting, and taking whatever, it’s been ‘ordered’” Physician, 
South America (09) 
 
For high-income settings, it was suggested that the involvement of a greater amount of stakeholders 
in the delivery of care was something which richer settings do not have, to their detriment: 
 
“You have a lot more involvement from the community, a lot more involvement of the family 
and there’s a stronger, I think, should I say ‘community approach and holistic approach to 
the care of the patient rather than what you see in the rich countries’ the rich countries are 
more, much more individualistic about addressing the very specific needs of the patient in a 
very, you know, self-centred and patient-centred approach, and what I’ve seen from working 
in Colombia is that it’s a more community-based approach, and it’s a whole unit of care” 
Physician, South America (09) 
 
Once more, this negative suggestion of a technical approach to patient care carries with it warnings 
regarding the transferral to other settings of a technocratic approach to medicine. Thus, processes 
of international lesson-learning hold the potential to both further the development of palliative care 
in all settings, as well as for the spread of less beneficial ideas and practices.  
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Lastly, although it was the attitudes and practices of doctors which emerged as a key barrier to the 
delivery of palliative care, the potential for an increased role of nurses in the delivery of pain 
medicine was identified as a key way in which access to pain treatment may be increased. 
 
Empowerment of nurses 
 
The potential for nurses to play a key role in increasing access to palliative care and pain medication 
was not a common suggestion amongst participants. However, as in many world settings people 
suffering from illness will never see a doctor and will be cared for solely by nurses, the proposal to 
educate nurses to be able to prescribe pain medications appears a rational way of increasing access 
to appropriate care. 
  
In most medical settings, nurses do not play a role in the prescription of medicine, however, in 
Uganda nurses are being educated in order to prescribe and deliver strong pain medication. There 
are few doctors in rural areas of Uganda, but there have been increases in community health 
programs, which have increased access to nursing services:  
 
“If we want palliative care to be provided at home, and if we want to control pain and only 
doctors can prescribe pain medication because it’s an opioid, and 60% of the Africans, or 
people having palliative care may never see a Doctor, it means you’re automatically 
excluding 60% of patients from accessing pain medication, because the person seeing them 
cannot prescribe. So make the case about task shifting” Activist, Africa (P16) 
 
Furthermore, the relative ease with which nurses may be empowered to medically treat pain as 
opposed to training doctors is significant: 
 
“For you to train these doctors, it takes about five years to train them, you train these 
doctors for five years, it costs so much [whereas] If I can invest, nine months, because the 
clinical training for nurses is nine months, if I can spend nine months and train these nurses, 
after nine months, they are able to do clinical assessment of pain, clinical prescription of pain 
without supervision, whatever costs worth [it]” Activist, Africa (P16) 
 
This example hints not only at additional economic benefits to health systems, but shows the 
feasibility of educational programs to train nurse prescribers. In this regard, the empowerment of 
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nurses appears to offer real potential to increase the reach of palliative care services. Indeed, 
although this example refers to Africa, a low-income setting, access to services in rural areas is a 
known international challenge.xlviii Referring to Australia: 
 
“As soon as you move away from the settled areas, the number of palliative care physicians, 
are much more limited, and very much it’s, it’s very much in the hands of local family 
practitioners, and also, palliative care nurses.” Physician, Australasia (14) 
 
This theme revealed most strongly, the need to challenge the existing culture of medical practice 
through doctor training. However the potential for an increased medical role of nurses represents a 
practical way of challenging this culture. Moreover, the apparent feasibility of nurse-training aimed 
at increasing overall access to pain medicine appears one worthy of serious consideration. However, 
the extent to which the suggestion is acceptable to nurses, who already face high workloads and 
pressures, was not revealed during discussions.  
Theme Two: Palliative Care as an Area of Global Need 
 
Although by nature of their participation in the study, it may be suggested that all participants had a 
shared view that there is a global need for palliative care, this viewpoint was not assumed during 
interviews. As such, participants were asked to reflect directly upon the question of ‘why do people 
need palliative care’? Understanding participants’ views on this question is extremely important in 
terms of the clarity with which current advocacy strategies are presenting an absence of palliative 
care services as a ‘problem’.  
 
On being asked ‘why there is a global need for palliative care’, many participants responded in terms 
of statistics. As one participant noted:  
 
“We attempted to define the need for palliative care for adults and children, using somewhat 
conservative methods for, from WHO, it’s a WHO publication, so we had to go by the rules 
which were risk averse, and anyway, the global need was estimated at 20 million at the end 
of life and 40 million if you count people prior to the end of life, which again is somewhat, 
probably conservative.” Physician, North America (P03) 
 
Whilst there is perhaps an issue of semantics here, the statement arises from an assumption of need, 
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and is not a description of why people need palliative care. Many respondents conceptualised the 
need for palliative care in terms of an antidote to issues emanating from current medical practice, as 
discussed in Theme One: 
 
“Why we need, why we have today a global need of palliative care and not in the past? 
Hundred years ago, physicians were at the side of the patient, at the side of the family, 
caring him, speaking him, attending the family, attending the suffering, with humanity, but 
not today.” Physician, Europe (P10) 
 
Other respondents presented the need for palliative care counterfactually; that is, that the problem 
was often presented less as ‘people need palliative care because…’ and more in terms of ‘this is what 
will happen if people do not receive palliative care’:  
 
 
“It’s the burden of suffering, not just the burden of pain, but suffering, so… without palliative 
care the burden of suffering would be a lot higher.” Activist, Europe (P02) 
 
Finally, the one Public Patient Representative within the study, concurred that there was a global 
need, and used an example of one person who was admitted to hospital with terminal lung cancer in 
the final stages of life and was left without pain treatment, stating:  
 
“It’s just humane, it’s wrong to leave people suffering, just wrong” PPI Representative, (P11) 
 
Presented in this manner suggests a moral imperative to address the suffering of people wherever it 
is feasible to do so. Indeed, many participants emphasised the word ‘suffering’ in terms of why 
people need palliative care. As demonstrated, the suggestion that there was a ‘global need’ for 
palliative care was shared by all participants. The full consequences of absence of palliative care 
services for a wide variety of stakeholders will be examined alongside the potential benefits it may 
offer in Theme 3. Firstly, however, the following section examines the wide range of factors which 
serve to limit access to pain and palliative care services. 
 
Inequality and inequity of access to palliative services  
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Inherently tied to the suggestion that there is a global need for palliative care were discussions 
regarding access to services. On this basis, it is necessary to determine the factors which determine 
access (or lack thereof) to palliative care. Often, the clearest reasons were described in terms of 
known problems such as lack of services and non-referral by medics to palliative care services.xlix 
However, it was notable that during discussions regarding ‘access’ discussions often moved 
somewhat interchangeably between ‘access to palliative care’ and ‘access to pain treatment’. For 
instance, the only Pharmacist interviewed within the study, described international inequity in terms 
of upon access to pain treatment:  
 
“In three quarters of the world or over, people hardly have any access to opioid analgesics, so 
they are not treated for their pain.” Pharmacist, Europe (P01) 
 
Reporting a similar story, a physician and activist from Europe, summed up the need for global 
development based upon egalitarian principles: 
 
“There is a strong inequity between countries, if we look at the development of palliative 
care, palliative care is more developed in countries with, more rich countries and less 
developed in countries with low incomes… Then why do we need the global development? 
Because we have very partial development at this moment, very very very partial 
development...” Physician, Europe (P10) 
 
What both quotes represent, are moral arguments for the extension of pain and palliative care 
services within poorer regions where services are less developed. The suggestion is that it is 
unethical for access to services to be determined by the wealth of the nation in which you live. 
Developing this argument, access to pain treatment and palliative care may be considered 
‘comparative needs’. That is, globally speaking, within groups with similar characteristics such as a 
serious illness, some are not receiving the same level as care as similar groups who are. This inequity 
exists both between countries as well as within them however, the narratives of inequity within 
countries ran counter to that presented for the international context.  
 
Unusually, whereas internationally, the example suggests that it is richer nations which have better 
access to palliative care, some participants reported that based upon their experiences, it was 
actually poorer sections of society which had better access to palliative care. Perversely, this inequity 
which poorer people benefit from, stems from financial inequality, whereby those with the 
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resources will seek cure ‘at all costs’ whereas, poorer people benefit from not being able to pursue 
such paths: 
 
“Poorer sections of society may access palliative care earlier [in India], and sometimes I feel I, 
I hate to say this, but sometimes I feel like they’re lucky you know, because of the fact that 
they would have landed up in the same state, but they would have spent far more money 
which they cannot afford, and many many families sell their land, sell their house because 
they want to save their loved one… I don’t want to sound presumptuous…but I think that 
sometimes, being poor helps you. The guy who is able to afford, and he’s able to afford a lot, 
he’s got very deep pockets, I think ultimately, it’s sad but he will suffer more, because he’s 
running after a chimera, running after a mirage.” Physician, Asia (P04) 
 
The issue of out-of-pocket expenditure will be returned to in due course, however, not only does 
this quote relate back to discussions presented above relating to attitudes to illness, it hints at 
something else. It was suggested that there is a perception that if something costs more, then it is 
‘valuable.’ This means, that people may be willing to spend a lot of money in the pursuit of cure 
where it is feasible – even if the cheaper alternative may be more appropriate. Expanding on this 
issue: 
“I’ve potentially had better satisfaction dealing with people who are very poor than those 
who are very rich… Because I find that you distil the issues of life and death into what truly 
becomes most important, to them, which is usually the values that they live by, whether it is 
family, being forgiven, being loved, being honest, being truthful and I find that those values 
reside so much better in those that have got less material wealth. The perception in Malaysia 
and I think in many, some other countries, is that palliative care is for the poor, it’s not for 
the well off. ‘I don’t need palliative care yet, I still have potential resources to deal with the 
disease’” Physician, Asia (P04) 
 
However, although the suggestion that poorer people are more likely to access palliative services 
than richer groups, this was not a consistent narrative amongst participants and indeed there was 
variation even when discussing the same country (India). There is a clear rationale for the suggestion 
that poorer people access services due to financial limitations. Yet, a different factor relating to 
finance centres arose around access to pain treatment: 
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“In India you know there were some states that would have fentanyl patches but they did not 
have basic oral morphine pills, and so the pharmaceutical industry was basically taking care 
of all of the regulatory nonsense… in order for the fentanyl, but they were not doing the 
same for the oral morphine tablets, and so as a result, the expensive medications are 
available, whereas the inexpensive medications are not available.” Physician, Asia (P04) 
 
Thus, unusually, socioeconomic status of patients was considered to act as both enablers and 
limiters of access for different social groups. However, socioeconomic status was not the only 
determinant of equality of access. With palliative care professed to have benefits for all patient 
groups suffering serious illness, many participants suggested that services are more commonly 
available to cancer patients rather than patient groups suffering other illnesses: 
 
 “In my country, mainly, the patients that are receiving palliative care are cancer patients 
and we know today that at least over half of the amount of patients that are in need of 
palliative care, are non-cancer patients”  Physician, Europe (P10) 
 
This focus upon cancer has its roots in the history of the development of palliative care.l 
Furthermore, this disease-specific association is strengthened by the aforementioned existence of 
global guidelines for treating cancer pain only. Consequentially, this focus upon cancer exists in 
many world regions. Indeed, only one participant, based in Africa, described palliative care services 
which appear more responsive to other illnesses and changing disease burden: 
 
“If you [look] at Uganda for example, the key patients who are accessing palliative care, this 
has shifted as the disease burden shifts, things shift, so initially in the 1980s it was the cancer 
patients, you know, really chronically ill patients with cancer, that was maybe 80 percent of 
the people accessing palliative care in the 80s. In the 90s, the balance shifted and [now] it’s 
more the HIV/AIDS patients.” Activist, Africa (P16) 
 
Nevertheless, we may describe people living with serious illnesses other than cancer as having a 
comparative need in relation to cancer patients. However, within discussions, what united 
participants was the perception that patients of all diagnoses represent a marginalised group within 
health care systems. 
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Understanding people living with serious illness as ‘marginalised’ is a complex issue. The label holds 
the potential to both raise awareness of suffering caused by illness, but also risks further 
marginalising such populations by increasing stigmatization. Speaking of the receptiveness of donor 
organization United States Agency for International Development (USAID) to rights-based discourses, 
one participant from Africa indicated: 
 
“When you look at their definitions of marginalised groups, they are talking about sex 
workers, they are talking about lesbians, they are talking about gay, that, you know, that 
type of grouping, so the palliative care, are also not very keen to have the palliative care 
patients to be put in that category of marginalised populations, or most at risk populations, 
because then it could cause stigma for them, so that’s kinds of a conundrum.” Activist, Africa 
(P16) 
 
Additionally, it may be suggested that there is an unequal distribution of suffering amongst the 
general population, and consequently, a societal responsibility to mediate the negative effects of 
illness. Indeed, it is of great concern, that beyond inequalities of access based upon diagnosis, 
further inequalities were identified based upon age, stemming from lack of education and access to 
medicine: 
 
“The suffering that children have because people don’t have the skills and the knowledge, 
and often medicines which are available are not in paediatric formulations.  People don’t 
know how to do pain assessment, symptom assessment in children, and for all those reasons, 
children’s palliative care has been left behind. It’s the Cinderella of palliative care” Physician, 
Africa (P06) 
 
A key focus of discussions relating to access to pain and palliative care services, were issues, or 
‘barriers’ to such access. Barriers were identified at both national and international levels, and in the 
following section, factors which are perceived to act as limiters – as well as enablers on access to 
services are reviewed, with a focus upon access to pain treatment.  
 
Barriers to access and further development  
 
Barriers to pain treatment were identified within nations, influenced by both international and 
national-level factors. How international drug policies and regulations influence access to pain 
 205 
 
medicine will be discussed in Theme 5. Here, however, the focus shifts to how national-level policies 
and circumstances serve to limit access – even in countries where regulations permit the use of 
strong pain medicines. 
 
Significant regional variation was identified in terms of national-level barriers to pain medicine 
(although some issues do overlap). Commonly, it was reported that in low-income settings, issues of 
national regulations, resources and education can interact to limit access, whereas, in higher-income 
settings, discussions focussed more upon lack of prescribing due to fears regarding misuse of strong 
medications. In terms of regulations and education: 
 
“We often see that the core medications we use, the opioids, the anti-psychotics, Haloperidol, 
the benzodiazepine, which we use for management of terminal delirium, and a few of the 
other medications, they’re often of very restricted use. They may be in the country, but the 
people who need to be able to prescribe them, can’t.” Physician, North America (P13) 
 
This quote is suggestive of regulatory limitations upon strong opioid use. Additionally, it may be 
understood as indicating a lack of education amongst physicians regarding how to prescribe strong 
medicines, a view shared by many participants and supports the idea that it is not simply regulatory 
issues which limit their use within countries as identified here: 
 
“We could suddenly liberalise all of the opioid laws around the world, which would be 
miraculous, but then you’d have the next challenge, for doctors and nurses who have not 
used those medicines, or have barely used them, to be, to be skilled and not ‘opiophobic’… or 
opioid ignorant in their ability to use them” Physician, Australasia (P14) 
 
More positively, evidence emerged regarding how access to pain medications is increasing through 
more enabling regulations. In India for instance, it was reported how prohibitive regulations had 
been overcome through advocacy: 
 
“In the good old days, you required six licenses before you were able to get morphine.... So by 
the time you have got the third license, your first license would have expired. , a couple of 
individuals realised that the government had the authority to take back the powers of 
legislation, on these multiple licenses from the State Government back to itself… and we 
 206 
 
lobbied for that and the government realised and we’ve put some excellent bureaucrats in 
place… so now, the law has been amended” Physician, Asia (P04) 
 
Furthermore, in Uganda, it was reported that access had been increased through enabling 
regulations, as well as by equipping nurses with the skills to prescribe as reported in Theme 1: 
 
“The opioid regulation, there is a statute about having the opioids available [now], so there is 
a legalisation of opioid availability, and even the nurses, are able to prescribe the opioids, 
which increases the access to opioids.” Activist, Africa (P16) 
 
Empowering nurses to deliver pain relief in circumstances where doctors are not available is a 
potentially effective strategy for improving access to pain medication. Yet, it is not simply a lack of 
skills which limit medical professionals’ prescribing habits. In many settings, ‘fears of opioid’ were 
reported. Most participants appeared to dismiss fears regarding opioid use as an issue of 
misunderstanding. However, justifiable concerns were identified relating to fears of opioid misuse. 
One participant described the balance which must be struck between under-availability and over-
availability of opioids from a public health perspective: 
 
“There are basically two public health interests here, one is patients who need opioids for 
pain management or other medical purposes need to have access to them. And on the other 
hand, there is the interest that you don’t, you want to avoid non-medical, non-supervised use 
of these substances, because, it creates, it creates another health problem, whether that is 
drug dependence, or its overdoses” Activist, North America (P16) 
 
Certainly there are potential health risks associated with long-term use of strong medications as 
identified above. However, the patient representative offered a different perspective regarding fears 
of dependence amongst end of life patients: 
 
“If opioids do cause dependency, who cares? Does it matter? To somebody who is in the last 
phases of their life, I think it’s going to be the last thing on their mind.” Public-patient 
Representative (P11) 
 
Understanding this quote broadly, is suggestive that even alongside dangers associated with opioids, 
that ensuring access is paramount – over and above the potential risks. This tension between 
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emphasising limitations upon the use of opioids and prioritising their facilitation is one which is 
mirrored at global level. Indeed many national-level barriers to access to palliative care and pain 
treatment are reinforced by global level policies. On this basis, the following section proceeds to 
review international and global level factors which influence access to palliative care. 
 
Global level influences over access to palliative care 
 
Considering how factors at global level may have influence over access to palliative care services, the 
broad perception amongst respondents erred towards understanding the global level as an 
untapped resource for the further development of palliative care. That is, rather than presenting 
barriers, that the global level is characterised by a lack of interest in palliative care – as well as a lack 
of understanding of why it is important. Few participants identified serious barriers at global level. 
Indeed, when asked ‘what key changes would you like to see at global level to further the 
development of palliative care?’ many participants responded with issues which would more 
appropriately be dealt with at national level. However, as has been demonstrated throughout this 
thesis and will be shown, global level policies have the potential to not only change the healthcare 
agenda for the global community, but to monitor progress and equip advocates with evidence which 
they can use to hold their governments responsible to commitments such as the WHA Resolution.  
 
Firstly, however, it is appropriate to reflect participant views which did not recognise a significant 
role for global level actors in the development of palliative care. For instance, one participant who 
responded to key questions in writing as well as by interview listed three changes as: 
 
 “Oral morphine is available in all countries signatories to the UN Conventions  
 Palliative care courses are incorporated in the undergraduate education of physicians, nurses 
and pharmacists. 
 Palliative care services are provided in primary care and community level.” Physician, South 
America (09) 
 
Indeed these changes would require national-level action. However, it was established in Chapter 
Three how the WHO is attempting to further such issues through leadership, formalised in the WHA 
Resolution. Moreover, it was shown how the regulation of strong medicines by the International 
Narcotics Control Board was contributing to a restrictive, rather than enabling, regulatory 
environment. Indeed, signatories to UN conventions on access to essential medicines are not 
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currently held accountable for failing to ensure access to medicines. However, as INCB regulations 
do permit restricted access to opioids and it is national-policies which specifically preclude this, 
regulatory barriers do exist most notably at national level. Furthermore, not all participants 
acknowledged any need for the involvement of global actors in improving access to essential 
medicines. Speaking of India, on participant stated: 
 
“I don’t see the global situation affecting us in any way, because of the fact that we grow 
enough opium” Physician, Asia (P05) 
 
This suggests that global level regulations are not limiting access and that neither is India reliant 
upon global trade in order to ensure opioid availability.  
 
Thus, not all participants acknowledged the potential role for global level actors to contribute to the 
further development of palliative care. However, more prevalently, participants acknowledged the 
need for increased engagement from global actors in palliative care issues. Yet although few global-
level barriers were identified by participants, there was broad frustration that global actors were not 
doing more to contribute to development. Perceived global inaction with regards to palliative care 
was attributed to a broad lack of awareness amongst global level policymakers which suggests that 
this national-level barrier is mirrored at international level:  
 
 “I think really the main pushback is really lack of understanding of what palliative care is and 
also the link of palliative care with end of life care, that is a big pushback.”  Activist, Africa 
(p16) 
 
This suggests that activists are not currently providing a clear message to global actors. Furthermore, 
the lack of any globally-collected indicators of palliative care development was seen as a major 
hindrance to the development of palliative care. Speaking at the cusp of the finalisation of the 
Sustainable Development Goals (SDGs), there was pessimism regarding the likelihood of a palliative 
care-relevant indictor being included: 
 
“We really would like an indicator for palliative care, but that’s not going to happen, I mean 
palliative care is like I said, is like 1 percent of the population requiring palliative care, we’re 
not going to get a health indicator.” Physician, Africa (P07) 
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Indeed no indicator for palliative care was included in the final SDGs. This must be of serious concern 
to the palliative care community, due to the importance attributed to an indicator, in terms of both 
raising awareness of palliative care as well a mechanism with which to hold national governments 
accountable to their responsibilities as well as for advocacy purposes:   
 
“Once we have an indicator, we can then go to our Ministry and say, ‘you need to be held 
accountable to this indicator, so you need this indicator to be part of your Country 
Operational Plan, then when we go to USAID, we can say, ‘this is part of the Kenyan 
Operational Plan’, ‘this thing is in the plan, please fund it’” Activist, Africa (P16) 
 
Yet, in-keeping with the complexity of outcomes associated with palliative care, the most 
appropriate global measure appeared to focus upon just one element of palliative care; opioid 
consumption. The consequences of focussing upon just one element of a complex intervention, such 
as palliative will be reviewed in Theme 4. However, before proceeding to give of an overview of the 
potential benefits that palliative care may have for a variety of stakeholders as well as the 
consequences which may occur, where palliative care is absent, it is first important to consider the 
implications of experts’ varied and at times conflicting, characterizations of the professed ‘global 
need’ for palliative care. 
 
Theme Three: Broad Benefits of Palliative Care and Consequences of its 
absence 
 
 “Strongly, I can say it, better palliative care is better society. This is what we’re looking for… to have 
healthy, better, compassionate societies.” Physician, Europe (P10) 
 
This theme emerged to reflect the wide reaching benefits which participants suggested that 
palliative care may offer. Counterfactually, where palliative care is not accessible, it was commonly 
suggested that there are negative effects, or harms, caused by absence of services. Additionally, 
understanding just what exactly palliative care offers, helps inform the ‘key message(s)’ of what 
palliative care advocates should be requesting when engaging with policymakers and funding 
agencies. 
 
Benefits of palliative care (and counterfactual harms) were revealed for a diverse range of 
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stakeholders. As such, although all stakeholder groups are inherently linked, benefits and harms are 
presented by group. Although it is acknowledged that a key tenet of palliative care is to treat 
patients and families/carers as the unit of care, potential benefits and harms for each group are 
presented separately. 
 
Patients  
 
The benefits of palliative care for patients living with serious illness are well documented in terms of 
reduced symptom burden and improved quality of life and were reported in Chapter Two.li On this 
basis, though such outcomes were present in discussions, the focus here regards less commonly 
reported benefits for patients in order to present original findings. 
 
For instance, in spite of historic associations between the introduction of palliative care following a 
cognitive shift, towards acceptance that not all illness can be cured, evidence emerged in contrary to 
this viewpoint. Participants revealed that the promotion of person-centred care and quality of life, 
was not tantamount to an acceptance of shortened lifespan. Indeed, whilst not a goal of palliative 
care, it emerged that palliative care may in fact extend life, a factor which was certainly presented as 
a ‘benefit’:  
 
“We actually have some emerging evidence that you have a better chance of survival if you 
get palliative care than if you don’t, I mean, one study that I did, and a more influential study 
that was published a couple of years ago on palliative care for non-small cell lung cancer 
[suggested that] in some cases they may live a little longer, whereas, if you’re in the 
healthcare system and you’re getting over-aggressively treated, you actually, may shorten 
someone’s life. We’re talking, a month or two here, not long term survival, but anyway.” 
Physician, North America (P03) 
 
With improved quality of life and length of life not necessarily in opposition, an additional ‘benefit’ 
suggested by participants was that effectively delivered palliative care has the potential to reduce 
the circumstances in which patients may seek to end their lives prematurely due to intolerable 
suffering. As one participant argued: 
 
“We often talk about palliative care being the answer to assisted dying, because if we can 
provide that comfort, that support, that relief of symptoms, spiritual care and all of 
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that…then we would think that a lot of people who would like to end their lives, would 
change their mind” Nurse, Africa (P06) 
 
Whilst this benefit was presented anecdotally, another participant described situations where 
absence and lack of awareness of services may actually lead to far more extreme, negative outcomes, 
for example:  
  
I’ve heard of current cases and I know cases that patients commit suicide because they do 
not have access to pain relief” Physician, South America (P09) 
 
Before proceeding to discuss broader benefits of palliative care beyond those of the patient, it is 
important to acknowledge that the benefits suggested thus far, have an implicit association with 
care delivered close to the end of life. Yet, several additional potential benefits for patients emerged 
in circumstances where palliative care was delivered much earlier in the course of illness. For 
instance, one participant from Africa spoke of how people through early introduction of effective 
symptom management, may experience fewer restrictions on their capacity to maintain their usual 
social functions: 
 
“Some of these people are able to go back to productive work, so it’s helping them make sure 
that these people stay as healthy, as pain free and as symptom free as possible, so that they 
can continue with their every day job. We have people who have gone back to their teaching 
job, or you know, whatever jobs they do, you know, driving jobs, because they are now, now 
their pain is controlled and their symptoms are well managed.” Activist, Africa (P16) 
 
Benefits such as ‘returning to work’ are implicitly associated with palliative care at an early stage in 
the course of illness. Certainly it seems unlikely that patients closer to the end of their lives would 
have the likelihood to return to employment. Although it may be suggested that such benefits may 
be extended to improvement of quality of life through maintenance of usual function for as long as 
is possible. Understanding benefits in this manner reveals a key tension within the field of palliative 
care, whereby some participants chose to emphasise improved quality of life through the early 
introduction of palliative care, whilst others focussed upon issues regarding the end of life, a point 
which will be expanded upon in subsequent sections.  
 
Before discussing the relationship of varied benefits for stakeholders beyond the recipients of care, 
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it is first appropriate to provide an overview of the suggested benefits for other groups. Here follows 
the suggested benefits for the broader targeted unit of care: families and informal carers. 
 
Families and Informal carers 
 
It is reasonable to suggest that all of the professed benefits to patients of palliative interventions are 
shared by their broader support system: families and carers. That is, that what is beneficial to people 
suffering illness extends to include those who care for them. Additionally, participants reported 
upon benefits which families and carers may receive through their incorporation within palliative 
care services which may be considered of specific benefit to them. The starting point here is to 
acknowledge the prevalence of such support systems within societies. One participant described 
family caregivers as “the largest workforce in the healthcare system [Physician, North America 
(P13)]”. More globally, another described how, when families are included in the statistics of disease 
prevalence alongside patients, the estimated need for palliative care rises from 54.5 to “More than 
100 million [Physician, North America (P03)]”.  
In order to understand the significance of palliative interventions for caregivers, it is important to 
acknowledge just how seriously the act of caring for a loved one with an illness can affect caregivers. 
One participant discussed the trauma that is experienced, indicating that: 
 
“There are studies of mortality and morbidity of caregivers, where there has been no hospital 
and palliative care, which show that families that don’t get good hospice and palliative care 
are much more traumatised and in fact have PTSD [post-traumatic stress disorder]-type 
symptoms” Activist, North America (P01) 
 
Equating caregiving with PTSD, an illness commonly associated with experience of warfare, 
underlines just how seriously caregivers’ lives can be impacted through experiences of caregiving. 
However, this is not to suggest universally negative experiences of caregiving through which people 
may have a wide range of positive experiences. Yet, potentially negative experiences of caregivers 
who are not receiving palliative care only serves to underline the need for families and caregivers to 
be supported in challenging circumstances. In this regard, it is of surprise, that when describing the 
global need for palliative care, that such conversations did not include specific reference to 
caregivers’ specific needs. 
 
Aside from discussions of the emotional and physical impact of caring for somebody with a serious 
 213 
 
illness, many participants alluded to how appropriate cessation of active treatments in favour of 
palliative care may have financial benefits for families. In circumstances where people pay ‘out-of-
pocket’ for care, it was revealed, how aside from the physical suffering which futile treatments cause 
for patients, they also create a heavy financial burden upon families. Reporting upon a study which 
reported upon the financial impact of illness upon families, one participant described: 
 
“Two unexpected outcomes … one of which was about 30% of families, even if they are well 
insured go bankrupt, and in about 25% of families, somebody needs to stop their career to 
become a caregiver, and loses their future career. Those are pretty profound effects [which 
were attributed to] spending more time in intensive care units, they were having more 
admissions, more transitions” [Physician, North America P13] 
 
Whilst the negative effects which such medical care may inflict upon patients, the consequences of 
heavy financial outlay may be felt most keenly by families. It is also worth noting the negative effects 
of ‘losing a future career’ both financially, as well as upon quality of life if a person cannot perform 
their usual duties. The suggestion here is that if palliative care is introduced effectively, that not only 
is more appropriate care given, but negative financial factors associated with costly (and ultimately 
futile) curative treatments are avoided. Thus, increased financial burdens upon families caused by 
out of pocket expenditure upon futile care are removed – to the benefit of both the patient and the 
family. However, it should be acknowledged that some studies have shown that palliative care can 
be associated with a high amount of out of pocket expenditure for families.lii In this regard, it is not 
known whether palliative care represents an overall reduction in overall expenditure for families, a 
circumstance which is likely to be highly context specific.  
 
Yet, perhaps the benefit emphasised most strongly by participants, though not related to 
‘inappropriate’ treatments, lies in how the families experience the illness suffered by a loved one. 
Examples emerged from around the world referring to how peoples’ experience of illness of a family 
member has implications for if and when that person may suffer illness themselves: 
 
“If you’re nervous and then frightened, as you enter your own illness experience, you’re 
probably not going to do very well, and it’s going to be a very frightening experience. If you 
realise from the beginning, because of a loved one’s story, that you can have great palliative 
care and hospice care. Gosh, it makes it very different.” Physician, North America (P13) 
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Thus positive experiences of illness and death through effectively delivered palliative care may lead 
both to benefits beyond improved health outcomes and reduced financial burden. Indeed it was a 
common narrative, that peoples’ attitudes towards illness and death may be improved through 
facilitative experiences through a realization that death “can really go quite well” [Physician, North 
America (P13)]. 
 
Finally, the PPI Representative within the sample concurred, that such support prior to bereavement, 
was important for positive experiences of death: 
 
 “A good death, well, when you your family and your community are prepared for it, where 
there’s no suffering,  and when you die in your sleep I suppose. Bit over ideal that isn’t it?” 
PPI Representative, Europe (P15) 
 
Considering the potential broad benefits of interventions for families and caregivers, adds a new 
perspective upon the value proposition that palliative care has to offer. Furthermore, as the quote 
alludes to, patients, their families and caregivers, exist within broader social systems. With this in 
mind, the following section proceeds to discuss how potential benefits from palliative care 
interventions, may be felt within broader communities and indeed societies. 
 
Communities and societies 
 
Whilst communities and societies are not the targets for palliative care interventions, many 
participants professed how the act of caring for people living with serious illnesses and their care 
systems has benefits much wider than simply for the unit of care. Such claims centred around how 
through increased acceptance of vulnerable people and improved attitudes to illness and death, 
hold the potential to increase societal and community resilience. In this regard, one participant 
commented palliative care can lead to: 
 
“Societies where the frail, the poor, the marginalised, can be included. Then, in some way 
palliative care is secular relation to have better societies. Is not only about the care of the 
terminally ill patient it’s about better societies.” Physician, Europe (P10). 
 
Such claims are somewhat intangible. It is therefore, appropriate to consider the type of community 
and societal level problems which palliative care may be able to alleviate. Predominantly, such 
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discussions regarded societal attitudes to illness and death. Such narratives are related to issues 
previously addressed regarding how people living with serious illnesses may be considered a 
‘marginalised group’. Specifically, stigmatization towards people living with illnesses such as 
HIV/AIDS were said to be treated with suspicion by the broader community. Speaking of 
communities attitudes at the onset of the HIV/AIDS crisis in Africa towards patients at a recently 
established hospice, one participant reported that people: 
 
“Wouldn’t support the adults we were caring for, because, ‘what have they done? They 
deserved it’” Nurse, Africa (P06) 
 
Evidently such perceptions of people living with illness are not conducive to community cohesion. 
That is, if people are isolated in this manner, then communities become segregated. More broadly if 
attitudes such as ‘they deserved it’ pervade, then such circumstances do not provide fertile ground 
for public support for palliative care services. In spite of such barriers, one participant reports upon 
how attitudes have been challenged by reaching out to communities and recruiting community 
members as volunteers: 
 
“I think what we have seen is when we have included communities as volunteers, as people 
who are supporting each other, you find first of all, you find the stigma of illness is reduced, 
because we are talking about it openly, people can see the benefits of being involved, now 
this brings people together, so people are not afraid to say ‘oh, my neighbour is having a 
problem can we help?’, so reaching out, knowing each other, knowing where you can get 
help, that has really brought villages together” Activist, Africa (P16) 
 
Such processes of inclusion are supported by studies regarding ‘health promoting palliative care’lxvi 
which will be considered in the discussion section, however would appear to occur in diverse ways in 
different world regions. For instance, one North American participant made the suggestion that 
palliative care challenged not only attitudes to illness, but held the potential to improve race 
relations in the United States. Informed by a historic circumstance where African Americans are less 
likely to access palliative care services, it was suggested that when they do, that attitudes are 
challenged: 
 
“When [African Americans] do come into hospice then there’s a lot of fear and mistrust, but 
again, when you bring the family unit into it, and then they see that they’re cared for and 
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helped in this really life-affirming way, that changes the dynamic and it changes the 
conversation around race and…it changes people’ experience so that they can then get to 
another level… If you think counterfactually, then it’s like, well, if that didn’t happen, then 
they wouldn’t have that resilience and they wouldn’t have that perspective and they might 
still hate white people” Activist, North America (P02) 
 
Evidently there is symbiosis between ideas regarding involvement of the community in providing 
palliative care as a mutually beneficial relationship. Furthermore, it was suggested that through the 
adoption of open conversations and involvement of stakeholders beyond healthcare professionals in 
the provision of care and patients’ lives, that stigma towards conversations about death were 
improved: 
 
“When I was in the hospice, and the patient was unwell, and probably at the end of life, the 
rest of the patients were aware that this was happening, and they’d come into the room and 
they would help, provide, or giving water to the patient or helping them to stand up, so they 
were quite involved in, not patient care, but I would say it’s much more important than 
patient care, it’s patient accompaniment... So it was a much more, or I would say, less ‘taboo’ 
also and much more community-approach than what you see [in North America].” Physician, 
South America (P09) 
 
Additionally, non-institutional care, that is, home care, was also suggested to be a facilitator of 
community cohesion: 
 
“In most African countries, palliative care is offered at home, within the community and at 
home. And that creates opportunities for bonding and coming together.” Activist, Africa (P16) 
 
In addition to benefits of palliative care felt at the community, it was suggested by a North American 
participant, that communities had an important part to playing in the provision of care. Moreover, it 
was claimed that the failure to utilise community resources to provide palliative care threatens the 
very sustainability of health systems: 
 
“The reality is that we need to mobilise the community to support these people… As we think 
about the Kerala [community-led] model, it’s quite interesting, it could be adapted, we don’t 
have the resources in Western Europe and North America to continue giving the care the way 
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we do it, we just don’t have the resources, and with the dependency ratio changing, and 
becoming actually quite serious in several countries, we’re going to have to have a different 
model because we’re not going to be able to afford it, people won’t have the money.” 
Physician, North America (P13) 
 
The suggestion that palliative care holds potential benefits for health systems will be explored 
further in the following section. Firstly, however, whilst increased cohesion may be felt at 
community-level, several participants suggested that improved community relations translated to 
the societal level. An idea supported by the PPI representative who makes additional links between 
different stakeholders identified within the theme: 
 
“Whoever is caring for someone who is having palliative care, their quality of life will improve 
as well. So, the ripples spread out to the whole of society, you know, one suffering person can 
bring a lot of misery and unhappiness to the family, and possibly even to the neighbourhood” 
PPI Representative, Europe, (P11) 
It is appropriate to say, that as the professed ‘benefits’ of palliative care move further and further 
away from the intervention itself, that they become less tangible. Concepts such as ‘community 
cohesion’ are difficult to measure, however this suggestion is by studies which have shown that a 
‘health promotion’ approach in palliative care is consistent with greater community engagement 
with caregiving and recognition of end of life issues.lxvi Moreover, the idea of ‘ripples spreading out 
to the whole of society’ as suggested by the PPI representative, was shared by other participants, 
one of whom went further, linking community benefits to global issues: 
 
“[Palliative care] delivers better outcomes for families, communities, states and regions and 
eventually the world than not having palliative care...It builds the kind of resilience that 
allows families, communities and individuals, we’ll just stay with those three, to address, 
other really critical problems, such as climate change, crime, migration, development, 
whatever you want to call it. Because, to me palliative care advances the emotional 
intelligence of society.” Activist, North America (P02) 
 
No direct causality is implied between individual palliative care interventions and issues such as 
climate change. Nevertheless, the idea of improvement in the ‘emotional intelligence’ of societies is 
conceivable in terms of some of the negative attitudes and practices towards illness and death 
identified within this theme. With this in mind, it is troubling that broadly, societies appear to be 
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acceptant of existing medical practice and its ‘search for a cure’. That is, that whilst palliative care 
remains so globally underdeveloped, that societies are unaware of the potential benefits of palliative 
care which have been suggested and are therefore not receiving them. A strong view emerged from 
Europe in this regard: 
 
“Probably from the sociological point of view or the political point of view, it’s interesting to 
look at our society as mad, it’s mad, it’s treating patients with chemotherapy, thousands of 
euros in the two weeks of life, what is that? That society, probably is mad, is mad, why don’t 
you explain to that patient at the end of life who is not receiving any benefit from this 
treatment, he will still be in the hospital, he will not recover from this chemotherapy, you 
know, it’s in some way, why we need palliative care, because we don’t have money to pay 
health.” Physician, Europe, (P10) 
 
As hinted in all sections within this theme, the relationships between the potential benefits to 
different groups are complex. This issue will be addressed following the final element of this theme, 
by turning to attention to how palliative care can benefit health systems and health workers – as 
suggested by the participant in terms of sustainability. 
 
Health systems and health workers 
 
Arguments for how further rollout of palliative care services may hold benefits for health systems 
followed three main strands. They centred around: 1) how better quality care as opposed to overly 
aggressive and expensive treatments may provide cost-savings to health systems whilst almost being 
more appropriate for patients, 2) how a public health approach, increases the skillsets of medical 
workers results in higher quality medical staff and 3) more resilient staff, better able to deal with the 
emotional burden which may come for caring with people with serious illness up until death and a 
consequent reduction in staff burnout.  
 
Health care professionals dealing with seriously ill people up to and including the death of the 
patient, face similar emotional and psychological challenges to those of families and informal carers. 
This point was made by several palliative care physicians with a great deal of experiences in such 
circumstances: 
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“Every single person helping a person with an advanced illness, so whether it’s the family, or 
friends, or whether it’s the healthcare workers, they’re all watching their own future!” 
Physician, North America (P13) 
 
Such experiences were echoed in an Africa setting: 
 
“[If] the patient has a comfortable death, that is not distressed because that improves 
bereavement outcomes and improves people’s future mental health. If they’ve had a good 
experience around a death compared to a really, bad, and upsetting experience around the 
death.” Physician, Africa (P07) 
 
This point echoes one of Cicely Saunders’ fundamental principles of palliative care, that ‘how people 
die lives in the memory of those who live on’, and the significance of a positive experience for health 
professionals in such circumstances should not be underestimated in terms of their own 
bereavement experience and mental health.liii This is significant also for health systems, as positive 
experiences in this regard “reduces the risks of frustration and burn out [Physician, South America 
(P15)”, a benefit which can be extrapolated to a potential reduction in absences from work due to 
such factors. Indeed, running counter to narratives of death as ‘failure’, it was reported how 
facilitating positive experiences towards the end of life can itself increase job satisfaction of health 
workers: 
 
“As a healthcare professional, when you’re working with that patient, if you can see that 
you’re relieving the pain, you’re dealing with the existential suffering of that adult or child, it 
gives you a feeling of success, you feel better about yourself, about your interventions.” 
Nurse, Africa (P06) 
 
Furthermore, arguments presented previously, that palliative care skills should be a fundamental 
part of undergraduate medical training, was said to have impacts within the health in all clinical 
settings: 
 
“The essence of the health professionals is the essence of palliative care, in other words, the 
essence of the medicine, the essence of the health professionals, are in palliative care, 
working with palliative care will mean better professionals, better medicine also to attend 
the patient, this is another reason to have palliative care.” Physician, Europe (P10) 
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Once more this revives questions regarding how the current medical approach of focus upon illness 
rather than upon the patient may be changed. It also suggests increased professional competence, 
which must benefit health systems, health workers as well as patients. 
 
In this regard, medical professionals’ decisions regarding cessation of futile treatments in favour of a 
palliative care approach may be linked to both patient-benefits as well as financial benefits for 
health systems. The final quote of the previous section painted health systems which treat patients 
with expensive, ineffective chemotherapy at the end of life as irrational and raises questions both 
about the appropriateness and sustainability of existing medical practice. This was a commonly held 
view amongst participants and indeed similar arguments were made for both high and low resource 
settings. Reporting on North America with the context of the costs of delivering palliative care 
towards the end of life as opposed to continuation of aggressive, futile treatment: 
 
 “We showed that for every patient seen by the consult service at our largest hospital, we 
saved a thousand dollars per patient admission to the hospital. And at the smaller hospital, 
which is 340/50 beds, we saved $500 for every patient seen.” Physician, North America (P13) 
 
These are significant savings and links to a previous point made by the same participant regarding 
the need for communities to be mobilised to be more active in supporting informal caregivers in 
delivering palliative care, not simply as a preference, but as a financial necessity. Thus the 
empowerment of informal carers may be linked with decreased (expensive) hospitalisations as well 
as more appropriate care. This suggestion was made for both low and high resource settings, as 
represented by the following quote, which relates firstly to the Indian setting, and then to ‘Western’ 
settings: 
 
“How do we create a whole process to reach out, these family caregivers, they don’t have 
any training in how to do care, we don’t give them any education, many of them are actually 
illiterate, and we hand them these fancy brochures, the hospital discharges them and sends 
them home, and then they come back and we wonder why. We don’t have the resources in 
Western Europe and North America to continue giving the care the way we do it, we just 
don’t have the resources, and with the dependency ratio changing, and becoming actually 
quite serious in several countries, we’re going to have to have a different model because 
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we’re not going to be able to afford it, people won’t have the money” Physician, North 
America (P13). 
 
On this basis it may be stated that all international health systems face challenges relating to their 
sustainability which may be reduced through further provision of palliative care. Echoing a finding 
from the systematic review in Chapter Five, is the suggestion that the potential for palliative care to 
save health systems money, is undermined by the lack of an evidence-base to demonstrate this: 
 
“Palliative care actually saves costs to the healthcare systems, by providing care which is 
actually cheaper and less expensive when it’s at home and then preventing that patient 
occupying a hospital bed and using the emergency resources and hospitals and third-care 
level facilities, which are quite expensive. That kind of community based, home care based, 
approach to palliative care does, you know, save a lot of money, but we need more studies 
and we need more data.” Physician, South America (P09) 
 
Such findings add weight to claims of advocates that a public health approach be taken to 
development. In this regard, governmental funding for palliative care may be represented as an 
investment in people and services, whereby financial input will ultimately lead to overall financial 
savings. 
 
However, in spite of broad support from all participants for a public health approach to be taken to 
palliative care development, many services continue to operate outside of the formal health system. 
Moreover, questions emerged during interview regarding the feasibility of integrating all elements 
of palliative care into mainstream health systems. Therefore, the following theme emerged to 
answer questions regarding whether any single aspect of palliative care should be prioritised over 
any other in order to make developmental progress as well as the relevance of public health 
approaches to private healthcare systems.  
 
Theme Four: Prioritisation Within Health Systems and Organization of 
Services 
 
To some extent traditional definitions of ‘health systems’ do not accurately capture the diverse 
range of formal and informal organizations which provide palliative care around the world. The 
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global development of palliative care has seen services develop patchily, both within and between 
nations. Similarly, development has been characterised by diversity, with models of palliative care 
provided formally by health systems, but perhaps more commonly, by charitable organizations, civil 
society led services and private institutions and services which operate outside of nationally funded 
health systems. This diversity raises real questions regarding the sustainability of services, whereby, 
funding streams are dependent upon bilateral relationships and services are often not underwritten 
by nation states. 
 
On this basis, a great deal of discussion regarded the feasibility of more fully integrating palliative 
care into both public and private health systems. Central to such discussions was a shared view 
amongst participants that palliative care should be integrated into all international health systems, 
using a public health approach, arguments which were strengthened based upon the benefits of 
palliative care for different stakeholders identified above.  
 
Given that palliative care continues to operate outside of formal health settings in many world 
settings and the shared challenges to the sustainability to all health systems, there is an urgent need 
for both new resources for palliative care both to fund and deliver services. This may be achieved 
either through gaining access to new sources of finance and labour, or by a reallocation of existing 
resources. The following section therefore reviews participants’ views on the extent to which a 
health systems approach to palliative care development can be encouraged, along with how the 
integration of palliative care should be funded. 
 
Health systems approach to development 
 
As identified in the previous theme, experts within the sample suggested that palliative care offered 
benefits to health systems including more appropriate care, increased competence of health 
professionals as well as cost savings. Additional to attitudinal barriers to palliative care development, 
questions regarding the feasibility of further integrating palliative care into formal health systems 
have emerged. Both global and national level healthcare governance systems are characterised by 
competing claims for limited resources. This is particularly true, for developmental health systems, 
which have not evolved to incorporate high quality services at primary, secondary and tertiary levels. 
Within such systems, activists face additional challenges regarding the integration of palliative care 
into health systems. Yet, even highly developed health systems face challenges to their sustainability, 
from increasing populations and shifts in the age dependency ratios, which have seen fewer people 
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paying into health systems which are attempting to meet the challenges of increased need and 
usage. 
 
With regards to how to ensure a sustainable approach to palliative care development, there was 
broad agreement amongst participants that national governments should adhere to WHO guidance 
regarding a public health approach to palliative care development. This guidance centres around 4-
key pillars: 
 
“The concept of palliative care from the World Health Organization, the pillars, the four 
pillars of palliative care. Policy, education, implementation and drug availability… if you think 
about that public health approach to palliative care, thinking about those our pillars. The 
WHO says that for palliative care to be accessible to all those that need it, those four pillars 
have to come into play” Activist, Africa (P16) 
 
There was broad acceptance that nations should follow such an approach. Moreover, few 
participants considered that government many need financing outside of their existing budgets and 
placed the financial burden for the integration of palliative care directly upon nations.  
 
“The funding for palliative care needs to come mainly from national governments. At least it 
depends, in some countries its healthcare insurance, in other countries it’s the government 
directly who finances healthcare and that’s the direction it needs to go in I feel. So, palliative 
care needs to be financed in exactly the same way as other healthcare interventions are 
financed at the moment. For me, that’s the ultimate objective.” Pharmacist, Europe, (P01) 
 
The point regarding healthcare insurance will be addressed in due course. However, the above 
quote regarding how palliative care ‘should be financed in exactly the same was as other healthcare 
interventions’, disregards the fact that in many world settings, financing comes from charities, 
philanthropists and global funders. For instance in Uganda where it is professed has achieved full 
integration of palliative care into the health system, it was reported that: 
 
“They [are] really working, even now, they do work with money from donors, with very 
limited support from the government.” Activist, Africa (P16) 
 
What is more, despite agreement that palliative care should be incorporated into national health 
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systems alongside all other aspects of medicine, there was recognition that ‘developmental’ health 
systems were likely to focus first upon the provision of primary care services: 
 
“If you think about it, developmentally in a country, if you have limited resources, and you’ve 
got a whole group of people dying from something like HIV, you want to do palliative care… 
where do you put your focus? Do you put it on palliative care, or do you put it on curing 
people? If you don’t think it’s important, people put it on curing people, or trying to save 
them, what people haven’t understood is that palliative care is actually very inexpensive to 
implement it, and you can actually do both. And what even the palliative care community has 
not talked about, is how palliative care can be involved with identification of other people at 
risk.” Physician, North America (P13) 
 
This links back to a previous quote regarding the role of palliative care in the whole continuum of 
care, including health promotion and prevention. Yet, in spite of this emphasis upon feasibility, the 
quote also displays pragmatism, based upon an understanding that this link is to some extent 
unexplored, and certainly does not represent the conventional wisdom amongst health policymakers. 
In this regard, there was implicit acknowledgement that donor-financing may be required in order to 
accelerate development.  
 
Yet, in order to access such funding responsibility was still placed upon national governments to 
have national strategies for palliative care in order to align donor objectives with those of national 
policy. This approach is consistent with donor commitment to alignment with national objectives 
identified in Chapter Three. The potential for palliative care to benefit from global level funding 
streams is considered in Theme Five. However, it should be noted that rather than a focus by 
participants upon engaging global funders, more common was the view that it is the responsibility of 
national governments to fund the integration of palliative care. 
 
Participants suggested that governments did not necessarily need new sources of finance, but 
identified the possibility for a reallocation of existing health resources to further palliative care 
development. Suggestions for how a reallocation of human resources within health systems held 
potential to advance the interests of both palliative care and health systems arose from two distinct 
premises. The first, related to how the non-treatment of patient symptoms within health systems 
increases the manpower required to treat that patient as reported by one participant: 
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“If there is a category of patients who are in pain, who are not treated for the pain now and 
need a lot of support almost continuously, healthcare systems or economies would save a lot 
of money if they treat the patients for their pain. And that can be either that a nurse can do 
something else, or you need less nurses or that a relative taking care of a person at home can 
go back to work or do other things” Pharmacist, Europe (P01) 
 
This strand of argument relates additionally, to how better and more appropriate use of resources 
may contribute to both more appropriate care, as well as the economic sustainability of health 
systems. Secondly, the quote is may be understood as being supportive of maximising use of existing 
human resources through the empowerment of nurses to prescribe as addressed previously. In this 
regard, it appears that there is an argument to be made, that if nurses were able to treat pain, this 
may not add undue work to their caseload and may in fact decrease workload, based upon the 
suggestion that patients who are not treated for their pain require more continuous attention. 
Conversely, it was suggested, that the implementation of palliative care as opposed to continuation 
of futile treatments in and of itself, raises the resources required to deliver palliative care. Reporting 
from Europe, one participant described how this circumstance occurred in practice when a palliative 
physician requested the costs of chemotherapy for people who did not live for more than two weeks 
post-treatment: 
 
With this data, he went back to the boss of the hospital and explained, ‘one palliative care 
physician is 30,000 euros per year, you are spending this with 30 of the patients you are 
treating at the very end of life with chemotherapy, but you are not treating in this hospital, 
30 patients, you are treating in this hospital 300 patients with chemotherapy in the last two 
weeks of life. With the money that I can save, you can contract 10 palliative care physicians.” 
Physician, Europe (P10) 
 
Ideas regarding how resources within healthcare systems may be used more appropriately, both by 
redistribution and by empowerment offer clear objectives for palliative care advocates and are 
consistent with a public health approach to development. However, public health systems represent 
only a proportion of international health care systems. In this regard, it was appropriate to consider 
the relationship between palliative care, private health care systems and other private healthcare 
actors.  
 
Palliative care and private hospitals 
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As referred to previously, in many settings, national governments are not the primary source of 
healthcare financing in many world settings and there has been a proliferation of private health 
systems worldwide.liv Three key industries were identified as being relevant to palliative care within 
the private sector; health insurers, pharmaceutical companies and private hospitals. There are 
inherent complexities within each of these industries in terms of their interests, however they are 
united by a shared ‘bottom ‘line’ to make money. This has significant consequences for palliative 
care activists in terms of how activists present the feasibility of integrating palliative care into private 
systems.  
 
Privately funded health systems, differ in their structural organization, however, commonly, people 
either pay for healthcare at the point of use, or pay routinely for medical health insurance for care 
which is free at the point of use. Each of these models presents both obstacles and opportunities for 
advocates to make arguments for the integration of palliative care into such systems. In this regard, 
whilst economic arguments for palliative care have emphasised ‘cost-reduction’ to health systems, 
this argument may not resonate with private healthcare providers. When asked how economic 
arguments may be made to private providers one participant responded: 
 
“That’s a good question, particularly in our setting [USA], where it means reduced revenue. 
Well it depends on the funding model doesn’t it? So if the funding model is ‘fee for service’, 
like in Ohio, 80% of our business is fee for service, there’s absolutely nothing attractive about 
saving revenue. What there is attraction is, saving expenses, because if I can have the same 
revenue and reduce expenses, then the hospital is very interested.” Physician, North America 
(P13) 
 
This distinction is significant as on the one hand, if the provision of palliative care within private 
hospitals is likely to reduce their profitability, then this can be considered a real barrier to the 
integration of services into such systems. Conversely, if private hospitals can be engaged using 
arguments regarding how providing more appropriate care may cut expenditure, then this may be 
considered a real opportunity for the integration of palliative care into private systems.  
 
However, real concerns emerged regarding the private sector in terms of the vested-interests that 
private industries have in the current technical approach to healthcare. That is, that the very futile, 
inappropriate and expensive treatments towards the end of life which palliative care advocates 
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oppose, are incredibly profitable to the private medical industry. Commenting upon this dynamic the 
PPI Representative stated: 
 
“[Patients] will go through anything to get the cure, they will have massive operations, they 
will have repeated surgeries, they will take any drugs and of course they’re pushed upon 
them, by I suppose you could say, predatory medical profession. I’ve heard a quote that ‘if 
you can’t get fifty thousand dollars out of a cancer patient, then there’s something wrong 
with your work’.” PPI Representative, Europe (P11) 
 
This suggestion is of real concern, particularly when another participant described how medical 
professionals may be both put under pressure within private hospitals to promote expensive 
treatments to patients and indeed have a vested-interest in doing so:  
 
“Private doctors are driven, by saying ‘yes, come back for fourth-line chemo’, even if it’s not 
working, because I’m going to get paid more for doing the chemo” Physician, Africa (P07) 
 
Yet, the one private-sector physician included in the study, urged caution when characterising the 
private sector as being a barrier to palliative care when asked about such circumstances: 
 
“The regimen that we follow is, ‘…I have full dedication to the hospital, then I receive my 
money, my amount of money, with independence of the amount of the patients I am treating 
each month, then it that way, I don’t feel the pressure of treating patients in one way or 
another way” Physician, Europe (P10) 
 
Furthermore, the same participant described how working within a private hospital, facing fewer 
pressures of demand, allowed freedom for innovation. Accordingly it was described how private 
systems with their additional resources for research and development, may be able to offer 
leadership through the creating of appropriate models of care which the public sector may be able 
to emulate: 
 
“I am privileged physician in that way, for me, I can develop things in an easy way, in an 
easier way, than other physicians in the public health system. Why? Because my hospital is a 
small hospital, with less patients, with less pressure, with less stress… And in that way I can 
develop better a model of palliative care, a model, and from that model I can influence in the 
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health system. This is one way. Private system could be a better system to design, to develop 
models for the public health system.” Physician, Europe (P10) 
 
Thus, conceptualising the relationship between palliative care and the private sector is extremely 
complicated and no single narrative is suitable for addressing this complexity. Yet, this positivity 
regarding how public and private systems may operate well in tandem was not shared amongst 
participants. Tensions were revealed in other settings where public and private health models exist 
alongside one another. Referring to this in the context of Uganda, one participant reported: 
 
“In terms of other private hospitals, private doctors, it becomes very tricky, because one of 
the things you want to be careful of, is to encourage them to include palliative care as their 
role, but then the problem is, you don’t want to refer patients to a private entity if you are 
not sure they are going to be able to pay, because then you are creating businesses for 
private entities with patients who you are not sure if they are going to be able to pay, so you 
have to be very careful about that” Activist, Africa (P16) 
 
Questions relating to pay-for-use services raise real concerns in terms of equity of access to 
palliative care. Within private systems, governments remain obliged to ensure that access is not 
determined by social status. Yet, as independent organizations, private health services are not 
subject to the same influence of government policies and regulations as national health services 
which may limit the ability of governments to act in this regard and there are known inequalities of 
access within private health systems.lv   
 
The predominant attitude of participants was to view the private sector with suspicion. With private 
systems so prevalent internationally however, it of concern that when speaking about ‘health 
systems’, that there was an underlying assumption that this referred to public health systems. Few 
ideas were presented regarding the different approaches which may be required in order to engage 
with privately run health systems in order to meet patient need with one participant commenting: 
 
“Aside from the pharmaceutical industry, I’m not sure that the private sector is that 
important” Pharmacist, Europe (P01) 
 
Engagement with pharmaceutical companies is of course important in terms of ensuring drug 
availability – one of the 4-pillars of a public health approach. What then is the relationship between 
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palliative care and the pharmaceutical industry?  
 
Palliative care and the pharmaceutical industry 
 
The overriding view which emerged from participants was that due to the low cost of generic 
medicines such as oral morphine, that pharmaceutical companies held little interest in palliative care: 
  
“I don’t think they have any interest in palliative care. Pharmaceutical companies don’t have 
much interest in us… because they don’t make any money from morphine and opioids are 
our…50% of all drugs we give patients are analgesics, and particularly opioids, and they’re so 
cheap that the drug companies can’t make a profit on it so they’re not really interested in 
selling it” Physician, North America (P03) 
 
Of further concern, some participants described how pharmaceutical influence could be exercised 
more damagingly. It has been noted previously, how physicians, funded by pharmaceutical 
companies have spread negative lessons, regarding the promotion of expensive alternatives to 
generic medicines in low-resource settings. With private companies fundamentally organised to be 
profitable, the vested-interests of the pharmaceutical industry in existing medical practice should 
not be underestimated. Referring to how private interests may be affected should the culture of 
medicine become more aligned with palliative care, one participant commented: 
 
“A lot of sectors are going to lose quite a bit of profit because the private industry profits 
from people being kept on machines and on quote/unquote drugs, medicines, until the last 
breath, it’s very profitable.” Activist, North America (P02) 
 
Some suggestions did emerge regarding how palliative care may be able to engage better with 
pharmaceutical industries. Firstly, it was noted how the power of the pharmaceutical industry can 
assist by promoting enabling regulations which enable better access to treatments: 
 
“Sometimes, the kind of interests, converge, so for example, in Mexico and actually in India it 
was the same, you have pharmaceutical suppliers of opioid analgesics, that realise that there 
is a huge market, out there that is untapped because so few physicians are able to prescribe 
the medications because of regulatory restrictions, right?… So, you know, in that kind of 
situation, the pharmaceutical industry can be pushing alongside palliative care advocates for 
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changes to regulations” Activist, North America (P12) 
 
Secondly, there was some evidence of positive engagement with pharmaceutical companies in terms 
of promoting ideas relating to corporate social responsibility. One participant referred to an 
undertaking whereby lobbyists encouraged pharma companies to contribute towards medical 
training in pain management with some success: 
 
“We actually generated about 300,000 dollars from American pharmaceuticals to really 
support training of doctors across Africa.” Activist, Africa (P16) 
 
Such examples were, however, atypical. Even in circumstances where ‘interests converge’ this does 
not negate the truism that ultimately, the term ‘private interests’ refers to profits. Therefore in spite 
of the example noted above, predominantly, the broad view was that pharma companies acted only 
in their own interests and promoted only expensive medicines which again raises concerns regarding 
equity of access. 
 
Palliative care and health insurance companies 
 
A potentially more fruitful strategy for engagement with the private sector emerged in relation to 
health insurance companies, in circumstances where patient and company interests coalesce 
through reduced time spent in hospital. In situations where health insurance is paid in order to 
ensure that medical care is free at the point of use, there may be real opportunities for palliative 
care to engage with health insurers as reduced time in hospital through more appropriate care, 
benefits patients and reduced costs to insurance companies as one participant explains: 
 
“In the healthcare industry, the private healthcare, the argument is coming across, is that if 
you can discharge people from hospital sooner, then as a health insurer you have less pay 
out, and if you’re not doing the futile care, or having people in ICU for days and days and 
days, or months and months and months, which is inappropriate care, then you’re also doing 
cost saving. So they, they’re driven by the health, the cost argument…” Physician, Africa (P07) 
 
Yet, a key challenge to the palliative care community emerges here, in terms of the specific 
interventions which health insurers should be covering. That is, just what does it mean to have a 
complex intervention such as palliative care, ‘covered by medical insurance’? This means that there 
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is a need for clear articulation regarding what health insurers are being asked to cover as one 
participant explained: 
 
“I think that with the insurance companies… think about including palliative care in their 
agendas or in the coverage plans, is this concept of holistic care, because when they want to 
cost it, they want to know how much it’s going to cost them. And so they don’t know if it’s 
going to be 3 visits by the doctor or 30 visits by the doctor, or is it going to be a nurse and a 
doctor, or a nurse, a chaplain and you know, 3 visits by a psychologist or a social worker. So I 
think that that’s one of the challenges that they face.” Physician, South America (P09) 
 
This circumstance raises challenges to the palliative care community. Just what is meant by ‘access 
to palliative care’, what does this consist of and indeed, as a complex intervention, must all elements 
be present for patients to be said to be ‘receiving palliative care’? Indeed, if the palliative care 
community is unable to determine what may be considered an adequate ‘coverage plan’, how can 
health insurance companies be expected to do so?    
       
Moreover, whilst participants expressed great optimism that palliative care would be included in 
what were at the time the forthcoming Sustainable Development Goals, as part of Universal Health 
Coverage (UHC), any such inclusion poses the same challenge to the palliative care community: 
 
“The Universal Health Coverage movement and what we are all aiming for, you know, there’s 
a global movement for UHC, so one of the things how we can get palliative care as a 
component of the Universal Health Coverage, they will also… want to know what is the 
minimum package that Universal Health Coverage needs to cover?” Physician, South America 
(P09) 
 
If we conceive of palliative care as being an inherent part of UHC, this increases the need for clear 
definitions of what access to ‘palliative care’ means in different settings. Furthermore, although 
palliative care is a complex intervention, comprising service delivery by diverse stakeholders, 
considerations of what constitutes a ‘minimal package’ of palliative care, also led to further 
problematisation, in terms of ‘what are the most important elements of palliative care’? That is, if a 
‘maximum package’ remains out of reach, then what would be the ‘key asks’ of the palliative care 
community, which services policymakers should focus upon meeting?  We turn to this now. 
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Prioritisation between elements of palliative care 
 
When speaking about prioritisation within developmental health systems, as described above, one 
participant inferred the need for pragmatic decisions to be made. That is to say, for instance, that it 
is rational to focus upon increasing life expectancy through interventions such as vaccinations, 
within contexts where life expectancy is particularly low. In the same sense, the question was put to 
participants in terms of palliative care, ‘if it is not feasible to roll-out all elements of palliative care at 
the same time, then what should come first?’ 
 
It is important to acknowledge before proceeding, that it runs counter to the very definition of 
palliative care as a multi-faceted discipline, to consider its potential divisibility into separate 
elements. However, within a context of resource-scarcity, considering potential ways in which 
‘palliative care’ might make policy gains seems appropriate. However, this suggestion did not meet 
with unanimous agreement amongst participants. For instance, when asked about the potential 
divisibility of different elements of palliative care, one participant responded: 
 
“We need to make sure we don’t lose sight of the fact that palliative care is holistic care and 
Cicely Saunders’ total care for total pain... Because that’s what palliative care is, bringing the 
heart and the compassion and the attitudes and the caring of the healthcare worker, 
whether they’re the social workers, the spiritual counsellor, or the doctor or the volunteer 
carer and it’s more…that attitude, that attitude of caring that is the intervention of palliative 
care. So when you say ‘does it have to be all at once’, it really should be.” Physician, Africa 
(P07) 
 
Although this participant was certainly not alone in regarding palliative care as non-divisible, other 
participants diverged from this view. Especially in terms of strategies for advocacy, other 
participants saw real value in advancing arguments focussed upon specific elements of palliative 
care. Referring to the work of their organization, one participant reported: 
 
“In our research and advocacy we’ve prioritized treatment of pain because it’s often the most 
pressing issue for patient and family” Activist, North America (P12) 
 
Focussing upon pain as the ‘most pressing’ issue for palliative care was also deemed appropriate to 
the PPI Representative, although this view was presented with some qualification: 
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 “Psychological help, social help, I think those are very nice things to have, so I guess if you’re 
going to try and save money, I think that pain relief is it… [Though] I think we’re very luck in 
this country [UK] to be even thinking of adopting such a holistic and rounded approach to the 
whole thing, and we should treasure that, not let it go.” PPI Representative, Europe, (P11) 
 
In this regard, it may be suggested that whilst there are potential prioritisations to be made within 
palliative care, that these are only relative and that all elements are perceived to be important. 
However, some participants did not err from the views supporting the idea that ‘everything should 
come at once: 
 
“It needs to be the whole package. Because if you’re just doing pain management, you’re not 
doing palliative care, if you don’t have the others, you’re not giving palliative care, we need 
to realise that palliative care is a package, it’s never, you don’t just do emotional care, you 
don’t just do spiritual care, you don’t just do clinical care, it’s the package.” Nurse, Africa 
(P06) 
 
However not all participants viewed palliative care development in such terms. Whilst not 
challenging the philosophy of palliative care as a holistic intervention by sub-diving it into elements 
one participant suggested: 
 
“I think some of the challenges we have had ourselves, as palliative care, is our, our 
unwillingness if I can put it like that, to put palliative care into different components, which 
are sellable to different players. Sometimes we always need to say, ‘we want people to take 
the whole thing’. And sometimes maybe we just need to promote pain, pain management, 
and just promote that. Sometimes maybe we need to promote just psychosocial support, and 
because that is what resonates with the person we want to promote this issue to.” Activist, 
Africa (P16) 
 
Thus, sub-division and prioritisation of different elements may hold potential for advocates to 
deliver clear policy messages, something which palliative care has traditionally struggled to achieve 
as has been discussed. Additionally, sub-division may lend itself to increased clarity regarding just 
what a ‘minimum package’ of palliative care, which is of real import as the palliative care community 
seeks to better engage with global priorities relating to Universal Health Coverage. 
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With advocates keen to place palliative care within such global-level priorities, it is appropriate to 
now consider participants’ perceptions of the challenges and opportunities for palliative care 
advancement amongst the current global governance system.  
 
 
 
 
 
 
 
Theme Five: Global Policies, Leadership and Actors for Change 
 
“Why do we need palliative care, because we don’t have money to pay [for] health, spending 
the money in the way we’re spending it now, it’s impossible to give better primary care to the 
populations, we cannot sustain the health system” Physician, Europe (P06) 
 
As identified throughout this study, global level policies and national-level practices are inextricably 
linked. Within such relationships, the power dynamics are varied, with different types of policy able 
to influence national governments in different ways (see Chapter Three). Certain policies are 
enforceable (international laws), whilst others provide attainable standards which governments are 
expected to enact (conventions) whilst others serve to limit practices with the aim of preventing 
harm (regulations).liv Within this environment, a wide range of actors operate to both influence 
change in policy approach as well as to enforce existing policies. Additionally, the complexity of the 
global governance landscapes means that certain actors and policies may serve to create an enabling 
environment for palliative care development, whereas others may act to limit such progress. 
 
Different actors hold different levels of relative power to achieve influence.liv Further complexity is 
raised in terms of the development of policies which are truly ‘global’, by which is meant, applicable 
and relevant to all regions of the world. Such circumstances present acute challenges in the 
formulation of policies relevant to palliative care, where the distance between global policies and 
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individualised patient-care is great. As such, discussions included comments upon the transferability 
and appropriateness of global-level policies to different national contexts.  
 
This theme therefore, reviews the views of participants regarding the existing international policy 
landscape, to consider its likelihood to lead to further palliative care development. Furthermore, key 
actors are identified who are seeking to affect such change. Following concerns regarding the 
sustainability of health systems presented above, the sustainability of palliative care development is 
critiqued based upon emerging questions relating to the sustainability of pioneer-led models of 
development and bilateral funding relationships. On this basis, the potential for structural and 
sustainable change is reviewed within the context of existing and diverse global guidance and 
policies.  
 
Emerging commonly from such discussions were ideas regarding both the need for more ‘leadership’ 
both within nations and from global actors as well as examples of where effective leadership both by 
individuals and organizations has affected positive change towards the further development of 
palliative care. 
 
Leadership 
 
A range of issues relating to leadership emerged. In terms of global-level leadership, almost all 
participants looked towards the World Health Organization (WHO) with almost universal approval of 
their work. A clear example emerged from Africa where one participant suggested: 
 
“The WHO has provided great leadership on palliative care. They recognise palliative care 
from the beginning, from diagnosis, so we are using that as, the global community has been 
using that as underpinning phrase for palliative care globally, and the WHO has also done 
the Resolution for palliative care, and that has given a huge credibility for the debate around 
palliative care. So that is increasing the awareness of palliative care at global level.” Activist, 
Africa (P16) 
 
As previously addressed, the need for increased awareness of palliative care issues at global level is 
acute and certainly participants concurred that WHO leadership was both necessary and occurring. 
In policy terms, this leadership has been crystallised in the passing of the World Health Assembly 
Resolution ‘Strengthening of palliative care as a component of comprehensive care throughout the 
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life course’.lvi Participants universally ascribed value to the passing of this Resolution. Commenting 
upon the current policy climate at global level in in this regard: 
 
I think it’s better than it ever has been, for, the global development of palliative care,  
country, I mean the Resolution passed unanimously and essentially, member states are 
countries calling on themselves to develop palliative care to include palliative care in their 
healthcare systems and they’ve never done that before, and now we have that a tool to use, 
and I think we actually have a window of opportunity in the next few years to really promote 
global palliative care development, which may fade over time.” Physician, North America 
(P03) 
 
Agenda-setting by the WHO and the signing of the Resolution by member states, are encouraging 
signs, however further discussions raised doubts regarding what the Resolution could feasibly hope 
to achieve. By their very nature, Resolutions are a formal commitment, yet there are no 
consequences for failing to live up to these voluntarily incurred obligations.liv That is, that there is no 
enforcement mechanism for governments who fail to enact the terms of the Resolution. One 
participant acknowledged the importance of the Resolution, as well as its limitations: 
 
“I think certainly as an international community… for those participants, the delegates for 
each country to make that vote publicly and in front of the world is a very very strong, a very 
strong first step… and the very fact that the topic was raised and responded to with that 
alacrity is very important. The actual then mechanism of process from that point on, of how 
countries pick up that vote that they’ve made, how they move with that vote I guess, that’s 
the question isn’t it? And you’re quite right, there’s no absolute enforcement, there’s no 
tribunal which will penalise a country.” Physician, Australasia (P14) 
 
In short, there is a lack of formal accountability mechanisms to hold governments to account, in 
circumstances where they do not fulfil their obligations. Further discussion regarding both formal 
and informal mechanisms for accountability will be discussed in due course following additional 
issues which were raised in terms of global and international leadership. 
 
Instances of positive leadership sat alongside a perceived need for greater leadership within the field 
of palliative care. One participant was included within the study population to represent a distinct 
stakeholder group, representing the charitable arm of a private company which sought to address 
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this perceived lack of leadership through an international training course in Europe. Having 
identified that often many palliative care ‘leaders’ were clinicians who were given into managerial 
and advocacy roles having not had any formal training as to how to perform them as described here: 
 
“We noticed that there are a lot of very competent people in palliative care, and the people 
that work in palliative care , you know, they know what they’re doing, they know exactly how 
to treat a patient, and they’re very caring towards that and these people often slip into 
managerial roles. They become heads of hospices, or they become, I don’t know, advocacy, 
or they’re heading some kind of organization, and although they are, you know, they know 
what they’re doing on a practical basis, that they sometimes just don’t have the managerial 
skills required to lead a team, or they’ve never learned how to lead a team. So they’re sort of 
doing it, learning by doing.” Program Officer, Europe (P08) 
 
What this suggests, is that in many circumstances, palliative care professionals are often thrust into 
situations for which they have no training. In this regard, whilst the emphasis in terms of education 
within this study has been upon the need for greater international awareness and understanding of 
palliative care, the field of palliative care itself has much to learn in terms of developing and leading 
service development within the broader healthcare architecture. 
 
This circumstance raises related issues concerning the sustainability of palliative care development. 
Pioneer-led models of development are common around the world, whereby motivated 
professionals, with palliative care skills have driven progress in palliative care in other national 
contexts. However, such models may be personality-driven and this perceived lack of leadership 
skills, causes concern for when such personalities discontinue their work. Commenting on what has 
occurred in Australia one participant reported favourably, but with implicit caution: 
 
“In the very early days it was those inspired champions that move and shook. Perhaps, not so 
much the medical establishment, but just the sense of the purpose of our palliative care, and 
there was quite a missionary zeal almost, for many of them. I think that [there is] a danger of 
course, where the pioneers, don’t attend to that issue of succession...The best leaders in this 
country have had that ongoing perspective,, I suppose part of it was the very fact of 
educating a whole group of junior doctors, who then became senior doctors, in palliative care, 
and a great sense of contentment that those doctors had been trained well and that services 
could be handed over, to those doctors. So there will be still, probably half a dozen of the 
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pioneers are still living, but retired now, and I think on the whole that succession has been 
smooth.” Physician, Australasia (P14) 
 
This is a long, but important quote, which illuminates two things. Firstly, that one way in order to 
affect structural change may indeed be, to follow WHO guidance and place ‘education’ as the 
cornerstone for the sustainability of development. Secondly, it contains a warning regarding this 
issue of ‘succession’ and the potential for deceleration and even a rolling back of progress if and 
when strong personalities who have developed pioneer-led models move on. 
 
Thus, it appears that a lack of leadership has been identified as a problem and that some solutions 
are being put into place in order to address this. Yet, it should be noted that the leadership training 
initiative described above, is not being provided by member-state funded International 
Organizations, but the international charitable arm of a private company, as philanthropic 
endeavour. Furthermore, this is a short-term program, taking place only in Europe. Where is such 
leadership coming from for other world regions? 
 
One participant reported upon an educational initiative emanating from North America, which is 
seeking to address the same perceived lack of leadership in Africa, Central Asia, Eastern Europe, 
Latin America, the Middle East, and Southeast Asia. This program arose due to similar perceptions of 
the existence of able people, being asked to operate in roles outside of their skills and experience as 
above. Describing how the initiative was conceived:  
 
“There was a real recognition that there were a group of international people who were 
palliative medicine consultants, but really needed leadership skills training” Physician, North 
America (P13) 
 
The same participant reported that the initiative was indeed having success through the 
empowerment of new national-level leaders: 
 
“It’s actually quite staggering what some of these people have done. Way beyond what a 
typical graduate in the UK, or the Unites States would do, these people are really advancing 
palliative care in their country, and they’re often doing it with great difficulty.” Physician, 
North America (P13) 
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Such examples reinforce the need for leadership, as well as how it can be beneficial for palliative 
care development. Yet, it is important to note, that once more, such initiatives have not been driven 
by kind of member-funded International Organizations or national governments and again is funded 
by philanthropy. This is significant, as such funding streams are often short-term and moreover, do 
not represent commitment from the formal international community to further palliative care 
interests. 
 
In this sense, leadership is occurring at national, international and global levels, though with 
different emphases. No global-level funding streams emerged from interviews which fund such 
leadership programs towards the enaction of the WHA Resolution and this has been left to civil 
society organizations to plug this gap.  
In this regard, different civil society actors emerged as important actors in terms of holding 
governments accountable for to their responsibilities to globally-set policies. The following section 
therefore considers the very appropriateness of global policies in terms of their potential to further 
develop palliative care on a global scale. Moreover it considers how civil society actors are working 
within the global policy landscape and alongside other actors to advance palliative care interests 
within national contexts.   
 
Civil society, accountability and appropriateness of global policies 
 
Aside from the WHO, other organizations under the umbrella of the United Nations, emerged as 
actors with roles to play in the development of palliative care including; United Nations Children's 
Fund (UNICEF) and the United Nations Human Rights Council (UNHRC). Discussions in this regard, 
applied to assertions that access to palliative care should be a human right and that failure to ensure 
access, is tantamount to cruel and degrading treatment, or torture. A more detailed account of how 
such arguments are constructed and their validity is provided in the final theme, ‘Framing Palliative 
Care’. However, here the focus of discussion is upon how participants viewed civil society 
organizations play a role in holding governments to account through lobbying, with a focus upon 
access to pain treatment. Additionally, questions regarding the relevance of rights-based arguments 
as global policies to all world regions are presented. 
 
At the time of interviews, the Sustainable Development Goals were on the cusp of finalisation. As 
was identified previously, no palliative care indicator has been included against which governments 
may be held accountable to their obligation to provide palliative care as signatories of the WHA 
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Palliative Care Resolution. In this regard, other approaches to holding governments accountable 
occupied a good deal of discussion. 
 
Several global level actors were identified as having roles to play in the assurance of citizens’ rights 
to pain treatment. Human Rights Watch (HRW), an International Non-Governmental Organization 
(INGO) emerged as a key actor for holding governments to account for failing to ensure access to 
palliative care essential medicines. Describing their work: 
 
 [They] have basically done research and advocacy in about a dozen countries looking at 
what barriers patients who need palliative care encounter, and analysing what the policy 
reasons for those barriers and then we have been conducting advocacy in order to try and 
convince governments to, to take steps to remove the barriers we have identified.” Activist, 
North America (P12) 
 
Such efforts aim to educate governments as to their obligations, as well as holding them to account, 
where government actions (or inactions) fail to take necessary steps to meet their commitments to 
human rights conventions. Describing the situation in India, prior to the easing of regulations which 
previously served to restrict access to morphine: 
 
“There was something like 29 regional cancer centres, which are supposed to be 
comprehensive cancer centres, and the majority of those did not have morphine, even 
though, 70% of their patients had incurable cancer and the vast majority, of them actually 
needed morphine. Now, that’s a clear cut situation, I mean, clearly there’s no, the 
government knows what’s going on, it acknowledges that the regulations are causing an 
enormous amount of suffering, and yet you have major cancer hospitals, that see tens of 
thousands of patients per year who are dying of cancer that do not actually have the 
medication.” Activist, North America (P12) 
 
Such enforcement requires nuance in order to influence change in governments’ policies. It is, for 
example, of no use for such organizations to approach governments overly aggressively accusing 
them of human rights abuses, in particular when as has been addressed palliative care issues are 
often not well understood by policymakers. However, as the above quote shows, a more direct 
approach is appropriate when governments are aware of their obligations but fail to take the 
necessary measures in order to meet them.  
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However, HRW does not act alone and there was acknowledgement by participants that a 
confrontational approach needs to be accompanied by more enabling assistance. In this regard, 
organizations such as the International Association of Hospice and Palliative Care (IAHPC) and the 
Worldwide Hospice Palliative Care Alliance (WHPCA) and other international-level palliative care 
organizations have adopted a two-pronged approach to holding governments accountable to human 
rights obligations. One participant described this dynamic: 
 
“Governments are actually a bit peeved when you come at them with human rights, it’s a 
confrontational discussion, but that’s one of the reasons why Human Rights Watch and 
WHPCA and IAHPC, have such a good partnership, because Human Rights confronts, and we 
say ‘how can we help you improve’.” Physician, Africa (P07) 
 
Success stories regarding the use of such an approach were also identified. In Mexico, for instance, it 
was described how prohibitive government regulations limited physicians’ ability and willingness to 
prescribe morphine. Through awareness raising and education by HRW, the government recognised 
that it was their own regulations which were causing people to suffer extreme pain, without 
appropriate medications and changed the regulations to facilitate easier prescribing processes and 
increase access to pain relief. Similarly, in India, prohibitive regulations were tackled through actors 
at global level, lobbying the national government, in tandem with actions by national-level palliative 
care activists: 
 
“I feel that what has happened is that India has signed the Convention on Narcotics, which it 
had not done any work on and organizations like Human Rights Watch, the WHO, had been 
very critical about it and I must pay tribute to people in the palliative care arena, who have 
been campaigning for you know, better opioid availability, for making palliative care a part 
of the National Health Program” Physician, Asia (P04) 
 
This quote highlights the interaction between global level action and national policymakers, most 
notably in this instance, Ministries of Health who were identified as key actors for change.   
Yet, alongside successful examples of rights-based approaches to lobbying governments, evidence 
also emerged to suggest that rights-based arguments are not necessarily well-received, or relevant, 
in all world regions as referred to below: 
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“I can understand, the perception of an individual right to have access to care as a political 
statement, as if to get governments to provide for their citizens, but, in some of the Eastern 
cultures, right is, you can have rights, but the right doesn’t always reside with the person… 
and it is seen in Malaysia for example… as a very secular way of dealing with things, whereas 
if you look at countries where they are more inclined to be spiritual and religious, the right of 
a man, the right of a human are very different from a human rights approach… I agree with 
the concept of human rights in palliative care, but I disagree on how it can be used to effect 
change, and I prefer to use things like ‘responsibility’ and ‘duty’, I think you can achieve the 
same thing by using a different approach.” Physician, Asia (P05) 
 
It is well known that approaches to palliative care development must include adaptation for local 
context.lvii In this regard, the above quote is significant, as it suggests that regional approaches to 
advocacy may also be appropriate. Regional palliative care associations were identified in all regions 
of the world, however, in terms of advocacy doubts were cast upon the possibility of a regional 
approach: 
 
“Can something be done at say regional level, I think that it’s actually difficult, because of the 
global environment now, you know, information is shared across the world, there is 
sometimes a challenge to follow what is done in different countries. Many indices and 
measurements are done globally as well as regionally, the quality of death index in 2010, 
done by the Asian Intelligence Unit, looked at 40 countries, and so, can you look at that 
regionally? You look at it globally.” Physician, Asia (P05) 
 
The quote is suggestive of ongoing processes of policy diffusion, whereby, what occurs in one 
country or region can have influence beyond borders. Additionally, it highlights the challenges of 
formulating global-level policies which are universally relevant in all regions. This question of which 
palliative care issues are ‘universal’, occupied much discussion with participants. For instance, 
universal truths were identified regarding mortality as well as physiology. However, even such 
universal experiences are not necessarily conducive to prescriptive, one-size-fits all policy 
approached as suggested here from the context of educating physicians in low-resource settings: 
 
If I’m doing pain management for example, the pharmacology is the same, the approach to 
assessment is the same, teaching that, what’s different is, ‘what drugs do they have?’ 
Physician, North America (P13) 
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In this regard, whilst the INCB regulations allow the use of strong medications in all national settings, 
medical practice remains dependent on the resources which are available within any one country. 
Therefore, global policies have to be general enough to cover all settings and often navigate this 
complexity by focussing upon ‘essential medicines’. This has led to an absence therefore of specific 
targets relating ensuring access to cheaper drugs such as oral morphine, and allows nation states to 
be compliant with regulations, even if they only ensure the availability of expensive drugs. Therefore, 
whilst global-level regulations do not specifically prohibit access to opioid analgesics, it does not 
necessarily follow that, this makes existing regulations ‘appropriate’.  
 
The importance of discourse was once more identified as relevant here. Essential medicines are 
regulated at global level by the International Narcotics Control Board. That is, the same organization 
which seeks to inhibit access to illicit drugs. Commenting upon this in terms of access to essential 
treatments, one participant commented: 
 
“That’s part of the deal, to stop calling them drugs and start calling them medicines” Activist, 
North America (P02) 
 
Furthermore, signatories to the United Nations Convention against Illicit Traffic in Narcotic Drugs 
and Psychotropic Substances, 1988, operate within guidance which tonally suggests that ‘drugs’ 
should be restricted rather than enabled for medical use. Additionally, this convention is distinct, as 
unlike other Conventions and Resolutions addressed in this section, as it has a formal accountability 
mechanism in terms of the INCB. However, more commonly organizations such as the World Health 
Assembly, lack both the power and the resources in order to implement their own policies.  
 
With this is in mind, it is appropriate to consider which global level organizations do have the 
resources in order to effect change through direct processes of policy transfer. On this basis, the 
analysis proceeds to discuss participant views on global financiers which are relevant to palliative 
care interests.  
 
Global level funding streams 
 
Arguments were presented relating to how a reallocation of existing healthcare resources, both in 
terms of financing and human resources, offered a realistic and sustainable model for palliative care 
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development in Theme Four. However, alongside such discussions was awareness that new sources 
of national and global level financing were needed in order to achieve progress. Before considering 
potential new sources of funding, firstly, existing funding models which exist internationally will be 
reviewed, in terms of both their adequacy and their sustainability. 
 
As identified above, philanthropic organizations, most notably the Open Society Foundation (OSF), 
were identified as being funders of both palliative care services as well as educational initiatives. As 
the following quote illustrates, however, concerns were revealed regarding an overdependence 
upon this funding stream: 
 
“Well, up until now and it’s drying up, it’s been from the Open Society Foundation, I mean, 
Soros1 has pretty much funded this stuff single-handedly. USAID has done a lot, but in terms 
of palliative care funding, there’s almost none, except through private philanthropy, and in 
fact, civil-society is doing member states jobs and doing the work of the International 
Financial Institutions, like the World Bank.” Activist, North America (P02) 
 
Many participants pointed to the important role which the OSF has played in funding development, 
yet it is an overstatement to say that they have done so ‘single-handedly’. However, real questions 
are raised regarding both the sustainability of and reliance upon on this source of funding. Although 
such organizations will operate with varying degrees of autonomy in terms of where they direct 
funding, in some sense, the involvement of philanthropists is consistent with ‘pioneer-led’ narratives 
of palliative care development. That is that individuals, in this sense both in terms of persons as well 
as organizations are driving development. Such involvement from civil society organizations is to be 
welcomed. However, this model raises grave questions regarding the sustainability of funding 
streams, whereby, priorities and interests can change, hinted at by the reference above to funding 
‘drying up’. Furthermore, short-term grants do not allow long term strategic planning without the 
involvement of additional stakeholders.    
 
As well as philanthropic organizations, similar critiques may be given to funding streams given by 
charitable organizations. In the context of Africa, the Diana Princess of Wales Memorial Fund was 
identified as being a key funder of Hospice Africa in Uganda. Yet, in spite of the professed success of 
the ‘Uganda Model’, it was revealed that in spite of their classification of a country which has 
                                                          
1
 George Soros is a billionaire philanthropist who has funded many palliative care programs through the Open 
Society Foundation. 
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achieved ‘full integration of palliative care into the health system’, it remains reliant on such 
charitable funding streams. As one participant reported: 
 
“Even now, they do work with money from donors, with very limited support from the 
government, despite the integration, so that is an area where it is lacking in terms of 
integration.” Activist, Africa (P16) 
 
This ongoing need for funding is not a problem isolated to one world region. In the United States 
(US), another country which has supposedly successfully integrated palliative care into the health 
system, hospices continue to have to raise their own funds through charitable work. This point was 
noted, alongside risks regarding equity of access, where services are reliant on benevolence: 
 
“You can’t really have an impact if you’re going to be outside the system and you’re going to 
just use charitable dollars to take care of a few patients, which somebody called, ‘deluxe 
dying for the few’” Physician, North America (P03) 
 
The funding provided by philanthropic and charitable organizations as presented, once more 
demonstrates the key role which civil-society organizations have played in the international 
promotion of palliative care. What then of the key multilateral global health financiers? 
 
As noted above, USAID was identified as having had involvement in the promotion of palliative care 
interests following involvement of the now defunct President's Emergency Plan for AIDS Relief. 
Whilst the involvement of such agencies with their high levels of potential resources should be 
considered positively, their involvement was, identified in the context of palliative care need relating 
to HIV/AIDS only. Referring to experience working with USAID it was suggested: 
 
“They supported the palliative care but it was from the perspective of HIV/AIDS” Pharmacist, 
Europe (P01) 
 
Whilst all support for the furthering of palliative care may be welcomed, a disease-specific approach 
to development is not in line with a key message which advocates are trying to deliver, that 
palliative care is needed for all serious and incurable illnesses. Furthermore, consistent with an 
approach which supports nationally-devised priorities, the support of USAID was perceived as reliant 
upon governments requesting funding for palliative care: 
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“USAID, in Kenya, they come to speak to the Ministry of Health in Kenya and say, ‘what are 
your plans?’, and the Minister of Health says, ‘these are the things we are tracking’. If 
palliative care is not part of the thing that the Minister of Health is tracking, it’s never going 
to be included in the USAID Country Operating Plan.” Activist, Africa (P16) 
 
This hints at the potential for greater of involvement of USAID, however, concerns must also be 
raised, due to the broad lack of awareness of palliative care amongst national policymakers as has 
been described. Furthermore, there is ongoing need for funding for palliative care not only at 
national level, but at global level itself. The WHO has been identified as facilitating the development 
of palliative care through the issuance of guidance. However, even global organizations are being 
hamstrung by a lack of financing to further palliative care interests as reported here:  
 
“Unfortunately, the WHO doesn’t have much money because since 1992 the states’ 
contributions have hardly increased, they followed inflation, but, that’s all. There was a 
palliative care resolution you may be aware of from the World Health Assembly last year 
that’s also requesting WHO to develop more pain guidelines. But, the funding is the problem 
there.” Pharmacist, Europe (P01) 
 
Thus, scarcity of funding is an issue which exists at all levels of global health governance. In this 
regard, it was suggested that civil-society is performing roles which should be the responsibility of 
national governments and global funding agencies.  Indeed, although many actors within civil society 
have been real drivers for change in terms of palliative care development, emerging frustration was 
identified at the lack of engagement of many actors who were deemed to be not living up to their 
obligations with regards to palliative care, with one activist asserting: 
 
“Civil society, academia, many of the colleagues that we all know are doing governments’ 
work for them and they’re doing the IFIs [International Financial Institutions] work for them 
and they’re doing, you know, the regional associations work for them and it’s time for 
governments and the UN and the World Bank to step up to the plate and stop letting us carry 
the water for them.” Activist, North America (P02) 
 
Owing to the key roles played by civil society individuals and organisations in driving palliative care 
development, frustration in this regard appears justified.  
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Organizations such as the World Bank have both the financial resources, as well as the technical 
expertise, necessary to both influence and support national governments in developing sustainable 
palliative care systems however they are simply not doing so. Indeed, a key area of consensus 
amongst participants was the assertion that a wide range of stakeholders held responsibilities which 
they were not fulfilling with regards to palliative care.  
 
Finally, as well as their roles as service providers, mechanisms for accountability and funders, one 
final role which civil-society members could play acting as drivers for change was identified, as 
advocacy. There was consensus amongst participants, that the way to engage new stakeholders at 
national, international and global levels was through targeted advocacy campaigns. It follows due to 
the diversity of potential stakeholders which it was suggested should be targeted through advocacy, 
that a multi-faceted approach would be necessary, which utilised all of the varied ways in which 
arguments may be made for further development of palliative care.   
 
Theme Six: Approaches to Advocacy and Framing Palliative Care  
 
“What is our contribution to the wider debate? What is the contribution of palliative care to saving 
mothers, what is the contribution of palliative care to saving HIV? You know?” Activist, Africa (P16) 
 
As described throughout this study, policy issues may be presented in different ways, using different 
‘frames’ to describe the same problem/solution (See Chapter Three). Different frames hold differing 
potential to influence different actors. Similarly, ‘frames’ are said to have relative power to achieve 
change, with ‘national security’ issues said to hold the highest likelihood of influencing national 
policymakers.vi Within this theme, participants’ views of the varied ways on which arguments can be 
made for greater roll out of palliative care services are given. Prior to presenting each of these 
‘frames’, a brief discussion of participants’ perceptions of more general issues relating to advocacy is 
given in terms of; ethics, strategic partnerships as well as potential targets for advocacy at both 
national and international levels. 
 
Key issues for advocacy 
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Thus far, a wide range of opportunities and barriers have been identified to the further development 
of palliative care. In this regard, there are many of issues advocates must engage with, in order to 
overcome obstacles and capitalise upon areas of potential gain. Within a context of different 
advocacy lobbies competing for attention, one participant and experienced advocate described their 
work as:  
 
Mainly looking at how palliative care can be integrated into drug policy, donor financing, 
international NGOs, international policies and making sure that other people really get 
aware, academics and research, making sure people get aware, get more knowledge and 
information about palliative care. Activist, Africa (P16) 
 
These are diverse foci, comprising many issues and actors. They address issues relating to access to 
medicines, finance, partnerships, policies and raising awareness through education as well as a need 
for an improved evidence-base. Issues relating to ‘access’ within this study have primarily focussed 
upon access to pain treatment and palliative care, however such issues also appear in terms of 
advocacy. A further challenge to advocates relates to gaining access to those whom they seek to 
influence. One participant described this barrier to advocacy along with some suggested 
organizations who palliative care advocates should be seeking to influence, from a perspective of 
paediatric palliative care: 
 
“The big UN agencies, of course, WHO, USAID, UNICEF, all of these we are acting with, at 
present, we actually have a side-event at the World Health Assembly in two weeks time 
specifically for paediatric palliative care, so that’s where we’re really going to give the 
message around paediatric palliative care, but I think you know, also…  global level funders, 
like Global Fund, USAID, the Gates Foundation, it’s just finding a way to get in there. I’m sure 
if we could get in there we could make the argument, but it’s not that easy…” Nurse, Africa 
(P06) 
 
The quote describes to some extent, how merely ‘holding a seat at the table’ and being present at 
policy events increases the likelihood of advocacy messages to be heard and understood by policy 
actors. Additionally, the key challenge of gaining access to policymakers who hold no pre-existing 
interest in palliative care is suggested, raising the question of how can you influence people whom 
will not hear your voice? This is a challenge faced by all advocacy lobbies, however one way in which 
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to increase the reach of an advocacy message is to form partnerships. Describing their work with the 
International Association for Hospice and Palliative Care (IAHPC), one participant reported: 
 
“We are an NGO in formal relations with the World Health Organization and in this capacity 
work with governments, policy makers and the civil society of many different countries. We 
maintain relations with presidents and directors of national and regional palliative care 
associations and programs throughout the world.” Physician, South America (P09) 
 
Once more the importance of ‘a seat at the table’ is referred to whereby advocates are involved with 
global level health discussions on an ongoing basis. Partnerships were referred to in the previous 
theme, where a two-pronged approach was adopted by HRW and IAHPC to both confront national 
governments who were limiting access to pain medications as well as to assist them, more 
supportively through technical assistance on how to address the issue.  Additionally, partnerships 
were one way in which it was suggested that palliative care advocates could engage with 
pharmaceutical companies on issues of shared importance. As referred to previously, much palliative 
care advocacy has prioritised the issue of access to essential medicines, an issue where the 
importance of policies which enable access to medicines, rather than ones which aim to restrict their 
use are paramount.   
 
Although participants identified existing and potential partnerships which may be able to further 
palliative care interests, it was notable that almost all examples related to actors involved in the field 
of palliative care. This suggests that advocacy efforts have thus far not focussed upon new potential 
allies outside the field or that they have been unsuccessful in forging any such partnerships. 
Instead, common narratives related to how cognitive change of actors not currently involved with 
palliative care could be achieved through experiential learning, or the elicitation of improved 
attitudes towards palliative care through story-telling. 
 
Experiential learning and story-telling 
 
Many participants attributed a high degree of value to the idea of changing perceptions and gaining 
influence through ‘story-telling’. What is meant by this is that through the presentation of palliative 
care narratives, which describe the patient journey, from illness related suffering, to improved 
quality of life once palliative care is introduced, new actors could be engaged with palliative care 
issues. Such an approach was said to be more effective, when it resonated with the personal 
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experiences of advocacy targets: 
 
“I’m aware… how an audience can be transfixed by a story…the striking nature in palliative 
care and I think there’s an innate, intrinsic intensity when you start to talk about an ill person 
who may be close to dying… and telling stories I think can be quite profound for policymakers, 
and indeed it may be their own personal stories, the loss of someone in their own lives that 
might be a catalyst, and quite a significant catalyst, for them to start to think along the lines 
of better access to opioids, or about palliative care” Physician, Australasia (P14) 
 
This relates to ideas of experiential learning and plays upon ideas of moral obligation. Such issues 
will be returned to in subsequent sections, however, in terms of strategy, the idea of story-telling, 
either orally or visually, was recurrent within participant discussions. One participant reported how 
‘patient narratives’ have been used to raise awareness of the consequences of absence of palliative 
care, as well as the benefits for patients once it is accessed. Describing the complicated ethical issues 
which arise in terms of the use of images and stories of suffering: 
 
“If you look at the palliative care it has evolved showing lots of graphic images and people in 
pain and screaming and that is absolutely not good, it’s counter-productive, and we don’t 
want to show, to even increase vulnerability for people who are already vulnerable. So, the 
way we have done this is to capture the voices of people, people giving their story…We have 
patients come to give testimonies, but these are not patients who are bed-ridden and having 
all these graphic photographs of patients, it’s a person saying ‘when I was in pain, this is 
what happened to me’.” Activist, Africa (P16) 
 
Issues relating to how the moral argument for palliative care is constructed will be returned to. 
However, this suggestion of influencing policymakers through experiential learning is one which was 
said to gain attention as described by one physician: 
 
“I think the experiential effect of knowing somebody who has received palliative care, 
reverberates around the community, and that, changes perceptions, it raises expectation. I 
was looking after a Minister’s mother, one of the Ministers in the government, and we 
provided palliative care to his mother and he said, ‘now, if you can do this, why can’t our 
hospitals do this? Because they had been in their own hospitals and private hospitals, ‘you’re 
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providing a free service and you’re doing what others can’t do’. I said, ‘that’s a challenge to 
you, you’re in a position of power…you make the change’” Physician, Asia (P05) 
 
Once more this approach remains reliant upon individuals and personalities, however, some such 
individuals may hold the potential to act as ‘gatekeepers’ for policy change and indeed, individuals 
such as Ministers for Health hold the power to influence not only national policy, but to garner 
global level support for action. A previously used example described how the formulation of a 
national-policy for palliative care allowed engagement with organizations such as USAID, who do not 
transfer policies ‘from above’ and instead support issues defined by national governments. 
Additionally, Ministers of Health hold the power to formulate such national plans to promote 
national-level action for palliative care: 
 
“What we say is that for them to make sure there is a national policy for palliative care. The 
reason why we want them to have a national policy for palliative care is… they are likely to 
have some funding allocated. Because that is how governments allocate their grants, 
whatever they are funding, whatever is in policy that is what they support.” Activist, Africa 
(P16) 
 
A further strategy for advocacy which was identified related to engaging actors such as communities 
and the media in order to raise awareness of issues relating to palliative care. In terms of 
community-engagement one participant described a local initiative: 
 
“Here in Kenya, the Kenya Hospice and Palliative Care Association, has been very very, active 
in doing public profiles, they do walks, they do like a public walk, where they talk about why 
they are walking the streets, they have t-shirts, talking about suffering, you know, ‘let’s end 
suffering’, they have all these t-shirts, and they don’t say what suffering it is, and people ask, 
‘what is this suffering you are talking about?’” Activist, Africa (P16) 
 
Such an approach focusses upon fostering community engagement by increasing understanding and 
starting conversations regarding the importance and need for palliative care. Additionally the 
importance of a message such as, ‘let’s end suffering’, which is at once clear but at the same time 
vague enough to provoke debate appears likely to encourage both discussion and understanding.  All 
such strategies must, however, be multi-faceted as the impact of such ‘public walks’ is likely to be 
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felt at community level only. Considering the national level, the importance of engaging the media 
was described in such terms: 
 
“There are so many different ways you can start public debate. Go to the TV, go to the Radio, 
and start a conversation, everybody in Kenya, 90% of people in Kenya have a radio, have a 
conversation on the radio, have people call in and ask questions, really use some of the 
generic ways we give people information, do a newspaper spread.” Activist, Africa (P16) 
 
This is a useful example, which demonstrates the value of locally-relevant advocacy approaches. 
Here the communication media suggested is ‘radio’ due to the wide audience which can be reached, 
however, in other contexts a different approach was adopted, which once more played upon locally-
relevant issues. Ruing what they perceived as the failure of the palliative care community to present 
itself effectively, as well the need to provide a message which is publicly acceptable, one participant 
commented: 
 
“When you look globally, there’s a lot of discussions around end of life care, and things like, I 
think there might be a session here on ‘the good death’, anything to do with death is not 
good, and whilst palliative care people are very open to talk about death and dying, the 
general population are not. And I think that’s where we do need better people at things like 
‘selling the product’, marketing. Physician, Asia (P05) 
 
This discussion continued following the conclusion of the formal interview and the participant 
described how their organization has produced awareness raising short videos, presented by 
national celebrities, which are played in national cinemas. Once more, such efforts are aimed at 
increasing awareness and fostering discussion, with the involvement of celebrities to deliver the 
message, an approach consistent with one element of a ‘successful advocacy strategy’ as suggested 
by WHO.lxix Similarly, the same participant described an additional local initiative: 
 
“We’ve created a symbol in Malaysia to hopefully try and change perception” Physician, Asia 
(P05) 
 
Real value was attached to the idea of symbolic representation of what palliative care is, the 
justification for which is presented in Figure 39. 
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Figure 39: Symbolising palliative care 
 
Source: Hospis Malaysia, 2014lviii  
The use of symbols has been prominent in other successful advocacy campaigns, for instance the 
‘red ribbon’ which is used to represent the fight against HIV/AIDS and is commonly understood. 
Once more, the use of symbols is in line with WHO guidance on how to conduct an advocacy 
campaign. 
 
However, symbols can only have meaning if they represent some kind of shared understanding. This 
is problematic in terms of ‘palliative care’ owing to the diverse ways in which the term is understood. 
In order to better understand they ‘key message(s)’ which advocates seek to present to 
policymakers, direct questions were asked regarding the diverse ways in which arguments can be 
constructed for palliative care to different audiences. Informed by Labonte and Gagnon’s studyvi, 
which ranked different ‘frames’ in terms of their relative likelihood of achieving policy change, here, 
the diverse frames with which advocates are seeking to present to policymakers are presented in 
order of their relative potential of achieving influence.  
 
However, as no characterisations were given within the theoretically ‘most powerful’ frame, health 
as a national security issue, attention is first given to the second most potentially influential frame, 
‘International Development’, or put another way, economic arguments for palliative care. 
 
Palliative care as an international development issue 
 
In order to understand how palliative care may be conceptualised as an international development 
issue, it is necessary to reiterate one of the key economic aims of development; poverty reduction.lix 
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Furthermore, it is important to understand that this aim may be achieved in one of two ways which 
are of relevance here. Either, poverty may be reduced by preventing people who are hovering above 
the poverty line from falling in to poverty, a strategy termed ‘poverty avoidance’. A second way is to 
promote economic growth through the empowerment of people to be economically productive, that 
is, a ‘human capital’ approach to development which aims to lift people out of poverty. Of relevance 
here, this means to consider health “no longer simply a consequence of growth, but one of its 
engines [2010].vi This is especially significant, as ‘poverty reduction’ is unceasingly professed to be a 
global priority and this commitment has once more been formalised in the SDGs.iii Furthermore, 
international financial institutions such as the World Bank, speak in language in terms of both 
poverty reduction and human capital, meaning that it may be said, that arguments presented within 
this frame may hold the potential to engage with new sources of global financing for palliative care. 
 
Several participants suggested ways in which palliative can contribute to ‘poverty avoidance’. That is, 
appropriately timed palliative care can reduce out-of-pocket expenditure for families, by the 
avoidance of futile and expensive treatments, which threaten to push people beneath the poverty 
line as described here: 
 
“In India I’ve seen it, where patients are referred to hospitals and for intensive treatment and 
families go into debt, and they become ‘debt-slaves’ that’s what some of my colleagues call it” 
Activist, North America (P02) 
 
This was an argument presented not only in low-income settings, but in in the United States also, 
where many families pay ‘out of pocket’ for healthcare within a private health system. Commenting 
in this regard one participant described the consequences of ongoing aggressive treatment in 
circumstances where palliative care was not accessed: 
 
“[A] study which was done in the mid-1990s, had two unexpected outcomes… one of which 
was [that] about 30% of families, even if they are well insured go bankrupt, and in about 25% 
of families, somebody needs to stop their career to become a caregiver, and loses their future 
career.” Physician, North America (P13) 
 
This quote adds weight to the suggestion that palliative care may have a role to play in poverty 
avoidance through reduced out-of-pocket expenditure on healthcare.  However, participants did not 
acknowledge that families and carers can actually incur high costs whilst caring for people with 
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serious illness.lii Yet the quote also hints at a second way in which palliative care may be able to 
contribute to poverty reduction, which we may term the ‘human capital argument for palliative care’.  
 
The ‘human capital’ argument suggests that nations’ potential for economic growth is reduced by 
patients and lay carers having to cease economic activity due to either illness or caregiving duties. 
Palliative care is said to be able to reduce such effects in two ways. Firstly, that people who have left 
the workforce due to their symptom burden may be able to return to economic productivity if such 
symptoms are effectively managed. Secondly, that when lay carers assume their caring role, that 
they may have to leave the workforce which may be prevented if they are supported and their care 
recipients’ condition better managed, that they too may be able to resume economic productivity. 
This scenario may not be a universal one in palliative care situations, however, as one participant 
described: 
“Some of the [patients’] symptoms once they are controlled… once pain is managed, some of 
these people are able to go back to productive work, so it’s helping them make sure that 
these people stay as healthy, as pain free and as symptom free as possible, so that they can 
continue with their every day job.” Activist, Africa (P16) 
 
However, as was discussed within Theme Three on Broad Benefits, this argument is highly 
dependent upon palliative care being introduced at an early stage. For instance, there is certainly a 
time in the course of illness where a return to work will not be possible. However, timing may be less 
important in terms of the benefits for families. Indeed such benefits may persist even when patients 
and carers are older people who are no longer in employment as such groups play important social 
roles within communities as described by the PPI representative: 
 
“[Families/carers] would be making contributions to their local community… If they’re able to 
continue picking the grandchildren up from school, which helps mother and father work, 
both work, so they can pay their mortgage, you know, that’s contributing to society and is a 
positive outcome” PPR Representative, Europe (P11) 
 
Thus, the benefits may be translated to extended families and support systems.   
 
Both the poverty avoidance and human capital arguments are extremely significant as they are 
speaking directly in terms of broader global development priorities. Unfortunately it appears that 
few palliative care researchers to date are providing the requisite evidence to back up such claims a 
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point noted in Chapter Five. Several studies have shown the links between serious illness at the end 
of life and increased household poverty, yet, no studies known to the author, show how palliative 
care can prevent this. That is that although the argument that reduced household expenditure on 
futile treatments would reduce household poverty appears rational, advocates do not have hard 
evidence of this to present to policymakers.  
 
A second way in which advocates may be able to integrate palliative care into broader global health 
development economic priorities centres around the reorganization of healthcare systems to 
become more efficient, with the aim of achieving Universal Health Coverage. Arguments relating to 
‘cost-avoidance’ whereby healthcare systems reduce expenditure on inappropriate care in favour of 
palliative care have been fully described within the Broad Benefits theme and no do require 
repetition here. Similarly, the argument that a redistribution of healthcare human resources away 
from aggressive treatment delivery at the end of life increases health system has been reported in 
full.  
 
It serves, therefore, to make the point that such a reorganization of health services may reduce costs 
within health systems, as well as facilitating the benefits relating to the ‘poverty avoidance’ 
argument. What is less resolved is the financial impact of palliative care delivery which commences 
at the point of diagnosis and introduced alongside curative efforts. The arguments for cost reduction 
and cost avoidance appear are convincing, however, without adequate evidence, they are open to 
be both ignored and disproven and great care should be exercised before exercising rhetorical 
arguments without sufficient evidence.  
 
However due to relative power of the ‘international development ‘frame’ as well as the potential for 
palliative care to frame itself, this warrants attention from both advocates and researchers. Indeed 
the very language of ‘poverty avoidance’ and ‘human capital’ is liable to resonate some of the major 
global health financiers such as the World Bank who include these as part of both their key aims as 
well as their strategy. Furthermore, organizations like the Bank have traditionally, discouraged talk 
of human rights in favour of discourses on human capital.lx 
 
However, human rights arguments do hold the potential to influence both national and international 
policymakers and have been used to affect progress towards the realisation of many social justice 
causes.lxi In this regard, attention here turns to how the human rights ‘frame’ may be used by 
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advocates, as well as competing rights based claims which may either further, or restrict palliative 
care development in terms of human rights. 
 
Palliative care and human rights 
 
Rights-based discussions were pervasive with all study participants, both in terms of language used 
as well as specific articulations of why palliative care is a human rights issue. Human rights issues are, 
however complex and may exist at the individual level, ie the right to freedom of movement, or at 
societal level in terms of obligations upon governments to ensure citizens’ rights, ie the right to 
health. Currently, there is no explicit global legislation which states the human right to palliative care 
or pain treatment. On this basis, the arguments that access to such services should be a human right, 
is based upon interpretation of existing human rights law.lxii Although there is some overlap between 
a potential human right to palliative care and one to pain treatment, here they are dealt with 
separately, firstly to examine the claim that there is a ‘right to palliative care’ as part of the existing 
‘right to health’. A human rights expert within the sample suggested: 
 
“You have to construct that right. You know, the right to the highest attainable level of 
physical and mental health. And clearly, palliative care falls within that right.” Activist, North 
America (P12) 
 
Based upon the premise that palliative care improves both the physical and mental health of 
patients and carers, this argument is fairly clear. If illness negatively affects quality of life and 
palliative care reduces such negative effects, it is rational to suggest that ‘the highest attainable level 
of physical and mental health’ is not achieved without palliative care. Access to pain relief is 
implicitly included within this ‘right’, however, a separate articulation of why access to pain 
medication is a human right was also reported. 
 
This suggestion is also made within the context of a pre-existing human right that of the right to 
freedom from torture. The suggestion being, that the allowance of extreme suffering which is 
caused due to physical pain, when treatments are known to prevent such distress, is tantamount to 
torture: 
 
“When you speak to people who are suffering severe pain due to cancer or other illnesses, 
and who do not have access to appropriate treatment, they really describe their suffering in 
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a way which is very similar to the way a victim of torture would describe their experience. 
They basically, both groups would tell you that the pain was ‘unbearable’, that ‘they would 
do anything to make it stop’…So what makes this a human rights issue, is that, that suffering 
could be prevented, or alleviated, generally, pretty easily with inexpensive interventions, and 
inexpensive medications and so there’s really no excuse for a healthcare system to not 
provide the service.” Activist, North America (P12) 
 
These arguments that access to pain relief and palliative care share two key tenets. The first is that 
the rights-based obligation falls upon national governments to provide the necessary services to 
ensure the rights of their citizens. Secondly, both arguments are based upon the interpretation and 
co-optation of existing human rights legislation. That is, that it is unlikely that the drafters of the 
formal rights to health and freedom from torture, had access to pain and palliative services in mind 
when drafting the legislation.  
 
Further complexity is raised in terms of both rights-based arguments in that in order to elevate the 
claims into human rights issues, they rely upon a pre-existing knowledge of the benefits of pain and 
palliative care services amongst national policymakers. That is, that in order to be in violation of such 
rights, there has to be a wilful intent to withhold pain and palliative care services, the arguments do 
not hold if policymakers are not aware of how either palliative care ensures the right to health, or 
absence of pain services results in suffering tantamount to torture.  
 
As a consequence of this distinction between wilful and unknowing failure to provide palliative 
services, the circumstances in which rights-based arguments may be used are in some ways limited 
to a role in raising awareness rather than as an accountability mechanism for holding governments 
responsible to their obligations. Reported in terms of the ‘appropriateness’ of global policies, it is not  
useful strategy for advocates to confront national governments of countries which have not 
palliative care at all by calling them human rights abusers. Similarly, at the individual level, it is not 
helpful to describe physicians’ failure to treat pain in circumstances where strong pain medicines are 
not available, as ‘torturers’. Indeed there was a clear emphasis amongst participants, that human 
rights in this regard, are governmental responsibilities and that the rights exist at societal level. The 
only exception to this circumstance was described thusly: 
 
“Say a physician has access to all the medications and the knowledge et cetera, to relieve 
someone’s pain, but the physician says, you know what, ‘you belong to this ethnic minority, I 
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don’t like you, I’m not going to give it to you’… Then there is an intent to cause severe 
suffering and that would be torture. But of course, you know, that’s a situation which you 
don’t generally see [laughs]. Activist, North America (P12) 
 
However, the relevance of conceptualising access to pain and palliative care services was reported 
as existing at the individual level only in this sense. That is that individuals hold the power to abuse 
the human rights of others, but not to advocate on their own behalf for their realisation. Human 
rights arguments may therefore be understood as being important as an advocacy tool in terms of 
engaging national and international policymakers, but not for the empowerment of individuals. 
Commenting in this regard, one participant reports: 
 
“I think [human rights is] a healthy argument at global level and at policymaker level, it’s not 
a helpful argument to the recipients of palliative care, I always say, ‘its pointless to say to 
someone who has no food for tomorrow that it is their right to have pain control, it is their 
right to have food yet they don’t have it’, so I see it’s an important point at the global level… 
at the patient level, perhaps not as much.” Activist, Africa (P16) 
 
At global level, advocates have had some encouragement for the arguments that there is a rights-
based claim for access to pain and palliative services. One participant reported how the UN has been 
receptive to this conceptualisation: 
 
“We had a statement from the UN special interlocutor on torture, cruel and inhumane and 
degrading punishment, that initially said, ‘if a government deliberately, willing prevents 
access to pain relief for its citizens, by essentially banning strong analgesics, that that’s an 
indirect form of torture’” Physician, North America (P03) 
 
Whilst such support from within the UN may be considered positively, holding governments 
accountable to their rights-based obligations is an ongoing concern for the UN, which lacks a great 
deal in terms of power of enforcement. Nevertheless, one participant did report that human rights 
legislation does present opportunities to hold governments accountable to their commitments: 
 
“There’s no absolute enforcement, there’s no tribunal which will penalise a country, but I 
guess I probably would link that vote with the Committee which oversees the International 
Covenant on Economic Social and Cultural Rights, which has the main articulation of the right 
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to health, so for instance, that Committee could well say to country a b and c which appear 
before it, ‘let’s talk about your fulfilment of the international right to health, and we do note, 
that you as a country a did vote, did make that vote at the International Health Assembly, so 
it’s, so you’re conscious of this, what therefore are you doing about it?’” Physician, 
Australasia (P14) 
 
Yet, the UN has not been fully successful in guaranteeing existing rights – let alone prospective 
additional claims. In this sense, questions are raised regarding who exactly are the targets for rights-
based arguments? Normative agencies like the UN appear to already be notionally on side. 
Additionally, national governments of countries where there are no palliative care services are 
perceived to be poor targets for rights-based claims, which appears to leave only national 
governments who are presiding over prohibitive opioid regulations as the key targets for rights-
based advocacy.  Again, this raises questions regarding the appropriateness of human-rights 
approaches in all world settings.  
 
However, there as has been a recent success emanating from rights-based ‘frame’. At the time of 
interview, one participant reported: 
 
“In the Americas, countries are negotiating a new treaty on the rights of older people, and 
that treaty, well, the text of that draft treaty right now includes an explicit right to palliative 
care.” Activist, North America (P12) 
 
These negotiations were conducted within the Organization of American States and indeed 
agreement was reached to recognise a formal right to palliative care for older people.lxiii It remains 
unknown how this right will be realised, however, it’s inclusion as a formal right represents a step 
forwards for rights-based activists and may be a significant tool for advocates to use in terms of 
holding governments accountable to their obligations in the region. Indeed formal recognition of a 
right to palliative care within a regional, but international organization may prove to hold influence 
even outside the Americas, in terms of actively spreading international norms and values. 
Less formal rights-based language was also endemic during interviews. Additional to formal rights-
based ‘frames’, participants often spoke in more general language referring to ‘rights’. For instance, 
the PPI Representative asserted that: 
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“I think that everybody has got a right to a pain free and dignified life and death.” PPI 
Representative, Europe (P11) 
 
Other participants spoke in terms of a ‘right to autonomy [Physician, North America (P12)’ and a 
‘right to self-determination’ [PPI Representative, Europe (P11)]’. Though such comments were not 
further articulated into serious rights-based claims, they raise further questions regarding the 
legitimacy of a ‘human rights approach’ which may be considered as a mechanism for the transferral 
of ideologies. That is, that whilst some participants spoke in terms of this ‘right to autonomy’, in the 
Asian context, this was not understood in the way in which it was intended. The distinction is 
reported here by a participant from Asia: 
 
In many Asian communities, [autonomy] is seen as collective rather than individual, the 
family structure becomes more important than the individual, and so, I like that in recent 
years, the discussion on autonomy, because autonomy is always see as the rights of an 
individual, I like that some of the discussions have now been about relational autonomy, the 
right of one, has to be in relation to another.” Physician, Asia (P05) 
 
In this regard, the power of the human rights ‘frame’ is shown to be further limited due to further 
restrictions upon the contexts in which they hold relevance. 
 
A further complexity of framing palliative care as a human rights issue arose in terms of how such 
arguments relate to other rights-based claims. Conversations in this regard referred almost 
exclusively to the ‘right to die’ movement. Many participants characterised a potential right to die as 
something to be avoided. Often participants made clear that they were representing their individual 
views, though there were some references to organizational resistance to right-to-die claims: 
 
“What we say as the International Children’s Palliative Care Network, and very clearly we 
have a statement about this, is that ‘assisted dying is not part of palliative care, is that it’s 
not an extension of palliative care, palliative care is about quality of life, a good death, but a 
good death which comes in its own natural time and supported’, so, we’re very clear about 
that.” Nurse, Africa (P06) 
 
Moral and ethical perspectives appear to be the main argument for resistance to the right-to-die 
movement, centring around assertions that the reason that people may request an assisted death is 
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due to intolerable suffering. Suffering which, it was suggested that effective palliative care has the 
potential to relieve. Speaking in this regard one participant reported: 
 
“Palliative care allows you to die with dignity, pain free, with comfort, with not necessarily an 
acceptance, I mean, I’ve nursed many patients and I know a lot of people fight to the end, 
but it preserves the dignity and it accepts dying as normal, if you were using it against an 
argument against assisted dying, and we often talk about palliative care being the answer to 
assisted dying, because if we can provide that comfort, that support, that relief of symptoms, 
spiritual care and all of that, you need good quality palliative care, then we would think that 
a lot of people who would like to end their lives, would change their mind.” Nurse, Africa 
(P06) 
 
Some softer attitudes were however revealed regarding a potential right-to-die. In this sense, the 
argument was that conversations on issues relating to assisted dying and euthanasia were 
premature whilst palliative care remains so underdeveloped around the world. Though not explicitly 
rejecting a right-to-die, participants suggested that it was a subject which only became relevant once 
patients had received the highest quality palliative care, which as is suggested above, was said to 
reduce circumstances in which people would request a premature end to their lives: 
 
“I don’t think that palliative care is an alternative to the right to die, but I don’t think that the 
right to die should be implemented, before there’s universal access to palliative care, 
because we find, and there’s a lot of research which says that people who have access to 
palliative care, I think in Oregon, I think it was a study which said that 47% of people who 
then had palliative care decided that they didn’t want to die anymore.” Physician, Africa (P07) 
 
This evidence is contestable, as reports from Oregon also suggest that there have been increased 
requests for an assisted death from patients receiving palliative care compared to those who are 
not.lxiv However it certainly seems appropriate for efforts to be made to relieve patient suffering 
before considerations of an assisted death.  
 
However, although views within the sample were broadly negative towards the idea of a right to die, 
some participants acknowledged that there was some suffering which palliative care could not 
resolve. For example: 
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“I think we can make an attempt to relieve all suffering, the point is finding out where that 
person is at and why has he got those wishes and what is, what is causing that existential 
suffering and seeing what we can help with, [but] there’s going to be things which are 
beyond us, or there are going to be things that are beyond the doctor.” Physician, Africa (P07) 
 
In such circumstances, one participant presented euthanasia as a stage which may follow palliative 
care: 
 
“At the moment even palliative care cannot help the person sufficiently anymore, then 
euthanasia comes in” Pharmacist, Europe (P01) 
 
This view was supported by the PPI Representative: 
 
“I think that palliative care should offer the opportunity to die at home, or a place of your 
own choosing, in comfort, at a time of your own choosing, if you find that life is just too much 
to bear, then the means should be provided for you to take that step. I can’t imagine 
anybody takes that step easily, or without a whole load of thought. People should not have 
to go to Switzerland to get the relief they need…. But no, I think [assisted dying] is something 
which should be instituted. Definitely. You have a right to self-determination. There is 
certainly a right to life if you want it, but I think there’s also a right to a decent death if you 
want it.” PPR Representative, Europe, (P11) 
 
It is not possible or appropriate to extrapolate the view of one public representative beyond the 
individual. Indeed, supportive voices for a right-to-die were often provided in a personal, rather than 
in a policy-related sense, however, it was suggested that a right to palliative care and a right to die 
were not in opposition to each other: 
 
“Overall I don’t think the right to palliative care is incompatible with a right to die. Personally 
I feel that if I were in a situation where I felt life no longer has any value that I should have 
the right to decide to step out, even if I can no longer actually do so myself.” Activist, North 
America (P12) 
 
This is a very sensitive issue and one which all individuals are likely to have an opinion. However, no 
strong reasoning was provided as to why palliative care is resistant to the right to die movement, nor 
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why the right to die movement has gained the most traction in countries like Canada which do have 
palliative care. Some clues as to this reasoning, however, may be perceived fears amongst 
participants – most notably physicians - that their personal views notwithstanding, if a right-to-die 
became legislated, then they would be the people who would be tasked with providing this service: 
 
“I don’t see, even if it were to be legalised, either in New South Wales, or anywhere, I would 
not see physician assisted suicide to be part of palliative care, I think that most of my 
colleagues here in Australia would feel that that would be very very separate. Unfortunately, 
if it were to be legalised, we would be exactly the persons that would be approached to be 
part of this process.” Physician, Australasia (P14) 
 
Finally, with regards to the relationship between a right to palliative care and a right to die, there 
were concerns regarding public perception of a link between palliative care and assisted dying. 
Additionally, fears were raised that the right-to-die movement is imposing undue Western 
influences onto settings like Asia, and moving public debate on to assisted dying, before adequate 
consideration of palliative care: 
 
“Very parallel to end of life issues, autonomy, human rights, is the increasing acceptability of 
euthanasia and physician assisted suicide, especially in the western countries. And the 
danger is that it comes down to other countries to say ‘well, if the European countries and 
America is taking it, it must be good, it must be the natural progression of the legal 
imperative of society’. So, I find that even in my country, we’ve suddenly talking about ‘let’s 
think about legislation about euthanasia’, without looking at the broader picture about, how 
are we doing with pain relief, how are we doing with addressing suffering and quality of life 
in palliative care, we’ve jumped straight into the fact that because the right to die stuff is 
happening in the UK.” Physician, Asia (P05) 
 
Not all participants, however, perceived discourses around a potential right to die as presenting 
barriers for palliative care development. In terms of advocacy, opportunities were presented for the 
palliative care community to engage with the increased dialogue around end of life issues which has 
been fostered by the right-to-die community, for the further development of palliative care: 
 
“I love when people are having the discussion, because it pushes people to have the 
discussion about palliative care, because you can’t leave the two separated. Do I think that 
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societies should be approving physician-assisted suicide or euthanasia when they don’t do 
palliative care? No” Physician, North America (P13) 
 
In spite of many participants expressing negative attitudes towards a potential right-to-die, it may 
also be considered developmentally. That is, that in the same way that participants accepted that in 
developmental health systems, that prevention and curative services would be prioritised before 
palliative care, that once universal access to palliative care had been secured, then a right to die may 
follow.  
 
It is however clear that there is a rational argument for palliative care to be considered a human 
rights issue. Additionally, it seems that the lobby is making gains beyond making arguments for how 
palliative care is applicable within existing human rights legislation, with new policies as identified in 
the Americas – written stating explicitly that access to palliative care should be considered a human 
right. However, concerns have been raised regarding the applicability of human-rights discourses in 
all regions of the world. In this regard, other arguments are necessary which may resonate more 
clearly with audiences less amenable to human rights discourse. With this in mind, attention turns to 
a further way in which palliative care may be ‘framed’, as an ethical and moral issue. 
 
Provision of palliative care as a moral and ethical imperative 
 
All participants within the sample presented access to pain and palliative care services as a moral 
imperative. Indeed participants took a highly principled stance in all interviews. The following 
statement form the PPI Representative in this regard was representative of more broadly held views: 
 
“Are we supposed to really leave them to writhe in their last moments of life and undergo 
terrible pain and discomfort? I think anybody who expects that needs their head looking at 
frankly. It’s an ethical problem, you cannot say, ‘we’re not going to give palliative care’, you 
can’t.” PPI Representative, Europe (P11) 
 
The moral/ethical argument for palliative care emanates from normative perceptions of the global 
need for palliative care. That is, that whilst the suggested palliative care population is in relative 
terms, small compared with the global population, that the burden of suffering which they endure is 
disproportionate. Yet, the relatively low numbers involved, led one participant to emphasise the 
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achievability of addressing global palliative care need with an implied moral imperative to do so. 
Speaking in terms of children: 
 
“I think there’s an issue of numbers as well…If I’m looking at a global level, one of the 
arguments that we’ve started making is, ‘sure the numbers of people needing palliative care 
aren’t enormous…We have a number that we can actually manage, when we talk about 
children, 30 million is not a big number in the scope of things, it’s manageable, the 
international agencies could actually achieve and they would feel good about it, as well, it’s 
like eradicating polio...” Nurse, Africa (P06) 
 
In this regard, other participants placed moral responsibility upon richer nations to assist poorer 
ones, to help them meet the palliative care needs of their populations. That is, that globally speaking, 
the inequity in access to palliative care services, where richer countries enjoy greater provision of 
services, that this imbalance is morally unjust: 
 
Under the principle of mutual and shared responsibility, which is a principle of international 
law, that the more developed countries with money would finance, with technical assistance 
or whatever, whatever needs in the lower resource countries that they have, to develop their 
workforce and to develop their medical industries or whatever they need, not as charity, but 
as mutual and shared responsibility, that they would see it as a responsibility, an ethical 
imperative and not just to improve their bottom line, but as an ethical imperative because 
that’s the kind of world that we want to live in, yeah.” Activist, North America, (P02) 
 
This issue of inequity applies both between and within nations as was discussed within the sub-
theme of ‘Inequality and inequity of access to palliative services’. The only thing to add here, is to 
suggest that this imbalance, often due to socioeconomic factors at both individual societal levels, 
may be used to add weight to moral and ethical arguments. That is that whilst people continue to 
suffer, due to the consequences of illness and the fact that such suffering is known to be avoidable, 
creates a moral imperative to do so.  
 
The issue of child suffering was deemed to be particularly emotive amongst participants. 
Considerable anxiety existed however regarding how child suffering may be presented, without 
being exploitative. Yet due to the perceived moral intolerability of children suffering needlessly in 
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circumstances where there is a lack access to palliative care services, opportunities were presented 
for how advocacy can make gains in this regard. Here, a paediatric nurse reflects upon this: 
 
“I’ve always said to my more adult focussed colleagues, that ignoring children for so long has 
actually diluted the message, because children do have that emotional impact on people, 
people don’t want to think about children suffering, you know, and adult, and I always say, 
an adult, someone who can understand, can try to make sense out of what’s happened to 
them, but the tiny little child, they can’t, all they know is that they feel sick, and they’ve got 
pain and they can’t play with their friends, they can’t understand what is happening, and so I 
think that if we could just show people that children as well as adults suffer, that we would 
have a little bit more… even more impact in our advocacy impact.” Nurse, Africa (P06) 
 
In this regard, a great deal of discussion related to the ethics involved with how to demonstrate child 
suffering to policymakers. As mentioned in terms of story-telling, patient narratives are one way in 
which the existential changes which occur when going from extreme suffering, to comfort through 
palliative care is one strategy. Another, however, involves the use of different media, such as video 
and imagery. There was, however, a great deal of unease amongst participants, regarding the risks 
of exploitation inherent in the visual demonstration of child suffering as well as doubts as to its 
potential impact due to potential desensitisation in the event of over exposure: 
 
“If you look at the palliative care it has evolved showing lots of graphic images and people in 
pain and screaming and that is absolutely not good, it’s counter-productive, and we don’t 
want to show, to even increase vulnerability for people who are already vulnerable... I think 
sometimes we have used patients and used the circumstances to meet our own advocacy 
demands, but without any direct benefit to the people we have used, so I’m always very 
careful when we are using patients, if there is no direct benefit to that patient.” Activist, 
Africa (16) 
 
A key debate in this regard, it whether it is justifiable to use the image of one child who may not be 
helped directly by doing so, but may lead to benefits for other people who may face similar 
circumstances in the future. Additional questions were raised regarding where there was a 
difference between the use of images of adult suffering and those of children. Yet, the view that use 
of images of suffering was counter-productive was not universal. The PPI representative grappled 
with the moral validity of such this question in relation to adults: 
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“We’ve seen some fairly horrific images in the past. There was the little girl running away 
from the Napalm burns, in the Vietnam war, that is regarded as one of the photos which 
helped stop the war, when people looked at it and decided that, you know, enough is enough 
and then started the Vietnam War movement. But, obviously, it would have to be with the 
consent of the person being depicted… I think possibly yes, I was going to say no, but I’ve 
changed my mind, I think possibly yes, and for patients to perhaps talk about their 
experience, if they can, as well.” PPI Representative, Europe (P11) 
 
Furthermore, although during interview the participant rejected use of images of children in this 
regard, the same participant got in touch subsequently to state: 
 
“I've changed my mind about using images of children to draw attention to catastrophes, 
famines, etc. My negative reaction was a response to the increasing exploitation of children, 
but on consideration - it has been done already very effectively.” PPI Representative, Europe 
(P11) 
 
Evidently the issue of use of images relating to suffering is a sensitive one and there was no 
consensus within the sample regarding the validity of doing so. Yet, such questions must be grappled 
with in order to increase the influence which advocacy can hope to achieve.  In this regard, the risks 
of ‘exploitation’ and ‘enhanced vulnerability’ may come to pass, if moral arguments and emotive 
imagery are used without a clear purpose. It must be asked therefore, who the moral/ethical ‘frame’ 
should seek to influence? 
 
One participant suggested that the focus should be upon national governments and it was suggested 
that the frame may be useful only in settings where there is little or no palliative care provision at all 
as well as noting that perhaps no single frame in isolation may be appropriate: 
 
“In countries where development is limited, prioritize the economic factor and the moral 
imperative, whereas in countries where already reached some development, maybe other 
factors become more important” Physician, South America (P15) 
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It follows, that whilst ‘moral and ethical reasoning’ is considered the frame, least likely to influence 
policymakers, that moralistic arguments, may be best used to contribute towards this idea of 
‘experiential learning’ and awareness raising.  
 
Yet, advocates must ask themselves clear questions in this regard. What is the use of presenting 
national governments with moralistic arguments for palliative care, when, within developmental 
healthcare systems, claims for increased palliative care sit alongside the need for other interventions 
such as vaccination programmes? Where life expectancy remains tragically low. Would such 
moralistic arguments be better presented to richer nations who have both the capacity and 
resources to further development? Palliative advocates must consider further, which of these 
‘frames’ is most likely to influence new stakeholders in palliative care and who these stakeholders 
may be. Moreover, with questions regarding the absence of leadership within the palliative care 
community, at both national and international levels, the future may lie in increased understanding 
of the relative place of palliative care within broader global health priorities. To consider this further, 
a short discussion follows. 
 
Discussion 
 
This chapter has revealed the diverse range of challenges and opportunities to the further 
development of palliative care internationally reported across six thematic categories. The elicitation 
of the views of a wide range of experts in the field has served to identify current advocacy strategies 
as well opportunities for new approaches. Contained within the six themes are a wide range of 
diverse issues, all of which interact in complex ways to present a full picture of the global 
environment in which advocates are using diverse approaches and arguments, to engage a wide 
range of organizations and policymakers. How then can we make sense of this complexity? In order 
to do so, the following section discusses the overall findings of the chapter, in relation to the aims 
and objectives.  
 
Re-defining why palliative care is needed 
 
A key objective of this chapter was to elicit the views of experts regarding how the presentation of 
the problem of lack of palliative care can be refined. It has been identified throughout this study, 
how policymakers are more likely to be influenced by problems which may be considered tractable. 
 270 
 
That is, a clear problem is defined, a solution presented as well as the benefits which would accrue 
from addressing the need.lxv  
 
In this regard, there appears to be missed opportunities concerning how the need for palliative care 
is conceptualised. A high level of diversity was identified regarding why there is a global need for 
palliative care and who this affects. Commonly, need was expressed in terms of the suffering which 
patients endure to a lack of palliative care, with statistics to demonstrate the level of need. However, 
during discussions regarding the ‘broad benefits’ of palliative care, potential benefits were described 
which are far more diverse than the ‘need’ or ‘problem’ which participants structured.  
 
For instance, whilst increased ‘community cohesion’ was presented as a benefit, it was not 
articulated clearly if and how there is a current lack of community cohesion with a consequent need 
for palliative care. Furthermore, in terms of ‘solvability’, community cohesion was presented as a 
benefit without consideration of how this could be measured as a ‘result’ of palliative care. This is a 
circumstance which may be remedied through consideration of literature on ‘health promoting 
palliative care’ an approach which is discussed in more detail in the following chapter.lxvi In this 
regard, it appears that palliative care advocates are missing opportunities to maximise the value 
proposition which palliative care has to offer for stakeholders beyond patients. Furthermore, an 
ongoing tendency to present  the ‘need for palliative care’ using disease statistics, may be 
considered meaningless if we accept the prominent viewpoint of participants that policymakers lack 
awareness and understanding of what palliative care is, why it is needed and what it’s benefits are. 
 
Importantly, ongoing confusion regarding just what palliative care is continues to undermine any 
message which activists are seeking to deliver to policymakers.lxvii In this regard, it was identified 
how terms such as ‘palliative care’, ‘hospice care’ and ‘end of life care’, continue to be used 
interchangeably as well as to describe distinct approaches. In seeking to raise awareness of all 
stakeholders, there is a serious need for consensus and consistency on such issues.  
More significantly, the term ‘palliative care’ continues be used to mean describe different 
approaches and with regional variation. Arising from contexts such as Africa, the term was used to 
denote a long term intervention which is appropriate from diagnosis and aimed at improving quality 
of life. Conversely in regions such as Europe and North America, the term ‘palliative care’ was 
commonly used to denote an end of life intervention. This circumstance should be of real concern to 
the field as many of the benefits which participants described that palliative care can offer are highly 
dependent upon the timing of the intervention. For instance, human capital arguments appear to be 
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reliant upon care introduced at an early stage, whereas, arguments that palliative care ‘reduces 
health system costs’ are less clear if care is introduced at an early stage.lxviii  
 
This circumstance has profound consequences for the arguments which activists can make regarding 
the need for, and benefits of palliative care. In studies which have shown the cost effectiveness of 
palliative care comparatively, there is a lack of clarity regarding what ‘usual care’ is and we therefore 
do not know if curative attempts were continued or not.lxviii Furthermore, Chapter Five identified no 
studies which provide evidence for increased economic productivity of patients or families following 
palliative care. What this means is that the two arguments are not only mutually exclusive, but are 
also not currently backed by firm evidence.   
 
More fundamentally, whilst ‘lack of awareness’ of palliative care has been identified as a key barrier 
to development, it is of real concern that activists are not providing a clear message to policymakers. 
An ongoing  lack of clarity regarding whether palliative care is a long-term, or end of life intervention 
threatens to not only reduce the clarity of the message which advocates are seeking to deliver, but 
to confuse advocacy targets to the point of disinterest. 
What are the key asks of the palliative care community? 
 
WHO guidance regarding key tenets of a successful advocacy strategy, suggests that when meeting 
with policymakers, advocates should always have clear answers to the direct questions ‘what do you 
want me to do?’.lxix In this regard it is of concern that participants often expressed key demands 
somewhat vaguely, using language such as ‘universal access to pain treatment’ and ‘universal access 
to palliative care’ without adequately explaining what such terms meant in reality.  
 
In terms of access to pain treatment, a clear aim for advocates was for national governments to 
introduced appropriate regulations to enable access to essential pain medicines. Indeed, effective 
strategies were described for engagement with national governments in order to de-regulate opioid 
medications using a human-rights approach. Moreover, some evidence of strategic partnerships was 
identified, with Human Rights Watch (HRW) confronting governments with problems, whilst the 
International Association of Hospice and Palliative Care (IAHPC), offered technical assistance. 
However, in spite of the success experienced by HRW in partnering with the pharmaceutical industry 
to ensure appropriate regulation of opioids in Mexico, no extrapolations were made regarding how 
such an approach may be applied in other settings.lxx Furthermore, doubts have been cast regarding 
the relevance of human-rights approaches in all world settings. 
 272 
 
 
Discussions regarding ‘access to pain treatment’ nevertheless were the most straightforward. Clear 
suggestions were made regarding how such access can be monitored, using indicators of opioid 
consumption. In this regard, it may be considered a major blow to the field, that the SDGs have not 
included an indicator with which to monitor access and use of pain medications. However, based 
upon the views of several participants, including the public-patient representative, it may be 
suggested that focussing upon improving access to pain relief is an appropriate strategy in 
circumstances which have little or no palliative care at all. This suggestion is made based upon the 
relative importance of pain treatment identified in relation to other elements of palliative care, as 
well as the tractability of the arguments which advocates are making. 
 
Less clear was what was meant by ‘universal access to palliative care’. Participants supported the 
statement that ‘access to palliative care was a human right’. However, there was little engagement 
with just exactly what is meant by this, for elements of palliative care aside from access to pain 
treatment. This means that there was no clear articulation of what a ‘minimum package’ of palliative 
care consists of and instead ‘access’ is often defined loosely for instance in terms of ‘availability of 
community-based services’.lxxi This is a key barrier for advocacy. For instance, in terms of human 
rights approaches, would a person’s human rights be violated if they received all elements of 
palliative care aside from ‘spiritual care’? This is a somewhat trite statement, but it does reflect the 
fact that most participants were unable to articulate just what was meant by ‘access to palliative 
care’.  
 
What is more, no suggestions were made for what a globally collected indicator for palliative care 
may be. Instead, it was stated that ‘access to palliative care’ should be measured in terms of ‘access 
to pain medication’. This situation is of real concern as palliative care seeks to ensure its place within 
Universal Health Coverage and additionally limits the potential for engagement with health 
insurance companies in private healthcare systems. If palliative care activists are unable to articulate 
just what access to palliative care means, then this further reduces the tractability of the arguments 
which they can make to policymakers.  
 
Indeed, just one participant described with any clarity what ‘access to palliative’ care may consist of, 
in terms of “access to generalised care” [Physician, Africa (P06)]. A key problem with this articulation, 
however, is that in many world settings, doctors are scarce and patients may only ever be seen by a 
nurse. In this regard, innovative suggestions based upon a model of practice in Uganda suggested 
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that nurses should be empowered in order to prescribe and deliver pain medications. Achieving this 
was said feasible, as nurse training was said to be cheaper and take less time than to train palliative 
care doctors. Furthermore, an evaluation of the Ugandan approach to opioid availability has been 
evaluated positively and recommended as a model for the rest of Sub-Saharan Africa.lxxii Based upon 
the findings of Chapter Six, it may be suggested further, that the model may be appropriate for other 
‘similar’ settings. 
 
We may understand ‘access to generalised care’ as a call for palliative care to represent an 
important element of undergraduate medical curricula. This may be considered a ‘key ask’ of the 
palliative care community. Calls for increased education are consistent with commitments contained 
the WHA Palliative Care Resolution for national strategies to be developed for palliative care, with 
education a key component of this.lvi Moreover, increased palliative care education at all levels is an 
important element of suggestions regarding how the existing culture of medicine can be challenged.  
 
Yet, although the WHA was passed unanimously, the overwhelming view of participants and 
supported by broader literature, was that national policymakers continue to have low awareness of 
palliative care.lxxiii Moreover, as was identified in Chapter Six, countries which have low levels of 
palliative care development, also face serious other developmental challenges, to be faced with 
limited budgets. Therefore, whilst many participants supported a reallocation of resources for 
palliative care, in such settings this would mean diverting resources away from other areas of 
pressing need. What is more, in countries where coverage of doctors is low, there appear to be 
fewer opportunities to make savings based upon reduction of ‘futile treatment’. Furthermore, any 
initiatives to empower nurses to provide pain relief, must be considered in the context of the 
existing pressures upon community health nurses, who are known to have high workload, with 
studies already reporting burnout amongst nurses due to their existing workloads.lxxiv  
 
Therefore the development of national strategies for palliative care may be considered in terms of 
attracting new sources of funding. Global funding agencies such as the Global Fund disburse funding 
for health based upon national health strategies. Accordingly in low and middle income countries, 
the key importance of developing national strategies for palliative care may be considered in terms 
of attracting new sources of funding which once again shows the complex interaction between 
national and global level forces.  
 
Framing palliative care; who needs to be influenced and how? 
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It was identified in Chapters Two and Three how palliative care has predominantly received policy 
attention from normative global agencies such as the WHO. In this regard it was shown how such 
organizations are amenable to human rights arguments for palliative care. However, due to the lack 
of funding available from such organizations it was suggested that new ways of presenting the 
importance of palliative care were necessary in order to reach out to new stakeholders and funders. 
Within Theme Six, ‘framing palliative care’ a wide range of arguments for the further roll-out of 
palliative care were identified. Broadly speaking, such frames may be summarised in terms of 
palliative care being; an international development issue, a human rights issue and a moral and 
ethical imperative. Additionally, a wide range of targets for advocacy were identified, from 
individuals such as Ministers of Health, the general public, National governments and global level 
actors, for instance USAID. Less clearly articulated was to which advocacy targets, each ‘frame’ 
should be targeted to and on this basis, some extrapolation is made here where such clarity was not 
provided. 
 
Firstly, it was suggested that Ministers of Health may be key actors who are able to implement 
palliative care education within medical curricula. In this regard, one participant, a physician, 
reported an example of ‘experiential learning’, whereby they found themselves caring for a 
government officials’ mother. The mother had attended several expensive private hospitals, none of 
which had been able to reduce her symptom burden. However, on attendance at a free palliative 
care service her condition was improved with the official asking ‘now, if you can do this, why can’t 
our hospitals do this?’ This serves as an example, where cognitive change has been achieved through 
experience. However, there remains an element of coincidence that the official came into contact 
with a palliative care service. This may therefore be considered a ‘hopeful’ advocacy approach, for 
which strategic planning is not possible. 
 
Therefore, a more astute approach may be to approach such Ministers of Health, and indeed 
national governments, using arguments which hold benefits for health systems. For instance, it was 
suggested by many participants that the introduction of palliative care instead of inappropriate 
curative treatments would reduce overall hospital expenditure, claims supported by some national-
level evidence.lxxv Moreover, there is a wide body of literature which suggests that effective palliative 
care can reduce unnecessary hospital admissions, particularly when care is delivered at home.lxxvi 
This argument also holds potential to engage private health insurance companies, however, as has 
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been described, it is not clear if this argument is viable in circumstances where palliative care is 
introduced alongside as opposed to instead of curative efforts. 
 
However, in spite of the apparent potential of economic arguments to influence policymakers, they 
were considered by participants as being potentially counter-productive method of engaging the 
general public. Indeed, it was reported how in America, the presentation of palliative care as a 
‘cheap’ intervention had led to misunderstandings regarding palliative care as a form of cost-saving 
‘abandonment’. This viewpoint represents broader barriers to the further roll-out of palliative care 
which has often been mis-associated with ‘abandonment’.lxxvii  
 
In this regard, participants emphasised that moral and ethical arguments may be a more effective 
way of engaging public interest in palliative care. Use of story-telling which describes patient 
experiences moving away from suffering towards improved quality of life was said to be a key way of 
raising awareness.lxxviii Moreover, the importance of engaging the media to deliver such messages 
was stated. Examples included, radio broadcasts discussing palliative care and the use of videos 
adverts, delivered by celebrities, which stressed the need and value of palliative care. 
Yet, gaining public support for palliative care is but one challenge to the palliative care community 
and there remains an urgent need for engagement from organizations such as the World Bank who 
have the capacity to fund further development. It has been argued throughout this thesis, that such 
organizations prioritise ‘human capital’ over ‘human rights’. In this regard, participants made 
arguments that human capital could be increased for patients, families and health-workers. It was 
suggested that in some settings, reduced symptom burden may allow patients to return to work for 
a period of time. Additionally, reduced symptom burden was said to relieve the burden on carers 
which may allow them to continue economic productivity. Lastly, ‘burn-out’ of hospital staff was 
identified as an issue, whereby, the act of treating patients with high symptom burdens leads to 
psychological distress and consequent absence from work. Palliative care, it was suggested, can lead 
to more positive experiences of treating people with serious illness for health workers, with 
consequent reduced psychological distress. However, such arguments must be used with caution, 
given that one study of burnout in palliative found that levels were no lower than those seen in 
other contexts.lxxix 
 
In this regard, theoretically there exist diverse and convincing ‘frames’ within which palliative care 
can be presented, though there must be ongoing concerns regarding the extent to which they are 
evidence-based. What is more, in spite of the range of ‘frames’ which are available to advocates, 
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participants retained views that palliative care activists were not doing enough. One participant 
indeed reflected upon the unhelpfulness of simplistic approaches which seek simply to demand that 
governments should introduce palliative care. Instead, it was suggested that specific arguments 
were necessary for specific issues, for instance, examining palliative care policy recommendations in 
relation to government financing and ‘making a case for that’. Or in terms of access to medicines: 
 
If we want to control pain and only doctors can prescribe pain medication because it’s an 
opioid, and 60% of the Africans, or people having palliative care may never see a Doctor, so it 
means you’re automatically excluding 60% of patients from accessing pain medication. 
Because the person seeing them cannot prescribe. So make the case about task shifting” 
Activist, Africa (P16) 
 
In many ways, owing to the vast range of challenges which of palliative care faces, it is inappropriate 
to criticise any advocacy efforts identified within this chapter aimed at further development of 
palliative care. To do so would be to undermine the strongly principled viewpoints which all 
participants adopted, with all efforts aiming to resource the burden of suffering faced by people 
with serious and life limiting illnesses. Yet, in spite of the varied ways in which the need for palliative 
care can be presented and the benefits which can accrue from its introduction, activists and 
researchers must ensure that such arguments move beyond anecdotal accounts and are backed by 
firm evidence. 
 
In this regard what has been evident throughout this chapter is that there remain serious challenges 
to the further development of palliative care. On this basis, this chapter concludes with a short 
discussion of these challenges as well as identification of new partnerships which may hold the 
potential to overcome them. 
 
Key challenges and the need to forge new partnerships  
 
It is suggested that partnerships in international development hold the potential to enhance 
outcomes and also to produce synergistic rewards for all partners concerned.lxxx Moreover it is 
suggested that partnerships can contribute to the sustainability of institutions involved with them. 
Therefore consideration of the limited partnerships which the palliative care community has forged 
identified within this chapter may be understood as revealing the fragility of palliative care 
development. Questions regarding the sustainability of development models which have relied 
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largely upon ‘pioneers’ are echoed by the temporal partnerships which palliative care has formed 
with funders such as the Open Society Foundation, who provide short term grants. 
 
In this regard, funding remains a key challenge for the field in both low and income settings. Yet in 
spite of the prevalence with which arguments for a ‘public health approach’ were used to further 
development, it was somewhat surprising, that participants did not give a clear ‘frame’ as to why 
palliative care may be considered a ‘public health issue’. Responses which emphasised the uneven 
burden of suffering, which the relatively small palliative care populations endure may be 
extrapolated to be considered a public health issue. There is some recognition that the need for 
palliative care is a public health issue in particular by the WHO and palliative care organizations.lxxxi 
However, participants identified that broader public health community has been identified as having 
paid little attention to palliative care. This may be as ’public health’ itself is a contested term 
palliative care does not appear to fit clearly into the somewhat nebulous definitions of just what a 
‘public health issue’ is.lxxxii The WHO defines public health as: 
 
All organized measures (whether public or private) to prevent disease, promote health, and 
prolong life among the population as a whole. Its activities aim to provide conditions in 
which people can be healthy and focus on entire populations, not on individual patients or 
diseases [WHO, 2015].lxxxiii  
 
In this regard, palliative care is once more left battling to make an argument for how palliative care 
can help prevent disease and be included as an inherent part of health promotion as above. This 
definition is broad enough to make such arguments, however, as has had to be done with existing 
international human rights legislation, palliative care must fight for its place within public health 
discourses.  
 
Palliative care activists must therefore consider reaching out to new partners in order to form 
synergistic relationships. Accordingly one participant acknowledged the potential role for palliative 
care in disease prevention, but lamented that the community was not currently reaching out to new 
partners to insert itself into broader discourses: 
 
“Maternal Child Health, everybody is talking about it, keeping mothers alive, keeping 
mothers and babies alive, there is an indicator for that, everybody is talking about it. 70% of 
the funding is going to MNCH even in countries and from USAID, you know. So it’s really 
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learning from those opportunities, but also, for us as palliative care people, thinking about 
how, what is our contribution to the wider debate? What is the contribution of palliative care 
to saving mothers, what is the contribution of palliative care to saving HIV? You know?” 
Activist, Africa (P16) 
 
In this regard, it was acknowledged that the broad public health community is not engaged with 
palliative care at global level. Moreover, activists appear to be too dismissive of serious public health 
issues which do arise regarding opioid availability. Whilst it is clear that pain medicines should be 
available, it is too simplistic to deem barriers such as ‘fear of opioids’ as being down to lack of 
awareness. One participant acknowledged that there were two public health concerns regarding 
opioids, both under and over availability of opiates, with addiction to such medicines a growing 
problem in settings such as the United States.lxxxiv However, the palliative care community must 
reach out to address such concerns rather simply dismiss them as ‘fear’, based upon ‘lack of 
awareness’. 
 
Palliative care must therefore attempt to move forwards and place itself within the wider health 
governance system. Elicitation of new partners such as maternal health and HIV as identified above, 
would raise awareness, allow palliative care professionals to conduct less usual roles such as 
identification of at-risk populations and disease prevention, whilst making gains towards their own 
bottom line. Additionally, re-consideration should be given regarding how palliative care can forge 
partnerships with private sector actors. That is, given the increasing prevalence of private health 
systems and public-private partnerships in global health, it is not appropriate to dismiss private 
actors as being irrelevant to palliative care.lxxxv  
 
Additionally, whilst participants situated palliative care firmly with the SDG of UHC, further 
opportunities remain for the community to reach out and contribute to other goals. For instance, 
inequality of access to pain treatment was identified as a serious inequality which may resonate with 
actors within SDG10, to reduce inequality within and between nations.lxxxvi 
 
Perhaps more significantly, what does palliative care have to say about Goal 1 of ‘No Poverty’? It is 
well established that serious illness can leave families vulnerable to the ‘poverty trap’ and 
participants suggested that palliative care can reduce, if not eliminate, household expenditure on 
healthcare. Yet, in spite of the wide range of arguments which can be made for palliative care across 
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multiple domains, and the benefits which accrue for a wide range of stakeholders at all levels, it 
appears that current advocacy approaches are not yet maximising this value proposition.  
 
Conclusion 
 
This broad chapter has revealed a number of key issues in terms of how palliative care is developing 
around the world. It has raised doubts in terms of the sustainability of development models, which 
have seen key champions and pioneers driving models of care which are reliant upon short term 
funding streams from charitable fundraising and philanthropy. 
 
Findings within the chapter represent a significant contribution to understanding the current place 
of palliative care at both global and national levels. For instance, it has been suggested, that in the 
absence of a clear vision of what a ‘basic package’ of palliative care consists of, is undermining 
advocates efforts to integrate palliative care into global health policies such as Universal Health 
Coverage. What’s more, due to the broad lack of engagement with issues relating to how palliative 
care may be better integrated into private health systems, it has been argued that the absence ‘key 
asks’ in terms of what a basic level of palliative care consists of, further limits the potential for 
advocates to engage with private healthcare providers. In this regard, access to pain treatment has 
been shown to be both the most pressing issue in terms of development, as well as the most clearly 
defined problem, with tractable solutions. 
 
With regards to how advocacy can help move the field forwards from the current rate of 
development, which has been shown in Chapter Six to be consistent with broader international 
development processes, several different ways of making arguments for further roll-out of palliative 
care have been identified. Different ‘frames’ including economic arguments, moral/ethical and 
human rights arguments have been presented. The value of each argument has been shown to be 
highly dependent upon the timing of palliative care as an intervention. This situation is highly 
problematic for the field, which continues to operate with differing perceptions and understandings 
of what palliative care is and from when it should be provided. The tension regarding whether the 
key message of palliative care should focus upon improved quality of life, for people living with 
serious illnesses, or upon end of life care and quality of death, goes to the heart of tensions within 
the palliative care movement, which remains conflicted, regarding the direction of the field. 
Although there was no suggestion that palliative care is not able to ensure both quality of life and 
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quality of death, advocates appeared split, regarding the gains which can be made in terms of public 
attitudes and policy when the key outcome is presented as quality of death. The counter to this was 
said to be to focus upon quality of life and “let the issue of death worry about itself [Physician, Asia 
(P05)].”   
 
In terms of how global policies are influencing the development of the field, it has become evident 
that palliative care continues to operate on the margins of global health discourses. The WHA 
Resolution in 2014 may be considered the first truly global palliative care policy and presents great 
opportunities for the field to develop. Additionally, although no indicator for palliative care was 
included within the SDGs, it has been shown how palliative care has benefits for stakeholder 
patients and families as the unit of care and can contribute to the overall strength of health systems.  
In this regard, the field retains great potential to maximise opportunities to benefit from the huge 
amount of resources which will be directed towards meeting the SDGs. On this basis, the final 
chapter of this thesis reviews the key findings of the study and identifies what more is needed in 
order for the field to move forwards. 
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Conclusion  
How Can Current Rates of Palliative Care Development be Accelerated? 
Introduction 
This thesis set out to contribute to understanding the international development of palliative care in 
the context of broader global health discourses and policies. More specifically, it sought to answer 
the research question:  
Can the global development of palliative care be furthered through increased understanding 
of global policymaking processes and the presentation of palliative care as an international 
development issue?  
In so doing, the thesis has made a number of important contributions. Firstly understanding of 
palliative care has been significantly increased through the application of a Global Social Policy (GSP) 
approach to place the development of the field within the broader global health landscape [Chapter 
Three].i Secondly, the application of a multiple-methods approach has demonstrated that in spite of 
a significant global need for palliative care, the type and quantity of available evidence for palliative 
care in the international context continues to limit the tools with which advocates can engage with 
both national and global policymakers [Chapter Five]. This is important, as the model of 
development which palliative care has followed has shown to be fragile. That is, that development 
largely has been driven by motivated individuals and individual organizations providing short-term 
funding streams. Therefore, there remains an urgent need for structural change within healthcare 
systems, to ensure that access to services is both increased and sustainable. 
The passing of a World Health Assembly (WHA) Resolution for palliative care in 2014 represented 
new attention for palliative care from global health actors.ii However, as indicated in Chapter Three, 
there is no enforcement mechanism for the Resolution. As a result, serious concerns remain 
regarding what such normative guidance can achieve. The Resolution places financial responsibility 
to implement palliative care upon national governments, many of which already face serious budget 
pressures and broader, more commonly understood development challenges. 
In order to consider how the field can move forward, the views of international experts in the field 
of palliative care were elicited (Chapter Seven). It was revealed how palliative care holds the 
potential for wide-ranging benefits: for patients, families/carers, communities and health systems. 
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However, significant divergence of understanding regarding what palliative care is, even within the 
field, means that many claims made by study participants are not backed by firm evidence. For 
example, instances where palliative care patients have been able to return to work were reported 
anecdotally but is an argument which appears reliant upon palliative care being introduced at an 
early stage of illness. Furthermore, no evidence is known to demonstrate such effects of treatment 
(see Chapter Seven). Moreover, an ongoing lack of clarity regarding just what palliative care is has 
been identified as a key limiter on the fields’ development and a contributing factor to ongoing 
practices of medical practitioners who maintain a highly technical curative approach to medicine at 
all stages of illness and do not provide appropriate care focussed on comfort and quality of life. 
The increased understanding provided by this study regarding how national and global level forces 
interact has identified significant opportunities for palliative care to make gains as the world sets its 
sights on achieving Universal Health Coverage (UHC). This concluding chapter reviews the main 
contributions of this thesis and draws out several key learning points for different types of 
stakeholders: practitioners, researchers, policymakers and advocates in terms of how to hasten 
palliative care development.  
Chapter One presented an overview of the main arguments and method of the thesis. This chapter 
therefore does not seek to do this, but rather aims to expand upon the key arguments of the thesis 
relating the findings within and between the different chapters. Unique insights and contributions 
are drawn out with regards to how reconceptualization of palliative care as an international 
development issue, may serve to hasten development.  
Synthesis of Research Findings 
Chapter Two identified how existing conceptualisations of the need for palliative care are based 
upon the unalleviated suffering of patients and families, which arises from lack of access to pain 
treatment and palliative care. However, by drawing upon the ‘broad-benefits’ of palliative care 
expressed by study participants in Chapter Seven, this need may be considered far more broadly. For 
instance, it has been uncovered that overly ‘technical’ approaches to medicine which proceed with 
aggressive and expensive treatments aimed at cure ‘at all costs’, may harm patients as well as 
threatening the very sustainability of health systems.iii Therefore, the ‘need’ for palliative care is 
extended as it has been presented as an approach which can both alleviate patient suffering as well 
as reducing costs to health systems. This finding is backed by a wide range of evidence, 
predominantly from Europe and North Americaiv However, one study in South Africa, found that 
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palliative care outreach teams were less costly than hospital-based palliative care, the authors 
concluding that community based services may be cost-beneficial.v Additionally, study participants 
suggested that patients and families are often forced to give up work due to the negative effects of 
illness. Therefore the ‘need’ for palliative care may be understood in terms of remediation of a 
circumstance which sees people leaving the workforce due to high symptom burden, and /or 
caregiving. 
Chapter Two also identified that existing narratives of palliative care development have focussed 
upon national-level processes, attributing a key-role to ‘pioneers’, grass-roots movements and 
government level leadership.vi In many ways, this viewpoint has been corroborated throughout the 
study, with such processes characterised as ‘international lesson learning’, whereby ‘transfer agents’ 
have spread practices of palliative care directly to other contexts.lxxi  Further examples of policy 
transfer were identified during interviews in Chapter Seven, for instance one participant from the 
study, studied in the United States and subsequently established the first hospice in a country in 
South America.   
However, in spite of these dynamic processes driven by individuals, Chapter Six demonstrated that 
levels of palliative care development within nations were highly consistent with broader 
development levels within countries in all settings. What this suggests, is that allied to dynamic 
personalities driving development, that palliative care becomes integrated within health systems 
over time, alongside other areas of development and that ‘similar’ countries (in development terms) 
have implemented palliative care to similar levels.  
This finding urges further attention to be paid to instances in which ‘model services’ have developed 
palliative care, over and above what may be expected based upon their broader developmental 
context. For instance, the example of Hospice Uganda which pioneered a model to increase access 
to pain treatment by empowering nurses to prescribe and administer pain medicines.vii This model 
was found to have had some success in Uganda more broadly, in particular with regards to 
increasing access in rural communities. Attention must therefore be drawn to Uganda’s inclusion of 
care within National Strategic Health Plans, which led to laws making morphine freely available and 
allowed nurses to prescribe.viii Such an approach appears to be a real opportunity from which other 
countries may learn, particularly in similar developmental contexts, where many people go through 
their lives without ever seeing a doctor and have access only to community based nurse-led health 
services. Indeed, there is some evidence that this policy may be being transferred to neighbouring 
countries, with The Nursing Council of Kenya, in conjunction with the Kenya Hospices and Palliative 
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Care Association (KEHPCA), currently advocating for the adoption of this approach in Kenya - a 
country which has “one nurse for every 4000 people as compared to one doctor for every 18,000 
people [2015].”ix  
However, the potential for roll-out of this model must be seen in the context of nurses’ existing 
workloads and whether they have the capacity to take on additional roles. Furthermore, in countries 
such as the UK, nurse-prescribing was opposed by doctors citing safety fears relating to people 
without formal medical training prescribing medicines.x Therefore, it is not known the extent to 
which the empowerment of nurses to prescribe in other settings would be acceptable to the broader 
medical establishment. 
Yet, despite the acclaim which Uganda has been given as a model of care for Africa, in Chapter Seven 
one study participant raised concerns regarding the sustainability of the development model. In 
spite of the WPCA study which credited Uganda with ‘full integration of palliative care into the 
health system’vi it was reported that “the work is being more sustained by grants, there really isn’t 
any government funding [Activist, Africa (P16)].” This reflects a broader picture which has been 
identified: that many services which have developed in all income settings (eg. Uganda and the 
United States) have been found to be reliant upon short-term funding streams from charitable and 
philanthropic organizations, revealing the fragility of the development model of palliative care has 
followed. Furthermore, the ‘pioneer-led’ models of development which have been identified raised 
issues regarding succession, in terms of, what happens when the pioneers move on? 
In many ways this circumstance is reflective of broader issues in global health development. A major 
criticism of the Millennium Development Goal (MDG) era was that a focus upon the eradication of 
specific diseases, led to targeted interventions and projects at the expense of overall health system 
improvement.xi As global attention switches towards the attainment of Universal Health Coverage 
(UHC) the need for national policies to situate palliative care within health systems becomes ever 
more urgent. Yet, it is known that many existing palliative care services operate outside of the 
formal health system with their own organizational autonomy.xii This means that there are risks that 
current palliative care funding models of service-specific financing may continue, with palliative care 
consequentially not incorporated as part of broader national health strategies and funding streams.   
This finding that palliative care continues to operate largely outside of formal health systems and 
budgets, means that the optimism surrounding the WHA must be tempered with caution.i The 
Resolution places the financial obligation for the integration of palliative care firmly on national 
governments, a suggestion broadly supported by study participants (Chapter Seven). Yet, the 
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demonstrated association between palliative care and broader processes of development [Chapter 
Six] shows that countries which have not developed services to a high level, face serious challenges 
to healthcare delivery. What this means is that in countries where life expectancy and other health 
indicators are low that governments may be being asked to reallocate resources away from other 
underdeveloped, yet essential, health services towards palliative care delivery.xiiiSuch concerns sit 
alongside an international trend towards the private delivery of healthcare which raises further 
questions regarding where resources may be reallocated from.i  
In this regard, many study participants suggested that palliative care ‘pays for itself’ in terms of 
reducing costs related to futile treatment, which could be spent upon palliative care services. 
However, conflicting evidence exists with which to both support and challenge such claims. For 
example, a systematic review of the cost and cost-effectiveness of palliative care in relation to ‘usual 
care’ reported contradictory findings. Palliative care was associated with reduced hospital 
admissions (and therefore costs) when compared with usual care for patients in the last month of 
life. However, no difference was detected for people receiving care for 120 days or over.xiv This 
raises doubts regarding claims that palliative care can ‘reduce costs’ to health systems when 
delivered concurrently with active treatment for a prolonged period. Furthermore, this circumstance 
underlines that distinct challenges exist in different world settings. Whilst there is some evidence to 
show that palliative care is associated with reduced hospital costs, in some settings (particularly low 
to middle income countries), people with serious illness may never even see a doctor therefore 
there are no associated costs of treatment to be reduced or reallocated.xv In such circumstances, 
new sources of funding for palliative care would certainly be required. 
In many ways however, this underlines the need for the implementation of the Resolution in terms 
of the development of national strategies for palliative care. Expressed viewpoints that governments 
must find the funds for palliative care belies the fact that a high amount of health care funding 
comes from global level funding agencies. Such funders may provide funds for palliative care if 
included within national health strategies. That is, since the Paris Declaration and Accra Agenda for 
Action on aid effectiveness, the donor community has sought to back projects which are aligned to 
national health priorities.xvi For instance, funding agencies such as The Global Fund to Fight AIDS, 
Tuberculosis and Malaria –profess to make funding decisions “informed by the specific needs and 
characteristics of each country [2015]”.xvii  
However, in spite of this political commitment to divert aid towards national priorities, studies have 
shown that multilateral funders continue to fund development in line with their own organizational 
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objectives. For instance, in Cambodia, a review of donor funding found that projects were funded 
which “correspond to the needs of the particular agency [eg multilateral banks], but not to those 
defined by the Cambodian government [2009].”xviii  
This circumstance is consistent with a broad argument of this thesis, that activists must use targeted 
arguments for the promotion of palliative care to engage with different actors [Chapters Three, Five 
and Seven]. For instance, ‘framing’ palliative care as an issue of human capital, as opposed to human 
rights, has been argued to hold potential to gain influence with funders such as the World Bank as it 
is consistent with their broader developmental priorities.xix In this regard, study participants 
suggested that through the early delivery of palliative care and effective symptom management that 
patients and carers would be able to continue contributing economically to society for longer 
periods and consequently increase household resilience.xx  Yet the findings from Chapter Five cast 
doubt upon whether researchers are currently equipping advocates with sufficient evidence to back 
such claims. For instance, no papers were identified which made a link between palliative care and 
extension of working lives. Similarly, although researchers have reported cost reduction to health 
systems through the delivery of palliative care, papers included in the systematic review did not 
make clear whether palliative care was introduced alongside, or instead of curative efforts. 
This reveals a known, but ongoing key tension within the field of palliative care. Is palliative care an 
end of life intervention or one which should be delivered upon diagnosis of serious illness? In 
practice, this distinction may not be so clear cut, with researchers reporting on best practice with 
regards to the ‘transition’ from curative to palliative care.xxi However, whether palliative care is a 
long or short term intervention has serious consequences in terms of ‘frames’ which advocates may 
be able to use. Furthermore, failure to use terms and definitions consistently, threatens to 
undermine efforts of advocates to ‘raise awareness’ of palliative care. 
What is meant by this, is that global funders have been shown to be more likely to engage with 
social activists, if they present a serious area of neglect, or ‘problem’, followed by a ‘solution’ 
showing the problem’s tractability and the benefits which would result from addressing it.xxii In this 
regard, this study has enlightened how the ‘problem’ of lack of palliative care can be presented. 
Moreover, a wide range of benefits which accrue from its introduction have been reported. What is 
less clear, however, is how ‘palliative care’ is the solution. 
By which it is meant, that given the lack of clarity regarding just what palliative care is, it becomes 
almost impossible to describe what is meant by access to it and therefore the overall coherence of 
the advocacy message is reduced.xxiii Moreover, if there is no single definition of ‘access to palliative 
 291 
 
care’, then how can it be measured? This is of serious concern and risks palliative care being 
relegated to a low priority within the Sustainable Development Goal (SDG) to achieve UHC. 
Furthermore, the failure to articulate a ‘minimum package’ of palliative care, risks a failure to engage 
with health insurance companies, the only significant private actors who have been identified whose 
interests coalesce with those of palliative care in terms of decreased length of hospital stay. 
In this regard, it was argued in Chapter Seven that advocacy should focus upon the most tractable 
argument for palliative care, that of access to pain relief. There was support from the public-patient 
representative amongst other participants, that access to pain relief was the most pressing challenge 
to the field. Moreover, suggestions were made regarding how access could be measured in terms of 
morphine consumption. What this means is that advocates are able to identify a problem (physical 
pain and its consequences), the solution (pain medication) and the benefits which accrue from 
addressing the problem (improved quality of life and maintenance of function). In spite of the 
complexities relating to how access can be secured, in terms of increasing education for nurses and 
physicians to prescribe, appropriate regulations etc. pain relief does appear to be the most 
straightforward way in which the field can make gains within global health development. This 
viewpoint is strengthened given that study participants were able to describe pain as a ‘universal 
experience’, whereas there was no such clarity regarding the consequences which occur in the 
absence of other elements of palliative care such as spiritual support. One reason for this may be 
that ‘spiritual care’ itself is a contested term and there is ongoing debate regarding the concept of 
spirituality and its relationship to religion.xxiv 
Yet, as was reported in Chapter Seven, there was some unwillingness amongst participants to 
delineate the different elements of palliative care, valuing them of equal importance. The promotion 
of pain relief is not to dismiss other elements of palliative care. However it has been shown in varied 
ways throughout the study that within a global context of limited resources for health care, that 
policy are determined through processes of prioritisation.i Therefore, in terms of advocacy, failure to 
delineate elements into their component parts in order to make clear arguments to policymakers, 
risks palliative care being overlooked altogether.  
However, in terms of both pain treatment and palliative care, many of the ‘frames’ and the benefits 
of increased access which were presented by participants continue to be undermined by a lack of 
evidence. Use of speculative economic ‘frames’ may ultimately prove harmful and researchers 
should aim to equip advocates with robust evidence around which advocacy approaches can be 
based.xxv There must therefore, be closer links between research and advocacy to determine how 
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each of these should inform practice. Indeed, palliative care activists may seek to look outside the 
field to see how the interaction of advocates and researchers has led to policy prioritisation of other 
health issues. For example in South America researchers uncovered evidence of high maternal 
mortality which led to advocates being able to confront policymakers with evidence of the problem 
and a subsequent policy response.xxvi  However, before considering the key implications for 
researchers and policy advocates, it is first appropriate to consider the short and long term 
implications of this study for medical and palliative care practice. 
Implications for practice 
As this was a high-level study, which primarily has examined global level policies and processes, the 
major issues identified predominantly relate to future research and policy priorities. Yet, mainly 
drawn from data gathered during interviews, several important implications have been identified 
primarily in terms of organization of palliative care services. 
As described in Chapter Seven, study participants held divergent views regarding the divisibility of 
different elements of palliative care. Yet with support from the public-patient representative, several 
participants suggested that improving access to pain services should be a priority for developmental 
health systems – over and above other elements such as emotional support. In this regard, evidence 
from Kenya suggests that, from a sample of 201 patients, 45.8% ranked ‘being in pain’ as the most 
concerning symptom at the end of life.xxvii However, access to pain medication has been shown to be 
limited by a combination of regulatory restrictions and lack of practitioner knowledge regarding how 
to adequately manage pain.  
There is an urgent need for increased education in pain management over and above other 
elements of palliative care. This suggestion however, must be viewed developmentally, that is, that 
if all elements of palliative care cannot be introduced concurrently, then it is rational to designate 
feasible short-term goals. There is therefore no implication that other elements such as ‘emotional 
support’ are unimportant. Instead, it is likely that there is significant regional variation in this regard 
and that a more holistic approach to palliative care may be more feasible in circumstances which 
have adequately developed pain treatment services. Yet, it should be noted that one study identified 
within Chapter Five, conducted across seven European Countries, also found a patient-expressed 
preference for pain to be relieved over and above other symptoms.xxviii  
A further implication for practice regards how to increase palliative care education amongst 
healthcare professionals. In this regard, several initiatives were identified in Chapter Seven regarding 
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international educational programmes, each with a different approach. Firstly, instances were 
identified of western medics delivering ‘sensitisation’ training in countries where palliative care has 
not developed. Such endeavours were presented thoughtfully, in the sense that whilst it is 
appropriate to raise awareness of the need for services such as pain treatment, it is less so if 
curricula advocate for the use of medicines which are not available to course recipients. In 
circumstances where awareness of care is limited or non-existent, such outreach efforts are needed 
in order to facilitate palliative care as an aspect of healthcare need. However, there are associated 
risks of short-termism and even for educators to make an overall negative contribution through the 
delivery of inappropriate ‘lessons’.xxix The benefits of such initiatives for palliative care have been 
noted by researchers, although there has been little or no evaluation of their impact in terms of 
patient care.xxx 
Secondly, as referred to above, doctors in countries which have little or no palliative care are 
travelling internationally to receive education which they are then able to apply to their own setting 
and disseminate information to colleagues. High value was attributed to such efforts within Chapter 
Seven. However, once more there are issues regarding the appropriateness of transferring certain 
lessons. That is, there may be associated dangers in terms of expectation-raising, if health 
professionals are taught to use treatments and technologies and are then not able to apply them in 
their home-setting due to lack of availability. Moreover this approach is consistent with narratives 
which placed individuals, or ‘pioneers’ at the centre of development efforts. As has been identified, 
although individuals are able to achieve a great deal in terms of development, there are associated 
dangers of this approach in terms of its sustainability.  
Third, one example was identified where a European university was working with an Indian hospice 
to offer a distance-learning, accredited diploma in palliative care. This initiative is funded by UK 
through the Commonwealth Scholarships project which aims to further international development 
in Commonwealth countries through education.xxxi This arrangement is consistent with views 
expressed by participants in Chapter Seven that richer countries have a responsibility to contribute 
towards the development of palliative care in other world settings.  
Lastly, a key change to practice suggested, is that nurses should be trained to provide palliative care 
and empowered to prescribe pain medications as discussed above. A less usual suggestion was made 
by one participant regarding the role of pharmacists in the provision of pain medication, particularly 
within private health systems.xxxii Responding to the dangers within private systems of doctors being 
placed under pressure to prescribe expensive medications equally appropriate cheaper alternatives 
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were available it was suggested that “one of the roles of a pharmacist is to separate the interest in 
what is prescribed, from the profits [Pharmacist, Europe (P01).” In spite of this, no evidence was 
identified in Chapter Five regarding the role of pharmacists. Nor did any other participants identify 
the key role which pharmacists may be able to play in facilitating safe supply of strong medicines in 
terms of ensuring sufficient supply whilst restricting over use, an issue which is expanded upon in 
the following section regarding future research opportunities.  
More usually, allusions which study participants made to what represents good palliative care 
practice reflected issues which are already well known to the field and do not bear repeating here, 
for example the suggestion that the unit of care should be both patients and families.xxxiii Specifically, 
it is well established that palliative care should be patient-centred and allow patients and families to 
determine their own goals of care. Furthermore, no participants identified instances where palliative 
care practitioners were acting inappropriately with a consequent need for new approaches. In this 
regard, suggested changes to practice were identified more for the broader medical discipline, 
mainly relating to an unrealistic pursuit of cure without acceptance that there is a ‘tipping point’ 
during illness when palliation becomes more appropriate.liv  
Researchers may have a role to play in providing evidence regarding when this ‘tipping point’ may be. 
However, the need for researcher to equip advocates with policy-relevant evidence extends much 
wider than this. The following section therefore considers key areas of priority for future research 
based upon the findings of the study. 
Implications for researchers 
It was shown in Chapter Five that palliative care research capacity in low and middle income 
countries is low. Moreover, low levels of research output are associated with lower palliative care 
development. This calls to mind a quote from the late Indian Prime Minister Jawaharal Nehru, who 
once said that it is “because we are a poor country, we cannot afford not to do research”.xxxiv Whilst 
it has been shown that researchers from richer nations are contributing to the evidence base for 
palliative care in other countries, there remains an urgent need for increased evidence in all regions. 
Specifically, policy-relevant research is needed in terms of cost-effectiveness of palliative care 
interventions. This is especially important given that organizations such as the World Bank will 
disburse financing for the attainment of the SDGs using ‘results-based financing’.xxxv   
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In this regard, this section considers key opportunities for researchers to conduct studies which may 
equip advocates with new types of robust evidence with which they may be able to engage with 
national and global policymakers in line with their own priorities. 
Outcome measurement tools to demonstrate value and benefit 
As has been demonstrated throughout this thesis, palliative care is one amongst many other health 
claims competing for policy attention and resources. As global health policy becomes ever more 
evidence-based, policymakers become ever more likely to allocate funding resources based upon 
cost-utility analyses.xxxvi That is, that similar to results-based financing, funding is likely to be 
allocated based upon cost in relation to perceived benefit to patients. 
For instance, in the United Kingdom (UK), the National Institute for Health and Care Excellence (NICE) 
makes recommendations for which drugs and services should be funded by the National Health 
Services based upon ‘cost per Quality Adjusted Life Year (QALY). Thresholds are set for what the 
national government should fund for one QALY, or additional year of perfect health.xxxvii Palliative 
care is not a good fit with such a cost-utility approach to funding allocation where ‘perfect health’ is 
not a feasible goal of care. It has been suggested that the lack of relevance of QALYs has led to 
palliative care being overlooked when funding allocations in favour of health services which have a 
clearer cost-benefit to patients and the health system.xxxviii  
Palliative care researchers must therefore renew efforts in order to produce evidence which shows 
that palliative care represents value for money. One study participant indicated this need for new 
metrics by noting a research project currently underway, which assesses “not just the burden of pain, 
but the burden of suffering [Activist, North America (P02)].” Efforts towards the production of a 
Suffering Adjusted Life Year (SALY) metric, may therefore be viewed favourably. An indicator of this 
kind, would allow researchers to demonstrate both levels of suffering as well as consequent benefits 
following the introduction of pain control and palliative treatment. Yet once more, whether 
palliative care is a long-term or end of life intervention is of importance. That is, if palliative care is 
introduced only at the end of life, positive and negative health impacts may be difficult to determine, 
when measured in terms of weeks and months and judgements on their cost-utility become highly 
ethically-charged questions.xxxix 
Yet, there is an urgent need to provide evidence to policymakers in terms of the economic aspects of 
palliative care given the relative likelihood which economic ‘frames’ hold to influence policymakers.xl 
In this regard, several studies have shown links between the onset of illness and the descent into 
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poverty, in both high and low income nations.xli These are negative effects of illness on families and 
households, which study participants in Chapter Seven suggested that palliative care could reduce. 
Yet, conflicting evidence exists regarding the potential for palliative care to mitigate such negative 
effects. For instance, it was suggested that effective palliative care can increase the human capital of 
patients and carers as well as contribute to poverty avoidance through reduced household 
expenditure on health. However, several studies have shown that palliative care can be associated 
with high out of pocket expenditure for families.xlii This relationship should be considered further, 
given the potential for ‘human capital’ arguments for palliative care. Additionally, attention should 
be given to claims that palliative care ‘reduces health system expenditure’ given the questions which 
arise when palliative care is introduced in addition to curative efforts as opposed to its introduction 
as an alternative.   
Furthermore, it may be fruitful for researchers to assist advocates by equipping them with evidence 
of the ‘benefits’ which study participants suggested accrue from palliative care to individuals, 
families, communities and other stakeholders. Yet, many of the potential ‘benefits’ of palliative care 
described in Chapter Seven appear somewhat nebulous and were presented with little clarity 
regarding how they may be measured. If activists are to make arguments such as ‘improved 
community cohesion’ to policymakers then there must be evidence to support such claims.  
In this regard, researchers should consider upscaling efforts regarding ‘health-promoting palliative 
care’, particularly with regard to developing robust outcome measures. This is a concept which 
emerged from the assertion that ‘death and loss’ should be recognised as a public health concern. It 
suggests that there is a need for community support and for ‘death education’ to combat the 
prevailing ignorance and misconceptions around death, dying and bereavement [2005]xliii.” A key 
challenge faced by such an approach, remains however, how to measure any potential gains. Yet, 
framing of palliative care in terms of health promotion allows its representation as something 
positive without abandonment of challenging negative attitudes towards illness and death. In this 
regard, researchers may again profit from looking outside of the field, to determine how other 
complex interventions with diverse inputs and outcomes have been evaluated.xliv 
Additionally, given the importance identified within this study regarding the need for increased 
access to pain treatment, researchers must produce evidence which can facilitate the removal of 
barriers to access. For instance, ‘fear of opioids’ was a common term used by study participants. 
Researchers should therefore consider how to engage with such fears as opposed to dismissing 
them as ‘lack of awareness’. The efficacy of pain treatments such as morphine for cancer pain is well 
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established.xlv Less so, are studies demonstrating the models of opioid availability which protect 
against public health risks such as over availability of morphine. Moreover, given the suggestion that 
nurses should be empowered to prescribe and administer strong pain medicines in rural areas, 
studies are needed which demonstrate how medicines may be safely stored in community settings. 
There are risks of misuse of medicines such as morphine and if nurses are to be asked to become the 
guardians of such potentially dangerous medicines then they must not be placed in positions of 
vulnerability. For instance, they must be assured of their own safety in terms of the risk that 
community health posts may be targeted by criminal elements of society seeking to access strong 
medicines for misuse. Moreover, greater attention is needed as to the key role played by 
pharmacists as custodians of opioid medications.xlvi Several studies have shown that pharmacists 
have concerns regarding their legal accountability for dispensing such medications inappropriately, 
and locally appropriate guidance is needed as to how they can safely do so – in all world settings.xlvii 
Considering the transferability of policies and practices 
In 2015 WHO published a report entitled ‘Tracking Universal Health Coverage’.xlviii Within this report, 
the term ‘palliative care’ is included, but appears just once. This underlines the scale of the challenge 
for the palliative care community to enmesh itself within global efforts towards UHC. Chapter Six 
demonstrated that countries of similar development levels have developed palliative care similarly. 
In this regard, evaluation of how countries such as Costa Rica have incorporated palliative care into 
health systems as part of universal health coverage is warranted in terms of considering the 
transferability of this model to ‘similar’ countries. xlix Research of this kind would help to provide 
lessons to other countries of similar development levels regarding how to integrate palliative care 
into health systems. A key element of this may be to move beyond purely financial characterisation 
of countries to consider demographic ‘similarities’ and the diverse challenges for the delivery of 
palliative care in rural and urban areas.  
Relatedly, there is a current study underway entitled The Harvard Global Equity Initiative–Lancet 
Commission on Global Access to Pain Control and Palliative Care. This international collaboration is 
ongoing, however, preliminary findings have suggested that “a systematic guide and tool for drafting 
national pain and palliative care plans [in Lower- Middle-Income Countries] is missing [2015].l” This 
suggestion supports the findings of this thesis and such gaps in understanding must be addressed.  
Furthermore, and as indicated above, there is an urgent need for clarity regarding what might 
constitute a ‘minimum package’ of palliative care. This may be defined, for example, as patients 
having continued access to health professionals who have received generalist palliative care training 
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at all levels of healthcare (Chapter Seven). Such an approach is consistent with a public health 
approach which has education as a cornerstone.li In settings where palliative care has already 
developed to a high level, ‘access’ may be extended to include consultations with specialist palliative 
care practitioners.lii Yet, as has been argued throughout, there must be a clear definition of what 
constitutes ‘access to palliative care’ in order for researchers to conduct economic evaluations, 
which consider clear inputs and outcomes of palliative care.  
Research of this kind may contribute towards a model upon which national health strategies can be 
based in order to make progress at national level and appeal to global funders in terms of the 
attainment of the SDGs. 
Engagement of new health disciplines through research 
A key emphasis within the study has been upon the need for a cognitive shift, whereby healthcare 
professionals acknowledge that there reaches a point in illness where ongoing curative efforts may 
no longer be consistent with patient-goals for treatment. Yet, whilst seeking to change such 
practices, doctors have little or no evidence-based guidance regarding when active treatments 
should be ceased. For instance, one oncology article identifies a need for agreed guidelines for the 
cessation of chemotherapy after a limited number of regimens to allow doctors to recommend 
discontinuation of treatment when it becomes unlikely that the patient will be ‘cured’.liii In the 
absence of such evidence, approaches such as ‘SPIKES’, provides guidance for oncologists on 
breaking bad news and encourages physicians to have realistic conversations with patients regarding 
their goals of care when the chances of curative success are remote.liv However, the extent to which 
such guidance is followed and why in different contexts is unknown and this approach stops short of 
giving evidence-based guidelines regarding when cessation of treatment becomes appropriate. 
At times, doctors have been painted as ‘uncaring’ within this thesis, in terms of medics overseeing 
the continuation of inappropriate curative treatments to the detriment of patient wellbeing. Yet, it 
seems unlikely that consensus will be reached regarding a point at which active treatment may be 
considered ‘futile’. Moreover, it has been shown throughout this thesis, there is an absence of 
patient-voice to demonstrate whether continuation of curative efforts is ever against patient wishes. 
That is, whether ongoing active treatment may be attributed to ‘lack of awareness’ of alternatives 
from patients as opposed to being consistent with their wishes.lv Accordingly, it may be that 
initiatives such as the UK AMBER care bundle, which encourages open conversation between health 
professionals, patients and families regarding future goals of care when there are concerns regarding 
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recovery, remain appropriate. However, there is a need for further evaluation of this approach to 
determine if it delivers sufficient benefits to patients and does not cause harm.lvi  
In this regard, it has been identified throughout the study (Chapters Two, Three and Seven) that 
death-denying attitudes persist and that there has not yet been a societal shift which acknowledges 
the importance of palliative care. Researchers may therefore seek to provide more evidence that 
palliative care has a role to play in disease prevention and cure.lvii Most clearly, it is known that there 
is a lack of research regarding the potential for palliative care to identify people at high risk of 
mental illness, for example patients’ family members and carers.lviii Emphasis upon the more publicly 
palatable potentials for palliative care may allow gains to be made within the broader aims of 
palliative care to achieve a pain-free and dignified death.  
Additionally one participant suggested that palliative care for children must be at the forefront of 
global advocacy efforts due to their vulnerability and the ‘blamelessness’ of people who may be 
born with an incurable illness such as HIV/AIDS. Furthermore, new WHPCA guidance suggests: 
Palliative care for children is based on good paediatric care which includes health promotion, 
prevention of infections and illnesses, immunisations, good nutrition, sanitation and 
management of the environment and customs that affect maternal and child health [2015].lix 
Linking palliative care research to established global health priorities such as maternal and child 
health may facilitate its insertion into broader healthcare and development discourses. As was 
identified in Chapter Two, HIV/AIDS became a global health priority through its presentation as a 
human rights issue, an economic limiter and a national security issue.lx In this regard, there is an 
urgent need for palliative care researchers not only to renew efforts to provide robust evidence of 
effectiveness and cost-effectiveness but to think more broadly about the contribution of palliative 
care to public health more generally. For palliative care to be integrated into medical and nursing 
practice, a rational approach may be to use less confrontational language and not use terms such as 
‘lack of awareness’ and ‘uncaring’, but to provide robust evidence for the relevance of palliative care 
to health care at all levels of delivery.  
Implications for policy and advocacy 
To consider the implications of this study for policy and advocacy, it is first necessary to consider 
theoretical understanding of how policy is made. An oft-cited understanding of policymaking is 
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known as the Kingdon Policy Window Model which suggests that in order for policy to be formulated 
on a given issue, three ‘streams’ must align for a matter to be dealt with: 
The problem stream (is the condition considered a problem?), the policy stream (are there 
are policy alternatives that can be implemented?), and the political stream (are politicians 
willing and able to make a policy change?) [Casamayou, 2003].lxi   
Understanding policymaking in this manner raises serious questions for the further development of 
palliative care based upon the findings of this study. Firstly, the broad lack of awareness of palliative 
care amongst policymakers identified by study participants in Chapter Seven suggests that absence 
of palliative care is not universally understood as a ‘problem’, in spite of global recognition of the 
issue in terms of the WHA Resolution. More encouragingly, although this study incorporated the 
views of participants with a vested-interest in the further development of palliative care, no policy 
alternatives were identified to increased palliative care provision. That is, that there are identifiable 
problems raised by the absence of effective care and symptom management for patients and 
families and that palliative care appears to be the only rational response to such suffering. However, 
it follows that as palliative care has largely not been identified as a serious area of need by many 
national and global policymakers, there is an absence of political will to increase palliative care 
provision especially as the issue sits as one amongst many social problems which nations are facing 
as identified in Chapter Six.  
In this regard, the opportunities presented by the WHA Resolution and the SDG of UHC must not be 
left to pass. The SDGs will be the global development priorities until 2030 and it is of great 
importance that these policies are translated from the global level, to national action. What is not 
yet known however, is if and how national-level policymakers will develop policies in order to enact 
the terms of the WHA Resolution and which elements of UHC will be prioritised over and above 
others. Additionally, even if nations include palliative care within national health strategies, the 
extent to which global funders will favour policies and strategies which are consistent with their own 
organizational mandates remains unknown.  
Furthermore, whilst the WHA Resolution passed unanimously and places obligations upon national 
governments, participants within this study laid great emphasis upon the need for advocacy to 
address the ‘lack of awareness’ of palliative care amongst the public, national and global 
policymakers (see Chapter Seven). Additionally, there is a need for palliative care to form new 
partnerships with both global organizations as well as with other health care disciplines in order to 
work as advocacy coalitions and situate itself within the broader landscapes of national and global 
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health to ensure that policymakers adhere to the obligations set out in the WHA Resolution.lxii In 
order to do so, however, the ‘palliative care community’ must first establish a clear message with 
which to raise awareness of policymakers and other potential partners. 
What is palliative care? An urgent need for shared understanding coherent advocacy 
Is palliative care a long-term intervention delivered from the time of diagnosis of a serious illness, or 
is it an approach which is introduced once curative efforts have become futile? 
There is an urgent need for consensus on this issue. In spite of all study participants’ acceptance of 
the WHO definition of palliative care which states that palliative care is appropriate at all stages of 
serious illnesslxiii it became clear throughout the study that there is great variety in practice. A key 
tenet of successful advocacy campaigns has been shown to be the delivery of a coherent message by 
varied actors working as advocacy coalitions.lxii Therefore, differing understandings of ‘palliative care’ 
must be considered a key limiter of the clarity of message which advocates are presenting to 
policymakers. Underpinning each of the diverse benefits of palliative care identified in Chapter 
Seven was a time-dependency. That is, that almost all benefits only held the likelihood to accrue if 
care was introduced at either an early or a late stage in illness. For instance, can it be said that 
palliative care reduces health care expenditure if it is introduced in addition to curative attempts? 
Alternatively, can the suggestion that palliative care may extend working lives be true if it is 
introduced only in the last days and weeks of life? 
In this regard, the previously identified lack of global leadership for palliative care may be considered 
a major limiter for the unification of understanding. Indeed, lessons from wider literature emphasise 
the need for ‘strong leadership’ and ‘shared ‘visions’ in order for advocacy to achieve influence.lxiv 
There is, therefore an urgent need for international and regional palliative care organizations to 
come together and reach agreement regarding how the term ‘palliative care’ should be used. In 
particular, as WHO guidance suggests that a key advocacy message must be ‘clear, consistent and 
convincing’ as well as being reinforced by a variety of sources.lxv In this regard, the findings of this 
thesis should encourage the diverse international associations to work in less isolation, but to 
coalesce and self-conceptualise as an advocacy coalition in order to increase the likelihood of 
cognitively influencing policymakers.lxii   
Yet the current lack of global leadership for palliative care remains a concern. Particularly as the 
WHO definition is broadly accepted, though understood in different ways as identified in Chapter 
Seven. Furthermore, whilst ‘lack of awareness’ has been identified as a major barrier for palliative 
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care development at all levels of governance, there is an ongoing failure to provide a consistent 
message, using specific terms with shared understanding. Accordingly, it is of surprise that the WHO 
definition of palliative care still appears within its broader section on Cancer which threatens to 
maintain historic misconceptions of palliative care as being for cancer patients only. Furthermore, 
there is an ongoing debate regarding whether the term ‘palliative care’ is fit for purpose at all.lxvi 
Whatever the answer is to this question, there is an urgent need for consensus amongst the 
palliative care community so that advocacy can begin to move forwards. Failure of advocates to 
provide a clear message to policymakers risks ‘palliative care’ being overlooked in both national and 
global policy prioritisation. 
Achieving global level funding; at what cost? 
Throughout this thesis, potential strategies have been identified for palliative care to present itself 
as an international development issue in order to attract funding from global level actors (See 
Chapters Two, Three, Five, Six Seven). However, ‘global funding’ carries both opportunities and risks 
in terms of how palliative care may develop in future. For example, any such funding may be short 
term and therefore not necessarily lead to sustainable palliative care development.lxvii Additionally, 
whilst the Global Fund allocates funding based on national health strategies,xvii others such as the 
World Bank continue to disburse funds through conditional loans, whereby funds are often allocated 
with conditionalities regarding how finance should be spent. Predominantly, this has meant funds 
diverted towards the private delivery of health care (see Chapter Three for further discussion of such 
issues).lxviii  
Given the predominant arguments made by study participants that palliative care is a human right 
and that there is a moral obligation for governments to ensure access to it (see Chapter Seven), 
palliative care and private provision does not seem a good fit. Moreover, there are fears that any 
private delivery of palliative care would lead to inequalities of access, based upon ability to pay, a 
circumstance which has occurred in the United States.lxix Yet this is not, however, a dilemma faced 
solely by palliative care. If we accept that ‘health’ is a human right then the concept of payment for 
the achievement of human rights becomes an issue for all health issues.  
Whether nations should accept funding for the private provision of palliative care is not a question 
for the author to answer. It serves to raise the question whether any means of further developing 
palliative care may be considered favourably? Chapter Seven showed how palliative care has 
developed to the highest levels in democratic societies. In such circumstances, it is through 
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democratic process that such decisions regarding any increase in private funding and delivery of 
service should be made. However, if the answer to this question is ‘no’, then what does this mean 
for people living within private healthcare systems? Furthermore, given the wide range of economic 
and societal benefits of palliative care identified in Chapter Seven, then what are the wider 
consequences of failing to provide palliative care beyond immediate suffering to patients?  
Whatever the answer to such questions the need for arguments and evidence for palliative care as a 
value proposition with wider societal benefits is not diminished (Chapter Seven). Instead, if national 
governments, with limited resources are to find national funding streams to fund palliative care then 
they are even more essential.  
Need for national palliative care policies 
That the SDGs have not incorporated an indicator to monitor progress towards the integration of 
palliative care into health systems does not preclude national governments from doing so. Increasing 
access to pain medications has been suggested throughout this thesis as a key first step towards 
alleviating the avoidable suffering of millions of people around the world. Yet although the challenge 
of ensuring universal access to pain treatment has been presented as the most pressing and 
tractable issue throughout the study, achievement of this aim remains complex.  
Several challenges to the safe provision of effective pain treatment have been considered above, in 
terms of risks of over-availability and storage of medicines as well as the role of pharmacists in the 
supply chain. However, these issues should be considered secondarily in relation to the key 
challenges of formulating national policy in terms of safe, yet enabling, regulations to permit the use 
of opioids as well as the challenge of training medical physicians to safely and effectively deliver 
medicines. The WHA Resolution was significant as it identified the lack of palliative care as a 
‘problem’. This may be considered the first step with regards to cognitive change of policymakers 
and the beginning of a search for a ‘solution’.lxx In this regard, it has been suggested through 
understanding theoretical literature regarding the process of policy transfer that it is rational for 
policymakers to look beyond their borders to determine how other, similar, countries have 
responded to this policy challenge.lxxi  
In this regard, ‘model services’ in all world settings have been identified in the thesis to which 
policymakers should consider in terms of their potential relevance to their own context (Chapter Six). 
Much is often made of the need for palliative care services to be ‘context-specific’. Such issues may, 
however, be considered less important with regards to the provision of pain services as ‘drug 
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regulations’ hold little relevance to context, either they permit and enable access to essential 
medicines for those in need of them or they do not. Additionally, owing to universal pharmacology, 
practically, the skills required to deliver pain treatment have little basis in context. With regards to 
both of these issues, the contextual challenge is to ensure the availability of affordable medicines 
and avoid the circumstance in India, whereby the de-regulation of opioids was reported to have led 
to the availability of primarily expensive medicines [Chapter Seven].  
National deregulation of opioid medications must therefore be a key target for advocacy 
organizations and researchers. Whilst deregulation would only be a first step in terms of assuring 
access to pain treatment, without availability of essential medicines, there would be little immediate 
benefit of educating either doctors or nurses to prescribe them (Chapter Seven). Indeed study 
participants were reluctant to raise expectations of doctors regarding how they can treat pain in 
circumstances where medicines are not available. However, if done appropriately, such processes do 
appear to hold some potential to turn medical professionals into powerful actors for change through 
the formulation of epistemic communities, which may be able to create advocacy pressure ‘from 
below’ and lobby national governments to ensure availability of medicines.lxxii  
Additionally, national governments should be encouraged to consider themselves comparatively in 
relation to other nations of similar development level. That is, there are opportunities for 
policymakers seeking to devise national palliative care policies and implement the terms of the WHA 
Resolution to look towards nations such as Uganda or Costa Rica who have done so in order to learn 
appropriate lessons. In this regard, one key way of increasing access to pain medication has been 
identified as the empowering of nurses to prescribe and deliver treatments (also known as task-
shifting’) – this was discussed in Chapter Seven of the thesis. This has been shown to be a feasible 
and effective way of dramatically increasing access to pain services based upon the relative lack of 
timing and resources required to train nurses as well as their relative prevalence in terms of 
coverage over doctors.vii  
Yet, policymakers in all settings do not only have to look at how ‘similar’ countries have responded 
to this policy challenge: for lessons to be learned from different countries does not imply that 
policies have to be directly transferrable. That is, in spite of differences between nations, this does 
not mean that they do not face shared challenges or that lessons can’t be drawn from one context 
and implemented in another, with appropriate amendments.lxxiii Such processes of international 
lesson-learning were identified in Chapter Five regarding the transferability of the Liverpool Care 
Pathway (LCP), a framework developed in the UK which aimed to ensure comfort at the end of life. 
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Although the LCP is now defunct, it may still be ‘rational’ to consider the policy response in the UK, 
given its top-ranking within the Economist Intelligence Unit’s Quality of Death study.lxxiv Additionally, 
the UK Department of Health developed an End of Life Care Strategy in 2008 which aims to promote 
high quality care for adults at the end of life.lxxv The strategy is said to be increasing instances where 
patients die in a location of their choice as well as raising the awareness of the general public 
regarding palliative care.lxxvi However, there are also reports that it has not had an impact in 
increasing equality of access to services for various ethnic groups, nor patients with a non-cancer 
diagnosis.lxxvii 
In any event, policymakers in other settings may wish to consider what kind of lessons may be 
learned from the UK. That is, that as a ‘national palliative care policy’, the emphasis is very much 
upon end of life care as opposed to the delivery of care over a longer period of time. Therefore, 
countries seeking to develop their own national policies must decide once more, whether the 
primary aim of any such policy would be to ensure access to palliative care from the point of 
diagnosis, or at the end of life only. 
Failure to engage with the right to die community 
Public calls for assisted dying have been growing in recent times and legislation has been introduced 
in countries in North America (eg Canadalxxviii) as well as in Europe (eg The Netherlandslxxix). Whether 
individuals have a ‘right to die’ is a complex ethical question, too broad for full consideration here. 
However, key concerns from opponents of such a right include fears of a ‘slippery slope’ whereby a 
right to die becomes a duty to die.lxxx  Study participants suggested furthermore, that there were 
fears amongst palliative care professionals that they would be the people called upon to enact such 
a right, potentially against their wishes. More fundamentally, many opponents of a right to die 
profess that life is sacrosanct and should not be taken under any circumstances.lxxxi 
What is important is that the ‘right to die movement’ is gaining increasing public acceptance in some 
countries and threatens to dominate discourses regarding how people should be treated and cared 
for at the end of life.lxxxii Furthermore, there is an uncomfortable association for the palliative care 
community, that the right to die movement has made the most gains in high income countries 
where palliative care has developed to a high level. For instance, in the United Kingdom, which is 
currently ranked as providing the best ‘quality of death’ in the world, people continue to travel to 
Switzerland in order to receive an assisted death.lxxxiii In this regard, in spite of efforts towards a 
‘right to palliative care’ it has been identified throughout the study that palliative care has not yet 
gained the attention and support of the public.lxxxiv  
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Sidestepping the ethical debates regarding assisted dyinglxxxv, there are potentially opportunities for 
palliative care to make gains by engaging with actors on both sides of the assisted dying debate. In 
most settings where assisted dying legislation has been introduced, there has been an associated 
rise in provision of palliative care. For instance, legalisation for voluntary euthanasia was introduced 
in Belgium in 2002 and by 2011 funding for palliative care had doubled.lxxxvi In Luxembourg, the 
legalisation of physician assisted dying in Luxembourg was accompanied by the designation of 
palliative care as a basic patient right.lxxxvi Moreover, increased engagement from the public in issues 
and discussions regarding how people spend the end of their lives could be used to make gains for 
palliative care. In this regard, it is not essential that the palliative care community either endorses or 
rejects assisted dying, rather advocates can remain humble regarding what palliative care can 
achieve and (in line with the view of an EAPC Task Force) engage in “direct and open dialogue with 
those within medicine and healthcare who promote euthanasia and physician-assisted suicide 
[2001]”.lxxxvii  
Conclusion 
The significant value proposition that further roll-out of services in terms of benefits for patients, 
families/carers, communities and health systems means that new approaches are needed for the 
international development of palliative care. The absence of pain and palliative treatments is felt 
most keenly by patients and families who endure high degrees of suffering. Owing to this global lack 
of services and most significantly, pain treatments, it has been argued that increasing access to 
essential medicines remains the most pressing challenge to the field. The new global health priority 
of achieving UHC offers opportunities for palliative care to make gains. However, activists should 
consider the field developmentally; that is to say, to focus upon achievable change and the most 
immediate ‘solvable’ problems which palliative care seeks to address. 
The alleviation of avoidable suffering is a moral and ethical responsibility of societies. Yet palliative 
care is but one of many other pressing global health needs. It has therefore been argued throughout, 
that there is a great need for activists to move beyond using only moralistic representations, to use 
different arguments for palliative care to engage with a wide range of national/global actors and 
health economists in particular. Moreover there remains an urgent need for wider forms of policy-
relevant evidence to examine claims such as ‘increased human capital’ from palliative care as well as 
to demonstrate its effectiveness and cost-effectiveness, factors upon which, national and global 
policymakers will ultimately make funding allocations. In this regard, it is essential that increasing 
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access to pain treatment and palliative care are not simply viewed as national issues and must be 
seen as problems for the broader international development community. 
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Appendix 3. 
Typology of country groups 
Country 
group 
Recoded 
category 
Characteristics of group 
Group 1 1 
No known hospice-palliative care activity: Although we have not been able to identify any palliative 
care activity in this group of countries, we acknowledge there may be instances where, despite our 
best efforts, current work has been unrecognised. 
Group 2 2 
Capacity building activity: In this group of countries, there is evidence of wide-ranging initiatives 
designed to create the organisational, workforce and policy capacity for hospice-palliative care 
services to develop, though no service has yet been established. The developmental activities 
include: 
 attendance at, or organisation of, key conferences 
 personnel undertaking external training in palliative care 
 lobbying of policy-makers and ministries of health 
 incipient service development. 
Group 
3a 
3 
Isolated palliative care provision: This group of countries is characterised by: 
 the development of palliative care activism that is patchy in scope and not well-supported 
 sourcing of funding that is often heavily donor-dependent 
 limited availability of morphine 
 a small number of hospice-palliative care services that are often homebased in nature and 
relative to the size of the population. 
Group 
3b 
4 
Generalised palliative care provision: This group of countries is characterised by: 
 the development of palliative care activism in a number of locations with the growth of 
local support in those areas 
 multiple sources of funding 
 the availability of morphine 
 a number of hospice-palliative care services from a community of providers that are 
independent of the healthcare system  
 the provision of some training and education initiatives by the hospice organisations. 
Group 
4a 
5 
Countries where hospice-palliative care services are at a stage of preliminary integration into 
mainstream service provision: This group of countries is characterised by:  
 the development of a critical mass of palliative care activism in a number of locations 
 a variety of palliative care providers and types of services 
 awareness of palliative care on the part of health professionals and local communities 
 the availability of morphine and some other strong pain-relieving drugs 
 limited impact of palliative care on policy 
 the provision of a substantial number of training and education initiatives by a range of 
organisations  
 interest in the concept of a national palliative care association. 
 
 
Group 
4b 
6 
Countries where hospice-palliative care services are at a stage of advanced integration into 
mainstream service provision: This group of countries is characterised by:  
 the development of a critical mass of palliative care activism in a wide range of locations 
 comprehensive provision of all types of palliative care by multiple service providers 
 broad awareness of palliative care on the part of health professionals, local communities 
and society in general 
 unrestricted availability of morphine and all other strong pain-relieving drugs  
 substantial impact of palliative care on policy, in particular on public health policy 
 the development of recognised education centres  
 academic links forged with universities 
 the existence of a national palliative care association. 
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Appendix 4. Theoretical rationale for inclusion of variables (n=28) 
 
 
 
 
Indicator Domain Description Year of 
data 
Measure 
Total 
records 
Theoretical relationship with palliative care development 
1 
Cause of death, by 
non-communicable 
diseases (NCDs) (% of 
total) 
Disease 
demographics 
Percentage of national 
population who die due 
to non-communicable 
illness.
1
 
2000 Scale 171 records 
There has been a historical association between palliative care and cancer 
(a non-communicable disease).
2
 Although palliative care is now 
recommended for both non-communicable and communicable diseases, 
inclusion of this variable allows an investigation regarding whether 
palliative care has developed primarily to meet the needs of NCD patients.  
2 
Cause of death, by 
communicable 
diseases (% of total) 
Disease 
demographics 
Percentage of deaths 
resulting from; 
Communicable diseases 
and maternal, prenatal 
and nutrition 
conditions.
3
 
2000 Scale 172 records 
The WHO recommends palliative care for any life-limiting illness. However, 
as palliative care emerged originally to meet the needs of cancer patients, 
the inclusion of this indicator allows assessment of whether palliative care 
services have now developed in countries where people predominantly die 
for infectious illnesses. 
3 
Life expectancy at 
birth, total (years) 
Socioeconomic 
Expected Life 
Expectancy for a 
newborn based upon 
assumed continuation 
of current mortality 
rates.
4
 
2011, 2010 Scale 195 records 
Life Expectancy is considered a key indicator of development as well as a 
major inequality between nations.
5
  Disaggregating life expectancy from 
the other components of human development score is appropriate in 
context of the global challenge of ageing populations. Inclusion of this 
variable allows examination of WPCA claims that palliative care has 
developed ‘to meet the needs of ageing populations’. 
                                                          
1
 World Bank. Cause of death, by non-communicable diseases (% of total). Available from: http://data.worldbank.org/indicator/SH.DTH.NCOM.ZS. Accessed 28 December, 2015. 
2
 Ten Have J and Janssens R (eds). Palliative Care in Europe: Concepts and Policies. 2001. Amsterdam: IOS Press. 
3
 World Bank. Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total). 2015. Available from: 
http://data.worldbank.org/indicator/SH.DTH.COMM.ZS. Accessed 06 January 2016. 
4
 World Bank. Life expectancy at birth, total (years). 2015. Available from: http://data.worldbank.org/indicator/SP.DYN.LE00.IN. Accessed 28 December, 2015. 
5
 Edwards RD. CEPR’s policy Portal. Rising inequality between countries in adult length of life. 2010. Available from: http://www.voxeu.org/article/life-expectancy-around-world. Accessed 07 
November, 2015. 
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4 
Age dependency ratio 
(% of working-age 
population) 
Socioeconomic 
Ratio of older 
dependents, people 
older than 64 to the 
working-age 
population, those ages 
15-64
6
 
2011 Scale 190 records 
This indicator is central to discourses around ageing and the sustainability 
of health systems. Its inclusion allows investigation of whether palliative 
care has developed most highly, in circumstances where fewer people are 
paying in to health systems. 
5 
Literacy rate, adult 
total (% of people 
ages 15 and above) 
Socioeconomic 
Percentage of adults 
(15+) who can read, 
write and possess basic 
numeracy.
7
  
2011, 2010, 
2009, 2008, 
2007 
Scale 136 records 
The ‘Keralan example’ also utilises social indicators including literacy rates 
as contextual factors in the development of palliative care services.xxxi 
Such links provide justification for examining of any relationship between 
literacy rates and level of palliative care development. It may be expected 
that higher literacy rates are indicative of higher levels of palliative care 
development. 
6 
Out-of-pocket health 
expenditure (% of 
total expenditure on 
health) 
Socioeconomic 
Any direct household 
outlay spent on 
restoration or 
enhancement of 
health.
8
 
2011 Scale 187 records 
This variable allows distinction between public and private health systems. 
Theoretically, lower out of pocket expenditure is indicative of high 
commitment from governments to health care.
9
 Conversely, greater out of 
pocket expenditure is suggestive of a greater role of the private sector in 
the provision of health care. Understanding palliative care development 
from a public health approach, it may be expected that out-of-pocket 
expenditure would be lower in circumstances which have higher levels of 
palliative care development.  
 
                                                          
6
 World Bank. Age dependency ratio, old (% of working-age population). 2015. Available from: http://data.worldbank.org/indicator/SP.POP.DPND.OL. Accessed 28 December 2015. 
7
 World Bank. Adult literacy rate, population 15+ years, both sexes (%). 2015. Available from: http://data.worldbank.org/indicator/SE.ADT.LITR.ZS. Accessed 28 December, 2015. 
8
 World Bank. Out-of-pocket health expenditure (% of total expenditure on health). 2015. Available from: http://data.worldbank.org/indicator/SH.XPD.OOPC.TO.ZS. Accessed 28 December, 
2015. 
9
 Farrington-Douglas J, and Coelho MC. Institute for Public Policy Research. Private Spending on Healthcare. 2008. Available from: 
http://www.ippr.org/files/images/media/files/publication/2011/05/private_spending_on_healthcare_1646.pdf?noredirect=1. Accessed 07 November, 2015. 
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7 
Death rate, crude (per 
1,000 people) 
Socioeconomic 
Total deaths per year 
per 1,000 people
10
 
2011, 2010, 
2007 
Scale 199 records 
Crude death rates indicate the number of deaths during the year per 1000 
population estimated at midyear
11
 and serves as an estimate of the 
prevalence of death within a population. Estimating death rates is 
important in terms of assessing potential need for palliative care services 
Competing hypotheses are firstly, that high death rates indicate greater 
need for palliative care and that palliative care may have developed to 
meet this need. Alternatively, it could be suggested that higher death rates 
are indicative of underdeveloped health systems where palliative services 
may not yet have emerged to meet palliative care need.  
 
8 
Prevalence of 
undernourishment (% 
of population) 
Socioeconomic 
Percentage of 
population below 
minimum level of 
dietary energy 
consumption
12
 
2011 Scale 125 records 
Tackling undernourishment can be considered a global health priority in 
line with MDG 1: to eradicate extreme poverty and hunger.
13
 The line of 
enquiry here, is that countries where undernourishment remains 
prevalent are less likely to have developed the infrastructure for palliative 
care. 
9 
GINI index Socioeconomic 
Extent to which income 
distribution or 
consumption 
expenditure among 
individuals or 
households within a 
nation deviates from a 
perfectly equal 
distribution.
14
 
2011, 2010, 
2009, 2008, 
2007 
Scale 152 records 
The GINI coefficient is a measurement of the level of income inequality 
and consumption expenditure within a country. A GINI index of 0 indicates 
perfect equality, whilst an index of 100 suggests perfect inequality.
15
 One 
theoretical hypothesis for including the variable is that it can be suggested 
that income equality (or inequality) is not something which occurs 
naturally, but which is guided by policies.
16
 One hypothesis is that more 
equal societies enjoy greater social cohesions, a circumstance which may 
have facilitated the development of palliative care.
17
 An alternative 
hypothesis was heard anecdotally by the author, that high income 
inequality in a country can actually facilitate access to palliative care 
services, as poorer people seek care as they are unable to seek more 
expensive curative alternatives. 
 
                                                          
10
 World Bank. Death rate, crude (per 1,000 people). 2015. Available from: http://data.worldbank.org/indicator/SP.DYN.CDRT.IN. Accessed 28 December, 2015 
11
 World Bank. Death rate, crude (per 1,000 people). 2014. Available from: http://data.worldbank.org/indicator/SP.DYN.CDRT.IN. Accessed 10 December 2014. 
12
 World Bank. Prevalence of undernourishment (% of population). 2015. Available from: http://data.worldbank.org/indicator/SN.ITK.DEFC.ZS. Accessed 28 December, 2015. 
13
 World Health Organization. MDG 1: eradicate extreme poverty and hunger. 2014. Available from: http://www.who.int/topics/millennium_development_goals/hunger/en/. Accessed 10 
December 2014. 
14
 World Bank. GINI index (World Bank estimate). 2015. Available from: http://data.worldbank.org/indicator/SI.POV.GINI. Accessed 28 December, 2015. 
15
 World Bank. GINI Index. Available from: http://data.worldbank.org/indicator/SI.POV.GINI. Accessed 09 December 2014. 
16
 International Monetary Fund. Income Inequality and Fiscal Policy. Available from: http://www.imf.org/external/pubs/ft/sdn/2012/sdn1208.pdf. Accessed 08 December 2014. 
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10 
International tourism, 
number of arrivals 
Socioeconomic 
Total tourist arrivals 
(under one year) per 
year
18
 
2010, 2008, 
2007 
Scale 196 records 
High levels of international tourism in a country are associate with both 
positive and negative health outcomes.
19
 A theoretical hypothesis is that 
where large numbers of tourists encounter avoidable suffering – absence 
of pain relief, for example – that this leads to a response. The work of 
Ecosphere, a tourism social enterprise, which is helping to introduce 
palliative care into an isolated Himalayan region in India (Himachal 
Pradesh), fits with this theory and provides justification to examine any 
potential broader trends. 
 11 
Internet users (per 
100 people) 
Socioeconomic 
Individual users of the 
internet per year (per 
100 people)
20
 
2011 Scale 202 records 
The WPCA reported growing awareness of new possibilities, better access 
to education and training, improved communication systems, access to 
information as well as ‘broader support networks’ as factors driving 
palliative care development. ‘Internet use’ was deemed to be a reasonable 
indicator of access to such systems and processes and was therefore 
included as a facilitator of such factors on that basis. It may therefore be 
expected that higher internet use is associated with higher levels of 
palliative care development.  
 12 
Consumption of 
morphine equivalent 
in mg per capita 
Health systems 
Total opioids 
distributed to licensed 
dispensaries (per 
capita)
21
 
2010 Scale 154 records 
Opioid consumption is sometimes referred to as the only indicator collated 
at global level which is relevant to palliative care provision. Morphine 
equivalents (ME) serve as a good indication of the availability and 
provision of pain relief within a country, although it does not reveal 
anything about equity of access in a country. Competing hypotheses are 
that firstly, availability of morphine equivalents has driven service 
development. Alternatively, it could be that advocacy from palliative care 
activists has led to greater ME availability. However, it would be expected, 
that the higher the level of consumption, the higher the level of palliative 
care development. 
                                                                                                                                                                                                                                                                                      
17
 Green A. Preston J. and Janmaat JG. Education, Equality and Social Cohesion: A comparative analysis. 2008, Palgrave Macmillan. 
18
 World Bank. International tourism, number of arrivals. 2015. Available from: http://data.worldbank.org/indicator/ST.INT.ARVL. Accessed 28 December, 2015. 
19
 Bauer I. The Impact of Tourism in Developing Countries on the Health of the Local Host communities: The need for more research. J of Tour Stud, 1999;10(1):2-17. 
20
 World Bank. Internet users (per 100 people). 2015. Available from: http://data.worldbank.org/indicator/IT.NET.USER.P2. Accessed 28 December, 2015. 
21
 Pain and Policy Studies Group. Opioid Consumption Data. Available from: http://www.painpolicy.wisc.edu/opioid-consumption-data#What do these data represent?. Accessed 28 
December, 2015. 
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13 
Hospital beds (per 
1,000 people) 
Health systems 
Hospital bed available 
per 1,000 people 
(public and private)
22
 
2011, 2010, 
2009, 2008, 
2007 
Scale 167 records 
This variable is included as an indicator of countries’ health infrastructure. 
The measure includes beds at public, private, general, and specialised 
hospitals and rehabilitation centres. It can be suggested, that the higher 
proportion of beds to people, the greater the chance that some of these 
are utilised for palliative patients. 
 
14 
Health system ranking Health systems 
Overall health system 
performance ranking 
measured in terms of; 
improvement in health, 
health system 
responsiveness and 
distribution of service
23
 
2000 Ordinal 187 records 
It has suggested that palliative care is an important element of health 
systems strengthening.
24
 Therefore, it may be suggested that stronger the 
stronger a health system is, the more likely that palliative care has 
developed to a high level. 
15 
Health expenditure, 
public (% of GDP) 
Political 
Public health 
expenditure as a 
percentage of Gross 
Domestic Product
25
 
2011 Scale 187 records 
In general, high public expenditure on health is consistent with social 
democratic health systems, whereas low spending, is associated with 
liberal health systems.
26
 The hypothesis here is that the greater the 
proportion of government resources which are directed towards health, 
the higher the level of palliative care development. 
                                                          
22
 World Bank. Hospital beds (per 1,000 people). 2015. Available from: http://data.worldbank.org/indicator/SH.MED.BEDS.ZS. Accessed 28 December, 2015. 
23
 World Health Organization. Measuring Overall Health System Performance for 191 countries. 2012. Available from: http://www.who.int/healthinfo/paper30.pdf. Accessed 28 December, 
2015. 
24
 Leng MEF. Health systems strengthening; a palliative care perspective. 2015. Available from: http://www.cairdeas.org.uk/archive/2015/Health%20systems%20strengthening.pdf. Accessed 
06 January 2016. 
25
 World Bank. Health expenditure, public (% of GDP). 2015. Available from: http://data.worldbank.org/indicator/SH.XPD.PUBL.ZS. Accessed 28 December, 2015. 
26
 Asthana S, and Halliday J. Developing an Evidence Base for Policies and Interventions to Address Health Inequalities: The Analysis of “Public Health Regimes”. Millbank Q, 2006;84(3):577-
603. 
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16 
Health expenditure, 
private (% of GDP) 
Political 
Private health 
expenditure includes 
direct household) 
spending, private 
insurance, charitable 
donations, and 
payments by private 
corporations as a 
percentage of Gross 
Domestic Product
27
 
2011 Scale 187 records 
This variable serves as an indication of political ideology, with higher 
private spending on health associated with liberal health systems and 
lower spending, when compared to social democratic models.  From a 
public health perspective, it may be expected that lower private health 
expenditure would be associated with higher palliative care development. 
17 
Corruption index Political 
Level of 
misappropriation of 
health funding for 
personal gain
28
 
2011 Ordinal 180 records 
Globally speaking, health targets have focussed upon the reduction of 
infectious disease.
29
 With increased funding, there is increased political 
pressure for these targets to be met. High levels of corruption have seen 
the misdirection of finances made available for health care.
30
 Therefore 
resources which have may been allocated to palliative care development 
were not spent on developing palliative services. As there are no global 
targets relating to palliative care, there is little accountability either. 
 
  
18 
Public spending on 
education, total (% of 
GDP) 
Political 
Government spending 
on education as a 
percentage of Gross 
Domestic Product
31
 
2011, 
2010,2009,
2008,2007 
Scale 151 records 
This indicator has been included for analysis as a further measure of 
government commitment to social outcomes amongst its population. 
Further, the context of Kerala, where educational indicators are highxxx, 
provides more anecdotal evidence of a potential relationship between 
these two variables.  
 
                                                          
27
 World Bank. Health expenditure, private (% of GDP). 2015. Available from: http://data.worldbank.org/indicator/SH.XPD.PRIV.ZS. Accessed 28 December, 2015. 
28
 Transparency International. Global Corruption Report 2006: Corruption and Health. Available from: 
http://www.transparency.org/whatwedo/publication/global_corruption_report_2006_corruption_and_health. Accessed 16 December 2014. 
29
 United Nations. News on the Millennium Development Goals. 2015. Available from: http://www.un.org/millenniumgoals. Accessed 07 November, 2015. 
30
 Mackey T. Corruption in Global Health: Governance Approaches in Dealing with Forms of Health Related Corruption. 2011. Available from: 
http://www.u4.no/assets/themes/health/Corruption-in-Global-Health.pdf. Accessed 07 November, 2015. 
31
 World Bank. Government expenditure on education as % of GDP (%). 2015. Available from: http://data.worldbank.org/indicator/SE.XPD.TOTL.GD.ZS. Accessed 28 December, 2015. 
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19 
Strength of democracy Political 
Composite measure of 
democracy strength 
including; pluralism, 
civil liberties and 
political culture
32
 
2011 Ordinal  167 records 
Inclusion of this variable follows other studies which have found a positive 
effect of democracy upon health.
33
 In this regard, it may be expected that 
palliative care has developed to higher levels within stronger democracies. 
20 
Population ages 65 
and above (% of total) 
Demographic 
Percentage of total 
population aged 65+
34
 2011 Scale 190 records 
‘The practical needs of an ageing population’ has been reported as a driver 
of palliative care development. The needs of people who die before the 
age of 65 notwithstanding, including this variable allows us to test the 
hypothesis that palliative care services have developed to meet the needs 
of older people (>65). 
 
21 
Mortality rate, infant 
(per 1,000 live births) 
Demographic 
Total deaths of infants 
under one year of age 
(per 1,000 live births)
35
 
2011 Scale 190 records 
Infant mortality rates are considered a key indicator of health system 
strength (or weakness).
36
 With a health systems approach proposed for 
palliative care development, it might be expected that high infant 
mortality rates are an indicator of health system weakness. Global 
prioritisation of improving infant mortality rates may suggest that this is 
being prioritised over and above rollout of palliative care. 
 22 
Urban population (% 
of total) 
Demographic 
People living in urban 
areas as percentage of 
total population
37
 
2011 Scale 207 records 
The geography and demographics of a country can present unique 
challenges for health systems to deliver quality health care. In terms of the 
urban:rural distribution of a population, a major issue centres around 
access to health services. Additionally, a systematic review reports that 
palliative care services have developed mainly in urban areas.
38
 Inclusion 
of this variable makes it possible to test this claim. 
 
                                                          
32
 Economist Intelligence Unit. Democracy Index 2011. Available from: 
http://www.eiu.com/Handlers/WhitepaperHandler.ashx?fi=Democracy_Index_2011_Updated.pdf&mode=wp&campaignid=DemocracyIndex2011. Accessed 12 December, 2014. 
33
 Safael J. Is democracy good for health? Int J Health Serv, 2006;36(4):767-86. 
34
 World Bank. Population ages 65 and above (% of total). 2015. Available from: http://data.worldbank.org/indicator/SP.POP.65UP.TO.ZS. Accessed 28 December, 2015. 
35
 World Bank. Mortality rate, infant (per 1,000 live births). 2015. Available from: http://data.worldbank.org/indicator/SP.DYN.IMRT.IN. Accessed 28 December, 2015. 
36
 Muldoon KA, Galway LP, Nakajima M, Kanters S, Hogg RS, Bendvald E, and Mills E. Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN 
member countries. Global Health, 2011;7(42) 
37
 World Bank. Urban population (% of total). 2015. Available from: http://data.worldbank.org/indicator/SP.URB.TOTL.IN.ZS. Accessed 28 December, 2015. 
38
 Evans R, Stone D, and Elywyn G. Organizing palliative care for rural populations: a systematic review of the evidence. Family Practice 2003;20(3):304-310. 
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23 
Birth rate, crude (per 
1,000 people) 
Demographic 
Live births each year 
per 1,000 persons
39
 
2011, 2010, 
2007 
Scale 201 records 
Birth rates have become used as a quasi-indicator of a countries’ level of 
development, with low birth rates prevalent in the countries of high 
development and higher rates found in lesser developed countries – in 
particular the world’s poorest countries.
40
 The theoretical argument for 
the inclusion of the variable is that in developmental health systems 
where countries have not yet tackled issues relating to high infant and 
maternal mortality, they have not been able to focus upon the needs of 
people at the end of life. 
 24 
Mortality rate, adult, 
male (per 1,000 male 
adults) 
Demographic 
Total adult (15-60) male 
deaths per 1,000 adult 
males
41
 
2011, 2010, 
2009, 2008 
Scale 190 records 
Mortality rates are included as a useful suggestion of the extent to which 
palliative care services have developed in response to need. In general 
terms, proponents suggest that most people would benefit from palliative 
treatment during the final phase of life – whenever that may be.xxiii On 
this basis, it can be suggested that higher mortality rates are indicative of 
greater level of need within a population and the responsiveness of health 
systems to palliative care need. Distinction between male and female 
mortality rates have been drawn to take into consideration potential 
gender difference. 
 
25 Mortality rate, adult, 
female (per 1,000 
female adults) 
Demographic 
Total adult (15-60) 
female deaths per 
1,000 adult females
42
 
2,011,201,0
20,092,000 
Scale 190 records 
As above 
                                                          
39
 World Bank. Birth rate, crude (per 1,000 people). Available from: http://data.worldbank.org/indicator/SP.DYN.CBRT.IN. Accessed 28 December, 2015. 
40
 Jackson A. Geography AS Notes. Fertility Rates. 2014. Available from: https://geographyas.info/population/fertility-rates/. Accessed 08 December 2014. 
41
 World Bank. Mortality rate, adult, male (per 1,000 male adults). 2015. Available from: http://data.worldbank.org/indicator/SP.DYN.AMRT.MA. Accessed 28 December, 2015. 
42
 World Bank. Mortality rate, adult, female (per 1,000 female adults). Available from: http://data.worldbank.org/indicator/SP.DYN.AMRT.FE. Accessed 28 December, 2015. 
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26 
Population growth 
(annual %) 
Demographic 
Annual population 
increase as a 
percentage of total 
population
43
 
2011 and 
2010 
Scale 207 records 
Generally speaking, growing national populations are associated with low 
and middle income countries and reducing populations, with high-income 
– and ageing - nations.
44
 The variable has been included as it can be said 
that there is an increased challenge of rolling out palliative care services to 
an increasing population. Changing population demographics (growing and 
reducing) present different challenges to policymakers. However, as 
palliative care is one recommendation from the United Nations as a policy 
response to global ageing, it can be said that we may expect to find 
greater palliative care development in countries where the population is 
reducing. 
 27 
GNI per capita 
(constant 2005 US$) 
Economic 
National income 
divided by mid-year 
population
45
 
2011, 2010, 
2009, 2008, 
2007 
Scale 141 records 
Gross National Income (GNI) per capita is one element of the composite 
measure of a country’s Human Development score. This variable has been 
included as it may be suggested, that the higher a nations income, the 
greater the financial resources which are available to have funded 
palliative care development.  
 
28 
Net ODA received per 
capita (current US$) 
Economic 
Net overseas 
development assistance 
divided by midyear 
population
46
 
2011 and 
2010 
Scale 141 records 
Official Development Assistance (ODA) is the term coined by the 
Organization for Economic Co-Operation and Development (OECD) for the 
transfer of resources from official agencies and governments which “is 
administered with the promotion of economic development and welfare 
of developing countries”.
47
 Much ODA is channelled to improving 
healthcare services of recipient countries. This variable is of interest, as it 
may be expected that countries are able to provide ODA have higher levels 
of palliative care development, yet, through ODA , opportunities may have 
arisen for lower income nations fund palliative care. 
 
 
                                                          
43
 World Bank. Population growth (annual %). Available from: http://data.worldbank.org/indicator/SP.POP.GROW. Accessed 28 December, 2015. 
44
 Haub C. Fact Sheet: World Population Trends 2012. 2012. Available from: http://www.prb.org/Publications/Datasheets/2012/world-population-data-sheet/fact-sheet-world-
population.aspx. Accessed 07 November, 2015. 
45
 World Bank. GNI per capita (constant 2005 US$). Available from: http://data.worldbank.org/indicator/NY.GNP.PCAP.KD. Accessed 28 December, 2015. 
46
 World Bank. Net ODA received per capita (current US$). Available from: http://data.worldbank.org/indicator/DT.ODA.ODAT.PC.ZS. Accessed 28 December, 2015. 
47
 OECD. Introduction to Official Development Assistance (ODA). Available from: http://www.oecd.org/dac/stats/intro-to-oda.htm. Accessed 09 December 2014. 
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Appendix 5.  
United Nations Countries and Territories with Palliative Care Rating Excluded 
from Analysis due to lack of World Bank Comparator (n=27) 
 
 
  
UN countries with palliative care rating excluded due to lack of 
comparative country classification 
PC 
rating 
 1 Aland Islands 2 
 2 Anguilla 1 
 3 British Virgin Islands 2 
 4 Cook Islands 1 
 5 Falkland Islands 1 
 6 French Guiana 1 
 7 Gibraltar 3 
 8 Guadeloupe 3 
 9 Guernsey 3 
 10 Holy See (Vatican) 2 
 11 Jersey 3 
 12 Martinique 1 
 13 Mayotte 1 
 14 Montesserat 1 
 15 Nauru 1 
 16 Netherlands Antilles 1 
 17 NIUE 3 
 18 Norfolk Island 1 
 19 Palestinian Authority 2 
 20 Pitcairn 1 
 21 Reunion 3 
 22 Saint Helena 1 
 23 Saint Pierre and Miquelon 1 
 24 Svalbard 1 
 25 Tokelau 1 
 26 Wallis and Fortuna 1 
 27 Western Sahara 1 
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Appendix 6.  
All countries included within analysis (n=207) by Country group ranking 
 
Group 1 Countries 
 
(1) Afghanistan, (4) American Samoa, (5) Andorra, (7) Antigua, (10) Aruba, (21) Benin, (23) Bhutan, 
(30) Burkina Faso, (31) Burundi, (32) Cabo Verde, (37) Central African Republic, (38) Chad, (42) 
Comoros, (52) Djibouti, (58) Equatorial Guinea, (59) Eritrea, (62) Faeroe Islands, (66) French 
Polynesia, (67) Gabon, (73) Greenland, (74) Grenada, (75) Guam, (77) Guinea, (78) Guinea-Bissau, 
(98) Kiribati, (99) Korea, Democratic Republic of, (103) Lao PDR, (107) Liberia, (108) Libya, (109) 
Liechtenstein, (117) Maldives, (120) Marshall Islands, (121) Mauritania, (124) Micronesia, (126) 
Monaco, (135) New Caledonia, (138) Niger, (140) Northern Mariana Islands, (144) Palau, (157) 
Samoa, (158) San Marino, (159) Sao Tome, (161) Senegal, (168) Solomon Islands, (169) Somalia, 
(173) St. Kitts, (175) St. Vincent, (181) Syria, (185) Timor-Leste, (186) Togo, (187) Tonga, (191) 
Turkmenistan, (192) Turks and Caicos Islands, (193) Tuvalu, (200) Uzbekistan, (201) Vanuatu, (204) 
Virgin Islands, (205) Yemen 
 
Group 2 Countries 
 
(3) Algeria, (13) Azerbaijan, (14) Bahamas, (24) Bolivia, (43) Congo, Democratic Republic, (54) 
Dominica, (63) Fiji, (80) Haiti, (81) Honduras, (114) Madagascar, (122) Mauritius, (128) Montenegro, 
(137) Nicaragua, (142) Oman, (146) Papua New Guinea, (153) Qatar, (163) Seychelles, (177) 
Suriname, (182) Tajikistan 
 
Group 3 Countries 
 
(6) Angola, (9) Armenia, (15) Bahrain, (16) Bangladesh, (17) Barbados, (20) Belize, (22) Bermuda, (26) 
Botswana, (27) Brazil, (28) Brunei, (29) Bulgaria, (33) Cambodia, (34) Cameroon, (36) Cayman Islands, 
(41) Colombia, (44) Congo, (48) Cuba, (53) Dominican Republic, (55) Ecuador, (56) Egypt, (57) El 
Salvador, (60) Estonia, (61) Ethiopia, (68) Gambia, (71) Ghana, (72) Greece, (76) Guatemala, (79) 
Guyana, (86) Indonesia, (87) Iran, (88) Iraq, (90) Isle of man, (93) Jamaica, (96) Kazakhstan, (100) 
Korea R, (101) Kuwait, (102) Kyrgyz Republic, (104) Latvia, (105) Lebanon, (106) Lesotho, (113) 
Macedonia, (118) Mali, (123) Mexico, (125) Moldova, (129) Morocco, (130) Mozambique, (131) 
Myanmar, (132) Namibia, (139) Nigeria, (143) Pakistan, (145) Panama, (147) Paraguay, (148) Peru, 
(149) Philippines, (155) Russia, (156) Rwanda, (160) Saudi Arabia, (164) Sierra Leone, (172) Sri Lanka, 
(174) St. Lucia, (176) Sudan, (184) Thailand, (188) Trinidad and Tobago, (189) Tunisia, (195) Ukraine, 
(196) United Arab Emirates, (202) Venezuela, (203) Vietnam 
 
Group 4 Countries 
 
(2) Albania, (8) Argentina, (18) Belarus, (25) Bosnia and Herzegovina, (46) Cote d'Ivoire, (47) Croatia, 
(49) Cyprus, (50) Czech Republic, (69) Georgia, (85) India, (95) Jordan, (110) Lithuania, (119) Malta, 
(133) Nepal, (151) Portugal, (178) Swaziland, (190) Turkey 
 
Group 5 Countries 
 
(39) Chile, (40) China, (45) Costa Rica, (51) Denmark, (64) Finland, (83) Hungary, (91) Israel, (97) 
Kenya, (111) Luxembourg, (112) Macao SA, (115) Malawi, (116) Malaysia, (127) Mongolia, (134) 
Netherlands, (136) New Zealand, (152) Puerto Rico, (162) Serbia, (166) Slovak Republic, (167) 
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Slovenia, (170) South Africa, (171) Spain, (183) Tanzania, (199) Uruguay, (206) Zambia, (207) 
Zimbabwe 
 
Group 6 Countries 
 
(11) Australia, (12) Austria, (19) Belgium, (35) Canada, (65) France, (70) Germany, (82) Hong Kong, 
(84) Iceland, (89) Ireland, (92) Italy, (94) Japan, (141) Norway, (150) Poland, (154) Romania, (165) 
Singapore, (179) Sweden, (180) Switzerland, (194) Uganda, (197) United Kingdom, (198) United 
States
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Appendix 7.  
Participant Information Sheet. v2.15.04.2015  
 
Participant Information Sheet 
 
What are the key aspects of a successful advocacy strategy for palliative care at global level? 
 
You are being invited to take part in a research project. Before you decide whether you would like to 
take part, it is important to understand why we are doing this research and what your involvement 
will consist of. Please read the following information and take as much time as you need to consider 
whether you would like to take part in the study. Thank you for taking the time to read this. 
 
 
What is the project’s purpose? 
Although palliative care is receiving increased attention at global level, worldwide the need for 
palliative care continues to outstrip supply and palliative care is not considered a global health 
priority. Global level actors have the power and influence to further the development of palliative 
care by influencing national-level policymakers as well as by providing the resources to implement 
projects. Different arguments can be made for palliative care, including; as a humanitarian issue, a 
human rights challenge and as a way to reduce health system costs whilst providing appropriate care 
to patients and families. Further, each of these arguments may resonate differently with different 
global actors. Amidst many competing claims at global level for policy attention and resources, this 
study explores how advocacy efforts for palliative care can be appropriately focussed at different 
global actors with a view to furthering the development of palliative care policies and practices.  
 
Why have I been chosen? 
You have been asked to participate as you have been identified as being involved with professional 
activities relating to international palliative care policy and advocacy. We are seeking to recruit 10-
15 participants and you may be asked if you are willing to suggest the names of other people who 
you feel may be able to contribute to the study. 
 
Do I have to take part? 
No. There is no obligation for you to take part in the study, participation is purely voluntary. You 
have been given this information to ensure that you understand the purpose of the project and why 
you are being asked to participate. You will retain the right to withdraw from the study at any time 
without giving a reason.  
 
What will happen to me if I take part? 
You are being asked to consent to a one-off interview, in which you will be asked a short series of 
closed and open ended questions. The questions will ask you to reflect upon how palliative care is 
represented at global level through advocacy. Additionally, you will be asked for your views on how 
advocacy can become more refined and better focussed. Interviews are expected to last 
approximately 30 minutes and will be conducted either via telephone, SKYPE or face-to-face at a 
time of your convenience. If you consent to take part, the interview will be audio-recorded, 
transcribed and anonymised. All information will be stored securely and your participation would be 
entirely anonymous. Only the study team would have access to your responses and personal details. 
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What are the possible disadvantages and risks of taking part? 
During the interview you will be asked about your professional views regarding palliative and end of 
life care which some people may consider to be sensitive. As you have been identified as a 
professional in this field, the risks involved in taking part are considered low. However, if at any 
stage in the interview questions raise issues which are personally sensitive to you, you may request 
to pause the interview or withdraw from the study entirely. You will be offered the opportunity to 
review the transcript from your interview to confirm that it fairly represents your views, but you do 
not have to do so.  
 
What are the possible benefits of taking part? 
Although there are no immediate benefits for people taking part in the study, it is hoped that this 
work will contribute to a greater understanding of how advocacy can be more appropriately 
targeted at global level actors who have the power and resources to promote the further worldwide 
development of palliative care. 
 
What will happen with the results of the project? 
The results of the study will be submitted to the School of Health and Related Research (ScHARR) of 
the University of Sheffield (UK) to be examined for a Doctor of Philosophy degree. The results will 
also be disseminated through publication in academic journals and conference presentations.  
 
Who is organising and funding the research? 
The project is funded by SCHARR of the University of Sheffield. 
 
Does the study have ethical approval? 
Yes. The study has been reviewed by the School of Health and Related Research Ethics Committee 
who have provided approval for the project. 
 
What if something goes wrong? 
If you have a complaint about the research project or conduct of the researcher, you should contact: 
 
Jon Nicholl  
Dean of the School of Health and Related Research 
School of Health and Related Research (ScHARR) 
Faculty of Medicine, Dentistry and Health 
University of Sheffield 
Regent Court, 30 Regent Street 
Sheffield 
S1 4DA 
Tel: (+44) (0)114 222 5453 
E-mail: J.Nicholl@sheffield.ac.uk 
 
Who to contact for further information 
If you have any other questions, please contact the researcher: 
Joseph Clark, School of Health and Related Research (ScHARR), The University of Sheffield, Regent 
Court, 30 Regent Street, Sheffield, S1 4DA, Email – joseph.clark@sheffield.ac.uk
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Appendix 8.  
 
Consent Form V2.17.04.2015 
 
Participant Consent Form 
 
Project Title: What are the key aspects of a successful advocacy strategy for palliative care 
at global level? 
 
Name of Researcher: Joseph Clark 
 
Participant Identification Number for this project:                                                Please initial box 
 
1. I confirm that I have read and understand the information sheet  
dated 15.04.2015 explaining the above research project 
and I have had the opportunity to ask questions about the project. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason and without there being any negative 
consequences. In addition, should I not wish to answer any particular 
question or questions, I am free to decline.  
 
3. I give permission for members of the research team to have access to my 
responses.  
 
4.    I agree for the data collected from me to be used in future research  
 
5.    I understand that my participation will be anonymous. 
 
6. I agree to take part in the above research project. 
 
________________________ ________________         ____________________ 
Name of Participant Date Signature 
 
_________________________ ________________         ____________________ 
 Lead Researcher Date Signature 
To be signed, dated and a copy provided to the participant 
Once this has been signed by all parties the participant will receive a copy of the signed and dated 
participant consent form, the letter/pre-written script/information sheet and any other written 
information provided to the participants. A copy of the signed and dated consent form will also be 
placed in the project’s main site file), which will be kept in a secure location.  
 
